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Abstract  
 
Background:  
Diabetes is a major public health problem in Saudi Arabia. One fifth (20%) of the Saudi 
population has diabetes and their healthcare takes almost a quarter (23%) of the total 
healthcare expenditure. A few sporadic small studies showed some evidence of 
suboptimal diabetes care.  
 
Aims:  
The aim of this study was to identify the deficiencies in diabetes care and the potential 
areas for quality improvement of service provision in Abha, a city representative of 
Saudi Arabia.  
 
Methods:  
A programme of research was undertaken using multiple research methods: semi-
structured interviews with key stakeholders encompassing patients, healthcare 
professionals, managers and pharmacists; standard checklist for evaluating available 
resources; analysis of routine healthcare data; questionnaires to medical directors and 
healthcare leaders; and examination of the case notes of patients with diabetes.  
 
Results:  
The local registered diabetes prevalence was found to be lower than the national 
estimate (3.75% versus 14-25%). Almost three quarters (73%) of people with diabetes 
 
xxi 
 
in Abha city have not been diagnosed. The vast majority (85%) of adult people with 
diabetes were either overweight or obese.  
 
Reviewing case notes of patients with diabetes at the primary health care centres 
(PHCCs) showed that only 4% had a record of HbA1c test and most patients (77%) did 
not achieve the recommended target of FBG of ≤ 130 mg/dl (≤7.2 mmol/l). Almost half 
the patients exceeded (47%) the recommended level of total cholesterol of ≤ 195 
mg/dl (5 mmol/l). Screening for diabetes complications is inadequate: foot 
examination was done for only 5.5%, neuro-examination for 37% and eye examination 
for 52%. Some medications e.g. mixed insulin and statins were not consistently 
available and inadequacies were identified in the provision of healthcare staff (e.g. 
dieticians and podiatrists) and laboratory resources (e.g. HbA1c test). Limited attention 
was given to health education and concerns were expressed about patient compliance. 
These findings were consistent across the multiple methods used. 
 
Conclusion:  
This study in Abha city found that a large number of Saudi patients with diabetes are 
not achieving recommended levels of glycemic, lipid and body mass index (BMI) 
control and are therefore at high risk of diabetes complications.  Inadequate provision 
of laboratory facilities, drugs and patient education programmes compound these 
problems. Recommendations are made for strategies to improve both the structure 
and processes of diabetes care and the healthy behaviours of people with diabetes.
 
1 
 
      
CHAPTER ONE 
 
  
Background to diabetes in 
Saudi Arabia 
 
This chapter provides a background to the size of the problem of diabetes as an 
epidemic disease in Saudi Arabia. It gives a review of research activities in 
Saudi Arabia on diabetes epidemiology, its clinical and complications profile. It 
begins with a general introduction to diabetes as a disease. It then briefly 
describes the country of Saudi Arabia and the major social and economic 
changes that affect the general health status of the Saudi population. Several 
demographic and public health indicators are presented. The chapter then 
reports in depth the time trend of diabetes development among Saudis, the 
current high prevalence of diabetes, its risk factors and complications. It also 
shows the huge burden and costs this disease imposes on the Saudi healthcare 
system.  
 
2 
 
Chapter 1: Background to diabetes in 
Saudi Arabia 
 
1.1. Introduction to diabetes 
Diabetes mellitus (DM) is currently recognized as a long term condition that comprises 
a heterogeneous group of disorders characterized by sustained hyperglycaemia and 
glucose intolerance with disturbances of carbohydrate, fat and protein metabolism. It 
is caused by insulin deficiency, impaired effectiveness of insulin action or both. (1-3)  The 
direct toxic effect of the sustained hyperglycaemia is significantly associated with long 
term damage, dysfunction, and failure of various organs, especially the eyes, kidneys, 
nerves, heart, and blood vessels.(3-6)  The clinical manifestations of the long term effect 
of diabetes, therefore, include retinopathy that may lead to blindness, nephropathy 
that may end with renal failure, and neuropathy that increases the risk of foot ulcers, 
amputation and sexual dysfunction. Diabetes also increases the risk of cardio-vascular, 
cerebro-vascular and peripheral vascular diseases.  
Diabetes is classified based on its etiological and clinical stages into four main types: 
type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes 
mellitus (GDM) and other specific types. T1DM usually occurs in childhood or early 
adult life. People with T1DM require insulin for survival in order to prevent the 
development of ketoacidosis, coma and death. T2DM is the commonest form of 
diabetes and usually occurs in obese middle-aged or elderly people. In contrast to 
 
3 
 
T1DM, T2DM is not dependent on exogenous insulin but may require insulin for 
metabolic control rather than for survival. GDM is carbohydrate intolerance first 
recognized in pregnancy. The other specific types of diabetes are less common and 
caused by or associated with several genetic, drug-induced or infectious diseases.  
Using the latest American Diabetes Association (ADA) and World Health Organization 
(WHO) diagnostic criteria, DM is diagnosed:  
1. If a person with clinical symptoms of diabetes such as abnormal thirst, 
frequent urination, constant hunger, lack of energy, weight loss or blurred 
vision has a random plasma glucose(RPG) ≥ 11.1 mmol/l (200mg/dl) or  
2. By Fasting plasma glucose (FPG) ≥ 7.0 mmol/l (126mg/dl) or  
3. By a plasma glucose ≥ 11.1 mmol/l (200mg/dl), 2 hours after 75 gram load of 
glucose given by mouth [the oral glucose tolerance test (OGTT)] or 
4. By glycated haemoglobin (HbA1c) ≥ 6.5%. 
The diagnosis of diabetes should be confirmed by repeat testing on a subsequent day if 
one of the criteria 2-4 was used and the level of hyperglycaemia was not unequivocal. 
(3, 7-8)   
The disease natural history usually passes through a stage of impaired glucose 
tolerance (IGT) which is defined as a plasma glucose ≥ 7.8 mmol/l (140 mg/dl) and ˂ 
11.1 mmol/l (200 mg/dl) two hours after an OGTT. An analogous stage, impaired 
fasting glucose (IFG), is defined as FPG levels of ≥ 5.6 mmol/l (100mg/dl) and ˂ 7.0 
mmol/l (126 mg/dl). Individuals with IGT or IFG are regarded as having pre-diabetes, 
indicating the relatively increased risk for the future development of diabetes.(3) Losing 
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weight, increasing physical activity and improving diet can prevent or delay diabetes in 
individuals with IGT.(9-10) Use of certain pharmacological agents such as metformin has 
also been shown to decrease the incidence of DM by 31%.(10) 
The ultimate goal of diabetes care is to prevent both acute and chronic diabetes 
complications. This is achieved by providing treatment, support and education to 
enable people with diabetes to achieve the target glycemic control. Several studies 
showed definitively that intensive glycemic control is associated with significantly 
reduced risk of retinopathic, nephropathic and neuropathic complications.(4-6, 11-12) 
Every percentage point in HbA1c reduction (e.g., from 8% to 7%) reduces the risk of 
microvascular complications (retinopathy, nephropathy and neuropathy) by 37%.(13) 
The Scottish Intercollegiate Guidelines Network (SIGN) and ADA recommend that 
lowering HbA1c to below or around 7% is reasonable to reduce the risk of 
microvascular and macrovascular complications.(14-15) Moreover, it has been suggested 
that, at the population level, the greatest number of diabetes complications will be  
averted by taking patients from very poor control to fair or good control.(14)  
It is also important to detect and treat early the complications of diabetes as well as 
the common coexisting conditions (e.g. hypertension and dyslipidemia). For example, 
tight control of blood pressure by angiotensin converting enzyme inhibitors (ACEIs) can 
substantially reduce the risk of death and complications due to diabetes.(16) Detecting 
and treating early eye disease with laser therapy can reduce the development of  
severe vision loss by 50-60%.(17) In addition, implementing a comprehensive foot care 
programme can reduce amputations by 45-85%.(17)   
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Therefore, properly planned healthcare services and preventive activities can greatly 
reduce the burden of diabetes on both the patients and the healthcare providers.  
Proper care of diabetes implies identification of all people with diabetes, early 
management of their diabetes and early detection of complications which will enable 
clinicians to take the steps needed to combat the disease.  An integrated system that 
delivers healthcare by collaborative and multidisciplinary teams is best suited to 
provide care for people with diabetes.(18-21)    
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1.2. Introduction to Saudi Arabia 
The Kingdom of Saudi Arabia (KSA) is located at the south west corner of the Asian 
continent (Map 1). It is the second largest Arab country by land area, constituting over 
2,149,690 million square kilometres (870,000 square miles) of the Arab peninsula. It is 
surrounded to the east by the Arabian Gulf, Qatar, Bahrain, and United Arab Emirates, 
and the Red Sea to the west, Oman on the southeast and Yemen on the south, Kuwait, 
Jordan and Iraq on the north. The terrain is mostly desert with mountainous areas 
along the western part and more than 2,600 kilometres of coastline. (22)    
Map 1: The Kingdom of Saudi Arabia 
 
Source: Google Maps (23) 
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1.2.1. Demographic profile 
The Saudi population comprises 50.9% Saudi males and 49.1% Saudi females. About 
10% of the population is from Afro-Asian ethnic groups while 90% is Arabs.(22) The 
majority of the Saudi population is young. In 2007, a national demographic survey 
showed that more than 85% of the Saudi population was under the age of 45.(24) 
However, it has been estimated that this percentage of the young population will 
decline to 62.5% at 2050 bringing those over the age of 45 years to represent 37.5% of 
the total population.(25) 
1.2.2. Health profile 
The Kingdom of Saudi Arabia has witnessed enormous changes over the last four 
decades that have touched every aspect of life. Saudi Arabia was founded in 1932 
when King Abdulaziz Alsaud succeeded in unifying the different parts of the Kingdom. 
At that time, the majority of land habitants were nomads or semi-nomad tribes with 
rudimentary facilities. In 1938, the discovery of vast reserves of oil provided Saudi 
Arabia with the chance to modernize. Therefore, in the middle of the twentieth 
century, the traditional, underdeveloped and poor young country started to develop at 
an extremely rapid rate.  The sudden wealth from increased oil production provided 
Saudi Arabia with economic prosperity. With help from neighbouring countries and 
western countries, and with large influx of foreigners, the infrastructure systems 
necessary for the operation of a modern society have been established. As a result, 
cultural, social, and economic modernization at an enormous scale has been 
witnessed. The healthcare services have also witnessed similar rapid developmental 
changes. An overview of the development of the Saudi healthcare system will be 
discussed in chapter 5.    
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As a consequence of all of these developments, significant improvements of the health 
status of the Saudi population have been observed over time.  In 1974, the first 
comprehensive national census showed that the population of Saudi Arabia was 
7,009,466 persons.(26) Later in 1992, the official figures of the Saudi population 
increased to 16,948,388 with an increase percent of 141.8%.(27) The most recent 
census in 2010 put the figures of the Saudi population at 27,136,977 persons. (28) This 
rapid growth within almost 4 decades could be attributed to the high fertility rate and 
the decline in mortality rates as shown in table 1 and figure 1. It also could be 
attributed to a large number of foreigners (8,429,401 in 2010). (28)  
The increased access to improved sanitation and clean water sources as well as the 
high immunization coverage against the majority of vaccine preventable diseases 
played an important role in improving the health status of the Saudi population (Table 
2, Figure 2, and 3). 
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Table 1: Demographic indicators for Saudi Arabia, 1992-2012  
Demographic Indicators 1992 1996 2000 2004 2008 2012 
Population Midyear Population (in thousands) 17,061 19,293 21,312 23,200 24,917 26,535 Growth rate (percent) 3.4 2.8 2.3 1.9 1.7 1.5 
Fertility Total fertility rate (births per woman) 5.5 4.8 3.9 3.1 2.6 2.3 Crude birth rate (per 1,000 population) 34 29 26 23 21 19 Births (in thousands) 578 567 559 529 511 509 
Mortality Life expectancy at birth (years) 71 71 72 72 73 74 Infant mortality rate (per 1,000 births) 26 24 22 21 18 16 Under 5 mortality rate (per 1,000 births) 31 29 26 24 21 18 Crude death rate (per  1,000 population) 4 4 4 4 3 3 Deaths (in thousands) 76 77 79 83 84 88 
Migration Net migration rate (per 1,000 population) 5 2 0 0 0 -1 Net number of migrants (in  thousands) 77 41 7 4 -11 -17 
Source: U.S. Census Bureau, 2012 (25) 
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Figure 1: Mortality indicators for Saudi Arabia, 1990-2010 
 
Data source: The World Bank data, Health, Nutrition and Population Statistics 
database, 2012 (29)  
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Table 2: Public health indicators for Saudi Arabia, 1985-2010 
Indicator Name 1985 1990 1995 2000 2005 2010 
Immunization  BCG (% of one-year-old children) 89 90 94 94 96 98 DPT (% of children ages 12-23 months) 81 92 96 95 96 98 Hep B (% of one-year-old children) -- 66 93 93 97 98 Measles (% of children ages 12-23 months) 79 88 94 94 97 98 Polio (% of one-year-old children) 81 92 96 95 96 98 
Sanitation Improved sanitation facilities (% of population with access) -- 81 81 86* -- 99* Improved water source (% of population with access) -- 89 90 93* 89* 100* 
Infectious diseases Incidence of tuberculosis (per 100,000 people) -- 17 17 20 17 18 Measles (number of reported cases)  -- -- -- 617* 373* 336* Malaria (number of reported cases)  16,242 15,666 18,751 6,608 1059* 1941* Bilhariziasis (number of reported cases) -- -- -- 1159** 497+ 120+ 
Urbanization Urban population (% of total) 72.6 76.6 78. 7 79.8 81.0 82.1 Urban population growth (annual %) 7.2 4.4 2.6 2.6 3.8 2.6 
Sources: The World Bank data: Health, Nutrition and Population Statistics database, 
2012. (29) 
 *WHO: Global Health Observatory (GHO), country statistics, Saudi Arabia, 2012.(30)  
** For 2002, MOH, health statistical year book, 2002, Saudi Arabia.(31)  
+ MOH, health statistical year book, 2005-2010, Saudi Arabia.(31)  
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Figure 2: Incidence rates of vaccine preventable diseases (1), 2002-2010 
 
Data source: MOH, health statistical year book, 2002-2010, Saudi Arabia.(31)  
* Incidence rate/100,000 population. 
 
Figure 3: Incidence rates of vaccine preventable diseases (2), 2002-2010 
 
Data source: MOH, health statistical year books, 2002-2010, Saudi Arabia.(31)  
* Incidence rate/100,000 population except for tetanus neonatorum which is /1000 Live 
births. 
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However, rapid modernization is a mixed blessing. Cultural and social lives rapidly 
developed but at the same time were associated with adopting unhealthy lifestyle 
choices such as cigarette smoking, physical inactivity, poor diet and inadequate sleep 
hygiene. Furthermore, a significant rise in the prevalence of obesity, diabetes, 
hypertension and cardiovascular disease has accompanied these lifestyle changes 
(Figure 4), particularly among the urban populations. (32-33) 
 
  
 
 
 
14 
Figure 4: Prevalence (%) of some chronic diseases and its risk factors in Saudi Arabia, 2007 
 
Source: WHO: Global Health Observatory (GHO), country statistics, Saudi Arabia, 2012.(30) 
* Diabetes: FBS ≥ 7 mmol/dl; Hypercholesterolemia: cholesterol level ≥ 5.2mmoL/dl; Hypertension: BP ≥ 140/ 90 mmHg; Low intake of fresh 
fruits and vegetables: ≤ 5 serving per day; Low physical activity: daily activity ≤ 10 minutes; Overweight and Obesity: BMI ≥ 25 mg/m2; 
Smoking: current daily smokers. 
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In summary, over the past 4 decades, the government of Saudi Arabia has achieved 
remarkable progress in improving the health status of Saudi population. However, this 
achievement was accompanied by remarkable negative lifestyle changes that led, 
accompanied by possible genetic susceptibility, to increased prevalence of some 
chronic diseases such as diabetes and its risk factors. 
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1.3. The scale of the problem of diabetes in Saudi Arabia 
In the Kingdom of Saudi Arabia, diabetes is one of the major national health issues. The 
National Medical and Health Research Strategy for the Kingdom identified diabetes as 
a national health priority area for research and strategic intervention.(34) Some studies 
have looked at different aspects of the problem of diabetes in Saudi Arabia over the 
last four decades. This section will discuss in depth the time trend of diabetes 
development in Saudi Arabia, the current high prevalence of diabetes and its risk 
factors. It will also show the current state of diabetes control and its complications, 
and the huge burden of diabetes in Saudi Arabia including its mortality, morbidity and 
costs.  
 
1.3.1. Prevalence of diabetes  
Diabetes Mellitus is now considered to be one of the most common non-
communicable chronic diseases globally. In 2011, there were 366 million people with 
diabetes, and this is expected to rise to 552 million by 2030.(35)  Arabian Gulf countries 
are among those with the highest prevalence worldwide.(36) The International Diabetes 
Federation (IDF) estimates that the prevalence of diabetes in Saudi Arabia for the 20-
79 years age group is 19.6%, which is one of the 10 highest prevalence proportions in 
the world. In 2030, almost a quarter of the population is expected to have diabetes 
(22.3%).(35, 37)  
The time trend and geographical variations of diabetes development in Saudi Arabia 
over the past 4 decades can be described across three time periods: 
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1975-1989 
1990-1999 
2000-2012 
 
The first period: 1975-1989: 
Overall prevalence: 
Little was known about diabetes prevalence in Saudi Arabia before 1975. Professor 
Cook was one of the earliest authors who referred to the prevalence of diabetes in 
Saudi Arabia.(38) He claimed, in an unpublished study, that impaired glucose tolerance 
and maturity onset diabetes were common among Arabs in Riyadh, most of whom 
were not obese. In an another study, he reported that this might be due to the rapid 
glucose absorption in Saudi Arabs as compared with African people from Zambia.(38) 
In the early eighties, Bacchus et al, in a rural area near Riyadh, showed that diabetes 
prevalence among females (4.7%) was almost twice that of males (2.5%).(39-40) Two 
hospital based case series studies reported that T2DM was the most common type of 
diabetes (83-94%).(41-42) In the mid-eighties, Fatani et al estimated a higher prevalence 
of diabetes (4.9%) in the urban population of the western region of Saudi Arabia than 
in the rural population (4.3%).(43-44) In 1989, a comparative study reported a higher 
frequency (7.9%) of hyperglycaemia (fasting blood glucose (FBG) ≥ 7.2 mmol/l) with 
marked variation among different areas of Saudi Arabia. (45) In 1990, Anokute 
published the first period prevalence study which involved screening of 3158 males in 
a University community between December 1985 and April 1987.(46) In this urban 
population, the study showed an ongoing trend of rising prevalence (6%) of 
hyperglycaemia (FBG ≥ 7.8 mmol/l). In another study (1989), a similar prevalence 
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(5.5%) among males was reported in a semi urban community near Abha city in the 
southern region of Saudi Arabia.(47) The overall prevalence of hyperglycaemia for both 
males and females was lower (4.6%), being significantly higher among males than 
females (3.6%).     
The prevalence of impaired glucose tolerance (IGT) was reported to range from 1.1% 
to 3.7%.(43-44, 47) Overweight, obesity, age and higher income were common risk factors 
among people with diabetes. (39-40, 43-44, 46) 
T1DM: 
Only a few studies from Saudi Arabia have specifically explored the incidence and 
prevalence of T1DM. The earliest one was an unpublished, retrospective, hospital 
based study which was conducted over 2 years (1980-1982) at a company (ARAMCO) 
hospital in the eastern province of Saudi Arabia. The incidence and prevalence of 
T1DM, in the age group of 0 – 14 years, were estimated to be 7 per 100,000 per year, 
and 20 per 100,000 respectively.(48-49) This incidence rate was higher than that 
reported by a population based study from Kuwait around the same time (3.96 per 
100,000 per year).(50) 
In the age group of 0 – 14 years of an urban community, Fatani et al in 1989 found that 
the prevalence of diabetes mellitus was 0.3%, which in this age group can be taken as 
an indicator of the prevalence of T1DM.(43) In addition, El-Hazmi et al reported that the 
bimodal distribution of hyperglycaemia among the male populations of Gizan and 
Khaybar cities might indicate that T1DM and maturity onset diabetes of youth (MODY) 
prevalence was higher than in the other cities included.(45)  
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A descriptive study of 1000 consecutive case notes of patients with diabetes at 
hospital settings showed that the proportion of T1DM was 11.7% based on the criteria 
of either diagnosing diabetes under age of 15 years or occurrence of ketoacidosis with 
insulin dependent control of glucose level.(42) Of these patients 64.3% were male. 
Maturity onset diabetes of youth (MODY): 
In 1981, a hospital based study in Jeddah reported that MODY was not a rare problem 
after identifying 3 cases out of 65 in-patients with diabetes seen over a period of one 
year at King Abdulaziz University hospital.(51)  Fonseca et al in Riyadh identified, in a 
series of 200 patients with diabetes attending a diabetes clinic, 9 cases of MODY who 
were below 30 years old, not obese and did not develop ketosis.  Famuyiwa et al 
reported a proportion of 4.4% of early onset non-insulin dependent diabetes among 
1000 patients with diabetes, based on the criteria of being diagnosed under the age of 
30 years plus control of diabetes with diet or oral tablets and a positive diabetes 
history among the first degree relatives.  Therefore, MODY was not an uncommon 
disease in Saudi Arabia at this time period. 
Gestational diabetes mellitus (GDM): 
Diabetes was occasionally seen in an obstetric unit at Riyadh Military Hospital in 
1979.(52) A decade later, a University hospital based study in the same city revealed a 
dramatic change. The study showed an overall prevalence of abnormal OGTT of 10.3% 
(112 of 1088) according to the WHO 1985 diagnostic criteria,(53) with 21 (1.9%) women 
having GDM and 91 (8.4%) having gestational impaired glucose tolerance.(54) The study 
also showed that GDM was related to some maternal characteristics such as increasing 
age, parity and weight. In another published case series study, the same authors 
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confirmed their earlier findings and showed that impaired glucose intolerance during 
pregnancy is a risk factor.(55)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
In 1989, a University hospital based study in another city, screened 455 consecutive 
pregnant women. Using a different method of glucose testing and different diagnostic 
criteria, the incidence of gestational diabetes was found to be 11% and that incidence  
increased with increasing maternal age, parity and weight.(56) However, in a study 
where adolescent pregnant women of 18 years of age or less were compared with 
pregnant women aged 20 to 29 years, maternal age per se was not found to affect the 
pregnancy outcomes or complications including diabetes.(57)  Among multiparous 
women, Alsibai et al in 1987 reported a higher incidence of diabetes mellitus while 
Mwambingu et al in 1988 reported a particular increased incidence of gestational 
diabetes.(58)  Infants of mothers with diabetes experienced shoulder dystocia more 
often than those without diabetes.(59)    
Mesleh et al screened 2010 pregnant women at the initial visit and found 15.6% had 
abnormal OGTT using WHO 1985 criteria.(53) After follow up OGTTs, the incidence 
dropped down to 3.5% (71), with 0.6% (13) diagnosed as having gestational diabetes 
and 2.9% (58) had impaired glucose tolerance. The study also confirmed the relation 
between abnormal OGTT and the increasing age or parity.(60)  
In summary, many of the early studies did not separate between the different types of 
diabetes but reported on the overall prevalence. The prevalence of T1DM was not 
specifically examined at a population level during the period of 1975 to 1990. Few 
studies described the clinical patterns and characteristics of patients with T1DM. Some 
studies reported on the prevalence of hyperglycaemia rather than the confirmed 
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diagnosis of diabetes.(45, 47) Both diabetes and impaired glucose tolerance were rising 
steadily over this period. The studies on gestational diabetes used different diagnostic 
criteria and glucose testing methods which make it difficult to compare the incidence 
of gestational diabetes across the studies. However, the mounting evidence suggests 
that gestational diabetes incidence is influenced by maternal age, parity and obesity. 
Limitations of the studies of the first period: 
The majority of the studies conducted during this period (1975 – 1989) shared several 
limitations. First, almost all the studies were regional or city based studies rather than 
national based. Second, apart from Fatani et al study,(43) all of the studies had relatively 
small sample sizes. Third, the sampling methods were not reported clearly. Some 
studies involved only men with special characteristics such as being salaried workers 
(Bacchus et al, 1982) or being University staff (Anokute, 1990) which limits their 
generalizability. In most of the studies, the OGTT was the main test for diagnosis of 
diabetes using either the WHO 1980 or WHO 1985 diagnostic criteria.(53, 61) However 
some studies used modified criteria or other different criteria. (45, 47, 56) 
In spite of the many limitations of the studies of this time period, they indicate the 
trend of rising diabetes prevalence in Saudi Arabia. The studies demonstrated 
correlations of diabetes with some risk factors such as age, gender, obesity, parity and 
the socio-economic classes.  
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The second period: 1990-1999: 
Overall prevalence: 
During the first half of the nineties of the last century, two national household surveys 
were conducted to determine the prevalence of diabetes and some other chronic 
diseases in Saudi Arabia. The first one was conducted by Elhazmi et al in 34 different 
areas of the county. It involved both sexes from urban and rural areas with a total of 
23,493 subjects of age ranging from 2 to 70 years.(62) The second national survey was 
conducted by Alnuaim et al at almost the same time. It also involved both urban and 
rural areas as well as both males and females with a total sample size of 13,177 
subjects over the age of 15 years. (32) 
Despite the fact that both surveys used the same diagnostic criteria (WHO’s 1985)(53), 
different screening methods were used which limits a valid comparison. Elhazmi et al 
used a glucometer to immediately measure whole blood glucose during fasting and 
after oral glucose load (OGTT), while Alnuaim et al measured the plasma glucose level 
by analysing the collected, frozen plasma samples in a central laboratory at King Saud 
University in Riyadh. Alnuaim et al also used first the random plasma glucose level as a 
screening method and subsequently performed OGTT for those of borderline glucose 
values (5.5 to 11.1 mmol/l). However, using the random plasma glucose is not a 
recommended screening method for diabetes as it can miss a significant number of 
patients and gives only a crude estimate of the prevalence of diabetes in a population. 
(53)   
Elhazmi et al published a series of 9 articles from 1995 to 2000 on the findings of their 
national survey.(63-71) The main article was published in 1996 in the Annals of Saudi 
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Medicine.(66)  It revealed an overall prevalence of 5.2%. When separated on the basis 
of sex, 5.7% of men and 4.8% of women had diabetes. The corresponding values for 
impaired glucose tolerance were 0.5% for men and 0.9% for women and the overall 
prevalence was 0.7%. 
A significantly higher prevalence was observed with age. When children less than 14 
years were excluded, the overall prevalence of diabetes increased to 8.2%, with 9.74% 
for men and 7.06% for women.  The corresponding values for impaired glucose 
tolerance increased to 0.72% for men and 1.35% for women and the overall 
prevalence was 1.079%. The highest prevalence of diabetes was among subjects from 
Taif in the western (Makkah) province. Later in 1998, the same authors published a 
follow up article with an additional 1844 subjects which gave a total sample size of 
25,337 subjects.(69) Almost the same findings were reported again.  
The other national survey by Alnuaim was published in 1995 as a governmental report 
and in 1997 as a single author study.(32, 72) The survey was able to estimate the age 
adjusted prevalence of diabetes and to map out the age, sex and regional differences 
in diabetes prevalence in both urban and rural areas.  The age adjusted prevalence of 
diabetes was significantly higher among the urban population (males 12 %, 95% 
confidence interval (CI) =11–13% and females 14 %, 95% CI =13–15%) than in the rural 
population (males 7%, 95% CI= 7–8% and females 7.7%, 95% CI= 7–9%). The age 
specific prevalence of diabetes increased with age from 2% for females aged 15-20 
years to 49% for females aged 51-60 years of the urban population. The corresponding 
values for the same age groups in the rural population were 1% to 26%. The study in 
addition showed that family history of diabetes, obesity, region of residence were 
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associated significantly with diabetes.  The highest prevalence among males (17.6%) 
was found in the Eastern region and the highest among females (18.6%) was in the 
Northern region.   
The prevalence of IGT was 9.5% for all, 10% for male subjects and 9% for female 
subjects. The urban population had higher prevalence of IGT (males 10%, females 11%) 
than the rural population (males 8%, females 8%). 
In Aseer region, Mahfouz et al reported that the recorded age adjusted prevalence of 
diabetes mellitus at the primary health care level among those aged > 15 years was 
2.9%.(73)  The prevalence increased with age and was significantly higher among males.  
In Alkharj city, a review of a random sample of 3747 case notes of patients attending a 
primary healthcare clinic showed an overall diabetes prevalence of 4.08%.(74) In 
contrast with the Mahfouz et al study, this study reported a higher prevalence among 
females (5.32%) than males (2.55%). 
T2DM and T1DM: 
The first study that estimated the prevalence of T1DM and T2DM at the national level 
was that by Elhazmi et al in 1996.(66) The overall prevalence of T1DM and T2DM was 
0.21% and 4.99% respectively. In the male population, the prevalence of T1DM and 
T2DM was 0.19% and 5.50%, while in the female population, the prevalence was 
0.23% and 4.55% respectively. 
The sex difference in the prevalence of T2DM was statistically significant and it rose 
with age from 0.38% in males aged 14 -29 years to 28.75% in males aged > 60 years 
and from 0.98% in females aged 14-29 years to 24.37% in females aged > 60 years. 
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Furthermore, the prevalence of T1DM among children (< 14 years old) was 0.17% 
which gives a prevalence of 1.7/1000 children. The study also calculated the 
prevalence of T2DM in the different cities of Saudi Arabia which is presented in figure 
5. In a follow up study, Elhazmi et al showed that obesity prevalence was significantly 
higher among patients with diabetes than those without diabetes in each region of 
Saudi Arabia.(71) 
In the eastern region, a hospital based study revealed an increase in the incidence of 
T1DM over a period of twelve years (1986-1997).(75) The age adjusted incidence rate 
increased from 3.2 per 100,000 in 1986 to 22.6 per 100,000 in 1997 with an overall age 
adjusted incidence rate of 12.3 per 100,000 ( 9.9 per 100,000 for boys and 14.8 per 
100,000 for girls). The increase was greater in girls and in those aged more than 10 
years. 
MODY: 
Elhazmi et al in their national survey identified thirteen children with MODY which 
gives a prevalence of 0.148% among children aged < 14 years and an overall 
prevalence of 0.055%.(66) Those 13 cases were considered to be MODY cases based on 
being having a positive family history of diabetes and controlling their diabetes by oral 
hypoglycaemic drugs. However, MODY diagnosis has not been confirmed by the 
authors. 
 GDM: 
In 1996 to 1998, Ardawi et al used the National Diabetes Data Group (NDDG) criteria to 
screen for GDM a total of 818 randomly recruited pregnant females who attended 
antenatal clinics at two hospitals in Jeddah.(76) The prevalence of GDM was 12.5% 
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which was much higher than had been estimated earlier in Alkhobar and Riyadh 
cities.(54, 56, 60) However, it should be kept in mind that different diagnostic criteria were 
used across the studies which may explain the large differences of GDM prevalence 
among different cities.         
Limitations of the studies of the second period: 
The studies on the prevalence of diabetes during this time period (1991 – 1999) 
featured two national surveys which avoided the many limitations of the studies of the 
previous decade (1975 – 1990).  However, some of the articles that were published 
between 1991 and 1999 were limited geographically to a specific area or were clinic or 
hospital based studies.(73-76) Only one study on the prevalence of T1DM and another 
one on the prevalence of GDM were published. However, both were hospital based 
and limited to specific areas.(75-76) The prevalence of diabetes varied widely among the 
studies; however, the overall prevalence appeared to continue its rising trend. The 
studies showed that age, overweight, obesity and family history of diabetes were 
higher among those with diabetes.  
 
 
 
27 
Figure 5: Prevalence of T2DM in different cities of Saudi Arabia 
 
Data source: Elhazmi, 1996.(66) 
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The third period: 2000-2012: 
Changes in diagnostic criteria for diabetes: 
Most of the studies on the prevalence of diabetes that were done in the 1990s used 
the WHO’s 1985 diagnostic criteria.(53) By contrast, most studies published after 2000 
used the WHO’s 1999 diagnostic criteria(77) or the ADA 1997 diagnostic criteria(78), 
which lowered the diagnostic cut off value for fasting plasma glucose (FPG) from ≥ 7.8 
mmol/l to ≥ 7mmol/l. In addition, a new category called impaired fasting glucose (IFG) 
which was defined as a FPG values between ≥ 6.1mmol/l to ≤ 6.9 mmol/l was 
introduced. In 2003, the ADA reduced the lower cut off value of this new category 
from ≥ 6.1mmol/l to ≥ 5.6 mmol/l (Table 3). This raised concerns within WHO about 
the impact of a significant increase in IFG prevalence on individuals and healthcare 
systems.(79) Therefore, WHO in 2006 maintained the lower cut off value for IFG at 6.1 
mmol/l.(8) The WHO justified this decision by arguing that the choice of lowering the 
cut off point of IFG to 5.6 mmol/l in order to reduce the future risk of progression to 
diabetes or to its complications was not supported by evidence (Table 3).(8) 
  
 
 
 
29 
Table 3: Summary of WHO and ADA diagnostic criteria for diabetes mellitus and intermediate hyperglycaemia at different points in time* 
 WHO 
1965(80) WHO 1980(61) WHO 1985(53) ADA 1997(78) WHO 1999(77) ADA 2003(79) ADA  2010(81) WHO  2011(82) 
Normal All the ADA 
2003 criteria 
retained. HbA1c 
test can be used 
to diagnose 
diabetes, with a 
threshold of 
≥6.5%. HbA1c 
values between 
5.7-6.4% are 
defined as the 
high risk range 
for diabetes 
(pre-diabetes)    
All the WHO 1999 
criteria retained. 
HbA1c test can be 
used as a diagnostic 
test for diabetes 
with a 
recommended 
value of 6.5% as the 
cut point for 
diagnosing 
diabetes. There is 
currently 
insufficient 
evidence to make 
any formal 
recommendation 
on the 
interpretation of 
HbA1c levels below 
6.5%.    
FPG Not specified Not defined Not defined <6.1 mmol/l <6.1 mmol/l <5.6 mmol/l 2-h PG <6.1 mmol/l -- -- <7.8 mmol/l Not specified 
but <7.8 mmol/l 
implied 
<7.8 mmol/l 
Diabetes FPG Not specified ≥8.0 mmol/l  
and /or  
≥7.8 mmol/l  
or  
≥7.0 mmol/l 
or 
≥7.0 mmol/l or ≥7.0 mmol/l 
or 2-h PG ≥7.2 mmol/l ≥11.0 mmol/l ≥11.1 mmol/l ≥11.1 mmol/l ≥11.1 mmol/l ≥11.1 mmol/l 
IGT FPG -- <8.0 mmol/l  
and 
<7.8 mmol/l 
and  
Not required <7.0 mmol/l and Not required  2-h PG 6.1 – 7.1 
mmol/l 
≥8.0 mmol/l 
and <11.0 
mmol/l 
≥7.8 mmol/l 
and <11.1 
mmol/l 
≥7.8 and 
<11.1 mmol/l 
≥7.8 and < 11.1 
mmol/l 
 ≥7.8 and 
<11.1 mmol/l 
IFG FPG Not defined Not defined Not defined ≥6.1 and 
<7.0 mmol/l 
≥6.1 and 
<7.0 mmol/l and 
5.6 to 
6.9mmol/l 2-h PG -- -- -- -- <7.8 mmol/l  
(if measured) 
<11.1 mmol/l 
(if measured) 
*Values represent venous plasma glucose, FPG: Fasting Plasma Glucose, 2-h PG: 2-hours Plasma Glucose after ingestion of 75g oral glucose 
load, IGT: Impaired Glucose Tolerance, IFG: Impaired Fasting Glucose, HbA1c: Glycated Haemoglobin, ADA: American Diabetes Association, 
WHO: World Health Organization
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Overall prevalence: 
Using the new ADA criteria, Alnozha et al designed a national population based survey 
to assess the prevalence of diabetes mellitus and coronary artery disease in Saudi 
Arabia.(83) Over a period of 5 years between 1995 and 2000, 16917 Saudi subjects aged 
between 30-70 years were screened for glucose intolerance. The overall prevalence of 
diabetes mellitus obtained was 23.7% (26.2% for men and 21.5% for women). The age 
adjusted prevalence was estimated at 21.9% (22.4% for men and 21.5% for women). 
The prevalence increased with advancing age from 12.1%, among those aged between 
30 to 39 years, to 36.5% at age of 60 to 70 years. Diabetes mellitus was more prevalent 
in urban populations (25.5%) than in rural populations (19.5%). Of those with diabetes, 
27.9% were unaware of having diabetes. Furthermore, similar to what has been 
reported before by both Elhazmi et al and Alnuaim et al national studies, Alnozha et al 
reported that the southern region had the lowest prevalence (18.2%).  
Alnozha et al also estimated the prevalence of the new defined IFG category (≥ 
6.1mmol/l to ≤ 6.9 mmol/l). Its crude prevalence was 14.1% and the age adjusted 
prevalence was 13.9%. The age adjusted IFG prevalence was similar in both males 
(14.2%) and females (13.9%). These prevalence proportions for IFG were much higher 
than what have been previously reported for IGT. The study also demonstrated an 
association between higher proportions of diabetes with central obesity particularly 
among females.        
In 2004, another national survey was conducted by the Saudi Ministry of Health (MOH) 
in collaboration with the WHO.(84) The WHO STEPwise approach to surveillance of non-
communicable diseases was used to ensure standardization and comparability with 
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international data. Diabetes mellitus prevalence was found to be 15.3% with similar 
prevalence for males (15.8%) and females (14.9%).  A similar prevalence (15.8%) was 
reported in a case series study in Riyadh city among the attendees of 4 primary 
healthcare centres.(85) However, the study reported a higher prevalence among males 
(24.2%) than females (11.3%).       
Among those aged ≥ 30 years, a screening campaign in the Eastern region of Saudi 
Arabia found that 17.2% of 197,681 participants had diabetes and 9% of those with 
diabetes were newly diagnosed.(86) The prevalence increased with age, and was higher 
among subjects who were unemployed, illiterate, widowed, divorced or had a low 
education level or income. In contrast to Alnozha and the MOH national surveys, this 
study found that females had higher diabetes prevalence (18.6%) than males (15.9%).  
In Alriyadh region, a recent population based study which screened Saudis aged 7-80 
years for T2DM showed a crude prevalence of 23.1% and an aged adjusted prevalence 
of 31.6% which is the highest adjusted prevalence ever reported (based on WHO 1999 
diagnostic criteria).(87)  The study found also that the age adjusted prevalence of T2DM 
was higher in men (34.7%) than in women (28.6%) which was consistent with the 
findings of the national surveys of Elhazmi, Alnozha and the MOH.  
In the western region, two recent studies were conducted in Jeddah. The first one used 
questioning patients to determine the presence of diabetes among patients attending 
a primary healthcare clinic. Of 6024 subjects, diabetes mellitus was present in 1792 
(30%) patients.(88) The second study screened overweight and obese pediatric patients 
attending a hospital clinic for the presence of T2DM. Over a 4 years period, 387 
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patients aged from 2 to 18 years were screened using the ADA 2003 criteria. Of which 
35 patients (9%) had T2DM.(89) 
T1DM: 
Three studies were conducted to estimate specifically the prevalence or incidence of 
T1DM between 2000 and 2012 in Saudi Arabia.(90-92) One was a national study 
conducted between 2001 to 2007 by Alherbish et al and the other two were city based 
studies.  
The national study was the first study of its kind to estimate the prevalence of T1DM 
among children and adolescents aged less than 19 years.(90) Since T1DM is typically in 
most of the cases, a self-evident disease, a questionnaire was used to document the 
presence of diabetes in the targeted family members of the randomly selected 
households.  The study found that the prevalence of T1DM was 109.5 per 100,000. The 
central region had the highest prevalence of 162 per 100,000 while the eastern region 
had the lowest prevalence of 48 per 100,000. 
Over a period of 18 years (1990 to 2007), a subpopulation based study revealed an 
alarming increase in the incidence rates of T1DM among children less than 15 years of 
age. The annual incidence rate increased from 10.13 per 100,000 per year in 1990 to 
52.93 per 100,000 per year in 2007. The average incidence rate was 27.52 per 100,000 
per year and the average annual increment in incidence rate was 16.8%.   
A city based study was conducted in Almadinah city which is the largest city in the 
northwest of Saudi Arabia. Over a period of 6 years (2004 to 2009), the mean annual 
age adjusted incidence rate was 29.0 per 100,000 person-years of children aged 0 – 12 
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years, which was the highest reported incidence in the Middle East and North Africa 
region. (92) The incidence was higher in girls (33 per 100,000) than boys (22.2 per 
100,000) and in children aged 10-12years (46.5 per 100,000) than in children aged 0-4 
years (17.1 per 100,000).  
Recently, the IDF in 2011, estimated the incidence of T1DM in children of 0 to 14 years 
old to be 31.4 per 100,000. (37)  
MODY: 
The exact incidence and prevalence of MODY is not known in Saudi Arabia. Recently, it 
has been suggested that testing for MODY in Saudi Arabia should not be considered 
routinely but for selected patients where clinical and biochemical indicators dictating 
that.(93)   
GDM: 
A hospital based study screened 633 pregnant women who attended a hospital 
antenatal clinic in Riyadh for GDM. The prevalence of GDM was 12.5% when the 
WHO’s 1999 criteria were applied (2-h PG ≥ 7.8 mmol/l). However, the prevalence 
dropped to 3.8% when the ADA criteria were used (2-h PG ≥ 8.6 mmol/l). In addition, 
the study showed that the prevalence of GDM increased with parity. However, this 
was shown to be due to the confounding effect of maternal age.(94)   
Limitations of the studies of the third period: 
The studies on the prevalence of diabetes during this time period (2000 – 2012) have 
used mainly fasting blood glucose as a screening method instead of OGTT or random 
blood glucose. In contrast, the studies on T1DM used either self-reported history or 
hospital data to identify patients with diabetes. The studies of this period pointed to 
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the exponential rise of diabetes prevalence. However, this rise can be explained in part 
by the lowering of the diagnostic criteria for diabetes, (Table 3) which will increase 
diabetes prevalence and make the rise look larger than it really was.  Involving young 
and older age groups rather than children would also explain, in part, this rise. 
However, confirming the rising trend of diabetes in Saudi Arabia by conducting a valid 
comparison between studies, either within each time period or between the three 
periods, was not feasible. This was because of the heterogeneity among the studies in 
terms of the screening methods used, the diagnostic criteria and the sampled age 
ranges as well as involving different genders and specific subpopulations. This is shown 
in appendices  1, 2 and 3 which summarize the characteristics of the prevalence 
studies of diabetes in Saudi Arabia for the last 3 decades. Furthermore, the incidence 
of T1DM seems to be increasing at dramatically higher rates compared to the reported 
global trend, and with unclear etiological factors.(95-96) 
 
 
 
 
  
 
35 
 
1.3.2. Modifiable risk factors for diabetes 
Impaired glucose tolerance (IGT): 
 At the global level, the prevalence of IGT is almost the same to that of diabetes, with 
somewhat higher prevalence in the Africa and Western Pacific Regions and slightly 
lower in the North America and Caribbean Region.(37) In contrast, the prevalence of IGT 
in Saudi Arabia was found to be much lower than diabetes prevalence which also 
contrasts with the neighbouring countries’ situation as shown in figure 6. The IDF 
estimates in figure 6 were calculated using the most recent, high quality data from 
different sources for each country. The data were adjusted to the current WHO 
standard population to generate comparative estimates.(37) Therefore, this might 
indicate that people with IGT in Saudi Arabia progress faster to diabetes but there is no 
clear explanation for this.   
This interpretation might be supported by the findings of a recent review study which 
reported that the lowest BMI threshold where diabetes risk escalates was reported in 
Saudi Arabia. It was as low as 21 kg/m2 in one study from Saudi Arabia while it was 
predominantly 30 kg/m2 in most other studies from the countries in the Middle East 
and North Africa.(97) 
  
 
36 
 
Figure 6: IDF estimates of diabetes and IGT prevalence (%) for 2011 (20-79 years)(37) 
  
Obesity and physical inactivity: 
The previous studies on diabetes prevalence in Saudi Arabia suggested that the rising 
trend has probably resulted from the changes in the patterns of lifestyle such as 
reduced physical activity, unhealthy eating habits, urbanization and the concomitant 
rise of obesity and consanguinity rates. Recently (2010), Midhet et al reported a strong 
association between the risk of acquiring T2DM and unhealthy dietary habits, lack of 
exercise and education in Saudi Arabia.(98) Certain dietary patterns such as regular 
eating of dates and Kabsa (rice with meat dishes) are indigenous habits in Saudi Arabia. 
The study found that the adjusted odds ratio was 5.5 (95% confidence limits: 2.3-13.5) 
for regular eating of Kabsa and 1.8 (95% confidence limits: 1.0-3.3) for regular eating of 
dates.(98)  
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Obesity and weight gain are major risk factors for T2DM. A national nutrition survey in 
Saudi Arabia in 1985-1988 found that among participants aged 18-61 years, 30.7% of 
men and 28.4% of women were overweight. The prevalence of obesity was found to 
be higher in women (23.6%) than in men (14.2%).(99)  Later, between 1995 - 2000, a 
community based national survey of people aged 30 - 70 years found that the 
prevalence of overweight was 36.9% with higher prevalence among males (42.4%) 
than females (31.8%). In contrast, obesity was more prevalent in females (44%) than 
males (26.4%). Furthermore, the age adjusted prevalence of obesity in Saudi Arabia 
was 35.5%.  
Another national survey, which estimated the prevalence of overweight and obesity in 
Saudi children and adolescents aged 5 to 18 years, found that the overall prevalence of 
overweight, obesity and severe obesity was 23.1%, 9.3%, 2% respectively.(100) In 
addition, girls had a higher prevalence of overweight (23.8%) than boys (22.4%) and in 
contrast, boys had higher prevalence of obesity (10.1%) than girls (8.4%).    
A review of the prevalence and trends of overweight and obesity in the Arabian Gulf 
States showed that in Saudi Arabia, Kuwait, Qatar and Bahrain two thirds to three 
quarters of adults and 25% to 40% of children and adolescents were either overweight 
or obese.(101) 
The high level of physical inactivity (96.1%) among Saudi adults aged 30 to 70 years is 
also a major public health problem.(102) Females were found to be less active than 
males (98.1% versus 93.9%). The southern region of Saudi Arabia had the lowest 
prevalence of inactivity (94.0%; 95% CI = 93.2-94.8%) while the central region was the 
highest (97.3%; 95% CI = 96.8-97.8%). In 2005, another national survey used the WHO 
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Global Physical Activity Questionnaire (GPAQ) to estimate the levels of physical activity 
(high, moderate or low) among Saudi population.(84)  The percentage of participants 
with low physical activity was 67.7% with a higher percentage among females (74.3%) 
than males (60.9%).  Moreover, moderate and high levels of physical activity were 
higher in males than females (20.4% versus 12.4% and 18.7% versus 13.4%) 
respectively.(84)      
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1.3.3. Diabetes control and complications 
Prolonged exposure to hyperglycaemia (raised blood glucose) leads to many 
pathological changes that damage the cardiovascular system at the macro and micro 
vascular levels. As a result, various organs of the body start to be gradually damaged. 
The initial changes are reversible but over time, chronic hyperglycaemia leads to 
irreversible damage. The United Kingdom Prospective Diabetes Study (UKPDS) and the 
Diabetes Control and Complications Trial (DCCT) showed that hyperglycaemia is 
directly associated with the severity of these complications. (5-6, 103) Intensive glycemic 
control was found to be the most effective method for preventing these 
complications.(5-6, 103) 
  
Glycemic control: 
In Saudi Arabia, a high proportion of patients with diabetes did not attain the 
recommended target of glycemic control. A national survey in 1993 showed that half 
(50%) of the patients with diabetes had poor glycemic control (random blood glucose 
(RBG) ˃ 10 mmol/l), especially older patients and those who were on insulin 
treatment.(104) Seven years later, a retrospective study of patients with diabetes 
attending 3 primary healthcare centres in Riyadh reported a similar percentage (49%) 
of poor glycemic control (FBG ˃ 10 mmol/l).(105) Six years later, another national study 
at the primary healthcare level showed that almost three quarters (72%) of patients 
with T2DM had a HbA1c level above the recommended target of ˂ 7%.(106) A screening 
campaign in the Eastern region of Saudi Arabia found that only one third (33.8) of 
patients with diabetes attained the recommended glycemic control of FBG ˂ 7.2 
 
40 
 
mmol/l or RBG ˂ 10.0 mmol/l.(107)  Even at the hospital level, similar proportions of 
poor glycemic control were reported. Qari in 2005 compared the glycemic control 
among the patients with diabetes who were regularly followed up at a University 
hospital and a private hospital in Jeddah. Poor glycemic control with HbA1C of ˃ 8% 
was reported in 42% of the University hospital patients and 46% of those in the private 
hospital.(108) However, a similar study in the same University hospital but compared 
with other private hospital reported that 88.5% of patients with diabetes in the 
University hospital and 39.1% in the private hospital have not achieved the glycemic 
control goal of HbA1c less than 7%.(109)  
Among the countries of the Gulf Cooperation Council (GCC), which consists of Saudi 
Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain, and Oman; a recent 
systematic review concluded that consistently, less than half of patients with diabetes 
achieved the target glycemic control (HbA1c < 7%).(110) One study, which reported that 
60.9% of privately treated patients in Saudi Arabia achieved the glycemic target, was 
an exception.(109-110) Moreover, a recent study in the GCC countries evaluated the 
effectiveness of insulin analogues in more than 10,000 T2DM patients. The study 
showed that the glycemic control was poor and the baseline HbA1c was 9.7 ±1.7%. (111)  
 
Diabetes complications overview: 
Among the Saudi population, diabetes has been reported as a risk factor or a predictor 
for several diseases such as coronary artery disease, (112-115) cerebrovascular disease, 
(116-117) erectile dysfunction, (118-120) end-stage renal disease, (121-123) and peripheral 
arterial disease.(124-125) In 1986, a hospital based case series study in Riyadh estimated 
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for the first time that 12% of 222 patients with T2DM had retinopathy, 3.6% had 
nephropathy and 36% had neuropathy. Twenty eight patients (13%) had hypertension 
and 85% were overweight at the time of diagnosis.   
A case note review study in a private hospital in Jeddah found that 60% of patients 
with T1DM had either one or more diabetes complications.(126) In Riyadh, a University 
hospital based study described the clinical pattern of diabetes and its complications in 
1000 patients who visited the hospital between 1983 and 1988. The study found that 
retinopathy, nephropathy and neuropathy were present in 31.5%, 17.8%, and 35.9% of 
patients respectively.(42) Ischemic heart disease was found in 11.3%, hypertension in 
25.6%, foot lesions in 10.5%, amputation in 5.1%, stroke in 9.4% and renal insufficiency 
in 6.9% of the reviewed patients. A similar study, but including patients with T2DM 
only who visited the security forces hospital in Riyadh between 1989 and 2004, found 
that the prevalence of retinopathy, nephropathy and neuropathy was 16.7%, 32.1%, 
13.7% respectively.(127) Acute coronary syndrome, myocardial infarction and stroke 
were found in 23.1%, 14.3% and 10.4% respectively. Seventy eight percent of patients 
had hypertension, 83% had obesity, 39% had dyslipidemia, 1.9% had amputations and 
4.3% had foot infections. In addition, the presence of these complications increased 
with duration of diabetes and age.(127)  
Although diabetes complications are uncommon among children with T1DM, coronary 
heart disease and some microvascular complications have been observed. In children 
aged 2-18 years with T1DM, over 12 years a hospital based case series study found 
that the prevalence of retinopathy was 1.3% and the prevalence of nephropathy was 
0.4%. Neuropathy was found in 2 patients (0.6%) and coronary heart disease was also 
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found in 2 patients (0.6%). Acute diabetic complications such as diabetic ketoacidosis 
and hypoglycaemia were found in 62% and 38.1% respectively. (128)  At diagnosis of 
T1DM, 55% of children in Almadinah region presented with ketoacidosis.(129-130)  In the 
Eastern region, more than three quarters (77%) of children with T1DM had 
ketoacidosis. (131)  In another hospital based study in Riyadh, 110 children were 
diagnosed with diabetes and followed up for 5 years (1985-1989).(132-133) Consanguinity 
proportion among their parents was 42.7%, either being first or second cousins. 
Diabetic ketoacidosis was the most common seen clinical presentation (67%).        
Most of the studies addressing the prevalence of diabetes complications in Saudi 
Arabia, however, suffered from the fact that they were mainly clinic or hospital based 
studies which might overestimate the prevalence of diabetes complications due to the 
selection bias inherent to this type of studies. Moreover, several studies used different 
inclusion and exclusion criteria that limit the generalizability and comparability of such 
studies. Despite these weaknesses, the studies are still useful as a measure of quality 
of diabetes care. The studies identified substantial inadequacies in healthcare which 
need to be addressed.  
 
Diabetic retinopathy: 
At a diabetes centre in Riyadh, Abu Elasrar et al reported a prevalence of retinopathy 
of 31.3% with higher prevalence among patients with T1DM (42.5%) than those with 
T2DM (25.3%). Advanced age (˃ 60 years), long duration of diabetes (˃ 10 years), poor 
glycemic control, hypertension, high cholesterol levels and presence of nephropathy 
were associated with retinopathy.(134)  At the same diabetes centre in Riyadh but in 
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another study by the same authors, the presence of retinopathy significantly predicted 
the presence of neuropathy, nephropathy, and cerebrovascular disease in both T1DM 
and T2DM patients.(135) In Alhasa district, a primary healthcare centre based study 
reported a 30% prevalence of retinopathy.(136) A hospital based study in Almadinah 
reported a higher prevalence of 36.1%.(137)  However in Abha city, a single primary 
healthcare centre study reported a lower prevalence of 11.3%.(138) A recent published, 
population-based study in Taif district, which screened people aged ≥ 50 years for 
diabetes and diabetic retinopathy showed a prevalence of 29.7% for diabetes and of 
whom 36.8% had retinopathy.(139) A summary of the reported prevalence of diabetic 
retinopathy in Saudi Arabia are shown in figure 7. However, the variation among these 
studies in the reported prevalence needs to be interpreted with caution because they 
covered a period of more than 25 years, they were conducted in different geographical 
regions and settings and used different methods of recruitment and diagnosis.       
Similar studies in neighbouring countries (Oman and United Arab Emirates), however, 
reported a lower prevalence of retinopathy (14.4% and 19%).(140-141) Conversely, other 
neighbouring countries reported higher prevalence, i.e. Egypt (42%)(142) and Jordan 
(64%).(143) These substantial differences in the reported prevalence of retinopathy 
could be due to the differences in the age distribution of different populations, study 
methodology, screening methods or places of recruiting participants. 
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Figure 7: Prevalence of diabetic retinopathy in Saudi Arabia, 1986 - 2012 
  Riyadh (1986),(41) Riyadh (1992),(42) Riyadh (1999),(134) Abha (2002),(138) Riyadh (2008),(127) Alhasa 
(2010),(136) Almadinah (2012),(137) Taif (2012).(139) 
 
Diabetic Nephropathy: 
Among the countries of the GCC, which consists of Saudi Arabia, the United Arab 
Emirates, Kuwait, Qatar, Bahrain, and Oman, diabetes was the primary leading cause 
of end–stage renal disease (ESRD).(144) In patients with T2DM attending a diabetes 
clinic in Riyadh, Alzaid et al estimated the prevalence of microalbuminuria (30 - 300 
mg/24 h) to be 41.3% and clinical proteinuria (dipstick-positive) to be 12.7%.  In 
contrast, a similar study by Huraib et al found that the prevalence of microalbuminuria 
(˂300 mg/24 h + urinary albumin to urinary creatinine ratio (UACR) > 3.5) was 16.8% 
and the prevalence of clinical proteinuria (˃ 300 - ˂ 3000 mg/24 h) was 30.4%. 
Hypertension and duration of diabetes were found to be correlated with the 
development of diabetic nephropathy.  In two regions of Saudi Arabia (Almadinah and 
Gizan), diabetic nephropathy was the commonest cause (30.4%) of ESRD.(121) In 
Almadinah, diabetic nephropathy has been reported to be the commonest cause of 
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ESRD (45.2%) while it was seen in only 12% of the cases of ESRD in Gizan region.(121)   
After 12 years, a study in Almadinah region showed a similar finding for diabetes to be 
the major cause of ESRD (42.5%).(123)  In the southern region of Saudi Arabia, a 
diabetes clinic based study in a primary healthcare centre in Abha city found that more 
than half (54.3%) of patients with T2DM who visited the clinic at least once during the 
last 12 months had dipstick positive proteinuria.(145)         
In Saudi patients with T2DM, several studies showed that diabetic nephropathy tends 
to be progressive with a rapid course.(122, 146-149) For example, one of the studies found 
that 66.8% of patients with diabetic nephropathy doubled their serum creatinine in 
3.59 ± 2.88 years.(147) Another study reported a lower prevalence of 39.9% over a mean 
duration of 9.98 ± 6.04 years of diabetes. At the end of the study, 15.2% of patients 
with diabetic nephropathy developed ESRD and 12.6% required dialysis.(148) 
In summary, a recent meta-analysis of 21 studies showed that the prevalence of 
diabetic nephropathy as a cause of ESRD in all the GCC countries is 17.27% (95% CIs, 
11.38–26.21%).(144) In Saudi Arabia, the summarized prevalence estimate of diabetic 
nephropathy is 31.41% (95% CIs, 7.39–133.59%) in the western region, 29.15% (95% 
CIs, 9.21–92.24%) in the eastern region, and 24.98% (95% CIs, 7.01–88.98%) in the 
central region, compared to 6% (95% CIs, 2–17.8) in the southern region (Figure 8). (144) 
Data on diabetic nephropathy among patients with T1DM is rare. In patients with 
T2DM, diabetic nephropathy is progressive over time.  
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Figure 8: Summarized estimate of diabetic nephropathy prevalence (%) as a cause of 
ESRD in the GCC countries and different regions of Saudi Arabia. (144) 
 
 
Diabetic Neuropathy and foot diseases:  
In 1991, Sulimani et al retrospectively reviewed the case notes of 1010 patients with 
diabetes at a University hospital in Riyadh.(150) The study revealed an overall 
prevalence of 10.4% for diabetic foot lesions. Of these, 88 patients were further 
described and 48.8% of them suffered from diabetic peripheral neuropathy, 54.5% had 
peripheral vascular disease, and 34.1% had suffered some type of amputation.(150)    
In 1998, a case series study in a private hospital in Riyadh, examined the presence of 
neuropathy, foot ulcers and amputations among 375 Saudi patients with T2DM.(151) 
The prevalence of neuropathy was 20%, foot ulcers 2.4% and amputations below the 
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ankle 1.3%. Among those patients who had diabetes for 10 years or more, the 
prevalence of neuropathy, foot ulcers and amputations increased to 38%, 4.7%, and 
3.4% respectively.(151)  Moreover, the author compared a group of Swedish patients 
with diabetes with similar age and sex matched Saudi patients. The prevalence of 
diabetic neuropathy was similar in both groups; however, the prevalence of foot ulcers 
and amputation was lower in the Saudi patients.(151)     
At King Abdulaziz University hospital in Jeddah, a total of 237 patients with a mean age 
of 54 years and mean duration of diabetes of 10.6 years were studied.(152) The 
prevalence of diabetic neuropathy was 82%, of whom 57% of patients were 
asymptomatic. This high prevalence of diabetic neuropathy is one of the highest in the 
world. This could be attributed to the involvement of high proportion of patients with 
T2DM (84%), with poor glycemic control (59.5%) and 10 years mean duration of 
diabetes. Old age, smoking, poor glycemic control and long duration of diabetes were 
related to the symptomatic diabetic neuropathy.(152) Another study at the same 
hospital reviewed a small sample of 34 case notes of those patients with diabetes who 
were admitted with diabetic foot.(153) Peripheral neuropathy was the major 
participating factor in 94%. Half (50%) of the patients had peripheral vascular disease. 
More than half of the patients (59%) presented mainly with foot ulcers and 8 patients 
(23.5%) underwent foot amputations.(153)    
Data on the prevalence and incidence of neuroarthropathy in patients with diabetes in 
Saudi Arabia is scarce. Only one study at King Khalid hospital in Najran has been found 
in the literature. This study reported that among 296 patients with long standing and 
poorly controlled diabetes, 37 (12.5%) had diabetic neuropathy and 11 (30%) of them 
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had bone and joint lesions. The overall prevalence of neuroarthropathy was 4% and 
18% of them ended up with amputation.(154) 
At King Fahd hospital in Almadinah, 263 patients with diabetes attended the hospital 
diabetes centre between 2008 and 2009; with diabetes mean duration of 13.89 ± 8.7 
years and 85% of them had T2DM.(155) The prevalence of both symptomatic and 
asymptomatic diabetic neuropathy was 79%.  Old age, poor glycemic control, long 
duration of diabetes and hyperlipidemia were reported as risk factors for 
neuropathy.(155)     
The overall prevalence of painful diabetic peripheral neuropathy among 1039 adult 
patients from 100 outpatient clinics across Saudi Arabia was found to be 65.3%.(156) 
Burning sensation, tingling and numbness were the most common symptoms.(157)  This 
prevalence was higher than a recent reported prevalence in the Middle East region 
(53.7%) (158)and far higher than the worldwide prevalence estimate of 15%. (159) 
A hospital based, case control study in Riyadh reported that duration of diabetes, 
presence of diabetic neuropathy and level of erythrocyte sedimentation rate (ESR) 
were independent predictors for diabetic foot after adjusting for both age and sex 
confounding effects. In addition, the study estimated the duration of 11 years of 
diabetes as the most valid cut-off point for the prediction of diabetic foot.  
A multicentre retrospective study in Jeddah found that among 275 patients with a 
mean age of 58.5 ± 11.6 years, and had diabetic foot disorders, 81.8% presented with 
foot ulcers and 48.8% underwent amputation.(160) In the eastern part of Saudi Arabia, a 
prospective study at ARAMCO Medical Services Organization assessed the clinical 
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presentation and management outcomes of type 2 diabetes patients with diabetic foot 
ulcers. The mean age of 62 included patients was 64.8 ± 12 years. Over 12 months 
(2003-2004), 19% of patients with foot ulcers had suffered some type of 
amputation.(161)   
The MOH data showed an increased trend of diabetic foot amputations. Among all 
those patients who had suffered some type of amputation and referred to the medical 
rehabilitation centres for follow up, 35.4% were due to gangrene of diabetes mellitus 
in 2011 (Figure 9).(162) The rapid rise between 2007 and 2008 is difficult to explain. This 
increase is unlikely to be real rise in the frequency of amputations due to diabetes. It 
might be due to different systems of detecting and recording complications.   
Figure 9: Proportions of amputation due to diabetes in MOH, Saudi Arabia, 2006 - 
2011 
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In comparison with the other parts of the world, a cross sectional survey in the United 
Kingdom (UK) found that 5.3% of patients with T2DM and 7.4% of those with either 
T1DM or T2DM had suffered from foot ulcers.(163) In Sweden, 5.4% of T2DM patients 
had foot ulcers and the annual incidence was 3.6%. The reported prevalence of 
amputation was 1.29%. (164) At the global level, a pronounced variation exists in the 
incidence of lower extremity amputation, ranging from 46.1 to 9600 per 100,000 
people with diabetes.(165)   
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1.3.4. Diabetes burden and costs 
Mortality:  
Diabetes Mellitus is one of the most challenging epidemic health problems in Saudi 
Arabia. However, data on its mortality and costs in Saudi Arabia is very scarce. 
Therefore WHO and IDF used modelling approaches to provide more realistic 
estimates of diabetes mortality in Saudi Arabia.  According to the latest WHO report on 
non-communicable diseases, 71% of all deaths in Saudi Arabia were attributed to non-
communicable diseases. Diabetes alone was estimated to account for 6% of all deaths 
in all ages in Saudi Arabia.(166) In 2012, the IDF estimated that the number of deaths 
due to diabetes in Saudi Arabia was 20,933.(167)  The age adjusted death rate was 
estimated to be 58.97 per 100,000 of population which ranks Saudi Arabia number 38 
in the world.(168) 
  
Morbidity: 
At the medical unit of King Abdulaziz University Hospital in Jeddah, 17% of hospital 
admissions over 4 years (1996 to 1999) were due to diabetes.(169) Macrovascular 
complications (38%) and hyperglycaemia (21%) were the most common causes of 
diabetes admission. The mean duration of hospital stay was 25.4 days and the 
mortality rate was 13%.(169)  A retrospective case control study at a teaching hospital in 
Saudi Arabia showed that hospital admission for T2DM patients was associated with 
male gender, presence of nephropathy and HbA1c ≥ 7%. (170) 
At King Khalid University Hospital in Riyadh, 2.6% of all hospital admissions over six 
years (1986 to 1991) were related to diabetes.(171) All hospital related diabetes 
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admissions occupied 3.5% of all hospitalization days and lasted longer than the 
average hospital admission. Diabetes mellitus was the primary diagnosis in 39%, 
secondary to other diseases in 47% and related to diabetes in pregnancy in 14%. 
Among those patients who were admitted primarily because of diabetes or its 
complications, the majority of admissions (89.4%) were for either initiation of diabetes 
therapy or management of its chronic complications. The remaining proportion 
(10.6%) was admitted because of acute metabolic complications such as ketoacidosis 
or non-ketotic hyper-osmolar states.(171) 
Analysis of MOH data between 2006 and 2011 revealed that diabetes mellitus was the 
third most common cause of visiting the primary healthcare centres (mean 6%). Of 
those patients, 45.71% were aged between 45 to 60 years and 24.26% were above 60 
years of age.(162)  In 2011, diabetes mellitus was the cause of 3.79% of patient visits to 
the outpatient clinics of the MOH hospitals. This proportion ranged from 1.63% in 
Jeddah district to 6.73% in Makkah district (Figure 10). This variation between MOH 
districts could be real or it could be due to differences in recording practices. Visits of 
patients with diabetes to the diabetes clinics at MOH hospitals has increased year on 
year over the past 6 years (Figure 11). The percent of diabetes emergency cases to all 
emergency cases in the MOH hospitals increased with time from 2.37% in 2006 to 
3.24% in 2011 (Figure 12). 
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Figure 10: Proportion of the visits to the outpatient clinics of MOH hospitals that 
were due to diabetes, Saudi Arabia, 2011 
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Figure 11: Number of visits of patients with diabetes to the diabetes clinics at MOH 
hospitals, Saudi Arabia, 2006-2011 
 
Figure 12: Proportions of diabetes related emergency cases in the MOH hospitals, 
Saudi Arabia, 2006-2011 
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Costs:  
Globally, in 2011, the estimated mean of healthcare expenditure per person with 
diabetes was 1,274 US$. In Saudi Arabia, the corresponding figure was 998 US$.(37)  
Furthermore, 1.4 billion US$ was spent on treating and managing diabetes in 2010 in 
Saudi Arabia which represent 21% of the national healthcare expenditure.(36, 172) This 
proportion of spending on diabetes is the second highest in the world and it is 
expected to rise to 3 billion US$ by 2030.(36, 172)    
Improved glycemic control in T2DM patients in Saudi Arabia by a 1% reduction in 
HbA1c was associated with reduction of diabetes direct costs by 4,289 US$, improved 
life expectancy by 0.71 years and increased time free from diabetes complications.(173) 
These clinical and economic benefits were driven by the reduced incidence of diabetes 
complications,(173) which carry a substantial financial burden on healthcare 
expenditure in Saudi Arabia.(174) Diabetic nephropathy was observed to cause the 
highest annual costs, (renal transplantation 62,571 US$; and haemodialysis 40,000 
US$).(174)  Cardiovascular complications such as  myocardial infarction, stroke, heart 
failure and peripheral vascular diseases were also associated with high annual 
costs.(174) 
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1.4. Rationale for the study  
This background shows that diabetes mellitus prevalence is rising and has become an 
epidemic disease in Saudi Arabia. One in five of Saudi Arabians beyond the age of 30 
has diabetes mellitus.(32, 66, 83) This dramatic increase in the prevalence of diabetes 
occurred alongside rapid economic development, progressive urbanization, ageing 
populations, adoption of sedentary lifestyle, poor dietary habits and increased 
obesity.(32, 99, 175) However, this rise is not expected to stop in the coming decades. The 
prevalence of T2DM among the Saudi population aged ≥ 25 years is estimated to 
continue rising from 31.4% in 2013 to 44% in 2022 if the prevalence of obesity and 
smoking continues to increase.    
Moreover, most of the reviewed studies showed consistently that more than half of 
patients with diabetes did not attain the recommended target of glycemic control. 
Poor patient compliance and ineffective diabetes care accompanied the poor diabetes 
control.(42, 104-105, 176-181) In addition, diabetes complications were common among 
hospital patients. However, most of the studies addressing the prevalence of diabetes 
complications were hospital based studies which might overestimate the prevalence of 
diabetes complications due to the selection bias inherent to this type of studies.  
As a result, this high prevalence of diabetes and its management has posed a 
substantial financial burden on the national healthcare budget. In 2010, 1.4 billion US$ 
was spent on diabetes management in Saudi Arabia which represents 21% of the 
national healthcare expenditure and is expected to rise to 3 billion US$ by 2030.(174) 
Therefore, diabetes mellitus is a major contributor to the morbidity and mortality; 
carries a huge socioeconomic burden in Saudi Arabia.  
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However, the health care system is generally not yet ready to deal with such an 
increasingly worrisome health problem. Public health planners and decision makers in 
Saudi Arabia need to be more aware of the current high burden posed by diabetes and 
its complications and, crucially, prepare for its most likely increase during the coming 
decades. 
Management of diabetes therefore needs to be improved. Optimal diabetes 
management is an important requirement. Implementing effective interventions to 
prevent diabetes, promote health and improve the quality of diabetes care are 
essential. The Saudi Arabian government responded to this rising prevalence of 
diabetes by implementing a national programme for diabetes mini-clinics at the level 
of primary care and established more than 20 specialist diabetes centres across the 
county. However, there is limited information on both the extent of implementation 
and efficacy of these diabetes management programmes.(182) Therefore, it is important 
to assess the quality of these diabetes care programmes at both the national and local 
levels. In addition, it is also important to investigate in depth the problem of diabetes 
to know first how this disease is managed and what care services are currently 
delivered. Second, in order to develop effective interventions to improve the quality of 
care, the specific deficiencies in diabetes care should be identified, the gaps in service 
provision should be explored and the needs of people with diabetes should be 
assessed. Moreover, barriers to optimal care and quality improvement should be 
addressed to facilitate care improvements and meet what patients and carers need.     
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Research is crucial to inform the development and implementation of any intervention 
to improve healthcare.  The National Medical and Health Research Strategy for the 
Kingdom of Saudi Arabia identified diabetes as a national health priority area for 
research and strategic intervention.(34) In Saudi Arabia, research on assessment of 
healthcare needs of people with diabetes, how diabetes care should be delivered, 
what are the potential areas for service improvement, and what are the barriers to 
improve diabetes care are very scarce. Moreover, research on developing effective 
behavioural change interventions to promote diet, physical activity and adherence to 
medications and follow-up appointments is needed. Therefore, the aims of this thesis 
were to fill these knowledge gaps by analysis of routine healthcare data, patient case 
notes and exploring the knowledge and experience of both the users and the providers 
of diabetes care. 
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CHAPTER TWO 
 
  
Research aims and 
objectives 
 
This chapter outlines the research aims and objectives. 
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Chapter 2: Research aims and objectives  
 
2.1. Aims 
The long term aim of this research project is to lead to improvements in detection, 
diagnosis, management and outcomes of diabetes in Saudi Arabia. The short term aims 
are first, to support the Saudi Ministry of Health by providing a robust assessment of 
the quality of diabetes care in Saudi Arabia; and secondly by identifying the potential 
areas of diabetes care that need to be improved. The domain of issues is broad, 
including how this disease is currently managed, identifying structural deficiencies and 
gaps in diabetes service provision, evaluating process and outcome measures of 
quality of diabetes care, assessing perceived healthcare needs of people with diabetes 
and identifying areas of priority for service improvement.  
Abha city in the southern region of Saudi Arabia was selected as the study area for this 
research project.  
 
2.2. Objectives    
The primary objectives of the study were to:  
1. Evaluate whether the diabetes services are structured and resourced in such a 
way as to allow quality care to be delivered. This requires an assessment of the 
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services and resources that are available for diabetes care, comparing these 
against national standards.  
2. Estimate the registered prevalence of diabetes, its complications and pattern of 
service utilization by identifying, collecting and analyzing available routine data 
about diabetes care for the preceding 12 months. 
3. Carry out an extensive review of the case notes of patients with diabetes to: 
a. Describe their demographic, clinical and behavioural characteristics,  
b. Assess to what extent healthcare providers implemented the key process 
measures of diabetes care, 
c. Assess to what extent the outcome targets of diabetes care were achieved.  
4. Conduct interviews with people with diabetes and key professionals to explore 
their views and priority perception to determine:   
a. What are the unmet healthcare needs of people with diabetes, 
b. What are the unavailable diabetes services, 
c. How the current diabetes services could improve and  
d. What the barriers are to service improvement. 
5. Explore the views of healthcare leaders on the priorities for improving diabetes 
care to meet the identified needs and close gaps in service provision.  
6. Produce evidence that can be used by healthcare leaders and decision makers to 
help in improving the organization and delivery of diabetes care in Saudi Arabia.  
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CHAPTER THREE 
 
  
Outline of the thesis 
 
This chapter outlines the chapters of this thesis. 
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Chapter 3: Outline of the thesis 
 
Chapter 4 provides brief background information about the study area and settings. 
The chapter discusses the study theoretical framework and why a combination of 
different methods was used. It then describes the objectives, advantages, 
disadvantages and source of data for each research method used. It presents the 
research flow and organization as well as the project setup and research team 
development. 
Chapter 5 reviews the structure and organization of the current healthcare system and 
diabetes care in Saudi Arabia. It gives an overview about diabetes care services in Abha 
city and presents the results of evaluating in depth the current available diabetes 
services and resources in Abha city against national standards. Several gaps in service 
provision are discussed. 
Chapter 6 discusses the methods and results of the case note review.  Demographic 
and clinical characteristics of people with diabetes in Abha city are presented. In 
addition, the process and outcome measures of diabetes care are discussed.  
Chapter 7 explores the view and perceptions of key informants including patients, 
physicians, nurses, managers and pharmacists on their experience with the current 
diabetes care and their priority needs. Conclusions are drawn regarding identified 
needs and areas for service improvement.  
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Chapter 8 reports the results of a survey with healthcare leaders to explore their 
perceived priorities for a number of recommendations to improve diabetes care in 
Abha city. The principal findings and limitations of the survey are discussed.  
Chapter 9 discusses the key findings of the whole research project and the implications 
of these findings for service improvement. Recommendations are made for future 
developments in diabetes care. Major priorities for research are identified. 
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CHAPTER FOUR 
 
  
Profile of the study area 
 
This chapter provides brief background information about the profile of the 
study area. It briefly describes Abha city in light of the available information. 
The chapter then describes how representative is Abha city to the whole country 
and what healthcare services available in the city. 
C APTER F R 
 
  
Research methods and 
project s tup 
 
This chapter provides brief background information about the study area and 
settings. The chapter discusses the study theoretical framework and why a 
combination of different methods was used. It then describes the objectives, 
advantages, disadvantages and source of data for each research method used. It 
presents the research flow and organization as well as the project setup and 
research team development. 
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Chapter 4: Research methods and project 
setup       
 
4.1. Introduction 
The aim of this chapter is to give an overview for the study area and settings, the 
theoretical framework for assessing diabetes care and the main research methods 
used in this thesis. It also aims to make the research strategies and approaches more 
explicit and to describe the foundation on which the thesis overall analytical frame is 
based. In addition, this chapter will discuss why a combination of different methods 
was used and what were the limitations and advantages of each method. Finally, this 
chapter will discuss some difficulties and challenges involved in the actual research 
process including team development and data collection and digitalization. 
 
4.2. Study area and Settings 
 The Kingdom of Saudi Arabia is divided into 13 provinces with 13 capitals (Map 2) and 
an estimated population of 28 million, of which almost one third (31%) is foreign 
expatriates.(183)  
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Map 2: Provinces of Saudi Arabia with Aseer province highlighted 
 
Apart from Aseer and Baha provinces, the climate is generally a desert climate with an 
average summer temperature of 45°C and winter temperature of 10 °C. In the autumn 
and spring, the mean temperature is around 29°C. The Aseer and Baha provinces are 
influenced by the Indian Ocean monsoons, which usually occur between October and 
March, causing mild climate and rainfall during this period.(184) 
The study was conducted in Abha city in Aseer province which is located in the 
southwest of the country (Map 3). Aseer region covers 81,000 square kilometres and 
has an estimated population of 1,913,392.(183) Aseer is a mountainous region and 
contains the country’s highest peak which is near Abha city (Jabal Alsoodah). Abha city 
is the capital city of Aseer province. It is located in the southern part of the province 
(Map 3) and contains the main governmental facilities such as banks, hospitals, 
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Universities and Ministries’ branches. It is a typical city similar to many other cities in 
the country in terms of population size, demography and availability of healthcare 
services and public facilities.    
Map 3: Aseer province and Abha city 
 
The national census of 2010 revealed that 7% of the total population was living in 
Aseer region.(185) Abha city was one of 19 cities where the population has exceeded 
100,000 people.(185) According to the national primary healthcare registry, the resident 
population of Abha city is currently 126,767.(186) Abha city has similar demographic 
characteristics to the whole country. For example, the ratio of men to women in Abha 
city is similar to the national ratio where there are 63,658 males (50.2%) and 63,109 
females (49.8%). Abha city is also similar to the whole country in having high ratio of 
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young population. The percentage of the young population (< 45 years old) is almost 
85%.(186) 
The primary healthcare services in Abha city are provided by 10 primary health care 
centres (PHCCs). Each PHCC provides primary healthcare services to specific catchment 
area. The secondary healthcare services are provided by one general hospital and one 
larger central hospital.  There is also one specialist diabetes centre which provides 
both primary and secondary care as well as specialist diabetes care. All these were 
included in the study. Map 4 shows Abha city and the sites of the PHCCs, hospitals and 
the diabetes centre in the city.     
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Map 4: Map of Abha city showing the sites of the PHCCs, hospitals and diabetes centre 
Source: Google maps using CartoDB online service, http://cartodb.com/
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4.3. Theoretical framework and research methodology     
Diabetes care is inherently complex and involves different professions and different 
aspects of care at different healthcare levels. Patients with diabetes are likely to need 
a wide variety of healthcare services during their lifetime with this disease, particularly 
if someone develops it in an early life. The English National Service Framework for 
diabetes summarized concisely but comprehensively the lifetime trajectory of an 
episode of diabetes in the figure below (Figure 13).(187)  
 
Figure 13: Summary of the lifetime trajectory of an episode of diabetes 
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The resultant multiplicity and diversity of services that have to be navigated by a 
person with diabetes makes it difficult to comprehensively assess all the components 
of diabetes care. In addition, globally, there is large diversity in diabetes care 
programmes and related quality indicators.(188) 
Further, it is not simple to assess the quality of care. As Avedis Donabedian, the 
acknowledged guru of medical audit and quality of care, said:   
‘There was a time, not too long ago, when this question could not have been asked. 
The quality of care was considered to be something of a mystery: real, capable of being 
perceived and appreciated, but not subject to measurement. The very attempt to 
define and measure quality seemed, then, to denature and belittle it’.(189) However, 
times have changed. The issue of quality of care is now paramount and as Donabedian 
said: ‘Now, we may have moved too far in the opposite direction’.(189)     
Although quality of care is often perceived as difficult to define, the Institute of 
Medicine in the United States has proposed the following widely accepted definition:  
“The degree to which health services for individuals and populations increase the 
likelihood of desired health outcomes and are consistent with current professional 
knowledge”.(190)  Donabedian constantly stresses that the quality of a service is defined 
as “the degree to which it conforms to pre-set standards of care”.(191) While many 
definitions for the quality of care have been offered, this practical and simple 
definition was adopted for the purposes of this study. This definition makes the 
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subjective nature of quality more explicit by measuring the quality of care against pre-
set standards.  
The quality of care is multidimensional and its assessment requires deconstructing it 
into its core dimensions.(192-193) A formal framework for evaluating the quality of care 
was suggested by Maxwell who described six dimensions to quality in healthcare.(192, 
194) These dimensions and its definitions are summarized in table 4. 
Table 4: Maxwell’s dimensions of quality 
Dimension Definition  
Effectiveness Is the treatment given the best available in a technical sense, according to those best equipped to judge? What is their evidence? What is the overall result of the treatment?  
Acceptability How humanely and considerately is this treatment/service delivered? What does the patient think of it? What would/does an observant third party think of it (“How would I feel if it were my nearest and dearest?”) What is the setting like? Are privacy and confidentiality safeguarded?  
Efficiency Is the output maximised for a given input or (conversely) is the input minimised for a given level of output? How does the unit cost compare with the unit cost elsewhere for the same treatment/service?  
Accessibility Can people get this treatment/service when they need it? Are there any identifiable barriers to service (e.g. distance, inability to pay, waiting lists, and waiting times) or straightforward breakdowns in supply? 
Equity Is this patient or group of patients being fairly treated relative to others? Are there any identifiable failings in equity e.g. are some people being dealt with less favourably or less appropriately in their own eyes than others? 
Relevance Is the overall pattern and balance of services the best that could be achieved, taking account of the needs and wants of the population as a whole? 
 Source: adapted from Maxwell 1992.(192) 
 
As long ago as 1966, Donabedian suggested that the quality of care of patients could 
be assessed in three dimensions: structure, process and outcome.(195) Structure refers 
to the availability of suitable buildings, equipment, facilities and adequately trained 
staff. Campbell et al identified two domains of structure: physical characteristics and 
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staff characteristics.(196) The first domain would include both the resources and how 
these resources are organised. For example, the availability of podiatry services in 
terms of personnel and equipment and how these services are organised (e.g. the 
existence of a booking system for appointments) are both structural elements of 
diabetes care. The second domain would include for example level of training and 
experience of the staff involved in delivering healthcare.   
Processes of care refer to the activities of healthcare and involve the interactions 
between users and the healthcare structure. In essence, care processes are all that is 
done to or with patients and characterize what care is actually delivered. For example, 
screening for retinopathy is a care process that can be measured by looking at what 
proportion of patients with diabetes had retinal screening for the preceding 12 
months. 
Outcome refers to the change in the patient’s current or future health status that can 
be attributed to the antecedent care.(197)  Outcomes are consequences of care and 
may be influenced either directly or indirectly by the structures and processes of 
care.(196) Availability of good structure increases the likelihood of good process, and 
good process increases the likelihood of good outcome.(189) In addition, structural 
capabilities might directly influence physician practice pattern.(198)  
Although it is necessary to distinguish between structure of healthcare, actual care 
delivered (processes) and the consequences of this care (outcomes) when they are 
assessed as measures of quality of healthcare, none of them is necessarily the best 
measure of quality. The main disadvantage of assessing the structure measures is that 
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the relationship between structure and process and/or structure and outcome are 
complex and developing evidence for such associations is difficult.(198)  
Assessing the quality of foot care for people with diabetes can be done by measuring 
how many foot clinics and podiatrists were available (structure). Alternatively, it can be 
measured by the number of patients with diabetes who were seen in foot clinics or the 
proportion of all patients who have had foot examination (process). Another option is 
to measure the quality of foot care by comparing the amputation rates (outcome). 
Each dimension has its own limitations in measuring the quality of care. For example, 
assessing the quality of foot care by the number of available foot clinics or podiatrists 
does not guarantee that the patients received care. In a similar manner, using the 
proportion of patients who have had foot examination does not mean that they had 
received the right management. Also, measuring quality through the outcomes is 
limited by many confounding factors that could explain the variation in outcome 
among practices.  
In addition, the outcomes do not directly assess the quality of the processes and 
structures of care.(199) This is because the relationship between the process and 
outcome might be modified by many factors, other than healthcare, that are 
integrated into the end result. These factors can be for instance related to patient 
health awareness, adherence to therapy prescribed or the socioeconomic status.         
This thesis has adopted Donabedian’s model as the theoretical framework for 
assessing diabetes care in the city of Abha in Saudi Arabia. This model was chosen 
because it is simple, explicit and comprehensive in defining the dimensions of the 
quality of care. Under these headings of structure, process and outcome, a wide range 
 
76 
 
of measures can be developed and assessed. Moreover, for each of the Maxwell’s 
dimensions of quality, measures of quality can be derived based on assessment of 
system structure, processes or outcomes of care.(199) In addition, Donabedian’s model 
is suitable for assessing diabetes care because the local diabetes care guidelines and 
quality assurance manuals have used the same dimensions in setting the standards of 
diabetes care.(200-202)  
In this study, all the three dimensions (structure, process and outcomes) were 
considered to assess diabetes care. By reviewing several diabetes management 
guidelines(8, 15, 81, 203-206) and several authoritative reports on diabetes care organization 
and assessment in Scotland,(207-213) a list of quality measures for each dimension were 
chosen to be assessed. However, after reviewing the current Saudi guidelines on 
diabetes care,(200-202, 214-216) the case notes of patients with diabetes and identifying 
which data are locally available, this list of quality measures was shortened. For 
example, measures such as length of waiting for appointment, numbers of patients on 
waiting lists for care and local mortality rate due to diabetes were not measured due 
to lack of data.        
Many experts in assessing the quality of care identified patient views and satisfaction 
as an important dimension of the outcome of healthcare. For example, Crombie said: 
“patient satisfaction is strictly a type of outcome measure, but because of its 
significance it merits a section to itself...Surveys of patient views can identify ways in 
which the service can be improved”.(217) Donabedian also identified the importance of 
the patients’ views on the delivery of care when he said: “quality cannot be judged by 
technical terms, by health care practitioners alone; that the preferences of individual 
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patients and society at large have to be taken into account as well”.(193) Therefore, 
assessing the views and perceptions of patients towards diabetes care was one of the 
measures this study aimed to evaluate.  However, because the perspectives of and 
approaches to quality of care would differ between patients, healthcare professionals, 
and managers, the views of all these three groups of stakeholders were considered.  
The study overall aim is to assess diabetes care in Abha city by evaluating several 
measures for each quality dimension. This was planned to be done by evaluating the 
availability of care resources (structure), estimating the proportions of patients who 
received recommended interventions (process) and assessing how many patients 
achieved the recommended targets of diabetes care (outcome). In addition, the views 
and complaints of key stakeholders regarding diabetes care were also assessed as one 
of the measures of the outcome dimension.     
To be able to assess the measures of each quality dimension as well as exploring 
perceptions of key stakeholders regarding diabetes care, several approaches and data 
collection methods were required.  “The approach adopted and the methods of data 
collection selected will depend on the nature of the inquiry and the type of 
information required”.(218) Therefore, a decision was taken to collect data from 
different sources using multiple research methods in order to achieve the research 
objectives and to assess as comprehensively as possible the diabetes care in Saudi 
Arabia.  
The healthcare system in Abha city is a paper based system and there are no electronic 
systems or electronic databases available. Therefore, the data on diabetes care and 
patient management has to be extracted from either the routine healthcare reports or 
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from the patients’ case notes using specific forms for data collection. This study uses 
multiple methods encompassing structured interviews, semi-structured interviews, 
standard checklist observation, routine data analysis and examination of patients’ case 
notes. It was considered that including the views of key stakeholders would usefully 
supplement and extend the methods used in a triangulation approach. Combining 
these approaches is a good way of approaching research as it counteracts the 
weaknesses of any single approach.(219) Each one of these research methods will be 
described briefly here and in detail in the next chapters.  
However, before that, it seems important to discuss in brief the multi-method 
approach that was used in this study and how it differs from mixed-method approach. 
The terms ‘mixed-method’ approach and ‘multi-method’ approach are often used 
interchangeably. However, it is important to distinguish between the two terms and 
approaches.  
The mixed methods approach is defined as a research in which the investigator collects 
and analyzes persuasively and rigorously both qualitative and quantitative data by 
mixing and treating them together as a whole. (220-221) These data can be mixed either 
concurrently by combining them or merging them or sequentially by having one build 
on the other or embedding one within the other.(221) In mixed methods approach, the 
researcher gives priority to one or to both forms of data and frames the study 
procedures within more than one philosophical worldviews (paradigm).   
The multi-method approach is “the conduct of two or more research methods, each 
conducted rigorously and complete in itself, in one project. The results are then 
triangulated to form a complete whole”.(222) The major difference between multi-
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method and mixed-method approaches is that in multi-method approach, each study 
(method) is conducted separately and is complete in itself.(222-223)    
In this study, each set of data were collected, analysed and presented separately and 
then some of the main findings were compared and triangulated in the discussion 
chapter. All the data were collected at the same time. It might have been better to use 
the sequential explanatory strategy to inform the design of a subsequent qualitative 
study by the findings of a previous quantitative study.(224)  This might help to design 
the subsequent approaches in ways that explore in depth some of the identified issues. 
However, because of the limited time and funds available, this approach was not 
feasible.       
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4.4. Methods of data collection 
Data collection was carried out between 2011 and 2012. Different types of data were 
collected from different sources. Table 5 shows the methods used, their objectives and 
the chapters in which these are presented. 
Table 5: The correspondence between the thesis objectives and the results chapters 
Objective Method of data 
collection 
Sources* Result 
chapter To evaluate what services and resources are available for diabetes care against national standards. 
Standard checklist PHCCs Chapter 5 Service evaluation  questionnaire for medical directors 
PHCCs, AGH, ACH, ADC Chapter 5 
To estimate the registered prevalence of diabetes, its complications and pattern of service utilization. 
Extracting related healthcare data from routine statistical reports  
PHCCs, AGH, ACH, ADC, RHA 
Chapter 5 
To describe people with diabetes in Abha and assess some process and outcomes measures of diabetes care.  
Review of the case notes of patients with diabetes using data collection forms 
PHCCs, ADC Chapter 6 
To explore views, priorities and perceptions of key stakeholders** regarding diabetes care.  
Semi-structured interview schedules  PHCCs, AGH, ACH, ADC,  RHA 
Chapter 7 
To explore healthcare leaders views on the priorities for improving diabetes care.  
Questionnaire for priority ranking of different recommendations 
RHA Chapter 8 
 *PHCCs: Primary Health Care Centres, AGH: Abha General Hospital, ACH: Aseer Central 
Hospital, ADC: Aseer Diabetes Centre, RHA: Regional Health Affairs 
**People with diabetes, healthcare professionals, managers and pharmacists 
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4.4.1. Evaluation of diabetes service provision (chapter 5)    
Evaluating the structure and provision of diabetes services had three main objectives. 
The first was to evaluate the availability of the resources of diabetes care in the PHCCs. 
Observation of available resources using a checklist is generally considered as a gold 
standard for other assessment methods; however, few empirical studies have 
validated this.(225) Therefore, a standard checklist for required resources, which was 
developed by local experts from the MOH, was used to assess, by direct observation, 
the available resources. This standard checklist was used because it was developed 
based on the national standards of diabetes care in primary healthcare. A numerical 
scoring system was developed for the standard checklist to allow for valid comparison 
between the PHCCs.  
The second objective was to assess whether strategies and policies are available for 
diabetes care and whether some specific services are delivered for patients with 
diabetes. Therefore, two separate structured questionnaires, one for the PHCCs and 
one for secondary healthcare, were developed by the researcher (AA) to assess the 
availability of these strategies and the provision of these services. The questionnaires 
were administered by face to face interviews with the medical director of each 
healthcare institution. These interviews supply information about what is available and 
what is routinely done. The face to face interviews allow the researcher to elicit much 
fuller information, probing responses to stimulate memory and give more explanation 
to make sure the questions were appropriately understood and the correct answers 
were obtained. Although most of the questions were closed-ended questions, the 
responses could be biased. The medical directors might give responses that 
underestimate what is available because of perceiving that this might bring more 
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resources. On the other hand, they might overestimate what is available in order to 
show that the care is done properly and there are no deficiencies. However, it was 
difficult to whether response bias was a problem.           
The third objective was to estimate the registered prevalence of diabetes, its 
complications and pattern of service utilization. The available routine data might be 
sufficient to serve these purposes. Every month, the PHCCs and hospitals have to 
collect, assemble and send healthcare statistical reports to the regional health 
authority. These reports include a variety of data and information that cover for 
example, demographic characteristics of registered population, patient attendances, 
healthcare activities and some other vital statistics. Therefore, the researcher decided 
to collect these routine reports for the preceding 12 months to extract and analyze the 
relevant routine data on diabetes prevalence, complications and how the diabetes 
care is utilized. As a result, 168 healthcare statistical reports were collected from 
different sources for the preceding 12 months. Data on diabetes care were extracted 
by the researcher (AA) from the reports and transferred to excel files for analysis. 
These are secondary data because they are being used for purposes secondary to the 
one for which they were collected, but they are potentially rewarding, can be very 
cost-effective and can make a powerful contribution.(199, 226) However, care must be 
taken with the potential shortcomings such as incompleteness, inaccuracy and 
unknown quality.(199)     
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4.4.2. Case note reviews (chapter 6) 
The review of the patients’ case notes sought to describe the characteristics of people 
with diabetes in Abha and assess some process and outcomes measures of diabetes 
care. Case notes are the most obvious sources of data and have been used for various 
methods of assessing healthcare.(217) Case note review allows for retrospective 
assessment of routine provider performance and can assess a large number of 
cases.(225) It enables the researcher to assess all the full range of patients with diabetes 
including severely ill, newly diagnosed, compliant and non-compliant patients.  
Therefore, two structured data collection forms, one for the PHCCs records and one 
for the Aseer Diabetes Centre records, were developed and piloted to obtain the 
required data. In each PHCC, two to three members of the project team reviewed all 
the records of patients with diabetes and filled one form per patient. In Aseer Diabetes 
Centre, three team members reviewed a sample of the records of registered patients. 
Reviewing patients’ records (case notes) are clearly an excellent source of data(217), 
however, they have limitations. For example, there is no control over the data 
available and there is limited control over missing records and missing records data. 
The patients’ records are not always available and accessible; sometimes it is difficult 
to identify the case notes of particular types of patients such as patients with diabetes. 
Hand-written notes may be unformatted, difficult to search and hard to read.(227) 
    
4.4.3. Stakeholder views (chapter 7) 
 The views of both the providers and the users of diabetes care should be explored and 
considered to inform care improvement. Exploring and eliciting the views of local 
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interested parties is the most appropriate method sensitive to local concerns and 
circumstances.(228) Therefore, key informants were interviewed to explore their views, 
experience, priorities and perceptions regarding diabetes care, its problems, areas of 
and barriers to service improvement. Four semi-structured interview schedules were 
developed and piloted. Fourteen physicians were recruited and trained on how to 
conduct a face-to-face interview using the novel semi-structured interview schedule. 
The main researcher and the physicians then conducted face-to-face interviews with a 
systematic sample of 235 patients with diabetes. The main researcher also conducted 
face-to-face interviews with a purposive sample of 29 healthcare professionals, 13 
healthcare managers and 13 pharmacists. 
Using the face-to-face Interviewing gives the researcher the opportunity to clarify and 
explain when questions are not understood. They can probe in depth to obtain key 
facts and discuss responses. The interviewees also have the chance, during or at the 
end of the interviews, to review their responses and modify any answer. The semi-
structured type of interview schedules was used because specific information, such as 
having a list of patients’ healthcare needs and a list of care problems and difficulties, 
were required. This type of interview schedules helps the researcher to remain flexible 
to collect information on other important issues as they arise.   
On the other side, the disadvantages of face-to-face interview are its high costs, time 
consuming and need to be conducted by skilled interviewers.       
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4.4.4. Healthcare leaders’ priorities (chapter 8) 
The healthcare leaders are usually very busy to offer time for long interview with a 
researcher; and their priorities and views are better to be explored using a structured 
questionnaire with fairly easy list of answers or a rating scale. Therefore, after analysis 
of the data collected from the above approaches, a questionnaire for healthcare 
leaders was developed to explore their priorities on some suggested recommendations 
for improving diabetes care.  A purposive sample of 18 healthcare leaders was asked to 
rate the priority of each recommendation on a rating scale of 0-100%, where 0% was 
the lowest priority and 100% was the highest priority. 
Using self-administered questionnaires was much quicker and cheaper to undertake 
than interviews. However, this method has some limitations. For example, the 
response rate tends to be relatively low and there may be more missing answers than 
in interviews.(229) 
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4.5. Research flow and team development  
Figure 14 shows the research flow and phases. The first phase was a preparatory phase 
which began by a literature review and ended by establishing a research team.  The 
reviewed literature included international and local diabetes management guidelines, 
authoritative reports and manuals on diabetes care organization and evaluation as well 
as studies on diabetes in Saudi Arabia. This review helped to give a comprehensive 
background to the scale of the problem of diabetes in Saudi Arabia in terms of its size, 
time trend, risk factors, complications and burden. Following this, a research proposal 
was written specifying the aims, objectives and approaches of the research. Moreover 
a field/work plan was written which specified the research phases, tasks and sources 
of data. The research tools such as the data collection forms, questionnaires and 
interview schedules were then designed and piloted. Ethical approvals and permissions 
to conduct the project were obtained from the University of Dundee, the King Khalid 
University and the Regional Health Affairs (RHA) in Abha city (Appendices 4- 6).  
Grants and support was also obtained from the University of Dundee, the King Khalid 
University and the Saudi Ministry of Health. With this support, the researcher 
established 16 research teams across Abha city. Inviting team members to participate 
in the project included several methods such as email invitation letter, phone calls, 
online invitation form, and direct visits to the PHCCs and diabetes centre. Figure 14 
summarizes the organization of the research teams and the tasks of each team. Four 
supervision teams were developed which included 2 to 3 supervisors who work in the 
administration of each healthcare sector. The tasks of these teams were to provide 
training and to monitor the progress of achieving our targets. Eleven working teams, 
one in each PHCC and one in the diabetes centre, were formed. These teams included 
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nurses and physicians. The participating nurses were given 2-3 days per week free of 
work by the RHA to review the case notes of patients with diabetes. The participating 
physicians conducted interviews with patients. 
 
88 
 
Figure 14: Research flow and phases 
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Figure 15: Project organization and tasks of each team* 
*AA: Abdullah Alshehri, the main researcher and author of this thesis, ADC: Aseer 
Diabetes Centre.  
 
After developing the research teams, several meetings were convened with the 
supervision teams to explain and train all the members on how to interview patients 
and fill in the data collection forms. The supervision teams then visited each PHCC to 
explain to the working teams how to fill in the forms and how to interview patients. 
The main researcher (AA) also visited all the PHCCs to provide the teams with the 
required copies of interview schedules and data collection forms and provide further 
training. Frequent visits to the different working teams were carried out by the main 
researcher each week. The aims of these visits were to collect the completed forms 
and interviews from each PHCC as well as to interview healthcare professionals, 
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managers, medical directors and pharmacists. Also during these visits, the routine 
healthcare reports were collected and the standard checklists were filled in. The 
department of statistics in the RHA was also visited to collect further healthcare 
reports. The collected data were then transferred to University of Dundee for the 
purposes of digitalization and analysis. All the data analysis in this thesis was done 
independently by the main researcher (AA). 
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CHAPTER FIVE 
 
  
Evaluation of diabetes 
service provision 
 
This chapter reviews the organization of the current healthcare system and 
diabetes care in Saudi Arabia. It gives an overview about diabetes care services 
in Abha city and presents the results of evaluating in depth the current diabetes 
services in Abha city against national standards. Several gaps in service 
provision are discussed. 
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Chapter 5: Evaluation of diabetes service 
provision 
 
5.1. Introduction 
5.1.1. Organization of healthcare system in Saudi Arabia 
Many autonomous governmental and private agencies are involved in healthcare 
delivery in Saudi Arabia. The governmental healthcare services are provided free of 
charge to all Saudi citizens and expatriates working in the public sectors. Figure 17 
shows the different governmental agencies which provide healthcare services in Saudi 
Arabia.  Currently, the Ministry of Health (MOH) and the Saudi Red Crescent provide 
healthcare services to the whole public while the other governmental agencies such as 
the military or education agencies provide services to a defined group of the 
population, usually employees and their families. The MOH is the largest provider of 
healthcare services in Saudi Arabia, providing almost 59% of inpatient care. (230) The 
other governmental healthcare providers and the private sectors provide 20% and 21% 
of the inpatient healthcare facilities respectively.(230)   
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Figure 16: Organization of healthcare services in Saudi Arabia* 
*MOH: Ministry of Health, MOHE: Ministry of Higher Education, MOE: Ministry of 
Education 
 
In 1979, the MOH in Saudi Arabia adopted the WHO primary healthcare approach for 
achieving the goals of Health for All by the year 2000.(216)  In 1980, a ministerial decree 
was issued to establish primary health care centres (PHCCs) by merging the existing 
local health offices, maternal and child health centres and dispensaries into single units 
(PHCCs).(231) The PHCCs carried out population census within their catchment areas, 
opened medical records for each resident and family, and implemented the 
components and strategies of primary health care in Saudi Arabia.(216)  
The MOH currently has 2,109 PHCCs scattered across Saudi Arabia. These networks of 
PHCCs are the first point of contact with public health providers. Proof of residency 
within the catchment area of the local PHCC and opening a medical record are 
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required before services are provided. Each group of PHCCs is linked to a secondary-
level local hospital by a referral and feedback system which, in turn, is linked to a 
tertiary-level central hospital and specialised hospital. Patients who require higher 
levels of healthcare at MOH facilities must receive a referral form from a PHCC except 
in case of emergency. 
The PHCCs provide healthcare services which are essentially promotional, preventive 
and curative. They include maternal and child healthcare, treatment of common 
diseases, management of chronic diseases (e.g. diabetes, hypertension, asthma), 
immunization, dental care, provision of essential medicines, environmental health, 
food hygiene, health education and control of endemic diseases.(216) These 
components of primary health care should be delivered with respect to equity of 
distribution, community participation, using appropriate technology and cooperation 
with other governmental sectors.(216) Ideally, each PHCC should include the following 
units and clinics:  
1. General adult clinic for males 
2. General adult clinic for females 
3. Nursing clinic for males 
4. Nursing clinic for females 
5. General Paediatric clinic 
6. Paediatric nursing clinic including vaccination facilities 
7. Maternal clinic 
8. Nursing clinic for the maternal clinic 
9. Waiting areas 
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10. Pharmacy 
11. Laboratory 
12. Mini-clinic for chronic diseases 
13. Nursing clinic for chronic diseases 
14. Clinic for health education and promotion 
15. X-ray unit 
16. Dental clinic for males 
17. Dental clinic for females 
18. Records unit 
19. Administration unit  
20. Health inspection unit 
21. Unit for staff meetings 
22. Toilets 
23. Room for storage 
24. Car parks  
At the national level, 60% of PHCCs are equipped with laboratories, 33% with x-ray 
equipment and 59% have dental clinics.(230) Each centre has, on average, 4 physicians 
and provides health services to 13,455 persons. In Aseer district, 36% of the PHCCs are 
equipped with a laboratory, 33% with x-ray equipment and 54% have dental clinics. In 
comparison to the other districts in the kingdom, Aseer district and the Eastern district 
had the lowest proportions of PHCCs with laboratory facilities (36% and 34% 
respectively). The Northern district has the lowest proportion (40%) of PHCCs with 
dental clinics while Bishah district has the lowest proportion (12%) of PHCCs equipped 
with x-ray machines ( Figure 18).(230)  
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Figure 17: PHCCs of MOH in Saudi Arabia by MOH districts and some selected indicators, 2011(230) 
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5.1.2. Diabetes care organization in MOH 
The increased prevalence of non-communicable diseases, their morbidity and 
mortality in Saudi Arabia necessitated the government to adopt several initiatives and 
programmes in order to prevent and control these diseases. The MOH established a 
General Directorate for preventing chronic diseases which is responsible for tackling 
and managing the prevalent chronic diseases such as diabetes, hypertension, obesity 
and asthma.  
The organization of diabetes care in developed countries has changed over time. 
Formerly, in the United Kingdom for example, people with diabetes were usually cared 
for by hospital clinics.(232) With time, the involvement of general practitioners in taking 
care of people with diabetes, particularly the routine and primary care, started to 
increase gradually.(232) Malins and Stuart described the first scheme of involving 
general practice in diabetes care in 1971.(233) In 1973, Thorn and Russell suggested that 
care of diabetes at the primary healthcare level is better than at hospital in the United 
Kingdom.(234)  
A similar story happened in Saudi Arabia. In the early years, patients with diabetes 
usually received primary healthcare at hospital clinics. After the establishment of the 
primary healthcare centres, the routine care of people with diabetes began to be the 
responsibility of primary healthcare physicians.     
  As a result, in 1994, the scientific committee of quality assurance issued guidelines 
and standards for a quality assurance programme in primary healthcare, which was 
approved by WHO.(200) It included guidelines and standards for diabetes care at the 
PHCCs. In addition, a programme of mini-clinics for diabetes, hypertension and asthma 
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was initiated at the level of primary healthcare in order to improve the control and 
management of these diseases. The MOH issued several guidelines and manuals to 
organise and appropriately implement this programme at all PHCCs.(201-202, 235)   
The main aim of the mini-clinic initiative is to standardize the process of care of 
patients with chronic diseases according to the best evidence and with optimal use of 
the available resources. Its objectives are first, to prevent the chronic diseases by:  
• Reducing risk factors,  
• Detecting people at risk,  
• Screening them for early diagnosis,  
• Early detection of complications and  
• Health education.  
The second objective is to manage patients through a follow up appointment system 
and shared care with hospitals. The third objective is to promote optimal use of drugs 
by patients.(201-202, 216)  
In 2008, the Gulf Committee for Control of Diabetes (GCCD) published an executive 
plan for control of diabetes in the Arabian Gulf countries. This plan was considered as a 
comprehensive guidance plan for the forthcoming ten years. Each country should put 
its operational plan within the components of this plan with taking proportionality into 
account for each country. The plan stated 7 objectives to achieve control of diabetes 
and improve diabetes care at all levels of healthcare.  
These objectives are:  
1. Primary prevention of T2DM. 
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2. Secondary prevention of T2DM. 
3. Quality Improvement of health services at all levels of healthcare as provided 
to patients with diabetes. 
4. Support of methods of control, monitoring, and evaluation of diabetes. 
5. Conduct and support of diabetes research and studies. 
6. Empowerment of patients and their families to take part in control of diabetes 
and its complications. 
7. Activating community participation and partnership for control of diabetes.  
Each objective included several targets, strategies, implementation mechanisms and 
performance indicators.(215) In Saudi Arabia, there was no operational plan except the 
already established mini-clinic programme at the level of primary healthcare. 
At the secondary healthcare level (hospitals), different specialist clinics were 
established such as ophthalmology, nephrology, endocrinology and nutrition clinics 
where referred patients can be managed at the request of the primary healthcare 
physician.(200) At these clinics, specialist or consultant physicians usually examine 
referred patients to confirm diabetes diagnosis and initiate treatment or to manage 
uncontrolled diabetes and its complications.(200) Primary healthcare physicians should 
also refer patients with diabetes each year to the general hospital in order to screen 
patients for any complications. If a patient needs advanced treatment, the treating 
physician will refer the patient to a tertiary hospital or to a diabetes centre where 
specialised and advanced care is offered.(200) Children, pregnant women, patients with 
T1DM and those with known complications of diabetes need to be managed by shared 
care with hospitals through the referral and feedback system (Figure 19).(200)      
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More than 20 diabetes centres were opened across Saudi Arabia. These specialist 
centres provide secondary and tertiary care specific for people with diabetes in 
cooperation and integration with both PHCCs and hospitals. Diabetes centres also 
provide health education and promotion services.      
Figure 18: Diabetes care services and pathway in MOH, Saudi Arabia 
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5.1.3. Overview of diabetes services in Abha 
Diabetes care services in Abha are provided by 10 individual primary healthcare 
centres (PHCCs), one general (maternity) hospital, one central hospital and one 
specialist diabetes centre. The healthcare services that are provided to those with 
diabetes by these PHCCs and hospitals are similar to what has been briefly described in 
figure 19.  
The PHCCs and their staff provide the healthcare services to those with diabetes either 
through the general clinic or the diabetes mini-clinic. The general clinic provides 
general medical care to all the registered population including those with diabetes. The 
diabetes mini-clinic provides the other elements of diabetes care services. 
 Abha General Hospital (AGH) is a maternity hospital with a variety of outpatient 
specialist clinics. The outpatient clinics provide healthcare services to all people with 
diabetes based on referral from either the emergency department of the hospital or 
from the PHCCs. Pregnant women with diabetes or gestational diabetes receive shared 
care by both the PHCCs and AGH. In case of emergency, the pregnant woman can be 
managed in the AGH emergency department and can be admitted in AGH for inpatient 
treatment.  
Aseer Central Hospital (ACH) provides a wide range of specialist services for patients 
with diabetes. These services include emergency care; inpatient care such as managing 
diabetes complications (e.g. amputation surgery), outpatient follow-up care, 
laboratory services and pharmacy services. The hospital also takes referrals as 
appropriate through its outpatient clinics.     
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Aseer Diabetes Centre (ADC) is a specialist centre for diabetes care. It provides follow 
up care for referred patients. The follow-up care includes management of diabetes and 
its complications. Patients with diabetes are registered in the centre based on referral 
from either the PHCCs or the hospitals.  
 
5.2. Objectives  
The aim of this chapter was to identify gaps in service provision for people with and at 
risk of having diabetes in Abha city, by comparing what was provided against national 
standards. This aim implies several objectives. The first objective was to evaluate 
whether the diabetes services are structured and resourced in such a way as to allow 
quality care to be delivered. This requires assessing the availability of the resources for 
diabetes care in both the primary and secondary healthcare. The second objective was 
to explore how diabetes is managed by reviewing the organization and delivery of the 
current diabetes care services. The third objective was to collect and analyze the 
available routine data on diabetes care in order to estimate the local prevalence of 
diabetes and its complications and to describe the pattern of service utilization.   
 
5.3. Methods 
5.3.1. Mini-clinic evaluation checklist for PHCCs 
A comprehensive checklist for evaluating the structural resources of the mini-clinics at 
the PHCCs was devised by experts in the department of primary healthcare and 
preventive medicine at the Regional Health Affairs (RHA) in Aseer region. This checklist 
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was used to identify the unavailable resources in each mini-clinic. A meeting was 
convened, by the researcher (AA), with 4 of those experts who developed the 
checklist. The aim of the meeting was to discuss how this checklist could be used in 
this study and how to improve its use. In the meeting, the researcher suggested 
developing a scoring system that enables the evaluators to assess and compare among 
clinics different aspects of resource availability by having: a total score that reflects the 
completeness of the clinics’ resources; a sub-score for the resources of each important 
functional unit of the clinic; higher scores to those important resources.  
 
Some items in the checklist were not actually resource-related items, therefore, the 
committee agreed to remove them from the list. At the end of the meeting, a 
consensus was reached on the score of each item in the list (Appendix 7) and a 
numerical scoring system for the checklist was developed. This scoring system was 
established on a scale of 0-10. A score of 0 reflects absence of the item in the mini-
clinic and scores of 1-10 reflect the presence of the item in the mini-clinic. The 
availability of some items in the mini-clinic is more important than other items. 
Therefore, the scores from 1-10 rank the importance of the availability of the items in 
the mini-clinic. For example, a score of 1 for an item means that the item is available in 
the mini-clinic and its importance rank is 1. Another item is given a score of 10 which 
means that the item is available and its availability importance is 10 (the highest 
importance available). The total score is obtained by summing the score of each item. 
By this system of scoring, the researchers were able to give a total score for each mini-
clinic in the city which reflects both the availability of each item and the availability of 
important items. 
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The resources of each mini-clinic were then evaluated using the checklist. The 
researcher, accompanied by the medical director of each PHCC, visited the mini-clinics 
and assessed the available resources by direct observation and by reviewing the 
routine monthly statistical reports.   
The evaluation checklist was divided into 7 parts including, important functional units, 
waiting space resources, consultation room resources, nursing room resources, 
laboratory resources, health education resources and pharmacy resources. Each part 
includes a list of resource items that should be available in each part of the PHCC 
(Appendix 7).  
 
5.3.2. Service provision questionnaire for PHCCs 
By reviewing the quality assurance in primary healthcare,(200) the MOH mini-clinics 
guidelines,(201-202, 216) and the Gulf Executive Plan for Control of Diabetes,(215) additional 
questions were organised into a structured interview questionnaire. This questionnaire 
was developed to review the current provision of diabetes care services in PHCCs and 
to identify the gaps in service provision with emphasis on the processes of diabetes 
care (Appendix 8). Specific questions were added to the questionnaire about whether 
some evidence based cost effective services are delivered for patients with diabetes or 
not.(206, 236-237) Most of the questions were closed questions and their answers were 
collected by face to face interview with the medical director of each PHCC. Each PHCC 
was visited by the researcher and permission to conduct the interviews was taken 
from the PHCC manager either verbally or by submitting a request. A consent form was 
also collected from each interviewee.  
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5.3.3. Service provision questionnaire for secondary care 
Another structured questionnaire was developed for reviewing the provision of 
diabetes care services at the level of secondary healthcare (hospitals and diabetes 
centre), (Appendix 9). In Saudi Arabia, there were no guidelines or manuals for the 
clinical standards or processes of how to manage diabetes at hospitals or diabetes 
centres to compare against. However, by reviewing the Gulf Executive Plan for Control 
of Diabetes,(215) several questions that cover the essential components of diabetes care 
were organised into a structured interview questionnaire. The questionnaire included 
questions about availability of strategies for tackling diabetes at the national or 
regional level, availability of essential resources such as antidiabetic drugs, records, 
education materials and specialist clinics. In addition, the questionnaire asked also 
about the workforce profile and provision of some specific services for people with 
diabetes.  
 
The medical directors, nurse managers or physicians who work in the outpatient clinics 
of AGH, ACH or ADC were interviewed by the researcher. These professionals were 
selected because they are the key stakeholders who know about the available services 
and resources for diabetes care. Formal permission to conduct the interviews was 
obtained from the hospital managers and consent forms were completed by the 
interviewees. 
  
5.3.4. Service utilization and healthcare burden 
Routinely collected data can answer some research questions despite being collected 
for other purposes, often unrelated to research. Routine data can provide information 
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on the use of healthcare resources and on the frequency of the different diseases.(238)  
In Abha city the available routine data, which were often collected for statutory and 
administrative purposes, were expected to give sufficient information on the local 
prevalence of diabetes, its complications and on the pattern of service utilization. In 
each clinic, unit or department in the PHCCs or the hospitals, there is a specific register 
for some data about the characteristics of the visiting patients and some related 
healthcare activities. Every month, the medical directors/managers of each healthcare 
institution (e.g. PHCC, hospitals, diabetes centre) have to extract data from large 
bound paper ledgers. These data are then assembled in form of a standard statistical 
report that is sent regularly to the regional health authority. These reports (168 
reports) were collected from the department of statistics in the regional health 
authority. The collected reports were in a paper format and cover the preceding 12 
months for all the PHCCs, AGH, ACH, and the ADC. The data on diabetes prevalence, 
complications, service provision and utilization were all extracted by the researcher 
(AA) from the reports and transferred to excel files for analysis. Estimating the local 
registered prevalence of diabetes would indicate how effective the screening services 
for diabetes are. Moreover, estimating the prevalence of diabetes complications, using 
routine data, is one of the methods of assessing diabetes care by one of its outcome 
measures. Using routine data to evaluate service provision and utilization would help 
to estimate the current workload in terms of time and place and might show the effect 
of insufficient resources on the processes of diabetes care.  
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5.4. Results 
5.4.1. Primary healthcare services 
Mini-clinic resources evaluation (structure of diabetes care):  
The availability of the resources to implement the mini-clinic programmes was 
evaluated in each PHCC. The scoring system showed that none of the 10 mini-clinics in 
Abha were completely equipped. The mini-clinics of Almowadafeen and Sultan city 
PHCCs were the best equipped mini-clinics followed by Almansak and Alnumais mini-
clinics (Table 6). The mini-clinics of Therah and Alaziziah PHCCs were the least 
equipped clinics in Abha.  
Availability of Important functional units: 
The buildings of seven PHCCs were rented houses while three, Almowadafeen, Sultan 
city and Alnumais PHCCs, were governmental buildings. There was no laboratory or 
dental clinic in Johaan PHCC. An ambulance was available only in Alkaabel and 
Alnumais PHCCs. All the PHCCs have waiting area for patients, consultation room for 
doctors, pharmacy and telephone lines. The nurses of the mini-clinics of Johaan and 
Alnumais PHCC do not have separate rooms. Also, there were no separate rooms for 
health education/promotion clinics in three PHCCs, Wasat Abha, Alaziziah and 
Alnumais. An X-ray unit was available in 5 PHCCs only. 
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Table 6: Evaluation of the resources of diabetes mini-clinic in each PHCC* 
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Ideal score 116 26 52 83 12 22 56 367 
Almowadafeen 102 18 38 70 8 14 39 289 
Sultan city 91 22 44 73 7 10 38 285 
Almansak 76 22 41 67 9 19 45 279 
Alnumais 95 17 34 65 10 7 39 267 
Almanhal 82 18 38 65 8 15 39 265 
Alkaabel 91 17 33 57 5 7 36 246 
Johaan 45 22 42 77 2 17 28 233 
Wasat Abha 70 18 24 58 9 6 35 220 
Therah 71 8 28 50 8 11 28 204 
Alaziziah 65 13 29 47 8 13 15 190 
Median 79 18 36 65 8 12 37 255.5 
* Green coloured scores are the 4 lowest scores in each category  
In Abha city, the total population served by PHCCs was 126,767 persons. Table 7 shows 
the workforce profile for all the PHCCs in Abha city. The total working physicians in 
primary care were 53 physicians. Only six of them were family medicine trained 
physicians. The number of physicians broadly followed population size in each PHCC. 
However, there were quite large inconsistencies. For example, in Alaziziah PHCC, each 
physician delivers healthcare services to 1465 persons while in Wasat Abha PHCC, each 
physician delivers healthcare services to 4021 persons. Moreover, each nurse in 
Johaan PHCC, for example, delivers healthcare services to 211 persons while in Wasat 
Abha the nurse delivers healthcare services to 1058 persons. This would indicate that 
the workload is high on the healthcare staff of Wasat Abha PHCC compared with other 
PHCCs. The laboratory of Almansak PHCC needs a laboratory technician and the x-ray 
units of Almowadafeen and Sultan city PHCCs need x-ray technicians. The table 
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indicates that there is a need to redistribute the working staff of some professions 
such as laboratory technicians and midwifes.  
Waiting spaces: 
Almanhal, Wasat Abha, Alaziziah and Therah PHCCs had limited waiting areas while 
Alkaabel, Alaziziah, Alnumais and Therah PHCCs do not have nearby toilets.  
Consultation room resources:  
Resources for the consultation rooms were apparently inadequate. For example, an 
ophthalmoscope was not available in 4 PHCCs and tuning fork was not available in 6 
PHCCs. Monofilament was not available in 8 PHCCs. Some physicians use their own 
instruments; however, these instruments should be provided by the MOH and should 
be available at all times in the mini-clinics. 
Table 7: Workforce profile of all the PHCCs in Abha city 
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Almanhal 18593 6 1 3 15 2 3 2 1 1 3 
Wasat Abha 20105 5 0 2 19 0 2 2 1 1 3 
Almansak 9774 5 1 2 16 2 2 0 0 1 1 
Almowadafeen 19473 6 2 2 23 0 2 1 0 2 4 
Johaan 1264 1 0 0 6 0 1 0 0 1 0 
Sultan city 10015 4 0 1 13 3 1 1 0 1 2 
Alkaabel 14082 5 0 2 15 2 1 1 0 1 2 
Alaziziah 7323 5 0 2 12 1 3 1 0 1 2 
Therah 7655 4 1 2 13 2 2 1 0 1 4 
Alnumais 17763 6 1 2 15 2 3 1 1 2 3 
Total 126767 47 6 18 147 14 20 10 3 12 24 
*FM physician: Family medicine physicians with either diploma or higher degree in 
family medicine   
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Nursing room resources: 
The nursing rooms were not completely equipped. Wasat Abha and Alaziziah nursing 
rooms had insufficient strips for the glucometer. An electrocardiogram (ECG) machine 
was available in 5 mini-clinics; however, tracing papers were sufficiently available in 2 
mini-clinics only. A computer with printer and scanner were only available in 2 mini-
clinics. Specific drugs called standard emergency drugs should be available in the 
nursing room of each mini-clinic; however, they were not available in the nursing 
rooms of 4 mini-clinics. Health education materials were available in the nursing rooms 
of all the PHCCs.           
Laboratory resources: 
Laboratory facilities were also inadequate. Complete blood count test (CBC) was 
available in 7 PHCCs. HbA1c test and blood electrolytes were not available in any of the 
PHCCs.  Blood glucose testing and urine dipsticks were available in all of the PHCCs. 
Erythrocyte sedimentation rate (ESR) and lipid profile tests were available in all the 
PHCCs except in Johaan PHCC.  
Health education resources: 
Seven PHCCs have dedicated a room for health education and promotion. Projectors 
were available in 4 PHCCs and TV (LED/LCD) was available in only 1 PHCC. Health 
promotion registers and records were not available in Wasat Abha PHCC.  
Pharmacy resources (medications): 
Two types of medications should be available in each PHCC according to the MOH 
updated essential drug list in December 2010. The first type should be available in the 
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pharmacy and the second type is an emergency type which should be available in the 
nursing room.  
Of the first type, oral antidiabetic (Glibenclamide, Metformin, and Gliclazide) and 
insulin (Isophan and regular) were available in all the pharmacies. Mixed Insulin 
(Mixtard) was available in Almanhal and Wasat Abha PHCCs while the Lantus pen was 
only available in Almanhal PHCC. Of Angiotensin-converting enzyme inhibitors (ACEIs), 
only Captopril was available in all the pharmacies while other ACEIs were not available. 
Of Angiotensin Receptor Blockers (ARBs), only Losartan was in the updated list and it 
was not available in all the PHCCs. Aspirin was available in all the pharmacies while 
statins (Simvatatin) was only available in 3 PHCCs (Almanhal, Almansak, Almowadafeen 
PHCCs). Other Statins in the list were not available (Pravastatin and Atrovastatin). 
Of the second type (emergency drugs), Dextrose 50% and Ringer lactate were available 
in 9 nursing rooms of mini-clinics. Adrenalin injections were available in 9 PHCCs, 
Atropine injections in 8 PHCCs, and Antihistaminic injections in 5 PHCCs. 
  
Evaluation of the service provision questionnaire (process of diabetes care):  
All 10 medical directors of the 10 PHCCs were interviewed. In addition to closed 
questions (yes or no), the respondents gave comments and explanations for their 
answers (Appendix 8). The interviewees used their knowledge, experience and clinical 
judgment to answer the questions. In this study, there were only 10 data points 
(answers) for each variable (question) which limit the analysis of data. However, the 
important findings and key deficiencies are reported in the following paragraphs.        
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There was no computer system, programs or electronic database for diabetes in any of 
the PHCCs. However, some PHCCs had computers that are used for limited 
administrative purposes such as typing and printing documents. There were also 
standard forms for monthly and yearly data collection that are used in each clinic in 
the PHCC to report its statistical data including data about diabetes. This has been 
considered by some medical directors as a system for diabetes data collection.    
All the PHCCs implement the programme of diabetes mini-clinics. They have assigned a 
specific equipped room for the clinic together with one or two physicians and one or 
two nurses. Other important parts of the programme were established in all the PHCCs 
such as having diabetes register, specific records for each patient with diabetes, and a 
system for identification of the record of the family of any patient with diabetes. Each 
PHCC has an appointment system for patients’ follow-up, defaulters’ follow-up system, 
referral and feedback system and forms. Nine PHCCs reported that they received the 
hospital feedback forms from patients rather than by post.   
The local guideline for diabetes management(214) was available in all the PHCCs. 
However, the protocol for emergency management of hypoglycaemia and ketoacidosis 
was not available in 5 PHCCs. A new national clinical practice guideline for diabetes 
management in primary healthcare was published while this study was underway. This 
guideline was not available in any of the PHCCs. There was no referral guideline that 
organizes and explains in detail criteria for referring patients and procedures for 
referral and feedback. Eight PHCCs reported that they do not receive hospital feedback 
for each referred patient.    
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Wasat Abha PHCC has not implemented the health education and promotion initiative 
and has not assigned a specific clinic for it. There were no trained physicians on 
diabetes management in Wasat Abha and Alkaabel PHCCs. Nurses at all the mini-clinics 
received some training on diabetes management except those in Almansak PHCC.   
The survey showed that there are two family medicine consultant diabetologists who 
work in the family medicine training programme and sometimes cover the diabetes 
mini-clinics of Almanhal, Almansak and Almowadafeen PHCCs. There were no 
dieticians, podiatrists or health educator specialists in any of the PHCCs.  
When the medical directors were asked about delivering specific education 
programme for patients with diabetes, all replied that there is no specific well 
structured programme for educating people with diabetes. However, there are some 
guidelines and educational checklists for the primary healthcare teams to consider 
when educating their patients as part of the mini-clinic programme. None of the PHCCs 
deliver any home care for people with diabetes. All those with diabetes complications 
are referred to AGH, ACH or ADC for management. Six medical directors reported that 
there were some difficulties in accessing the hospital laboratory and requesting some 
tests for patients such as renal function test, HbA1c test and lipid profile.     
 Some of the known cost-effective diabetes services are provided as part of the mini-
clinic programme. For example, retinopathy screening for all patients with diabetes 
and foot screening for those at high risk are provided in AGH through the referral for 
annual review. Screening obese people for IGT is provided in each mini-clinic of each 
PHCC.    
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All the primary healthcare medical directors reported that they do not provide the 
following diabetes services in their PHCCs:  
1. A programme for tight control of blood glucose and blood pressure for 
patients with diabetes.   
2. Retinopathy screening for all patients with diabetes. 
3. Foot screening for those at high risk. 
4. Multiple risk factor management programmes. 
5. A structured patient self-care education programme.  
6. Reduction of obesity and physical inactivity in high-risk groups. 
5.4.2. Secondary healthcare services 
Evaluation of the service provision questionnaire for secondary care: 
Secondary healthcare resources and processes of diabetes care: 
In the outpatient department of AGH, the medical director, the nurse manager and the 
physician of the diabetes clinic were interviewed by the researcher using the 
questionnaire described in section 5.3.3 (Appendix 9). In ADC, the manager of the 
centre (paediatric endocrinologist), and the nurse manager were interviewed. In ACH, 
a consultant diabetologist was interviewed.      
The secondary healthcare specialist teams in AGH, ACH and ADC provide specialist 
diabetes care services to the Abha population through referral of patients from the 
PHCCs. The available resources for providing high quality secondary care for people 
with diabetes were found to be suboptimal. Several deficiencies were identified. Some 
deficiencies were common to all hospitals and the diabetes centre. These deficiencies 
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are described first, in the next two paragraphs, and specific deficiencies for each 
healthcare institution are then identified.          
The interviews confirmed that there is no National Service Framework to address 
variation in standards of diabetes care and to achieve greater consistency in the 
availability of services and resources. The Gulf Executive Plan for Control of Diabetes 
was considered as a national strategy for tackling diabetes in Saudi Arabia by four of 
the six interviewees. There was no published national or local operational plan for 
control of diabetes. Further, there was no local managed clinical network for diabetes 
management or published diabetes care pathway. At the level of secondary care, there 
was no national or local clinical practice guideline for diabetes management. However, 
some physicians stated that they follow other guidelines such as the American 
Diabetes Association (ADA) guideline and the American Association of Clinical 
Endocrinologists (AACE) clinical practice guidelines. There were no national or local 
strategies for promoting physical activity or healthy eating, even though the Gulf 
Executive Plan for Control of Diabetes recommends setting and implementing 
strategies for promoting physical activity and healthy eating.   
In AGH, ACH and ADC, there is no electronic database or system that enables provision 
of data for evaluation of diabetes care. On the other hand, there is a simple paper-
based system for collecting brief data about diabetes statistics.  
Abha General Hospital (AGH): 
In the outpatient clinics of AGH, there is a specific diabetes clinic which provides a 
wide range of diabetes care services such as taking referrals, confirming diagnosis, and 
conducting annual check-ups. The physicians who cover the clinic were either 
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specialists or consultants in internal medicine but were not diabetologists. There is an 
appointment system for those patients who were referred from the PHCCs but there is 
no follow-up system for registered patients or defaulters. There was an ophthalmology 
clinic, dermatology clinic, dietetic clinic and clinic for emergencies. In addition, there 
was a specialist clinic for pregnant women with diabetes which was covered by an 
obstetrician. There was no foot care clinic (podiatry services) or health education clinic. 
However, health education leaflets and diabetes identification cards were available. A 
pharmacy and a laboratory were available. 
 The hospital recently started the process of opening a diabetes register with a specific 
file for each patient visiting the hospital. The referral of patients to other clinics in the 
same hospital or to other hospitals is available. However, there is no feedback system 
or feedback form and there is no guideline for explaining the referral process. The 
outpatient clinics provide specific diabetes services to those patients who were 
referred for annual review. These services include, retinopathy screening, foot 
screening, ECG, chest x-ray and conducting several laboratory investigations such as 
blood glucose, urine dipstick, cholesterol, triglycerides and creatinine tests. On the 
other hand, the outpatient clinics do not provide the following diabetes services:  
1. A programme for tight control of blood glucose and blood pressure for 
patients with diabetes. 
2. Screening obese people for IGT.   
3. Multiple risk factor management programmes. 
4. A structured patient self-care education programme.  
5. Reduction of obesity and physical inactivity in high-risk groups.  
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Among the staff of the outpatient clinics of AGH, there were no diabetologists, 
dieticians or podiatrists. There was only one ophthalmologist and one dietetic 
technician. Only 2 nurses out of 12 nurses in the outpatient clinics had received 
training on diabetes management. 
The available antidiabetic drugs in AGH pharmacy were the following: 
1. Metformin tablets, 500 mg 
2. Glibenclamide tablets, 5 mg 
3. Gliclazide tablets, 80 mg 
4. Insulin injections, human isophan, 100 units/ml 
5. Insulin injections, human regular, 100 units/ml 
6. Mixed human insulin, 100 units/ml (Mixtard) 
7. Insulin detmir or insulin glargine 100 units/ml (Lantus vial) 
8. Glimepiride tablets, 3 mg, 2 mg  
Aseer Central Hospital (ACH): 
ACH is a central large hospital which takes referrals from other hospitals and provides 
emergency, inpatient and outpatient specialist diabetes services. There are outpatient 
clinics for different specialists such as endocrinologists, ophthalmologists, surgeons 
and many other specialties. These specialist teams provide a wide range of healthcare 
services for people with diabetes such as inpatient treatment and outpatient follow-up 
care for patients with diabetes complications. However, there is no specific clinic for 
podiatry services, dietetic services or health education services.   
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The available computer (electronic) system in ACH is used mainly for administrative 
proposes such as registering patients’ information and making appointments. There is 
no recall system for defaulters. Also, there is no electronic records system or electronic 
database for diabetes. Simple forms are used in the emergency and outpatient 
departments to collect data on diabetes. This would be considered as a simple paper-
based system for collecting data on diabetes. 
The referral of patients to other specialist clinics in the same hospital or to other 
hospitals is available using a specific form. However, there is no feedback system or 
feedback form and there is no guideline for explaining the referral process. 
The hospital provides services for management of all diabetes complications but does 
not provide the following services:  
1. Specific educational programme for people with diabetes. 
2. A programme for tight control of blood glucose and blood pressure for 
patients with diabetes.   
3. Retinopathy screening for all patients with diabetes. 
4. Foot screening for those at high risk. 
5. Screening obese people for IGT 
6. Multiple risk factor management programmes. 
7. A structured patient self-care education programme.  
8. Reduction of obesity and physical inactivity in high-risk groups.          
The available antidiabetic drugs in ACH pharmacy were the following: 
1. Metformin tablets, 500 mg 
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2. Glibenclamide tablets, 5 mg 
3. Gliclazide tablets, 80 mg 
4. Insulin injections, human isophan, 100 units/ml 
5. Insulin injections, human regular, 100 units/ml 
6. Mixed human insulin, 100 units/ml (Mixtard) 
7. Insulin Lispro or Insulin Aspart 100 units/vial 
8. Insulin detmir or insulin glargine 100 units/ml (Lantus pen) 
9. Insulin detmir or insulin glargine 100 units/ml (Lantus vial) 
10. Glimepiride tablets, 3 mg, 2 mg, 1mg 
11. Glucagon powder 1mg/vial   
Aseer Diabetes Centre (ADC): 
In ADC, several specialist diabetes services are provided which include general clinics 
for routine diabetes care of adults, specialist clinic for children with diabetes, diabetic 
foot clinic, diabetic eye clinic, insulin pump clinic, nutrition and dietetic clinic and 
health education clinic. The centre has a diabetes register, specific record for each 
patient with diabetes, an appointment system without a recall system for defaulters. 
The centre does not include a pharmacy or laboratory but has full access to the ACH 
laboratory services and pharmacy. Also, the referral to ACH emergency or outpatient 
clinics is available using a specific referral form and any feedback will be kept in the 
ACH record of the patient. However, there was no guideline for the referral process.  
Health education materials were available in the centre.  
The working team in ADC was inadequate. The current workforce profile of ADC was as 
following:  
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• One consultant paediatric endocrinologist,  
• One internal medicine consultant, 
• Two internal medicine specialists,     
• Three general physicians, two of whom have a diploma in diabetes 
management, 
• Four nurses with training on foot care 
• Five nurses with training on diabetes education 
• Eleven general nurses 
• Two dieticians 
• Five administrative technicians 
There was no specialist in podiatry services or social workers. Therefore, there is a 
need for more high qualified diabetologists, podiatrists, specialist nurses on diabetes 
management particularly foot care, dieticians and health educators as well as 
psychologists or social workers.  
There are five to six clinics opened daily in the centre (Sunday-Thursday, 8 am – 3 pm) 
which include three to four follow up clinics and one ophthalmology clinic. In addition, 
there are clinics which open one to two times per week. These include diabetes 
paediatric clinic, foot clinic, dietetic clinic and health education clinic. 
The centre does not provide routine annual checkups or a specific programme for 
screening of diabetes complications. The follow-up period and the investigations 
carried out depend on the patient’s condition.  
The ADC does not provide the following services: 
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1. A programme for tight control of blood glucose and blood pressure for 
patients with diabetes.   
2. Retinopathy screening for all patients with diabetes. 
3. Foot screening for those at high risk. 
4. Screening obese people for IGT 
5. Multiple risk factor management programmes. 
6. A structured patient self-care education programme.  
7. Reduction of obesity and physical inactivity in high-risk groups. 
Retinopathy and foot screening as well as referral to the dietetic clinic or the education 
clinic are done based on the clinical judgement of the treating physician.           
5.4.3. Other healthcare services 
There is no tertiary or specialist hospital in Abha city. However, ACH can refer patients 
in need for advanced healthcare to King Fahad Medical City, King Fisal Specialist 
Hospital and Research Centre or King Khalid Eye Specialist Hospital in Riyadh.  
A programme for home care services to the population of Aseer region is in its 
development and there were no data available yet regarding these services.  
 
5.4.4. Service utilization and healthcare burden 
Data on deaths from diabetes were not available for Aseer region or Abha city. Data on 
diabetes morbidity and diabetes care were limited. The available data included: a 
description of the age group, gender and nationality of the registered population of 
each PHCC; the total number of registered patients with diabetes in each PHCC; the 
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total number of patients with diabetes who visited the PHCC; and their age group, 
gender and nationality. At secondary healthcare level, additional data were available 
on type of diabetes and type of complications each patient had. 
 
Prevalence of diabetes in Abha:  
The number of people with diabetes in Abha city is increasing. In 2011, 251 patients 
were diagnosed with diabetes (Figure 19). The current registered prevalence of 
diabetes in all age groups in Abha is 3.75%.  In the National Reference for Diabetes 
Mellitus Guidelines in Primary Health Care in Saudi Arabia, the Minister of Health 
reported a national prevalence of diabetes for all age groups to be 14%.(239)  This would 
indicate that 73% (12988) of people with diabetes in Abha city are undiagnosed (Table 
8).   
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Figure 19: Number of registered patients with diabetes in Abha city in the preceding 
12 months, 2011 
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Table 8: Number of diagnosed and undiagnosed people with diabetes in Abha city, 
2011 
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Wasat Abha 20105 845 4.20 2814.7 1969.7 69.98 
Almanhal 18593 726 3.90 2603 1877 72.11 
Almowadafeen 19473 565 2.90 2726.2 2161.2 79.28 
Almansak 9774 218 2.23 1368.4 1150.4 84.07 
Sultan city 10015 509 5.08 1402.1 893.1 63.7 
Johaan 1264 91 7.20 176.96 85.96 48.58 
Alkaabel 14802 785 5.30 2072.3 1287.3 62.12 
Alaziziah 7323 332 4.53 1025.2 693.22 67.62 
Alnumais 17763 471 2.65 2486.8 2015.8 81.06 
Therah 7655 217 2.83 1071.7 854.7 79.75 
Total 126767 4759 3.75 17747 12988 73.18 
* Expected number of patients with diabetes was calculated based on the reported MOH 
national prevalence of diabetes in all age groups (14%). 
 
Visits of people with diabetes to healthcare services: 
The data on visits of patients with diabetes to Almansak PHCC were not recorded 
routinely. In 2011, the analysed routine data for the other PHCCs, ADC, AGH and ACH 
showed that there were 29917 visits for patients with diabetes to healthcare. As 
shown in Figure 20, 61.7% (18463) of these visits were to the PHCCs while 23% were to 
ADC and 9.4% were to the outpatient clinics of AGH.   
At the PHCCs, the ratio of the number of visits to the number of registered patients 
with diabetes would roughly show the variation in service provision between PHCCs. 
For example, Wasat Abha PHCC received or offered around 3 visits for each registered 
patient with diabetes per year while Therah PHCC offered 6 visits per year for each 
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registered patient with diabetes (Table 9). Of the total visitors with diabetes in 2011 to 
the PHCCs, 53.3% were male, 24.7% were aged between 15 to 44 years, 48% were 
between 45 to 59 years and 25% were 60 years or older. No data were collected 
routinely on the presence of complications among visitors at PHCCs.    
Table 9: Total number of visits of patients with diabetes to the PHCCs for the 
preceding 12 months, 2011 
PHCCs Total number of 
registered patients 
Total number of 
visits  
Visit: patient ratio 
Wasat Abha 845 2415 2.86 
Almanhal 726 4250 5.85 
Almowadafeen 565 3045 5.39 
Almansak 218  Not available  Not available 
Sultan city 509 1281 2.52 
Johaan 91 275 3.02 
Alkaabel 785 1948 2.48 
Alaziziah 332 1357 4.09 
Alnumais 471 2575 5.47 
Therah 217 1317 6.07 
 Total 4759 18463 4.07 
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Figure 20: Total number of visits of patients with diabetes to all healthcare 
institutions in the preceding 12 months, 2011 
 
At the secondary healthcare level in 2011, the outpatient clinics of ACH and AGH 
received more female visitors with diabetes (54%) than males; while the ADC and the 
emergency department of ACH received similar number of  visits from male and 
female patients with diabetes (53.5% and 51.3% respectively). More than two thirds of 
the visitors to the outpatient clinics of ACH and AGH were aged 45 years or older 
(67.7% and 72% respectively). The children (< 15 years) with diabetes represent 12.4% 
of the visitors to ADC, 27% of the visitors to the ACH emergency department, 5.7% of 
the visitors to ACH outpatient clinics, and only 0.2% of the visitors to AGH outpatient 
clinics.  
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The data showed that 17.2% of the visitors to the AGH outpatient clinics and 9.6% of 
the visitors to ADC had chronic complications. No data were collected on presence of 
complications among the visitors to the ACH.   
 
Variation of visits over a 1-year period: 
Over a one year period, the variation in the total number of visits of patients with 
diabetes each month to the PHCCs, AGH outpatient clinics, ADC and ACH are shown in 
figures 21-25.  At the PHCCs, AGH outpatient clinics and ADC, the lowest number of 
visits was consistently during month 9, the month of Ramadan. In contrast, the 
number of visits to the emergency department of ACH reached its peak in the same 
month of Ramadan (Figure 25).  
Whether fewer appointments were offered during Ramadan or the patients did not 
attend their appointments, the end result was a sharp rise in the visits of patients with 
diabetes to the emergency department. This rise could also be attributed to the fasting 
during Ramadan in addition to delayed visits. 
The majority of patients (92.5%) who visited the emergency department received the 
necessary treatment and were discharged in the same day (Figure 25).   
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Figure 21: Total number of visits of patients with diabetes to the PHCCs each month 
for the preceding 12 months, 2011 
 
 
Figure 22: Total number of visits of patients with diabetes to the AGH outpatient 
clinics each month for the preceding 12 months, 2011* 
 
*The clinic was closed at months 1 and 8. 
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Figure 23: Total number of visits of patients with diabetes to the ADC each month for 
the preceding 12 months, 2011 
 
 
Figure 24: Number of visits of patients with diabetes to ACH outpatient clinics in the 
preceding 12 months, 2011 
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Figure 25: Number of visits of patients with diabetes to ACH emergency department 
in the preceding 12 months, 2011 
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5.5. Discussion 
This review of existing resources, available routine data and interviews with key 
personnel shows that gaps exist between recommended diabetes care and the care 
patients actually receive. Several gaps in diabetes care service provision at both the 
primary and secondary healthcare level were identified. These gaps will be discussed in 
the following paragraphs for each component of diabetes care.  
A comprehensive diabetes service should provide the following components of 
diabetes care: primary and secondary prevention of T2DM; diagnosis; initial 
management; education for self-management; ongoing management; and regular 
screening for and treatment of complications. These components of diabetes services 
should be organized and delivered in a collaborative and coordinated way using an 
effective and efficient integrated approach. However, the current evidence for the 
most effective and efficient approach to organizing the inherently complex diabetes 
care is weak.(19)  
 
5.5.1. Gaps in prevention 
Primary prevention:  
There were no specific interventions that targeted people at risk of developing 
diabetes with the specific aim of preventing diabetes. However, a health promotion 
initiative was implemented in some of the PHCCs of Abha city. The attendees of the 
health promotion clinics were offered counselling, history taking, clinical examination, 
health education and screening tests according to their age group and the 
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recommendations of the relevant guidelines.(240) Among 429 patients who attended 
the clinic in 2009, 98% had imbalanced diet, 99% were inactive, 28% were overweight 
and 46% were obese, one fifth (21%) were found to have pre-diabetes (FBG: 100-125 
mg/dl, 5.6-6.9 mmol/l) and 3% were confirmed as having diabetes.(240) Most of the 
participants had three or more risk factors for coronary heart diseases (73% among 
males and 69% among females). All the attendees were counselled about the need for 
a well balanced diet and physical activities. Individuals who needed further care were 
referred to the chronic diseases mini-clinics for management and follow-up.   
The Gulf Executive Plan for Control of Diabetes, which was not available in any of the 
PHCCs, recommended 3 strategies for primary prevention of T2DM which are:  
1. Raising health awareness about diabetes risk factors 
2. Encouraging healthy nutrition and physical activities 
3. Setting regulations which help reducing risk factors (e.g. labelling foods...)(215) 
The mechanisms of achieving these strategies need to be properly implemented at the 
national and local levels. Several campaigns are conducted about diabetes and its risk 
factors every year in Abha by the PHCCs and ADC.   
There is a need to support and expand the health promotion initiative to cover all the 
PHCCs in Abha city. Specific programmes within this initiative to tackle obesity, 
promote exercise and healthy eating should be developed and implemented. However, 
there is a need first to develop national or local guidelines and strategies for promoting 
health, particularly for physical activities and healthy eating. Tackling the underlying 
determinants of T2DM in Saudi Arabia and making our environment less obesogenic is 
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a great challenge that will require a broad range of policy measures across multiple 
sectors. Multiple risk factor management programmes have been shown to be 
effective in some developed countries.(237) These programmes need to be considered 
in planning for prevention of T2DM in our primary healthcare system. 
  
Secondary prevention:  
One of the components of the mini-clinic programme is to identify those at risk of 
diabetes and screen them periodically according the relevant guidelines.(201) However, 
this component of the programme seems to be poorly implemented due to the low 
prevalence of diabetes in Abha when compared to the national figure. The routine 
data showed that 200 to 400 patients are diagnosed with diabetes every year in Abha.  
 The Gulf Executive Plan for Control of Diabetes recommended 2 strategies for 
secondary prevention of T2DM which are:  
1. Early detection of T2DM among high risk groups 
2. Providing care to healthy people to reduce the risk factors of diabetes 
The screening of those at risk of having diabetes is part of the mini-clinic programme 
and the health promotion clinics initiative in PHCCs. This can partially meet the 
requirements of the gulf executive plan for secondary prevention of T2DM. Several 
studies have reviewed the effectiveness and cost-effectiveness of screening for 
T2DM.(241-243) However, the reviewed evidence by IDF showed that targeting those at 
high risk is at best likely to have a moderate impact on the prevalence of T2DM.(37)  
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Additional support and efficient implementation might increase the effectiveness of 
these screening programmes. However, there is a need for studies to evaluate the 
effectiveness and cost-effectiveness of these programmes in real world settings in 
Saudi Arabia. These gaps in primary and secondary prevention of T2DM need to be 
addressed by the MOH.  
 
Tertiary prevention: 
There are no specific programmes for tight control of blood glucose and blood 
pressure for patients with diabetes. Also, there is no separate programme for 
retinopathy screening for all patients with diabetes, or foot screening for those at high 
risk. Although it was obvious that controlling blood glucose, blood pressure and blood 
lipids are one of the aims of the mini-clinics programme and the Gulf Executive Plan for 
Control of Diabetes, it did not include programmes for tight control of blood glucose 
and blood pressure for patients with diabetes.  However, one of the components of 
the mini-clinics programme is to annually screen at hospital all patients with diabetes 
for retinopathy, nephropathy and foot problems. In spite of that, the implementation 
of these screening tests is inadequate and needs to be improved.  
Therefore, it might be better to review how existing programmes can be better 
delivered and what the causes of poor implementation are. In addition, providing 
programmes for tight control of blood glucose and blood pressure within the mini 
clinics programme should be included.   
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5.5.2. Gaps in diagnosis and initial management 
Diabetes can be initially diagnosed in primary health care. Then the patients should be 
referred to hospital to confirm diagnosis and plan for treatment. The current referral 
system usually uses the patient as a postman between the PHCCs and the hospital. 
This method of communication between the PHCCs and the hospital causes many 
problems to the referral and feedback system. Some patients might lose the referral or 
feedback sheets and then decide not to go to the hospital or bring the feedback to the 
PHCC. Other patients might just decide not to go and throw the papers away. There is 
a need to review the current system of referral and feedback and to develop rules and 
guidelines that explain in detail the processes and steps of successful referral and 
feedback. 
In the absence of an electronic recall system, it is difficult to trace each referral. Having 
an electronic healthcare system would not only facilitate the provision of healthcare 
and the communication between the different levels of healthcare, but it would also 
help to easily monitor and audit the healthcare services provided.     
 
5.5.3. Gaps in education for self-management 
One of the components of the mini clinics programme is to educate patients about a 
specific list of topics. Brief guidelines for educating people with diabetes were listed in 
the quality assurance manual.(200) This list of topics and these brief guidelines need to 
be more structured and comprehensive. The consultative section on diabetes 
education of the International Diabetes Federation has published:  
 
 
136 
 
First:  “International standards for Diabetes Education”,(205) which designed standards 
for structure, process and outcome for diabetes education that can be measured at 
basic and optimal level. 
Second: “International Curriculum for Diabetes Health Professional Education”(244) 
which provides a curriculum framework to assist organizations to prepare education 
programmes for diabetes educators. 
These references in addition to “the national reference for educating people with 
diabetes in Saudi Arabia”(245) should be used to design a diabetes education 
programme that can help patients to develop their skills, knowledge and confidence to 
make informed decisions and self-manage their diabetes.    
 
5.5.4. Gaps in routine ongoing diabetes management 
Routine diabetes care is provided mainly in the PHCCs. The mini clinics programme for 
diabetes in the PHCCs improved the process and outcomes of diabetes care.(246) In 
ADC, there was no specific programme or guidelines for the provision of routine care 
for patients with diabetes. The organization of the annual review for patients and 
screening for diabetes complications was not obvious. These gaps in service provision 
should be addressed by the MOH.  
 
5.5.5. Gaps in care policy, planning and organization 
There is a need to develop or update several national policy statements in order to 
improve diabetes care in Saudi Arabia. A National Service Framework which 
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determines specific standards and strategies for delivering diabetes care needs to be 
developed to drive up service quality and tackle variations in care. The current quality 
assurance in primary health care needs to be updated particularly after the 
implementation of the mini clinic programmes. The Gulf Executive Plan for Control of 
Diabetes was a very important and comprehensive executive plan. However, it needs 
to be available to all the medical directors of PHCCs and hospitals. Also, each country 
needs to translate the broad targets and strategies into specific actions and 
interventions that suit the system and resources of that country. The new national 
clinical practice guideline for diabetes management in primary healthcare needs to be 
available in all the PHCCs and needs to be implemented.   
 
5.5.6. Gaps in working staff 
The national average ratio for population: physician ratio is 3364: 1. Only Wasat Abha 
was above this ratio. Therefore, there is a need for more physicians in Wasat Abha 
PHCC. Most of the working physicians did not have postgraduate training. Therefore, 
providing continuous professional education and training courses is important to 
improve the quality of care. The number of lab technicians and x-ray technicians need 
to be increased. In AGH outpatient clinics, there is a need for more physicians to 
ensure continuous cover for the diabetes clinic. 
     
5.5.7. Gaps in resources 
Governmental buildings are needed for the PHCCs that are currently in rented houses. 
Most of diabetes care in Abha city is delivered in primary care. Therefore, it is 
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important to give much more resources to PHCCs in order to improve the quality of 
diabetes care in Abha city.  
The expected increase in total population, middle and old aged population and 
number of patients with diabetes should be considered in the planning for service 
provision in the future. 
 
5.5.8. Limitations 
In this chapter, three research methods were used, each of which has its own 
strengths and limitations. The first one, which was by inspecting the actual physical 
facilities in which care is provided using a standard checklist, is generally considered as 
a gold standard method.(225) In this study, the observers assessed only whether specific 
resources are available in the PHCCs but they did not assess the adequacy of required 
supplies, amount, type, or condition of equipment. This was one of the limitations of 
the checklist used; another was the inability to confirm the proper use of available 
resources.  
In addition, the scoring system which was developed for the checklist was not tested 
for reliability and validity of measuring the degree of completeness of clinic’s 
resources. However, when the findings of this scoring system were triangulated with 
the findings of the case notes review, which will be presented in the next chapter, they 
both showed consistent findings. The best resourced PHCCs according to this scoring 
system were also best PHCCs at implementing the process measures of diabetes care 
(Almanhal, Almansak, Almowadafeen, and Alnumais).The consistency between the 
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findings suggested that the assessment and scoring methods are valid. However, this 
simple scoring system needs to be tested to determine accurately its important items 
for high quality diabetes care and its usefulness in predicting the clinical outcomes. 
 
The second method was by using the purposive sampling technique to identify and 
interview 16 lead clinicians. This method of sampling was particularly useful in this 
evaluation research. It involved identifying who the major stakeholders are by 
selecting those who are involved in designing, giving or administering the diabetes 
services. This group of stakeholders are best placed to answer the research questions. 
  
The structured questionnaires asked whether strategies and policies are available for 
diabetes care and whether some specific services are delivered for patients with 
diabetes. The face to face interviews gave the researcher the chance to give more 
explanation to make sure the questions were appropriately understood and the 
correct answers were obtained. However, there is still possible that some answers 
were biased. Some interviewees might perceive that underestimating what is available 
would bring more resources. On the other hand, some may perceive that 
overestimating what is available would show that they are running a high quality 
service. This would occur if the lead clinicians thought they will be held responsible for 
any deficiency reported. In reality, it was difficult to know if response bias was a 
problem. 
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The third method was by collecting and analysing routine data on diabetes prevalence, 
complications and service utilization.  Evaluating healthcare using routine data is now a 
common approach, particularly after the increasing availability and use of 
computerized datasets. However, its accuracy has been regularly questioned, with 
concerns including the completeness of registration and the accuracy of coding and 
recording.(238) The collected routine data were of unknown validity as its accuracy has 
not been assessed in published research. Therefore, care must be taken in the 
interpretation of the findings. 
This study found several instances of these limitations. For example, the number of 
visits of patients with diabetes to Almansak PHCC was missed due to incomplete 
recording (Table 9). In addition, misclassification or under recognition of diabetes 
complications is possible, particularly in hospital. It was expected that the patients 
with diabetes who visited the hospitals would have more complications than those 
who visited the PHCCs. But, the collected routine data reported lower proportions of 
diabetes complications among patients with diabetes who visited AGH and ADC (17.2% 
and 9.6% respectively) when checked against the records of patients in the PHCCs, 
which showed higher proportion of diabetes complications (32%), (See: next chapter). 
This would raise concerns about how accurate and complete the complications are 
coded and recorded in hospitals.   
A strength of this study is that the routine data were checked (triangulated) against 
other sources of data in this thesis, they showed similar findings. For example, the data 
on registered diabetes prevalence were similar to what has been reported by the 
structured questionnaire to the medical directors and the case notes reviewed (See: 
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next chapter). Insufficient medications, staff, laboratory resources and health 
education resources were also reported or identified by other research methods used 
in this thesis. These consistent findings will be discussed in the next chapters and 
triangulated in the final chapter.    
Despite these disadvantages, routine data are often used regardless of lack of 
completeness and inaccuracies.(247) They can be cost-effective and can make a useful 
contribution.(199) It is relatively cheap to use, comprehensive, regularly updated and 
quick to obtain, particularly if computerized.(227, 247) Therefore, these types of data are 
used officially by higher authorities of the MOH. 
  
5.6. Conclusion  
The current provision of diabetes care services in Abha city is inadequate. Several gaps 
in service provision were identified. None of the 10 diabetes mini-clinics were 
completely equipped. The buildings of 7 PHCCs were rented private houses. There was 
no laboratory or dental clinic in one of the PHCCs. Insufficient and inconsistent 
distribution of some healthcare professions was identified. There is a need for 
electronic healthcare system and electronic databases to facilitate care organization, 
provision and auditing. Explicit policy statements, strategies, action plans and care 
guidelines are needed to organize diabetes care and achieve greater consistency in the 
availability of care services and resources. In order to achieve high quality diabetes 
care, these gaps should be addressed. Then continued evaluation and audit of diabetes 
services should be implemented periodically to ensure high quality and effectiveness.     
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CHAPTER SIX 
 
  
Case note reviews  
 
This chapter discusses the methods and results of the case note review.  
Demographic and clinical characteristics of people with diabetes in Abha city 
are presented. In addition, the process and outcome measures of diabetes care 
are discussed. 
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Chapter 6: Case note reviews 
 
6.1. Introduction 
Patients’ health records play an important role in modern healthcare systems. 
Healthcare records contain important information about patients which usually include 
both personal and clinical information. The records also contain information on the 
previous medical history, treatment received, laboratory test results and relevant 
lifestyle information. Therefore, health records and case notes are a commonly used 
and valuable source of data for audit and scientific research.(217, 238) However, they 
have several limitations. For example, the case notes are not always available and 
accessible, some case notes might not contain all the data required for a research 
study, some pieces of data are not consistently recorded and sometimes it is difficult 
to identify the case notes of particular types of patients such as patients with 
diabetes.(217, 238)      
In spite of all of these limitations, reviewing patients’ case notes is by far the most 
widely applied method to assess some aspects of healthcare such as the occurrence of 
adverse healthcare events in hospitals,(248)  Moreover, electronic medical records are 
increasingly seen as a potentially comprehensive source of data on the process and 
outcome measures of healthcare.(249)  
In Abha city, all the healthcare records are in form of paper and handwritten records. 
The Regional Health Affairs (RHA) in Aseer region, in 2007, tried to transform the 
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traditional healthcare system in primary healthcare into electronic information system 
including electronic medical records. However, several difficulties were faced and the 
attempt failed.   
 
6.2. Objectives 
The aim of this chapter was to abstract specific data from the case notes of all 
patients with diabetes at the PHCCs and from a sample of patients who are registered 
in the Asser Diabetes Centre (ADC). The objectives were first to describe the people 
with diabetes in terms of their demographic and clinical characteristics. Secondly, to 
assess to what extent healthcare providers implemented the key process measures of 
diabetes care. Thirdly to assess to what extent the outcome targets of diabetes care 
were achieved.  
 
6.3. Methods 
6.3.1. Designing stage 
Prior to designing the study data collection forms, decisions were to be made on what 
categories of information and type of data are relevant to the study objectives and 
need to be collected. To determine and categorize the required information, several 
steps were taken. The first step reviewed international diabetes management 
guidelines(8, 203-205, 250), authoritative reports on diabetes care organization and 
evaluation in Scotland(207-212, 251-252) as well as the previous research on diabetes and its 
management in Saudi Arabia (chapter 1). The second step focused on exploring the 
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current system of diabetes care in Saudi Arabia. Several studies, reports and guidelines 
were reviewed including the national quality assurance protocol in primary health care 
and the diabetes mini-clinic manuals (chapter 5).(200-202, 216, 231, 253-254) This step helped 
to identify the types of care programmes which are provided in Abha and the current 
standards of diabetes care at the local and national levels. This gave an indication of 
the range and types of data that can be collected on the assessment of diabetes care. 
The final step was to determine whether specific data could be gathered from the 
patient records. Thus, a copy of the records of patients with diabetes at the PHCCs was 
obtained and reviewed to identify the type of data that are available in these records. 
Finally, the data items that can be collected from patients’ records were converted 
into easily understandable and answerable questions. These questions were then 
gathered and ordered to generate an initial data collection form in order to collect 
specific data from the records of patients with diabetes at the PHCCs. 
Appendix 10 shows the first data collection form that was designed to collect data 
from the patient’s records in the PHCCs. This data collection form was divided into five 
categories.  The first category was about patient’s demographics and bio-data. This 
category was divided into 3 sub-categories (A, B, and C). Sub-category A collected 
demographic data such as age, gender, education and marital status. Sub-category B 
gathered information about the clinical characteristics of each patient such as height, 
weight, blood pressure, and fasting blood glucose. Sub-category C was for evaluating 
what each patient is currently treated with, the degree of patient’s compliance with 
diet, exercise, follow-up appointments and drugs. It also included recording the 
number of follow-up visits and referral to hospitals for annual review. The second 
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category was used to evaluate the quality of recording of patient’s information, 
investigations and examination results. The third category was solely for identifying 
patients with diabetes complications. The fourth one was to assess the degree of 
implementing the health education programme for each patient. The final category 
was devoted for evaluating the annual review of patients. 
  
6.3.2. Piloting stage 
Three researchers tested the data collection form for its feasibility, question wording, 
order, range of answer options and deciding on a coding scheme. The form was piloted 
at Almanhal PHCC by three researchers (AA, YA and LO). The researchers reviewed 15 
records and several required changes were identified. For example, the question that 
asks about the ethnic groups was deleted because patients’ records do not include 
information regarding ethnicity. Moreover, two additional options which are (illiterate 
and read-write) were added to the answer options of the question about education 
because many patients were illiterate. Also, the answer options for the question about 
the type of the current treatments were changed from a list of three options 
(Diet+exercise only, oral antidiabetic, or insulin) into a broad list of many drugs which 
are used for treating diabetes. Other drugs that are recommended to be used in 
treating diabetes complications such as ACEIs, ARBs, aspirin and statins were also 
added to the list. These drugs are recommended to be available in each PHCC 
according to the MOH essential drug list. In addition, more questions were added to 
record the results of the annual investigations and examinations such as HbA1c, 
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creatinine and cholesterol levels. Moreover, each section in the form was modified to 
fit easily for collecting quickly the available information from the patients’ records. 
 
ADC’s form: 
Because the records of patients in ADC might be different from PHCCs’ records, the 
form was piloted again at the ADC by three researchers (AA, MA and LO). The 
researchers reviewed 15 records and found that several modifications were needed in 
order to collect the required data from the records of ADC. Therefore, a separate form 
was designed specifically for collecting data from the records of ADC (Appendix 11). In 
this form, the information categories/sections were similar to that of PHCC’s form but 
some sections were slightly modified. For example, a question was added to the first 
section about the past history of diabetes complications. The questions about level of 
education and marital status were deleted because the ADCs’ records do not routinely 
record this information. Moreover, the questions about the annual referral and 
patient’s compliance were deleted since there is no need for referral at ADC and the 
compliance was not recorded routinely. The number and format of record’s sheets at 
ADC were different from those at the PHCCs, therefore, the names and numbers of the 
ADC record’s sheets in the second section were modified accordingly. The third section 
of both forms was similar; however, the fourth one was modified by reorganizing the 
education programme checklist to fit the ADC records. 
 
 
 
148 
 
6.3.3. Methods of administration and collection 
 PHCCs: 
In each PHCC, two to three nurses from the project team who were interested in 
diabetes or working in the diabetes mini clinic reviewed all the records of patients with 
diabetes and filled one form per patient. The members of the supervision team visited 
each PHCC and trained the nurses on how to fill in the form properly. The specific 
number of the required forms for each centre were printed, delivered and later 
collected by the main researcher. At the beginning, the main researcher and the 
supervision teams double checked the completed forms to ensure the data are 
extracted accurately and completely. At this stage many forms were returned, for 
second review, to the working teams due to inaccurate or missed information. In 
addition, further training and discussion were conducted with the members of the 
working teams by the researcher to ensure accurate and correct data extraction. After 
two weeks, the nurses were able to fill in the forms accurately; therefore, then only a 
random sample of 5-10 % of forms were regularly reviewed to check for accuracy and 
completeness.       
ADC: 
At ADC, the total number of patient’s records was more than 5000 records. Due to 
resources and time limitations, we decided to review only 10% sample of these. As the 
records were stored in a different department (Aseer central hospital records 
department), full access to these records was difficult. Therefore, it was not possible to 
get a random sample of these records. Instead, each day for 7 weeks, when the 
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records of those patients who had appointments transferred to the ADC clinics, 3 
nurses reviewed the records of those patients who were living in Abha city.  
 
6.3.4. Methods of analysis 
The data were first entered into the Epi Info software (version 7) which helped to 
create a simple digital data collection form that allowed for rapid and accurate data 
entry.  Two data entry clerks were employed to enter the data from the paper forms 
into the Epi info Form. The researcher (AA) then reviewed manually about 200 forms 
at the beginning of data entry to eliminate any errors and check the accuracy and 
completeness of entered data. A random sample, of about 10 per 100 forms, was then 
checked regularly by the researcher (AA) to make sure the data were entered in an 
accurate and complete manner. They were later transferred to SPSS Statistics version 
20 to perform the statistical analysis. In addition, the charts and figures were produced 
using the Excel software 2007. 
The case records of non-nationals were excluded from this review. This decision was 
taken for several reasons. First, the non-national population are a heterogeneous 
group of people which consists of many nationalities and ethnic groups. In addition, 
they are mostly people who go to Saudi Arabia to work. Thus, the majority are young 
and healthy. These factors might confuse our results and obscure the health status of 
the Saudi national people.   
A detailed analysis of the case records of the PHCCs and the ADC was carried out 
separately. Descriptive statistics and frequency tables were generated for questions on 
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demographic characteristics and related process and outcome measures of diabetes 
care. The glycemic control among patients with diabetes was evaluated and described 
using the most recent readings of the fasting blood glucose (FBG) instead of HbA1c. 
This was because very few patients have had a record for HbA1c test. In order to 
assess the glycemic control as accurately as possible, the mean of the most recent 
readings of the FBG within the preceding 12 months was used for each patient instead 
of the reading of the last occasion.   
6.4. Results 
The total number of registered Saudi patients with diabetes in the 10 PHCCs of Abha 
city is 4583 patients. More than 97% (4458) of their medical records were reviewed. At 
ADC, there were 5023 registered patients with diabetes. A total of 551 (11%) case 
notes were reviewed. The results for both the PHCCs and ADC case notes analyses will 
be presented separately. The first set of analyses explores the demographic 
characteristics of the people with diabetes in Abha city. Then, key process measures of 
diabetes care will be described such as diabetes therapy, follow-up care, annual review 
and health education. Finally, key outcome measures of diabetes care such as the 
indictors of glycemic control and obesity will be described in addition to the 
prevalence of diabetes complications. 
6.4.1. Demographics of diabetes in Abha city 
PHCCs: 
Table 10 shows that more than 85% of the people with diabetes in Abha city were over 
age of 45 years. More than 40% of the patients were illiterate and more than 47% 
were unemployed.     
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Table 10: Demographics of patients with diabetes in Abha city, Saudi Arabia 
Variable Number Percentage 
PHCCs Almanhal 668 15.0 Wasat Abha 796 17.9 Almansak 208 4.7 Almowadafeen 527 11.8 Johaan 83 1.9 Sultan City 498 11.2 Alkaabel 700 15.7 Alaziziah 314 7.0 Therah 204 4.6 Alnumais 460 10.3 Total 4458 100 
Age Categories 
Children ≤ 14 Y 30 0.7 
Youth (15-24 Y) 113 2.5 Adults (25-44 Y) 486 10.9 Middle Age (45-64 Y) 2284 51.3 
Older people (≥ 65 Y) 1528 34.6 Missed 16 0.4 Total 4458 100 
Gender Male 2288 51.3 Female 2077 46.6 Missed 93 2.1 Total 4458 100 
Occupation Retired 1121 25.1 Unemployed 2130 47.8 Employed 983 22.1 Irregular work 78 1.7 Missed 146 3.3 Total 4458 100 
Education Level Illiterate 1804 40.5 Read & write 410 9.2 Secondary school level or lower 1385 31.1 University level (Bachelor) or above 495 11.1 Missed 364 8.2 Total 4458 100 
Smoking status Smoker 219 4.9 X-smoker 53 1.2 Non-smoker 3940 88.4 Missed 246 5.5 Total 4458 100 
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Marital status Single 242 5.4 Married 3840 86.1 Divorced 51 1.1 Widowed 227 5.1 Other 4 0.1 Missed 94 2.1 Total 4458 100 
 
The majority of illiterate patients (80%) and those unemployed (87%) were females 
(Table 11). For males, 47% had at least a primary or secondary school education and 
almost 17% had a bachelor degree. Forty four percent of male patients were retired 
and 37% were employed. The mean age for all was 58.26 ± 14.7 years and the mean 
diabetes duration was 9.25 ± 6.6 years. Only around 5% were smokers and the 
majority (86%) was married. The patients mostly (83%) had T2DM and almost 74% 
were either overweight (28.4%) or obese (45.3%). Body mass index (BMI) is 
significantly associated with gender among patients with diabetes. Overweight was 
more common among males than females (35.5% versus 20.6), however, the 
proportion of obesity among females (61.6%) was double of that among males (31%), 
(Table 11), (χ2=449.7, df=5, P ˂ 0.001) (OR=3.7, 95% CI: 3.26-4.26, P < 0.0005).  
Comparison between T1DM and T2DM patients’ characteristics are shown in table 12. 
Of patients with T2DM, 90% were aged 45 years or older, 43% were illiterate and more 
than 76% were either overweight or obese. Of patients with T1DM, 53.7% were aged 
45 years or older, 23.7% were illiterate, and 56.8% were either overweight or obese.     
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Table 11: Characteristics of male and female patients with diabetes 
 
  Gender Male % (/2288) Female % (/2077) Missed 
Occupation  Retired 1015 44.4 77 3.7 29 Unemployed 238 10.4 1855 89.3 37 Employed 846 37.0 115 5.5 22 Irregular work 65 2.8 12 0.6 1 Missed 124 5.4 18 0.9 4 Total 2288 100 2077 100 93 
Education Level  Illiterate 304 13.3 1458 70.2 42 Read & write 253 11.1 151 7.3 6 Secondary school level or lower 1075 47.0 283 13.6 27 University level (Bachelor) 387 16.9 91 4.4 8 Postgraduate levels 8 0.3 0 0.0 1 Missed 261 11.4 94 4.5 9 Total 2288 100 2077 100 93 
Smoking status  Smoker 209 9.1 2 0.1 8 X-smoker 43 1.9 9 .4 1 Non-smoker 1875 81.9 1983 95.5 82 Missed 161 7.0 83 4.0 2 Total 2288 100 2077 100 93 
Marital status  Single 134 5.9 102 4.9 6 Married 2060 90.0 1706 82.1 74 Divorced 23 1.0 25 1.2 3 Widowed 2 0.1 218 10.5 7 Other 3 0.1 1 0.0 0 Missed 66 2.9 25 1.2 3 Total 2288 100 2077 100 93 
Type of diabetes T1DM 313 13.7 241 11.6 12 T2DM 1887 82.5 1748 84.2 76 GDM 0 0.0 8 0.4 0 Other 7 0.3 10 0.5 0 Missed 81 3.5 70 3.4 5 Total 2288 100 2077 100 93 
BMI class  Underweight       <18.49 kg/m2 32 1.4 12   0.6 2 Normal                 18.5-24.99 kg/m2 365 16.0 146 7.0 6 Overweight         25-29.99 kg/m2 812 35.5 427 20.6 29 Obese I                 30-34.99 kg/m2 501 21.9 657 31.6 14 Obese II                35-39.99 kg/m2 138 6.0 405 19.5 10 Obese III               ≥ 40 kg/m2 71 3.1 219 10.5 5 Missed 369 16.1 211 10.2 27 Total 2288 100 2077 100 93 
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Table 12: Characteristics of T1DM and T2DM patients in Abha city 
  Type of diabetes T1DM T2DM Number % (/566) Number % (/3711) 
Age Categories 
Children ≤ 14 Y 29 5.1 1 0.0 
Youth (15-24 Y) 104 18.4 5 0.1 Adults (25-44 Y) 129 22.8 341 9.2 Middle Age (45-64 Y) 178 31.4 1998 53.8 Older people (≥ 65 Y) 126 22.3 1352 36.4 Missed 0 0.0 14 0.4 Total 566 100 3711 100.0 
Gender Male 313 55.3 1887 50.8 Female 241 42.6 1748 47.1 Missed 12 2.1 76 2.0 Total 566 100 3711 100 
Occupation Retired 89 15.7 992 26.7 Unemployed 294 51.9 1753 47.2 Employed 135 23.9 805 21.7 Irregular work 16 2.8 60 1.6 Missed 32 5.7 101 2.7 Total 566 100 3711 100 
Education Level Illiterate 134 23.7 1595 43.0 Read & write 29 5.1 366 9.9 Secondary school level or lower 233 41.2 1101 29.7 University level (Bachelor) 114 20.1 353 9.5 Postgraduate level 1 0.2 8 0.2 Missed 55 9.7 288 7.8 Total 566 100 3711 100 
Smoking status Smoker 34 6.0 178 4.8 X-smoker 4 0.7 44 1.2 Non-smoker 496 87.6 3300 88.9 Missed 32 5.7 189 5.1 Total 566 100 3711 100 
BMI class Underweight     <18.49 kg/m2 30 5.3 16 0.4 Normal                18.5-24.99 kg/m2 128 22.6 371 10.0 Overweight        25-29.99 kg/m2 149 26.3 1076 29.0 Obese I                30-34.99 kg/m2 110 19.4 1010 27.2 Obese II               35-39.99 kg/m2 36 6.4 495 13.3 Obese III              ≥ 40 kg/m2 28 4.9 251 6.8 Missed 85 15.0 492 13.3 Total 566 100 3711 100 
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The highest proportion of illiteracy was among the patients of Alaziziah PHCC where 
58.6% were illiterate and 22.6% have not received any official education but can read 
and write. The lowest proportion of illiteracy was at Almansak PHCC (13.9%). The 
proportions of patients with T1DM ranged from 3.5% of all the registered patients at 
Alaziziah PHCC to 25% at Almowadafeen PHCC as shown in table 13. The variation in 
the numbers of patients with T1DM and T2DM among PHCCs was statistically 
significant (χ2=150, df=9, P ˂0.000). On the other hand, the variation in the numbers of 
patients in each BMI class among the PHCCs was not statistically significant (χ2=32.4, 
df=27, P=0.215). 
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Table 13: Demographic characteristics of patients with diabetes in each PHCC 
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* The registered prevalence was presented here as a percentage by dividing the total number of the registered patients with diabetes on the 
total population for each PHCC.  
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ADC: 
Of the reviewed sample of case notes at ADC, 65% were over 45 years old. In 
comparison to PHCCs, more children and youths are managed in ADC (3.2% versus 
18.6%) and therefore more patients with T1DM (12.7% at PHCCs versus 22% at ADC). 
The unemployment rate was almost 40% (47.8% at PHCCs) and the proportion of non-
smokers was almost similar to that of the PHCCs’ (88% versus 82% respectively). More 
than 55% of the reviewed case notes were referred to ADC from Aseer central hospital, 
16.5% from Abha general hospital and 9.6% from the PHCCs.  
Table 14 shows the characteristics of the reviewed sample of patients with diabetes 
attending the ADC. The sample had demographic characteristics similar to the PHCCs 
group. For example, the majority of female patients were unemployed; most of the 
patients were non-smokers and overweight was more common among males than 
females (30.9% versus 16%), while obesity was more common among females than 
males (50.3% versus 33.2%). However, there were higher proportions of T1DM 
patients and underweight patients at ADC than at PHCCs. 
 Table 15 shows the characteristics of T1DM and T2DM patients at ADC. T1DM patients 
at ADC were younger (70% were less than 25 years old versus 23%) and thinner (20% 
were either overweight or obese versus 56.8%) than those at PHCCs.   
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Table 14: Characteristics of the reviewed sample of patients with diabetes at ADC by 
gender 
  Gender Male Female Missed Number % (/265) Number % (/256) Number 
Age categories           
Children ≤ 14 Y 32 12.1 24 9.4 6 
Youth (15-24 Y) 21 7.9 17 6.6 2 Adults (25-44 Y) 32 12.1 50 19.5 5 Middle Age (45-64 Y) 115 43.4 114 44.5 10 
Older people (≥ 65 Y) 65 24.5 50 19.5 7 Missed 0 0.0 1 0.4 0 
Occupation           Retired 87 32.8 1 0.4 4 Unemployed 18 6.8 191 74.6 10 Employed 69 26.0 10 3.9 10 Irregular work 0 0.0 0 0.0 0 Student 44 16.6 41 16.0 3 Missed 47 17.7 13 5.1 3 
Place of referral          ACH 141 53.2 148 57.8 17 AGH 46 17.4 42 16.4 3 PHCC 27 10.2 23 9.0 3 Other 1 0.4 2 0.8 0 Missed 50 18.9 41 16.0 7 
Smoking status           Smoker 22 8.3 1 0.4 2 X-Smoker 13 4.9 2 0.8 0 Non-Smoker 194 73.2 235 91.8 25 Missed 36 13.6 18 7.0 3 
Type of diabetes           Type 1 55 20.8 58 22.7 8 Type 2 199 75.1 187 73.0 22 Gestational Diabetes 0 0.0 0 0.0 0 Other types 0 0.0 0 0.0 0 Missed 11 4.2 11 4.3 0 
BMI class       Underweight  <18.49 kg/m2 24 9.1 21 8.2 4 Normal           18.5-24.99 kg/m2 49 18.5 41 16.0 5 Overweight   25-29.99 kg/m2 82 30.9 41 16.0 6 Obese I           30-34.99 kg/m2 52 19.6 63 24.6 8 Obese II         35-39.99 kg/m2 27 10.2 38 14.8 5 Obese III        ≥ 40 kg/m2 9 3.4 28 10.9 1 Missed 22 8.3 24 9.4 1 Total 265 100 256 100 30 
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Table 15: Characteristics of T1DM and T2DM patients at ADC  
  Type of diabetes T1DM T2DM Number % (/121) Number % (/408) 
Age Categories Children ≤ 14 Y 54 44.6 5 1.2 
Youth (15-24 Y) 31 25.6 9 2.2 Adults (25-44 Y) 22 18.2 61 15.0 Middle Age (45-64 Y) 8 6.6 221 54.2 
Older people (≥ 65 Y) 5 4.1 112 27.5 Missed 1 0.8 0 0.0 Total 121 100 408 100 
Gender Male 55 45.5 199 48.8 Female 58 47.9 187 45.8 Missed 8 6.6 22 5.4 Total 121 100 408 100 
Occupation Retired 2 1.7 86 21.1 Unemployed 34 28.1 175 42.9 Employed 9 7.4 78 19.1 Irregular work 0 0.0 0 0.0 Student 73 60.3 13 3.2 Missed 3 2.5 56 13.7 Total 121 100 408 100.0 
Place of referral ACH 66 54.5 229 56.1 AGH 14 11.6 72 17.6 PHCC 11 9.1 40 9.8 Other 1 0.8 2 0.5 Missed 29 24.0 65 15.9 Total 121 100 408 100 
Smoking status Smoker 3 2.5 21 5.1 X-smoker 1 0.8 14 3.4 Non-smoker 101 83.5 340 83.3 Missed 16 13.2 33 8.1 Total 121 100 408 100 
BMI class Underweight <18.49 kg/m2 44 36.4 2 0.5 Normal           18.5-24.99 kg/m2 45 37.2 46 11.3 Overweight   25-29.99 kg/m2 15 12.4 112 27.5 Obese I           30-34.99 kg/m2 7 5.8 111 27.2 Obese II          35-39.99 kg/m2 0 0.0 67 16.4 Obese III         ≥ 40 kg/m2 2 1.7 36 8.8 Missed 8 6.6 34 8.3 Total 121 100 408 100 
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6.4.2. Processes of diabetes care 
According to national manuals and guidelines,(200-202, 214-216) there are 16 healthcare 
checks (or care processes) that everyone with diabetes should receive either at each 
visit to the PHCC or each year by referral to the nearest hospital. At each visit to the 
PHCC, the patient with diabetes should receive the following healthcare checks: BMI 
measurement, FBG or RBG and blood pressure (BP), assessment of patient compliance 
and foot examination. These healthcare checks in addition to HbA1c, cholesterol, 
triglycerides, blood creatinine, urinary albumin, ECG, cardiovascular system 
examination, eye (fundus) examination, chest X-ray and smoking review should be part 
of the annual review. These checks are done by referring to hospital. (214) 
 
Antidiabetic drug prescribing (PHCCs): 
Among adults (≥ 20years) with diabetes in Abha city, 63.7% take oral antidiabetic 
medications, 20.3% take insulin only, 9.9% take both insulin and oral medication and 
only 3.3% were on no medication (diet and exercise). For all patients with diabetes, the 
most commonly prescribed antidiabetic medications, either alone or in combinations, 
were metformin (59.7%) and glibenclamide (42.6%). Only 2.7% of patients were on 
diet and exercise monotherapy and more than 31% (1391 patients) were on either 
insulin monotherapy or one of its combinations. As shown in table 16, the most 
common prescribed classes of drugs were metformin in combination with 
glibenclamide (31.5%), followed by Insulin monotherapy (21.4%), metformin 
monotherapy (12.1%), glibenclamide monotherapy (9.8%), insulin in combination with 
metformin (8.3%) and metformin in combination with gliclazide (6.8%).  
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Table 16: Gender distribution of drugs prescribed to patients with diabetes in PHCCs 
Treatment class Gender Male Female Missed Total No. % 
(/2288) 
No. % 
(/2077) 
No. % 
(/93) 
No. % 
(/4458) 
Monotherapy Diet & Exercise  53 2.3 64 3.1 3 3.2 120 2.7 Metformin  246 10.8 275 13.2 17 18.3 538 12.1 Glibenclamide 265 11.6 163 7.8 7 7.5 435 9.8 Gliclazide 67 2.9 48 2.3 2 2.2 117 2.6 Insulin 521 22.8 411 19.8 23 24.7 955 21.4 
Combination therapy Metformin+Glibenclamide 711 31.1 671 32.3 21 22.6 1403 31.5 Metformin+Gliclazide 149 6.5 145 7.0 7 7.5 301 6.8 Glibenclamide+Gliclazide 2 0.1 3 0.1 0 0.0 5 0.1 Insulin+Metformin 158 6.9 201 9.7 9 9.7 368 8.3 Insulin+Glibenclamide 7 0.3 8 0.4 0 0.0 15 0.3 Insulin+Gliclazide 1 0.0 2 0.1 0 0.0 3 0.1 Insulin+Metformin+Glibenclamide 18 0.8 21 1.0 0 0.0 39 0.9 Insulin+Metformin+Gliclazide 7 0.3 4 0.2 0 0.0 11 0.2 Other combinations or missed 83 3.6 61 2.9 4 4.3 148 3.3 
Total 2288 100 2077 100 93 100 4458 100 
 
Metformin or any of its combinations was prescribed more to females (63.5%) when 
compared to males (56.4%). Both glibenclamide monotherapy and insulin 
monotherapy or any of their combinations were prescribed to both males and females 
almost equally (44% versus 42% for glibenclamide and 31% versus 31% for insulin 
respectively). Table 17 illustrates that among children, youth and adult patients, insulin 
monotherapy was the most frequently prescribed antidiabetic drug, while metformin 
combined with glibenclamide was commonest among the middle and older age 
groups. 
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Table 17: Age category distribution of prescribed antidiabetic drugs among patients with diabetes in PHCCs 
Treatment class Age Categories 
Children & Youth (0-24Y) Adults  (25-44 Y) Middle age  (45-64 Y) Older people  (≥ 65 Y) Missed Total No. % 
 (/143) 
No. % 
(/487) 
No. % 
(/2284) 
No. % 
(/1530) 
No. % 
(/14) 
No. % 
(/4458) 
Monotherapy Diet & Exercise  0 0.0 18 3.7 77 3.4 25 1.6 0 0.0 120 2.7 Metformin  1 0.7 84 17.2 307 13.4 145 9.5 1 7.1 538 12.1 Glibenclamide 0 0.0 41 8.4 203 8.9 189 12.4 2 14.3 435 9.8 Gliclazide 0 0.0 9 1.8 44 1.9 63 4.1 1 7.1 117 2.6 Insulin 134 93.7 151 31.0 348 15.2 322 21.0 0 0.0 955 21.4 
Combination therapy Metformin+Glibenclamide 2 1.4 103 21.1 793 34.7 499 32.6 6 42.9 1403 31.5 Metformin+Gliclazide 1 0.7 22 4.5 182 8.0 95 6.2% 1 7.1 301 6.8 Glibenclamide+Gliclazide 0 0.0 0 0.0 2 0.1 3 0.2 0 0.0 5 0.1 Insulin+Metformin 2 1.4 34 7.0 213 9.3 119 7.8 0 0.0 368 8.3 Insulin+Glibenclamide 0 0.0 1 .2 7 0.3 7 0.5 0 0.0 15 0.3 Insulin+Gliclazide 0 0.0 1 0.2 2 0.1 0 0.0 0 0.0 3 0.1 Insulin+Metformin+Glibenclamide 1 0.7 3 0.6 24 1.1 11 0.7 0 0.0 39 0.9 Insulin+Metformin+Gliclazide 0 0.0 0 0.0 7 0.3 4 0.3 0 0.0 11 0.2 Other combinations or missed 2 1.4 20 4.1 75 3.3 48 3.1 3 21.4 148 3.3 
Total 143 100 487 100 2284 100 1530 100 14 100 4458 100 
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Table 18: Antidiabetic drug prescribing variability among PHCCs for patients with 
T1DM 
PHCC Name Treatment class (%) Insulin monotherapy Insulin combinations Missed Total No. % 
Almanhal 69.0 29.3 1.7 58 100 
Wasat Abha 90.8 3.9 5.3 76 100 
Almansak 75.0 25 0.0 24 100 
Almowadafeen 51.9 48.1 0.0 131 100 
Johaan 100.0 0 0.0 17 100 
Sultan City 82.8 16.1 1.1 93 100 
Alkaabel 93.7 5.0 1.3 79 100 
Alaziziah 90.9 9.1 0.0 11 100 
Therah 90.0 10 0.0 20 100 
Alnumais 91.2 8.8 0.0 57 100 
Total 78.3 20.5 1.2 566 100 
 
Table 18 shows that there is significant variation among different PHCCs in the type of 
antidiabetic therapy prescribed for patients with T1DM. For example, insulin 
monotherapy was exclusively (100%) the pattern of therapy prescribed for patients 
with T1DM at Johaan PHCC, while only about half of the T1DM patients at 
Almowadafeen PHCC received this type of therapy. The other half of the T1DM 
patients at Almowadafeen PHCC received insulin therapy in combination with one or 
two oral antidiabetic drugs. For all T1DM patients in Abha city, insulin monotherapy 
was the commonest class of treatment prescribed, accounting for 78.3%, followed by 
insulin + metformin combination (17.8%).  
As shown in table 19, among different PHCCs, there was a considerable variation in 
prescribing insulin monotherapy or insulin in combination with other oral antidiabetic 
drugs for patients with T2DM. Few patients with T2DM were treated by insulin or 
insulin combinations at both Sultan city (7.5%) and Almowadafeen PHCCs (1.4%) when 
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compared to other PHCCs. For all T2DM patients in Abha city, metformin + 
glibenclamide combination was the commonest class of treatment prescribed, 
accounting for 36.2%, followed by metformin monotherapy (13.9%), insulin 
monotherapy (13.3%), glibenclamide monotherapy (11.3%), metformin + gliclazide 
(7.7%) and insulin + metformin (6.8%).   
Table 19: Antidiabetic drug prescribing variability among PHCCs for patients with 
T2DM 
PHCCs Treatment class (%) Diet & Exercise only One oral drug Two oral drugs Insulin monotherapy Insulin combinations Others + Missed Total No. % 
Almanhal 1.3 23.7 43.8 8.1 22.4 0.7 607 100 
Wasat Abha 1.9 30.5 39.9 17.5 4.1 6.1 691 100 
Almansak 2.5 31.9 37.5 9.4 16.2 2.5 160 100 
Almowadafeen 1.7 38.3 56.0 0.9 0.5 2.6 350 100 
Johaan 1.5 33.3 43.9 12.1 9.2 0.0 66 100 
Sultan City 8.5 26.1 50.8 5.1 2.4 7.2 376 100 
Alkaabel 3.3 25.7 48.1 14.7 6.9 1.3 599 100 
Alaziziah 2.4 30.3 34.8 19.5 8.5 4.5 287 100 
Therah 3.8 20.9 36.8 19.2 12.2 7.1 182 100 
Alnumais 1.5 28.0 41.0 25.7 3 0.8 393 100 
Total 2.8 28.3 44.0 13.3 8.3 3.3 3711 100 
 
For 60% of the registered patients with diabetes at all the PHCCs, the mean FBG of the 
most recent readings during the preceding 12 months was calculated. Table 20 
summarizes the distribution of the FBG for each type of antidiabetic therapy. As 
shown, over half of patients, who were on insulin monotherapy or insulin combined 
with other oral drugs, had poor glycemic control (FBG > 180 mg/dl (10 mmol/l)). Those 
patients who were on oral monotherapy were more likely to attain an acceptable level 
of FBG than those on oral combination therapy.  
Based on the local management protocol, the initial prescribed therapy for T1DM is 
insulin monotherapy. For T2DM, if the diet and exercise failed to control diabetes 
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within the first 1-3 months, the initial prescribed drugs are either metformin if the 
patient’s BMI ≥ 30 kg/m2 or glibenclamide if the BMI ˂ 30 kg/m2. If monotherapy failed 
to control the level of blood glucose then combination therapy is used by adding more 
oral antidiabetic drugs. For T2DM, if the oral combination therapy failed to control 
diabetes then the patient should be shifted to insulin monotherapy or insulin 
combination therapy. It is expected that those patients who are on insulin 
monotherapy or insulin combination therapy should have the best control of blood 
glucose. However, table 20 shows that as intensity of treatment increases, the 
proportion of patients with poor control rises from 14% to over 50%. This means that 
prescribing more oral antidiabetic drugs or adding insulin is not sufficient to control 
blood glucose. 
      
Table 20: Distribution of antidiabetic drugs by categories of FBG 
Treatment Types FBG categories 
Excellent 
˂ 126 mg/dl (7mmol/l) Acceptable 126 - 180 mg/dl (7-10 mmol/l) 
Poor 
˃ 180 mg/dl (10 mmol/l) Total No. % No. % No. % No. % Diet & Exercise  22 44.9 20 40.8 7 14.3 49 100 Metformin  122 32.1 188 49.5 70 18.4 380 100 Glibenclamide 42 24.3 86 49.7 45 26.0 173 100 Gliclazide 16 29.1 24 43.6 15 27.3 55 100 Metformin combinations (oral)* 195 16.6 487 41.5 492 41.9 1174 100 Insulin 86 17.6 143 29.2 260 53.2 489 100 Insulin combinations** 43 13.9 106 34.3 160 51.8 309 100 Missed 8 19.5 12 29.3 21 51.2 41 100 
Total 534 20.0 1066 39.9 1070 40.1 2670 100 
*Metformin combinations are Metformin+Glibenclamide or Metformin+Gliclazide 
**Insulin combinations are Insulin+Metformin or Insulin+Metformin+Glibenclamide 
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For both overweight and obese patients, the commonest prescribed therapy was the 
combination of metformin plus glibenclamide (36% and 32% respectively), followed by 
insulin monotherapy and metformin monotherapy. For patients with underweight or 
normal weight, the commonest prescribed therapy was insulin monotherapy (65% and 
31% respectively), followed by the combination of metformin plus glibenclamide and 
the monotherapy of glibenclamide. Other types of drugs, such as glimepiride, glipizide 
and glitazones, were not usually prescribed to patients because they are not available 
at the PHCCs. 
Other co-prescribed medications: 
Aspirin, antihypertensive and lipid-lowering medicines were commonly prescribed 
medications along with the antidiabetic drugs. However, huge variability and inequity 
in prescribing of these medications was observed among the PHCCs in Abha city. At 
Wasat Abha PHCC, aspirin was prescribed for 9.3% of the registered patients with 
diabetes; while at Almanhal PHCC, it was prescribed for more than 72% of the 
registered patients. Other medications such as Angiotensin II Receptor Blockers (ARBs), 
Angiotensin Converting Enzyme Inhibitors (ACEIs) and statins were variably prescribed 
to patients as shown in table 21.  
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Table 21: Variability of prescribing other drugs for patients with diabetes by PHCCs  
PHCCs 
Treatment class (%) ACEIs* ARBs** Aspirin Statins Total No. 
Almanhal 42.7 2.1 72.2 28.4 668 
Wasat Abha 6.9 0.6 9.3 1.1 796 
Almansak 2.9 1.4 49.0 2.4 208 
Almowadafeen 0.2 0.0 58.4 17.5 527 
Johaan 0.0 0.0 10.8 0.0 83 
Sultan City 11.0 0.6 26.5 0.6 498 
Alkaabel 5.7 6.4 23.4 0.3 700 
Alaziziah 5.1 0.0 11.8 0.0 314 
Therah 16.2 0.0 37.7 0.0 204 
Alnumais 2.6 0.0 12.0 0.0 460 
Total 11.3 1.6 32.3 6.8 4458 
* ACEIs: Angiotensin Converting Enzyme Inhibitors  
** ARBs: Angiotensin II Receptor Blockers 
 
Antidiabetic drug prescribing (ADC): 
At ADC, the most commonly prescribed antidiabetic medications, either alone or in 
combinations, were metformin (66.4%) and insulin (62.6%), (Table 22). The proportion 
of insulin prescriptions at ADC was twice of that at the PHCCs (62.6% versus 31.2% 
respectively). The combination therapy of insulin + metformin was the commonest 
prescribed type of treatment (28.9%) at ADC, whereas in PHCCs, it was one of the least 
prescribed therapies (8.3%).  The second commonest therapy method was the insulin 
monotherapy (27.8%), followed by metformin + glibenclamide (15%) and metformin 
monotherapy (13%). 
At ADC, there was no significant variation in the type of therapy prescribed for males 
or females patients (χ2=3.6, df=11, p=0.9). Among children and youths, insulin 
monotherapy was the most frequently prescribed antidiabetic drug (88.2%), while 
among adult patients, insulin monotherapy and insulin + metformin were almost 
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equally prescribed (28.7%, 29.9% respectively). Among the middle and older age 
groups, the combination of insulin + metformin was the commonest prescribed 
therapy (35% and 34% respectively), followed by the combination therapy of 
metformin + glibenclamide (18% and 20% respectively), and the monotherapy of 
metformin (16.7% and 15.6% respectively).          
It is apparent from table 22 that the vast majority of T1DM patients at ADC were on 
insulin monotherapy (91.7%). Few patients were on insulin + metformin combined 
therapy. Insulin monotherapy was given to a higher proportion of T1DM patients in 
ADC than in the PHCCs (91.7% versus 78.3% respectively). 
Table 22: Distribution of antidiabetic drugs by types of diabetes in ADC 
Treatment Types Type of diabetes T1DM T2DM Missed data Total No. % 
(/121) 
No. % 
(/408) 
No. % 
(/22) 
No. % 
(/551) 
Monotherapy  Diet & Exercise  0 0.0 0 0.0 0 0.0 0 0.0 Metformin  0 0.0 67 16.4 5 22.7 72 13.1 Glibenclamide 0 0.0 12 2.9 0 0.0 12 2.2 Gliclazide 0 0.0 3 0.7 0 0.0 3 0.5 Insulin 111 91.7 36 8.8 6 27.3 153 27.8 
Combination therapy Metformin+Glibenclamide 0 0.0 80 19.6 3 13.6 83 15.1 Metformin+Gliclazide 0 0.0 24 5.9 2 9.1 26 4.7 Insulin+Metformin 9 7.4 146 35.8 4 18.2 159 28.9 Insulin+Glibenclamide 0 0.0 4 1.0 0 0.0 4 0.7 Insulin+Gliclazide 0 0.0 3 0.7 0 0.0 3 0.5 Insulin+Metformin+Glibenclamide 1 0.8 18 4.4 1 4.5 20 3.6 Insulin+Metformin+Gliclazide 0 0.0 6 1.5 0 0.0 6 1.1 Missed 0 0.0 9 2.2 1 4.5 10 1.8 
Total 121 100 408 100 22 100 551 100 
 
For T2DM patients, more than one third of ADC patients (35.8%) were treated by the 
combination of insulin and metformin therapy, while in the PHCCs, only 6.8% of T2DM 
patients were using this type of combination therapy. At ADC, another one third (36%) 
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was treated by either metformin monotherapy or metformin in combination with 
glibenclamide.  
For almost half (49%) of the reviewed sample of the registered patients with diabetes 
at ADC, the FBG for the preceding 12 months was obtained. Table 23 shows that the 
patients in the ADC are more likely to have better glycemic control when compared to 
those at the PHCCs (Table 20). However, the overall glycemic control was suboptimal. 
Other medications such as insulin mixtures (Mixtard), fast acting (Lispro, Aspart) and 
glimepiride were available but in small amounts.  
Table 23: Distribution of antidiabetic drugs by FBG categories at ADC 
Treatment Types FBG categories 
Excellent 
˂ 126 mg/dl (7mmol/l) Acceptable 126 - 180 mg/dl (7-10 mmol/l) 
Poor 
˃ 180 mg/dl (10 mmol/l) Total No. % No. % No. % No. % 
Monotherapy Diet & Exercise  0 0.0 0 0.0 0 0.0 0 0.0 Metformin  21 47.7 14 31.8 9 20.5 44 100 Glibenclamide 1 14.3 1 14.3 5 71.4 7 100 Gliclazide 1 50.0 1 50.0 0 0.0 2 100 Insulin 9 17.6 19 37.3 23 45.1 51 100 
Combination therapy Metformin+Glibenclamide 13 30.2 14 32.6 16 37.2 43 100 Metformin+Gliclazide 5 41.7 2 16.7 5 41.7 12 100 Insulin+Metformin 19 21.8 28 32.2 40 46.0 87 100 Insulin+Glibenclamide 1 50.0 1 50.0 0 0.0 2 100 Insulin+Gliclazide 1 33.3 2 66.7 0 0.0 3 100 Insulin+Metformin+Glibenclamide 3 33.3 4 44.4 2 22.2 9 100 Insulin+Metformin+Gliclazide 0 0.0 1 50.0 1 50.0 2 100 Missed 4 57.1 1 14.3 2 28.6 7 100 
Total 78 29.0 88 32.7 103 38.3 269 100 
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Other co-prescribed medications: 
At ADC, the patients were given more co-medications than those at the level of 
primary healthcare centres. This is might be because ADC provides diabetes care to 
more patients who suffer from diabetes complications. At ADC, aspirin and statins 
were prescribed to a greater proportion of T2DM patients than those at the PHCCs 
(Table 24).  
    
Table 24: The distribution of some medications by place of care and type of diabetes 
  
Drugs 
PHCCs ADC T1DM % (/566) T2DM % (/3711) Total (including missed) % (/4458) T1DM % (/121) T2DM % (/408) Total (including missed) % (/551) 
ACEIs* 6.0 12.4 11.2 4.1 18.4 15.2 
ARBs** 0.4 1.8 1.6 0.0 1.7 1.3 
Aspirin 20.8 34.1 32.3 6.6 71.3 56.4 
Statins 5.1 7.1 6.8 4.1 19.6 16.5 
Others  4.4 14.4 12.9 7.4 35.5 28.7 
* ACEIs: Angiotensin Converting Enzyme Inhibitors  
** ARBs: Angiotensin II Receptor Blockers 
 
Annual referral and review in PHCCs: 
According to the local protocols, each patient with diabetes should be referred from 
the PHCC to the hospital to undergo some clinical examinations and lab investigations. 
In 2011, only 43.7% (1946/4458) of all patients with diabetes were referred from the 
PHCCs to Abha General Hospital (AGH) for annual checkups and hospital feedback rate 
was 71.3% (1387/1946).  When looking at the most recent referral whatever the 
date/year was, 13.2% of patients have not been referred to AGH.  
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The proportions of patients who were referred for annual review in the preceding 12 
months were low in Sultan city PHCC (18.8%), Wasat Abha PHCC (21.8%) and Alaziziah 
PHCC (26.5%). These centres in particular need to increase their annual referral rates.  
The most recent annual referral and hospital feedback for each patient with diabetes 
were reviewed (Figure 26). Some lab investigations such as blood glucose, creatinine, 
cholesterol, triglycerides, and ECG were assessed for more than 73% of patients. On 
the other hand, HbA1c, chest x-ray and 24 hours urine protein have been assessed for 
very few patients. Clinical examinations conducted were much less frequently than lab 
investigations. Eye and foot examination was conducted for 52% and 5.4% of the 
patients respectively. Cardiovascular and nervous system examinations were 
conducted for 41.8% and 37.2% of patients respectively.  
 
Patient review in ADC: 
By reviewing the progress notes of the most recent visits within the preceding 12 
months for a sample of patients at ADC, the data on the recorded clinical examinations 
and investigations were collected. The chart in figure 27, when compared with the 
data in figure 26, shows that only foot examination, blood glucose and HbA1c 
investigations were conducted at higher proportions in ADC than in the PHCCs. 
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Figure 26: The proportions of conducted annual examinations and investigations for patients with diabetes at PHCCs (/4458) 
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Figure 27: The proportions of conducted examinations and investigations for patients with diabetes at ADC (/551) 
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Follow-up visits to PHCCs: 
According to local protocols, each patient with diabetes should visit the diabetes clinic 
in the PHCC at least one time every three months.(201) However, as shown in figure 28, 
only 37.7% are actually doing that. According to the national standards,(200) those 
patients who have not visited the PHCC for six months or more should not exceed 20% 
of patients. However, this study found that almost 44% of patients have not visited 
their diabetes clinics during the previous 6 months. The proportion of those patients 
who attended the diabetes clinic for two times or more during the previous 6 months 
ranged from 17.5% at Wasat Abha PHCC to 68.8% at Almansak PHCC.    
For the preceding 12 months, the most recent 3 readings of FBG and blood pressure 
(BP) were collected by reviewing the lab results or the diabetes follow-up chart of each 
patient’s record.  
The proportions of identified patients in whom the FBG and BP have been assessed 
within the preceding 12 months are shown in table 25. Although patients should be 
seen at least three times a year, where FBG and BP are assessed routinely each time, 
more than one third of patients had no records of FBG or BP in the preceding 12 
months. Only 31.4% of patients had three or more records of FBG and 37.9% had three 
or more records of BP. These low proportions indicate that the compliance of patients 
to attend their routine appointments is poor. This suggests that there is a need to 
improve the current appointment system and the compliance of patients to attend 
their follow-up appointments at the diabetes mini clinics in the PHCCs.  
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Figure 28: Proportions of patients who visited the diabetes clinics at the PHCCs during the preceding 6 months, 2011 
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Table 25: Proportions of patients with diabetes who have been assessed within the 
last year for FBG and BP Indicator Number % 
FBG, (/4458) No  record of FBG 1766 39.6 One record of FBG  791 17.7 Two records of FBG 503 11.3 Three or more records of FBG 1398 31.4 
BP, (/4458) No record of BP 1574 35.3 One record of BP  748 16.8 Two records of BP 448 10.0 Three or more records of BP 1688 37.9 
 
As shown in table 26, the proportion of poor glycemic control dropped from almost 
50% among those patients who have not visited their diabetes clinic during the 
preceding 6 months to 36.8% among those patients who visited the diabetes clinic 2 
times or more during the preceding 6 months.  
Table 26: The distribution of the FBG by number of follow-up visits during the 
preceding 6 months  
Number of 
follow-up 
visits 
Mean FBG categories 
Excellent Acceptable Poor Total 
˂ 126 mg/dl (7mmol/l) 126 - 180 mg/dl (7-10 mmol/l) ˃ 180 mg/dl (10 mmol/l) No. % No. % No. % No. (FBG) % 
0 Visit 73 17.0 144 33.6 212 49.4 429  (196.8) 100 
1 Visit 147 21.5 247 36.2 289 42.3 683  
(182.3) 100 
≥ 2 visits 
(Ideal) 
316 20.0 683 43.2 581 36.8 1580  (173.1) 100 
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When comparing the PHCCs, as the proportion of patients who visited their diabetes 
mini-clinics ≥ 2 times in the preceding 6 months rises, the proportion of patients with 
FBG > 180 mg/dl declines (Figure 29).   
Figure 29: The relationship between follow-up visits and FBG among the PHCCs 
 
    
Health education process: 
PHCCs: 
Health education is an essential part of successful diabetes care. Assessing the best 
health education checklist sheet for each patient showed that the health education 
programme was not implemented properly. The programme contained 13 topics that 
cover the important aspects of diabetes care. The first 5 topics in the list were 
explained to almost two thirds of patients (Table 28).  The role of exercise and how to 
take care of feet were explained to more than half of the patients. The other topics 
were explained to a proportion of patients ranging from 24 to 30%.  Johaan and 
Alnumais PHCCs were implementing the health education programme better than the 
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other PHCCs. Wasat Abha and Therah were poorly implementing the programme 
(Figure 30).   
It was expected that provision of health education would improve the glycemic 
control. However, those patients who received education for more topics were less 
likely to have excellent glycemic control (Table 27).  
Table 27: Number of health education topics given to patients by degree of glycemic 
control in PHCCs 
Number of 
explained 
topics 
FBG categories 
Excellent Acceptable Poor Total 
˂ 126 mg/dl (7mmol/l) 126 - 180 mg/dl (7-10 mmol/l) ˃ 180 mg/dl (10 mmol/l) 
No. % No. % No. % No. % 
No topics  82 25.8 130 40.9 106 33.3 318 100 
1-5 topics 132 20.1 229 34.9 295 45.0 656 100 
6-10 topics  183 18.3 414 41.4 404 40.4 1001 100 
˃ 10 topics  139 19.4 301 42.0 277 38.6 717 100 
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Table 28: The proportions of patients who received education by topics and PHCCs 
 PHCCs 
Health education topics 
Almanhal Wasat Abha Almansak Almowadafeen Johaan Sultan City Alkaabel Alaziziah Therah Alnumais Total 
%  
(/668) 
% 
(/796) 
%  
(/208) 
% 
(/527) 
% 
 (/83) 
% 
 (/498) 
%  
(/700) 
%  
(/314) 
% 
 (/204) 
%  
(/460) 
% 
(/4458) 
Explanation of diabetes 94.0 73.4 66.8 62.6 94.0 87.1 84.6 81.2 77.0 88.0 80.8 
Provision  and use of diabetes 
card  
99.6 74.6 65.4 57.7 94.0 71.3 84.3 67.2 64.7 87.0 77.7 
Explanation of anti-diabetic 
drugs 
83.5 57.3 63.0 46.9 92.8 66.1 55.6 62.4 59.8 85.9 65.1 
Understanding hypoglycaemia  76.0 46.9 63.5 50.3 83.1 65.3 67.4 65.6 52.5 77.6 63.1 
Role of diet 85.0 52.6 64.4 48.0 91.6 64.3 72.1 63.4 56.9 75.2 65.9 
Seeking medical aid in illness  21.0 8.7 47.6 30.6 78.3 40.2 15.9 53.5 10.3 71.7 30.6 
Urinalysis  and urine dipsticks at 
home 
19.5 6.7 51.0 27.3 15.7 35.9 12.0 47.8 7.8 69.8 26.8 
Care of feet 83.5 37.3 60.1 39.5 79.5 49.6 58.9 64.0 52.0 68.9 56.9 
Risk of smoking 20.5 6.8 53.4 28.5 63.9 36.3 21.9 56.7 17.2 66.7 30.5 
Role of Exercise 84.4 18.7 61.5 34.0 81.9 55.6 49.9 58.6 59.8 63.5 51.9 
Blood glucose measurement 
technique 
18.7 3.1 56.3 24.1 78.3 30.7 11.7 52.9 11.3 62.0 26.2 
Patients' home monitoring chart 16.5 2.0 51.4 23.0 73.5 25.1 12.9 47.8 9.3 60.4 24.2 
Special circumstances  16.2 1.8 8.7 24.9 72.3 16.1 52.9 45.2 12.3 55.7 27.0 
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Figure 30: The delivery of health education programme in diabetes mini-clinics at PHCCs by number of topics 
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ADC: 
As illustrated in table 29, the topics of the health education programme at ADC were 
slightly different from the primary healthcare programme. Data from this table can be 
compared with the data in table 28 which shows that the health education programme 
for patients with diabetes was better implemented at the primary healthcare level 
than at ADC. It is apparent from this table that the implementation of the health 
education programme at ADC is far from satisfactory for most of its topics and it needs 
to be improved. 
Table 29: The proportions of patients who received education by topics at ADC 
Health education topics No.           % 
(/551) Explanation of diabetes 271 49.2 Hypoglycaemia & hyperglycaemia 245 44.5 Diabetic card provision  233 42.3 What is insulin? 226 41.0 Role of diet 364 66.1 Role of exercise 217 39.4 Oral anti-diabetic drugs 207 37.6 Self monitoring of blood glucose 341 61.9 Special issues and circumstances  125 22.7 Complications of diabetes 157 28.5 Roles of bad habits such as smoking & overeating  125 22.7 Role of hygiene: foot care, eye care & other hygiene 216 39.2 
 
Completeness of patients’ records and recording: 
PHCCs: 
Recording details of patient’s management, investigations and care outcomes in the 
medical records is important. It supports informed decision making, effective 
communication between healthcare professionals and delivering of good follow-up 
care. The patient’s records are a valuable source of data and information for scientific 
research, audit and healthcare service evaluation. The completeness of recording the 
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required information in each sheet of the patient’s records was assessed. Structured 
questions were used to assess each sheet in the record to decide whether the 
presence of the required information was complete, partly complete or the sheet was 
not available in the record.  
In each sheet, specific information should be recorded. If all the information were 
recorded then the sheet is completely filled in. If any information was missed then the 
sheet is partly filled in or completed.  
As shown in table 30, the completeness of recording information was variable among 
PHCCs for each sheet in the patients’ records. The most completed sheet was the bio-
data sheet (76.2%) followed by the annual referral sheet (60.5%). The recording of 
information in the other sheets was mainly partly completed. There were many 
records with some sheets missing (absent sheet). The most common unavailable sheet 
was the hospital feedback sheet (21.6%) and the annual referral sheet (11.9%). 
ADC: 
At ADC (Table 31), the progress form was the most frequently completed form (92.9%). 
All the other sheets were often partly completed. The most common unavailable sheet 
was the diet plan assessment sheet (2.0%). 
  
Recording patient compliance: 
There are four types of compliance that can be recorded in the diabetes follow-up 
chart (diet, exercise, appointment and drug compliance). At ADC, these four types of 
compliance are not recorded routinely. At the primary healthcare level, Almanhal 
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PHCC was the best centre at recording the degree of patient compliance; notes about 
compliance in the preceding 12 months were missing in only 29% of records of 
patients with diabetes. Five PHCCs do not record compliance routinely (Wasat Abha, 
Almowadafeen, Sultan City, Alaziziah, and Therah). The other four PHCCs are poor at 
recording the patient compliance. Therefore, the data on compliance were not 
presented here.  
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Table 30: Completeness of record's sheets of patients with diabetes in the mini-clinic of each PHCC 
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Table 31: Completeness of record's sheets of patients with diabetes in the ADC 
 Record’s sheets  completeness of recording No. % 
(/551) 
Bio-data information sheet Completed 167 30.3 Partly completed 377 68.4 Absent sheet 2 0.4 Missed data 5 0.9 
Complication sheet Completed 103 18.7 Partly completed 419 76.0 Absent sheet 1 0.2 Missed data 28 5.0 
Progress note form Completed 512 92.9 Partly completed 31 5.6 Absent sheet 1 0.2 Missed data 7 1.3 
Last diabetes follow-up sheet Completed 8 1.5 Partly completed 499 90.6 Absent sheet 7 1.3 Missed data 37 6.7 
Diabetic eye file Completed 59 10.7 Partly completed 475 86.2 Absent sheet 4 0.7 Missed data 13 2.4 
Diabetes education programme Completed 80 14.5 Partly completed 428 77.7 Absent sheet 4 0.7 Missed data 39 7.1 
Diabetic foot registry Completed 125 22.7 Partly completed 417 75.7 Absent sheet 1 0.2 Missed data 8 1.5 
Diabetic foot progress sheet Completed 196 35.6 Partly completed 325 59.0 Absent sheet 2 0.4 Missed data 28 5.1 
Nursing diabetic assessment Completed 62 11.3 Partly completed 467 84.8 Absent sheet 7 1.3 Missed data 15 2.7 
Diet plan assessment Completed 102 18.5 Partly completed 400 72.6 Absent sheet 11 2.0 Missed data 38 6.9 
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Variation of process measures among PHCCs: 
The variation in diabetes management between PHCCs was explored by comparing 
process measures (Table 32). A colour coding was used to show the best 3 PHCCs 
(green in colour) and the poorest 3 PHCCs (red in colour) for each measure. All the 
processes of diabetes care in all the PHCCs need to be improved.  
Generally, the lab tests were commonly done for cholesterol, triglycerides and 
creatinine in addition to the ECG. But, all the clinical examinations were done less 
frequently and showed marked variation between PHCCs. There was marked variation 
between individual PHCCs in referring patients to hospital for annual review, 
measuring FBG, assessing the cardiovascular system, nervous system eye and foot 
examination. For example, the variation between individual PHCCs in the proportion of 
patients receiving FBG test ranged from 88% in one PHCC to 28% in another PHCC. Eye 
examination was done and recorded for 72% of people with diabetes in one PHCC but 
only for 28% in another. The most striking result to emerge from the table 32 is that 
foot examination was done and recorded for only 5.6% of people with diabetes. In 
addition, foot examination also showed marked variation which ranged from almost 
1% in one PHCC to 47% in another.     
Across all the measures, Wasat Abha, Sultan city and Alaziziah PHCCs were the poorest 
centres (red) in carrying out and recording these healthcare checks while Almanhal, 
Almansak, Alnumais and Almowadafeen PHCCs were the best (green).   
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Table 32: Process measures of diabetes care in the PHCCs 
 
*The test or measure was done in the PHCC in the previous 12 months 
**The test or measure was done in the hospital; the most recent result was collected at any time (not only in the previous 12 months) 
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6.4.3. Outcomes of diabetes care 
It is essential that everyone with diabetes receives all the healthcare checks according 
to the local guideline. It is just as important that people with diabetes achieve the 
recommended targets. This will minimise the risk of future diabetes complications. In 
adults with diabetes the recommended outcome targets for both national and local 
guidelines were summarized in table 33.  
Table 33: Summary of the targets of some outcome measures 
Outcome 
indictors 
Local guideline(214) National manual(200) Target value Target patient % Target value Target patient % 
Fasting blood 
glucose (FBG) 
≤ 130 mg/dl (recommended) -- < 126 mg/dl (Excellent control) > 40% < 126 mg/dl  (good control) ≥ 40% 126-180 mg/dl (Acceptable control) -- 126-140 mg/dl  (Fair control) 40% > 180mg/dl  (Poor control) < 10% > 140 mg/dl  (poor control) < 20% -- -- 
Random blood 
glucose (RBG) 
≤ 180 mg/dl -- -- -- 
Glycated 
haemoglobin 
(HbA1c) 
< 7.0% (recommended) -- < 8.0% (Excellent control) >40% -- -- 8-11% (Acceptable control) -- -- -- >11% (Poor control) < 10% 
Blood 
pressure (BP) 
< 130/80 mm Hg (recommended) ≥ 80% -- -- 
Body mass 
index (BMI) 
Normal > 50% -- -- Overweight < 30% -- -- Obese  < 20% -- -- 
Cholesterol -- -- -- -- 
Triglycerides < 150 mg/dl  (recommended) -- -- -- 
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The outcomes of diabetes care in Abha city need to be improved. Only 23% of people 
with diabetes achieved the recommended FBG target of ≤ 130 mg/dl (7.2 mmol/l). In 
addition, according the local guideline 68.6% of patients had poor glycemic control of > 
140 mg/dl (7.8 mmol/l) and according to the national guideline, 40% of patients had 
poor glycemic control of > 180 mg/dl (10 mmol/l). The FBG tests that were conducted 
in hospitals during the annual review confirmed the poor glycemic control and showed 
similar or even higher proportions. 
 
Overview of outcome measures: 
PHCCs: 
At the primary healthcare level, there were widespread deficiencies in diabetes care 
processes and clinical outcomes. In adult patients (≥ 20 years) with diabetes, 33.3% 
(1263/3796) were overweight and 53% (2014/3796) were obese. They had a mean BMI 
of 31 kg/m2 which is within the obesity range. Thirty one percent of patients with a 
recorded BMI and type 1 diabetes and 33.4% of those with a recorded BMI and type 2 
diabetes were overweight (BMI 25-29.9 kg/m²), while 36.2% of those with type 1 and 
54.5% of those with type 2 were obese (BMI ≥ 30 kg/m²). In this study, the proportion 
of obese patients among all patients with diabetes was higher than the proportion of 
overweight patients (45.3% versus 28.4% respectively), (denominator = 4458).   
The mean BP of patients from the PHCCs was within the recommended target (≤ 
130/80 mmHg), while the mean fasting and random blood glucose were higher than 
the recommended targets (≤ 130 mg/dl) or (≤ 7.2mmol/l) for FBG and (≤ 180 mg/dl) or 
(≤ 10 mmol/l) for RBG (Table 34). The proportions of patients with mean FBG ≥ 130 
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mg/dl among males and females were similar (77.1% and 77.3% respectively). 
However, when different PHCCs are compared, Therah and Sultan city PHCCs had the 
highest proportions of patients with mean FBG ≥ 130 mg/dl (84.2% and 81.4% 
respectively). Therah, Sultan city in addition to Wasat Abha PHCCs were having also 
the highest proportions of patients with poor glycemic control of mean FBG ˃ 180 
mg/dl (54.1%, 50.2%, and 48.2% respectively).    
Table 34: Outcome indicators of diabetes care among adults (≥20 years) using the 
most recent readings of routine follow-up investigations at the PHCCs 
 Indicators Number of patients Mean Std. Deviation 
Body mass index, BMI (Kg/m2) 3796 31.03 6.63 
Blood pressure, BP (mmHg) 
Systolic BP 2848 124.77 17.74 
Diastolic BP 2848 77.53 10.28 
Fasting blood glucose, FBG (mg/dl) 2655 179.46 71.39 
Random blood glucose, RBG (mg/dl) 72 251.50 98.16 
 
T1DM patients were at a higher risk of having FBG above the recommended target (> 
130 mg/dl) than T2DM patients (odds ratio (OR) = 2.03, 95% CI: 1.4-2.9, P < 0.0005). 
T1DM patients were also at a greater risk of not being referred to hospital for annual 
checkups than patients with T2DM (OR = 1.4, 95% CI: 1.1-1.6, P < 0.001). 
The annual hospital clinical examinations and lab investigations confirmed what 
happens in PHCCs (Table 35). Furthermore, the mean of the annual readings of FBG 
and RBG that were conducted at AGH lab were higher than those at the PHCC’s lab.  Of 
those patients who have had a HbA1c test at hospital (161 patients), 82.6% had a 
reading higher than 7.5% (Table 36). The mean value of HbA1c for 156 available 
readings for adult patients was higher (11.5%) than the target for glycemic control (< 
7.0%). Mean creatinine was within the normal range (0.5 – 1.4 mg/dl) whereas mean 
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cholesterol and triglycerides were higher than the target values (< 156 mg/dl or < 4 
mmol/l for cholesterol and < 150 mg/dl or < 1.7 mmol/l for triglycerides) as shown in 
table 35.   
  
Table 35: Some outcome indicators of diabetes care among adults (≥ 20 years) using 
the most recent readings of annual hospital investigations at AGH  
 Indicators Number of 
patients Mean Std. deviation 
Blood pressure, BP (mmHg) 
Systolic BP 2292 125.66 16.25 
Diastolic BP 2292 78.24 8.95 
Fasting blood glucose, FBG (mg/dl) 3418 196.31 78.04 
Random blood glucose, RBG (mg/dl) 1524 282.47 97.35 
HbA1C,  % 156 11.53 4.90 
Creatinine, mg/dl 3343 1.02 2.78 
Cholesterol, mg/dl 3412 195.63 46.32 
Triglycerides, mg/dl 3262 183.53 101.01 
 
Of those patients who have had their FBG measured in the preceding 12 months at 
their PHCCs (Table 36), 77% have a mean reading that is more than 130 mg/dl. Almost 
78% of those patients who have had their BP measured in the preceding 12 months 
have a reading of 130/80 or less.  Of patients who have a record of having their 
cholesterol measured, 52.7% have a reading of 195 mg/dl (5 mmol/l) or less. 
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Table 36: Proportions of patients with raised values for some outcome indicators of 
diabetes care in PHCCs 
Indicators Number % 
Fasting blood glucose, FBG, (/2692): the mean reading for the preceding 12 months 
FBG  ≤ 130 mg/dl  617 22.9 
FBG  ˃ 130 mg/dl   2075 77.1 
HbA1c, (/161) 
HbA1c ≤ 7.5%  28 17.4 
HbA1c ˃ 7.5% 133 82.6 
Blood pressure, BP, (/2884): the most recent reading in the preceding 12 months 
BP ≤ 130/80  Systolic    2243 Diastolic  2272 77.8 78.8 
BP ˃ 130/80 Systolic      641 Diastolic    612 22.2 21.2 
Cholesterol, (/3447): the most recent reading  ≤ 156 mg/dl (4 mmol/l)  646 18.7 
˃  156 mg/dl (4 mmol/l) 2801 81.3 
≤  195 mg/dl (5 mmol/l) 1817 52.7 
˃  195 mg/dl (5 mmol/l) 1630 47.3 
 
ADC: 
The sample of adult patients that were reviewed at ADC had similar unsatisfactory 
outcome indicators. However, in general, the mean values of these indicators were 
slightly better than the corresponding values at the PHCCs (Table 37 and 38). 
Table 37: Outcome indicators of diabetes care among adults (≥ 20 years) using the 
most recent readings of follow-up investigations at the ADC during the last 12 
months 
 Indicators Number of 
patients 
Mean Std. Deviation 
Body mass index, BMI (Kg/m2) 420 30.79 6.516 
Blood pressure, BP (mmHg) 
Systolic BP 435 122.33 15.48 
Diastolic BP 435 77.00 9.685 
Fasting blood glucose, FBG (mg/dl) 244 168.89 67.87 
Random blood glucose, RBG (mg/dl) 172 239.49 88.98 
HbA1C, % 339 9.086 2.091 
Creatinine, mg/dl 281 0.89 0.545 
Cholesterol, mg/dl 235 181.84 43.68 
Triglycerides, mg/dl 239 143.94 76.11 
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Table 38: Proportions of patients with raised values for some outcome indicators of 
diabetes care in ADC 
Indicators Number % 
Fasting blood glucose , FBG, (/269): the mean of the readings for the preceding 12 months 
FBG  ≤ 130 mg/dl  86 32.0  FBG  ˃ 130 mg/dl   183 68.0 
HbA1c, (/403) 
HbA1c ≤ 7.5%  94 23.3 
HbA1c ˃ 7.5% 309 76.7 
Blood pressure, BP, (/287): the most recent reading in the preceding 12 months 
BP ≤ 130/80  Systolic    406 Diastolic  401 83.4 82.3 
BP ˃ 130/80 Systolic      81 Diastolic    86 16.6 17.7 
Cholesterol, (/257): the most recent reading  ≤ 156 mg/dl (4 mmol/l)  83 32.3 
˃  156 mg/dl (4 mmol/l) 174 67.7 
≤  195 mg/dl (5 mmol/l) 164 63.8 
˃  195 mg/dl (5 mmol/l) 93 36.2 
 
Variation of outcome measures among PHCCs: 
The variation of diabetes care outcome between PHCCs was explored by comparing 
some outcome measures (Table 39).  As shown in these tables, a colour coding was 
used to show the best 3 PHCCs (green in colour) and the poorest 3 PHCCs (red in 
colour) for achieving the recommended target for each measure.  
The variation between individual PHCCs in the proportion of patients with poor 
glycemic control was small. Also the variation was small between individual PHCCs in 
the proportion of patients with obesity, cholesterol ˃ 156 mg/dl (4 mmol/l) or 
triglycerides ≥ 150 mg/dl (1.7 mmol/l).     
 By comparing the PHCCs and their process and outcome measures (Table 32 and  39), 
those PHCCs which had the poorest process measures (Wasat Abha, Sultan city and 
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Alaziziah PHCCs) also had the poorest outcome measures. Similarly, those PHCCs with 
good process measures such as Almanhal, Almansak and Almowadafeen also had the 
best outcome measures.   
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Table 39: Proportions of outcome measures of diabetes care in the PHCCs 
 
*The test or measure was done in the PHCC in the previous 12 months 
**The test or measure was done in the hospital; the most recent result was collected at any time (not only in the previous 12 months) 
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Diabetes complications: 
PHCCs: 
The proportion of patients identified as having at least one of the complications of 
diabetes was 32.2%. Hypertension was the most common complication among 
patients with diabetes in Abha (22.5%), followed by diabetic retinopathy (10.5%), 
ischemic heart disease (2.9%), nephropathy (1.8%) and cerebrovascular disease (1.4%). 
The proportions of other complications of diabetes such as peripheral arterial disease, 
neuropathy and foot problems were almost lower than 1%. These low proportions 
might suggest that the screening and documenting of these complications is not 
appropriate at the level of primary healthcare. Identification of hypertension among 
patients with diabetes at the primary healthcare was not related to the number of 
follow-up visits during the preceding 6 months or the annual referral for checkups 
during the preceding 12 months.    
ADC: 
At ADC, the proportions of complications among the reviewed cases (551 patients) 
were higher than what has been observed at the PHCCs. Hypertension was also the 
most commonly reported complication, accounting for 31.6% of patients, followed by 
retinopathy (19.8%), ischemic heart disease (16.2%), foot problems (7.4%), neuropathy 
(3.8%), cerebrovascular disease (2.7%), and nephropathy (2.7%). The proportion of 
peripheral arterial disease was less than 1%.   
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6.5. Discussion 
This comprehensive review of 97% (4458/4583) of the records of patients with 
diabetes in the 10 PHCCs of Abha city has identified several important findings. 
Variations in proportions of patients with T1DM and T2DM among the PHCCs were 
substantial. There was also large variation in the types of therapy prescribed for 
patients with diabetes among PHCCs. Glycemic control was poor among a large 
proportion of patients, and obesity was a common coexisting risk factor. Finally, the 
prevalence of diabetes complications was lower than expected. 
 
6.5.1. Variation of types of diabetes 
The proportion of patients with T1DM ranged from 3.5% at Alaziziah PHCC to almost 
25% at Almowadafeen PHCC (Table 13). This large variation in the proportions of T1DM 
and T2DM among the PHCCs could be related to either misclassification of diabetes 
types or under-recognition of T2DM or both. 
 The misclassification explanation was supported by the fact that at Almowadafeen 
PHCC, almost all the T2DM patients are on oral therapy (94.3%) and all the T1DM 
patients are on insulin therapy. This might indicate that once the patient is treated by 
insulin or insulin combination, the clinicians misclassify his/her diabetes as T1DM. The 
other finding that supports the misclassification explanation is that about 48% of 
people with T1DM in Almowadafeen PHCC are on insulin plus oral combination 
therapy which is not routinely prescribed for T1DM patients. Therefore, it is likely that 
many patients with T2DM were misclassified as T1DM when insulin was added to their 
oral therapy. This is also supported by the age of T1DM patients. The proportions of 
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T1DM patients who were above 45 years old ranged from 35% to 59% except at 
Almowadafeen PHCC where 80% of them were above 45 years old. The question here 
is why this PHCC had the highest proportion of patients with T1DM who were above 45 
years old. A possible explanation might be because the effect of misclassification.  
Review of current local and national guidelines and protocols (200-202, 214, 216), identified 
that there was no agreement on specific criteria which clinicians can use to classify 
types of diabetes. Therefore, it is important to have a guideline that specifies the 
definition of type 1 and type 2 diabetes and agree on specific criteria for diagnosis of 
different types of diabetes to reduce the chance of misclassification. 
 As described in chapter 5, the prevalence of diabetes in Abha city was lower than the 
published national figures. Thus, it is likely that more than 70% of people with diabetes 
in Abha city are undiagnosed. T1DM typically presents in an abrupt manner with acute 
symptoms, such as ketoacidosis, weight loss, nausea, vomiting and polyuria, and the 
obvious need for insulin injections to control diabetes. Therefore, it is easy to identify 
and diagnose most of the patients with T1DM. However, there still few cases where it 
is ambiguous clinically whether someone has T1DM or T2DM. On the other hand, 
T2DM is typically of an insidious mild onset which may take many years to be 
diagnosed. Therefore, it is likely that the substantial undiagnosed diabetes is mostly 
T2DM. If there was variation between PHCCs in under-recognition of T2DM, this could 
cause a high proportion of T1DM in some PHCCs.    
The under-recognition of T2DM explanation can be supported by the low and variable 
diabetes prevalence among different PHCCs and the probable large number of 
undiagnosed T2DM patients in Abha city. Therefore, it is important to implement 
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effectively the screening programme for diabetes to identify those undiagnosed 
patients. Also, it is important to implement interventions to increase the awareness of 
the whole population about symptoms and signs of diabetes. 
  
6.5.2. Variation in therapy prescribed  
Current prescribing practice in Saudi Arabia differs substantially from the United State 
of America (USA). In the USA, 58% of adult patients with diabetes are prescribed oral 
medications only compared to 63.7% in Abha city; 12% take insulin only versus 20.3% 
in Abha and 14% take both insulin and oral medication versus 9.9% in Abha. In the 
USA, about 16% were on no medication (diet and exercise)  versus 3.3% in Abha.(255)  
Previous small sample size studies in Abha city reported a proportion of those who 
were on diet and exercise ranged from 8-10%.(246, 256) Thus, it seems that more 
Americans who are on diet and exercise can control their diabetes better than Saudi. 
This could be due to the poor compliance of Saudis with diet and exercise.(84, 98, 102, 179) 
Therefore, more Saudis were on either oral medication or insulin than Americans.  
These findings suggest that more efforts are needed to promote patient compliance 
with diet, exercise and oral medication.  
One of the more important findings to emerge from this case notes review is the large 
variation among the PHCCs in the type of therapy prescribed for different types of 
diabetes. For example, the proportion of those patients with T1DM who were on 
insulin monotherapy ranged from 51.9% at Almowadafeen PHCC to 100% at Johaan 
PHCC. A similar variation was reported among those patients with T2DM where the 
proportion of those on insulin monotherapy ranged from 0.9% at Almowadafeen PHCC 
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to 25.7% at Alnumais PHCC. This variation might be due to the effect of the problem of 
misclassification of types of diabetes where some PHCC, such as Almowadafeen PHCC, 
classified all those patients with T2DM who were on insulin plus oral combination as 
T1DM. This will increase the total denominator of T1DM patients which will reduce the 
proportion of those patients with T1DM who were on insulin monotherapy. A finding 
to support this explanation is the lower variation among PHCCs in the proportions of 
those patients with T2DM who are on oral antidiabetic monotherapy (ranged from 
21% to 38%) or oral antidiabetic combination therapy (ranged from 35% to 56%)(Table 
19). 
These differences may be in part due to the effect of variation between physicians’ 
qualifications, practice and knowledge in different PHCCs. Most of the primary 
healthcare physicians are from overseas with different experience and training 
qualifications. 
One unanticipated finding was that there was large variation and inequity in the 
prescribing of aspirin, statins and ACEIs for patients with diabetes. This variability can 
be attributed mainly to the unavailability of some of these medications, such as 
statins, ARBs and ACEIs, in some of the PHCCs. These drugs were not available because 
they were only recently added to the essential drug list of the Ministry of Health 
(MOH) that are routinely provided to PHCCs. Therefore, they were available mainly in 
those PHCCs which are official training centres for family medicine residents such as 
Almanhal and Almansak PHCCs. Besides this, the experience and qualifications of the 
treating physician may play a role in the variability of prescribing. For example, in the 
PHCCs which train family medicine residents, the patients were more likely to be 
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prescribed aspirin and statins than in the other PHCCs.  Prescribing of aspirin, statins 
and ACEIs was also higher in Almowadafeen PHCC clinic, where trainers sometimes 
give cover. 
The regional health affairs should address this inequity in prescribing of aspirin, statins, 
ARBs and ACEIs by providing them to all the PHCCs. Medications such as glimepiride, 
glipizide and glitazones which are not currently on the list should also be added to the 
list and provided to the PHCCs. Taken together, these findings suggest that the MOH 
essential drug list for PHCCs should be updated to include all of these medications that 
are necessary to achieve better diabetes care. 
 
6.5.3. Glycemic control 
Glycemic control was poor among a large proportion of patients with diabetes. 
According to the national standards, fewer than 10% of patients should have a FBG ˃ 
180 mg/dl (10 mmol/l) and more than 40% should have a FBG of < 126 mg/dl (7 
mmol/l).(200)  FBG was recorded in 60% of patients within the previous 12 months and 
the target of ≤ 126 mg/dl (7 mmol/l) was achieved by only 19.9% of them, while more 
than 40% had poor glycemic control (˃ 180 mg/dl (10 mmol/l)). These data concur with 
previously described national data (chapter 1) which shows consistently that < 50% of 
patients with diabetes achieved the target glycemic control at the primary healthcare 
level across different regions of Saudi Arabia. 
 This suboptimal glycemic control is complex and multidimensional and cannot be 
attributed to a single factor. However, the analysis showed a relationship between the 
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levels of glycemic control and other process measures such as the type of diabetes 
therapy, the number of follow-up visits and the number of health education topics 
discussed with the patients.  
At the PHCCs, as intensity of treatment increases from diet and exercise to insulin plus 
oral combination therapy, the proportion of patients with poor glycemic control (FBG ˃ 
180 mg/dl) rises from 14% among patients on diet and exercise to over 51% among 
patients on insulin plus oral drug combination. This might indicate that increasing the 
intensity of diabetes therapy was not successful at controlling blood glucose. This 
could be due to failure to comply with therapy, diet or physical activity. 
The proportion of patients with poor glycemic control dropped from almost 50% 
among those who did not visit their diabetes clinic during the preceding 6 months to 
36.8% among those patients who visited the diabetes clinic 2 times or more during the 
preceding 6 months. This might indicate that as the number of patient visits rises, the 
number of patients with poor glycemic control drops. However, the interpretation of 
this finding should be cautious; compliance of patients with follow-up appointments 
(visits) might be related to compliance of patients with drugs and diets and could 
confound this relationship. 
 Patients who received health education on more topics were less likely to have 
excellent glycemic control. This rather contradictory result may be explained if the 
clinicians gave more education to those with poor control than the other patients. It 
may also indicate that the health education programme is not implemented equally in 
a systematic manner to all patients. A previous study in Wasat Abha PHCC 
corroborates this inappropriate implementation by reporting that educated and male 
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patients with diabetes received education on more topics than illiterate and female 
patients.(257) The current study has been unable to demonstrate similar findings, but it 
supports the idea that the delivery of health education might be based on some 
patient characteristics rather than systematic provision to all patients. 
Achieving optimal glycemic control requires cooperation of the persons with diabetes 
and their healthcare professionals. Patient compliance with diet, exercise, drug 
therapy and attendance of routine appointments is essential in achieving an optimal 
glycemic control. Also, the right amount of support and advice from healthcare 
professionals as well as proper implementation of the processes of diabetes care will 
help to control blood glucose and prevent health deterioration. Therefore, further 
research is needed to investigate why glycemic control is poor and what interventions 
can be used to promote patients’ health-related behaviours. In addition, doctor 
awareness of their role in promoting patients’ health-related behaviours need to be 
increased. 
  
6.5.4. Obesity and overweight  
The local guideline for diabetes management set targets for proportions of patients 
with normal weight, overweight and obesity to be > 50%, < 30% and < 20% 
respectively.(214) However, overweight and obesity are common coexisting risk factors 
amongst patients with diabetes in Abha city and their recommended targets were not 
achieved (Table 40). This is in contrast to earlier findings of Elhasmi et al who found 
that the prevalence of obesity in patients with diabetes was lower than the prevalence 
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of overweight at the national level (29.9% versus 33.3% respectively) and the regional 
level (23.7% versus 34.2% respectively).(71)  
Table 40: BMI categories proportions by types of diabetes in the PHCCs 
BMI (kg/m2) Normal weight 
18.5-24.9 
Overweight 
25-29.9 
Obesity 
>30 
Targets > 50% < 30% < 20% T1DM (481) 26.6% 31.0% 36.2% T2DM (3219) 11.5% 33.4% 54.5% 
Total (3700) 13.5% 33.1% 52.2% 
 
It is apparent from the table that the proportion of patients with obesity is higher than 
the proportion of overweight patients, particularly among T2DM patients. This 
difference could be explained if the prevalence of obesity among people with diabetes 
is rising. In this study, it has been also found that higher BMI was associated with 
higher risk of diabetes complications (χ2 for trend = 25.4, df=1, P < 0.001). This is 
worrying because obesity will increase the risk of diabetes complications. Therefore, it 
is important to tackle effectively the problem of obesity among the whole population 
and particularly among patients with diabetes. Further research needs to be done to 
develop interventions that are effective in promoting compliance with diet and 
physical activity particularly among patients with diabetes. 
     
6.5.5. Diabetes complications 
According to the local guideline, the proportion of patients with diabetes 
complications should not exceed 5%. However, in Abha city, 32.2% of patients had at 
least one of the complications of diabetes. Earlier studies reported a complication 
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prevalence lower than found in this study. In 1997, 10% of patients with diabetes in 
Wasat Abha PHCC were found to have at least one diabetes complication.(246) In 1999, 
13% of the patients with diabetes had at least one reported complication in Alasyah 
PHCC at Alqassim region.(258) In 2006, a study which included T2DM patients at 3 
PHCCs in the Industrial Jubail City reported a higher prevalence for the presence of at 
least one diabetes complication (45%).(259) In 2004, a hospital based study reported 
even a higher proportion (60%) of patients with T1DM who have had one or more 
diabetes complications.(126) It is therefore likely that among patients with diabetes, the 
prevalence of diabetes complications is increasing over time.  
The prevalence proportions of diabetes complications in this study are similar to what 
have been reported in the previous primary care based studies (Table 41). The studies 
that were conducted at the level of the primary health care however reported lower 
prevalence for diabetes complications than hospital based studies. A possible 
explanation for this is that diabetes complications are usually treated in hospitals. 
Therefore, hospital based studies are likely to overestimate the prevalence of diabetes 
complications and report higher prevalence. However, it is also still possible that the 
primary care based studies might underestimate the prevalence of diabetes 
complications due to several reasons. First, inadequate availability of laboratory and 
clinic resources at PHCCs might be one of the causes of ineffective screening for 
diabetes complications. Second, inappropriate referral and feedback systems between 
PHCCs and hospitals might result in poor documentation of diabetes complications in 
the records of patients at PHCCs. Third, more than half (55%) of patients were not 
referred to the hospital for annual screening for complications in 2011 and finally, even 
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when they were referred, some clinical screening examinations were not done or 
documented for the majority of patients e.g. foot examination. These inadequacies of 
the care processes of identifying complications would lead to poor identification of 
diabetes complications. 
Due to lack of internationally agreed standards for diagnosing and assessing the 
presence of diabetes complications, it is difficult to make comparisons between 
different populations.(37) Despite these limitations, comparing of prevalence 
proportions of diabetes complications among different countries provides some 
indication of diabetes control and morbidity. It has been reported that some diabetes 
complications are very common. In the UK for example, by the time the patients with 
diabetes are diagnosed, 50% of T2DM patients show signs of diabetes 
complications.(260) At the global level, Amos et al reviewed 119 studies from different 
countries and showed that there is considerable variation among countries in the 
prevalence of diabetes complications. However, it was clear that most of the reviewed 
studies across the world reported retinopathy prevalence of >30% (44/58), 
nephropathy prevalence of >6% (32/38), neuropathy prevalence of >20% (30/34), 
coronary heart disease of >10% (38/48), hypertension prevalence of >25% (35/40), 
peripheral vascular disease of >3% (20/25) and amputation prevalence of >0.5% 
(13/16).(261)     
The Scottish diabetes survey in 2010 estimated that 28.5% of people with diabetes had 
retinopathy, 4.4% had foot ulcer, 9.1% had myocardial infarction.(213) In the United 
states, it has been estimated that 67% of adult patients with diabetes had 
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hypertension and about 60-70% of all patients with diabetes have mild to severe 
neuropathy.(255)  
By comparing these studies with those conducted in Saudi Arabia, it is clear that the 
prevalence of diabetes complications in this study was lower than would be expected. 
What is now needed therefore is a cross-national population based study to estimate 
accurately the prevalence of diabetes complications in Saudi Arabia using standardized 
criteria for the screening and diagnosis of diabetes complications. This would help to 
estimate the actual current burden of diabetes in Saudi Arabia and encourage the 
government to initiate preventive strategies and promote diabetes control.    
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Table 41: A summary of the reported prevalence of some diabetes complications in Saudi Arabia 
Study settings Primary health care settings Hospital settings 
Complications 
% (/N) 
% (/N) % (/N) % (/N) % (/N) % (/N) % (/N) % (/N) % (/N) % (/N) 
Study author, 
year, (diabetes 
type) 
Khattab, 
1995(256) Alowayyed, 1995(262) Alalfi,  1999(258) Alkhaldi, 2002(246) Current study Famuyiwa, 1989(42) Ammari, 2004, 
(T1DM)(126)* 
Alwakeel, 2004, (T2DM)(263) Alarfaj, 2006(264) 
Hypertension -- 31 (390) 35.2 (159) -- 23.5 (4279) 25.6 (930) 25 (100) 78 (1952) 38.5 (260) 
Retinopathy 8 (88) 17.9 (240) 3.8 (159) 8.4 (107) 11.1 (4243) 31.5 (584) 7 (100) 16.7 (1952) 16.5 (260) 
Nephropathy 2 (146) 13.3 (218) 1.3 (159) 1.2 (87) 1.9 (4253) 17.8 (931) 2 (100) 32.1 (1952) 16.5 (260) 
Neuropathy 2.7 (146) 4.8 (--) 1.9 (159) 2.3 (169) 0.7 (4247) 35.9 (689) 6 (100) 13.7 (1952) 11.5 (260) 
Cardiovascular 2 (146) 6.6 (--) 1.9 (159) 3.6 (169) 3 (4271) 11.3 (995) 4 (100) 37.4 (1952) 13.5 (260) 
Foot diseases 1.4 (146) 0.8 (--) 2.5 (159) 1.3 (60) 0.9 (4240) 10.5 (1000) -- 6.2 (1952) -- 
PAD** -- -- -- -- 0.4 (4256) -- 1 (100) -- 2.7 (260) 
*Ammari’s study is a private hospital based study, **PAD: Peripheral arterial disease.
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6.5.6. Referral and feedback system 
The referral and feedback system between PHCCs and hospitals is inefficient. Only 45% 
of people with diabetes were referred to the hospital for annual checkups in the 
preceding 12 months and the rate of feedback was 71%.  Therefore, the shared care of 
patients by the primary care team and the specialist hospital team is still inadequate. A 
study at Wasat Abha PHCC in Abha city assessed the referral system eight years after 
its implementation.(265) It found that the hospital feedback rate was only 39.2%. The 
study reported several inadequacies and omitted items in both the PHC referral letters 
and the hospital feedback reports. Inadequacies included missed information, unclear 
handwriting and lack of recommendations.(265) At the same PHCC, another study 
audited the referral of patients with diabetes to the hospital eye clinics.(138) At the end 
of 1996 and 1997, 40% and 68.5% of patients with diabetes were referred to the 
ophthalmology clinics respectively. The feedback rates were 72% in 1996 and 71.2% in 
1997 which was lower than the national target (100%).(138)  The processes of referring 
patients and receiving hospital feedback need to be reviewed. It is essential to develop 
clear patient pathways and referral guidelines between the PHCCs and the hospitals. 
These guidelines should then be implemented in appropriate ways in order to increase 
both the referral and feedback rates. 
 
6.5.7. Illiteracy and health education 
Illiteracy was common among patients with diabetes particularly among females. 
Contrary to experience in the western world, the data showed no difference between 
illiterate and non-illiterate patients in risk of having FBG above the recommended 
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target (FBG > 130 mg/dl), (OR=0.8, 95% CI: 0.7-1.0, P < 0.123). In fact, illiteracy is not 
an indicator for the socioeconomic status of patients in Saudi Arabia due to several 
historical, social and cultural contexts. However, poor educational status of more than 
40% of patients with diabetes in Abha city should be considered when planning for 
health education programmes and interventions. For example, health education by 
verbal discussions might be better than providing pamphlets and posters for such 
group of patients. Several studies either in the same region of Abha or from different 
regions of Saudi Arabia reported similar or higher proportions of illiteracy among 
patients with diabetes.(85, 246, 258, 266-267)   
The current health education programme should be improved not only in its 
implementation for all individual with diabetes but also its components and its 
methods of delivery. Health education programme should incorporate knowledge and 
skills development as well as behavioural interventions. The components of the 
programme and its method of delivery should be tailored according to the current 
stage of diabetes, type of treatment, level of education, ability and readiness for 
change and other individual needs and circumstances. More research is needed to 
explore what are the effective educational interventions that can be implemented in 
the Saudi culture and healthcare system.  
 
6.5.8. Variation of the process and outcome measures 
Inadequacies of the process and outcomes measures of diabetes care were found in all 
the PHCCs. For example, HbA1c was measured in only 4% of patients with diabetes in 
Abha city, which is exceptionally low in comparison to other countries. HbA1c was 
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measured for 96% for people with diabetes in the previous 12 months in the Tayside 
region of Scotland.(20) In England, it was measured for 92% of patients.(268) FBG should 
have been measured and recorded for 100% of people with diabetes in the preceding 
12 months, however, it was measured and recorded for about 60% of patients. The 
same inadequacies occurred for measuring blood pressure. In addition, the majority of 
patients did not achieve the recommended targets for glycemic control (77%) or lipid 
control (81%). The referrals for annual review and screening for diabetes complications 
were also inadequate, particularly the clinical examination of the cardiovascular 
system, nervous system, eye and foot.  
These inadequacies could be attributed to the complex interaction of all the healthcare 
elements including professionals, patients, and healthcare system. A similar 
explanation could apply to the differences in the process and outcome measures 
between the PHCCs. The variation of the resources available in each PHCC as well as 
the number of healthcare staff and as a result the workload could produce variation in 
the process and outcome measures of diabetes care. The availability of family 
medicine trained physicians in some PHCCs such as Almanhal, Almansak and 
Almowadafeen PHCC might contribute to this variation. In addition, the socioeconomic 
status of the population of each PHCC might play a role in this variation. Almansak 
PHCC for example is located in a new established neighbourhood where its population 
is expected to be more young and affluent than other parts of the city. This PHCC was 
one of the best PHCCs in having adequate resources, process and outcome measures. 
On the other hand, Alaziziah PHCC, which is located in an old and less affluent area, 
was one of the poorest centres in both the process and outcome measures of diabetes 
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care. It was also the least equipped centre in the city according to the findings of the 
scoring system that was presented in the previous chapter.  
Because of the lack of data on the socioeconomic status at the individual and 
neighbourhood levels, it is recommended to have a system and measures for assessing 
the socioeconomic status. It is important to show the relative levels of social and 
economic deprivation across the entire city or even the country to assess the actual 
effect of the socioeconomic status on patients’ health and service delivery. Lack of 
these data is one of the limitations that should be addressed. 
Diabetes care in the previous Saudi literature   
Previous studies in Saudi Arabia have reported similar inadequacies. A limited number 
of studies assessed specifically the quality of diabetes care in Saudi Arabia. Most of 
these studies were limited to one or a few healthcare centres or hospitals. In 1995, an 
audit of diabetes care in a Almanhal PHCC in Abha city showed that only 19.8% of 
patients achieved good diabetes control according to the national quality assurance 
protocol.(256) In 1997, Khattab and his colleagues reported a poor diabetes care at 
Almanhal PHCC.(269) Alkhaldi and Khan, in another study, assessed the impact of a 
diabetes mini-clinic on the quality of diabetes care at Wasat Abha PHCC in Abha city. 
They showed that the initiative of diabetes mini-clinics improved the process and 
outcomes of diabetes care.(246) However, several other studies in Aseer region 
reported deficiencies and inadequate availability of some diabetes care resources such 
as lab facilities, drugs and health education essentials. (257, 270-271)  Similar deficiencies 
and inadequate care process were reported in other regions of Saudi Arabia.(180, 258, 264)   
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A national study published in 2009, which was a part of an international study, 
evaluated the current medical care of T2DM in Saudi Arabia.(106) The study collected 
data on diabetes management and control from 28 PHCCs and included 353 patients 
with diabetes. Of all patients, 63 to 86% had never been screened for diabetes 
complications or cardiovascular risk factors during the previous year.(106) Only 31% 
were screened for retinopathy or nephropathy and 14% had their cholesterol 
measured. More than two thirds of the patients had not reached the target HbA1c of ˂ 
7% and its average was 8.20±1.89%. In addition, only 16% attained the target blood 
pressure of ˂ 130/80 mmHg and 65% had lipid profile above the recommended target. 
Only 45% were educated by diabetes educators.(106) 
At the hospital level, a study compared the achievement of NICE guidelines for care of 
T2DM patients at two hospitals in Riyadh, Saudi Arabia (SA) and Grimsby, United 
Kingdom (UK). The recommended annual screening for blood pressure, albuminuria, 
lipid profile and HbA1c were more frequently carried out at Diana Princess of Wales 
Hospital in Grimsby, UK than King Fahad National Guard Hospital in Riyadh, SA (100, 
81, 92, 95% versus 95, 51, 84, and 89% respectively).(272) The proportions of patients 
who achieved the recommended target for total cholesterol (˂ 5mmol/l), LDL-
cholesterol (˂ 3mmol/l) and HbA1c (≤ 7.5%) were better achieved at Grimsby, UK than 
Riyadh, SA (71, 75, 35% versus 54, 51 and 18% respectively).(272) However, the 
recommended targets for systolic and diastolic blood pressure (˂ 140/˂80mm Hg) 
were achieved at higher percentages in the Saudi hospital than the UK hospital (53 and 
55% versus 46 and 39% respectively). (272) In comparison with the neighbouring 
countries, a systematic review reported that the quality of care of T2DM in all the GCC 
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countries based on glycemic, blood pressure and lipid control indicators was sub-
optimal.(110)  
Recommendations 
It is important to improve the processes of diabetes care in Saudi Arabia in order to 
optimally control diabetes and thus reduce its complications and burden. The lab 
resources and services in all the PHCCs and also in the Abha general hospital should be 
improved. The HbA1c test is an important measure of the overall blood glucose 
control. It is not available in the PHCCs and only recently one machine became 
available in AGH. It should be available and easily accessible to all patients with 
diabetes.  
 
The Regional Health Affairs should look at how the annual reviews for people with 
diabetes is organized and implemented and try to ensure that all the required 
investigations and examinations are carried out and their results are recorded. 
Introducing electronic records and information systems will help to facilitate auditing 
and improve diabetes care. The current guidelines for diabetes care need to be 
improved and its implementation should be assessed and monitored. As a result, the 
screening for diabetes and its complications will be more effective.  
It is not only recommended to increase availability of resources of diabetes care but it 
is also important to improve and promote the health-related behaviours of both 
professionals and patients. Thus, we need more research to understand the 
healthcare-related behaviour of both professionals and patients. For example, the 
underlying reasons for poor implementation of diabetes guidelines by healthcare 
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professionals need to be explored. Recording of patient information including health 
history, examinations conducted and their results needs to be improved. Patient 
compliance needs to be assessed and recorded in all the PHCCs and more research is 
required to understand the barriers to compliance among people with diabetes in 
Saudi Arabia. There is a need also for research to develop culturally sensitive 
behavioural change interventions for Saudi patients that can be used in order to 
improve health-related behaviours. 
     
6.5.9. Limitations 
A number of important limitations need to be considered. First, the data were 
obtained from paper-based case notes. Evaluation of the quality of care through case 
note review is critically dependent on the quality of recording in the case notes. 
Validity of the collected data depends on the accuracy and completeness of the 
patients’ records. Poor recording could limit the value of retrospective critical review 
of care. Further, there might be a relationship between poor case notes and poor 
quality of care.(273) The quality of recording information in the paper-based case notes 
of patients with diabetes has not been assessed in published research in Saudi Arabia.   
Patients who did not have a recorded result for any measure were assumed not to 
have received that measure. This might imply that the conducted process measures 
could be underestimated because of missed recording. Nevertheless, case notes are 
the most obvious source of data for research and assessment of healthcare.(217) 
Reviewing patient case notes allows collection of data on large numbers of patients 
and for the full range of diabetes cases including for example newly diagnosed,  well-
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controlled and severely ill patients. However, it is recommended to undertake research 
to assess the quality of recording information in the patient case notes and 
subsequently develop interventions to improve recording if required.  
 
Secondly, some data items were not consistently recorded. For example, patient 
compliance with diet, exercise, medications and follow-up appointments were not 
recorded consistently among the PHCCs. Therefore, assessing some patient related 
behaviours such as compliance was not feasible. It is important to develop 
standardized sheets and forms for all the PHCCs to allow and facilitate consistent 
recording.  
 
Thirdly, a specific team of nurses was assigned for each PHCC to review the case notes. 
The experience and knowledge of each team member might contribute to the 
variation of some findings between the PHCCs. Further, it has been found that 
different types of staff undertaking case notes review appeared to interpret the 
recorded care differently when they each reviewed the same records. (273) However, 
they all performed reasonably well when using criterion-based review. (273) Therefore, 
the data collection forms were designed using simple and easy-to-fill questions with 
specific list of answers, mostly yes or no answers.  This might help to reduce this 
difference in interpreting the recorded measures of care. In addition, to overcome this 
problem, at least one meeting was conducted with each team to explain and train the 
teams on how to fill in the questionnaire correctly. Moreover, a mobile phone number 
of the main researcher (AA) was given to all the teams in case if they need an answer 
to any question during the working hours.  
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6.6. Conclusion 
Reviewing the case notes of people with diabetes provided insight into the current 
status of diabetes, its management, complications and the quality of diabetes care in 
Abha city. It is not just that some PHCCs failed to achieve the targets; actually none of 
the PHCCs have achieved the targets. The health status of people with diabetes was 
not satisfactory. Diabetes management was found to be suboptimal. Process and 
outcome measures of diabetes care were variable among PHCCs, did not meet their 
recommended targets and need to be improved. Fewer than 50% of patients meet 
targets for glycemic and lipid control indicators. The prevalence of diabetes 
complications was lower than expected. A cross-national population based study to 
estimate accurately the prevalence of diabetes complications in Saudi Arabia is 
needed.  
Poorly controlled diabetes is a challenge. Doctors try to control diabetes by moving 
patients to higher doses of medications, initiating insulin therapy when required and 
delivering more health education. It is important to Increase diabetes care resources 
and services to improve diabetes care; however, promoting patients’ health-related 
behaviours should be targeted as a matter of urgency. 
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CHAPTER SEVEN 
 
  
Stakeholder views  
 
This chapter explores the view and perceptions of key informants including 
patients, physicians, nurses, managers and pharmacists regarding their 
experience with the current diabetes care and their priority needs. Conclusions 
are drawn regarding identified needs and areas for service improvement. 
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Chapter 7: Stakeholder views 
 
7.1. Introduction 
Patients often have insights and expertise to share in health services research. 
Including patients in health services research could improve the quality and impact of 
research.(274) Therefore, the knowledge, preferences and experience of patients should 
be respected, valued and drawn upon to influence and shape the organization of 
healthcare.  
In developed countries such as the United Kingdom, the involvement of patients and 
the public in the planning and development of the healthcare services is an explicit 
policy.(275-277) Involving patients in making decisions about their healthcare is 
considered now as an essential part of evidence based healthcare.(278) 
In order to inform diabetes service provision, the views of different interested parties 
particularly patients with diabetes, should be considered. Patients’ perspectives often 
complement those of healthcare professionals and researchers. (274) The views and 
input of patients may influence the identification of healthcare needs and problems as 
well as the interpretation, dissemination, and implementation of research findings. (274)  
 In healthcare services research, particularly in health needs assessment research, the 
views of interested parties should be assessed in a systematic way.(279) The needs 
assessment approach used to assess the views of interested parties and canvass their 
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demands and wishes called corporate approach.(199, 228) The commentators emphasise 
the importance of “the systematic collection of the knowledge and views of informants 
on healthcare services and needs”.(228) Being responsive to local informants’ views is 
likely to result in healthcare services which are better suited to local needs and 
therefore more appropriate.(279-280)    
 
7.2. Objectives   
The objectives of this chapter were first to explore the views and perceptions of 
patients and key health professionals to determine:   
• What are the unmet healthcare needs of people with diabetes? 
• What are the unavailable diabetes services? 
• What are the current problems in delivering diabetes care? 
In addition, it sought to gain an understanding of patient/carer experience in using the 
diabetes services and to seek views on how services could improve and what are the 
barriers to service improvement.  
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7.3. Methods 
7.3.1. Methods of constructing the interview schedules 
To ensure a diversity of ideas, experience, knowledge and perspectives, four different 
key informants were interviewed including, people with diabetes, healthcare 
professionals (physicians and nurses), healthcare managers and pharmacists. Four 
semi-structured interview schedules were prepared to interview each group of key 
informants (Appendix 12-15). The interview schedules included both unstructured and 
structured questions. The unstructured format included open-ended questions such as 
“what are the health needs that have not been currently met?” The structured format 
included specific questions of fact or opinions that can be answered with numerating a 
simple list of items, or by choosing from a multiple choice set, or by responding to 
ratings on a rank scale. All questions in each interview schedule were designed to fit 
the role and responsibility of each interviewee. Based on the purpose and objectives of 
this chapter, a set of themes were investigated. These themes included perception of:  
1. Unmet health needs  
2. Healthcare problems  
3. Diabetes services that are unavailable  
4. Service improvement needed  
5. Barriers to improving services  
Participants were also asked to prioritize health needs and problems by ranking them 
from 1 to 5, where 1 was the highest priority. The participants were asked to consider 
a number of prioritization criteria which included size of the need; its urgency; severity 
and seriousness; impact; and availability of solutions.  
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Under each theme, several carefully worded questions were developed to explore the 
local views on priority and current concerns. In addition, interviewees were asked to 
give demographic information such as age, sex, occupation, level of education, and 
type of accommodation. The interview schedule to patients also enquired about some 
patient characteristics such as type of diabetes, current medications used and if 
patient had any complications.  
The healthcare professionals and managers were asked to rate the perceived 
importance of preventing diabetes, early diagnosis of diabetes by screening and 
preventing diabetes complications. A five point scale, 1 being not important and 5 
being very important, was used to collect responses. 
The pharmacists were asked specifically about the drug supply problems that might 
affect people with diabetes, the perceived priority of these problems and the solutions 
suggested. Moreover, they were asked about the availability of drugs related to 
diabetes (Appendix 15).  
 
7.3.2. Selecting and training the interviewers 
The main researcher (AA) interviewed healthcare professionals, managers and 
pharmacists and some patients with diabetes. An invitation letter to join the research 
team was given to all the physicians who work in the PHCCs (Appendix 16). The 
invitation letter explained the goals and reasons for doing the research, the benefits 
and nature of participation and how to join the team. An online web-based 
membership form was designed by (AA) to facilitate responding.(281)  Fourteen 
 
 
224 
 
physicians joined the research teams to interview people with diabetes. Due to some 
cultural beliefs which are deeply embedded in the Saudi communities, it was expected 
that most of Saudi women would prefer to be interviewed by female doctors. 
Therefore, the aim was to recruit the same number of male and female interviewers. 
However, only three female physicians agreed to join the research team as 
interviewers. The main researcher (AA) organized a half-day meeting with all 
interviewers to be trained on how to conduct a face-to-face interview using the novel 
semi-structured interview schedules. Those physicians who were not able to attend 
the meeting were trained in interview methods by the main researcher (AA) at their 
clinics. The mobile phone number of the main researcher was given to all the 
interviewers so that he could answer any questions that might arise. The members of 
the supervision teams visited each PHCC on a weekly basis to provide additional 
training and answer any questions. 
 
7.3.3. Piloting 
At the half-day meeting, the interviewers reviewed and tested the semi-structured 
interview schedules. Some questions were deleted and some were amended in 
response to the suggested comments of the participating physicians. Then the semi-
structured interviews schedules were tested again by the main researcher (AA) at 
Almanhal PHCC by interviewing 3 patients, 2 healthcare professionals, one manager 
and one pharmacist. As a result, additional re-wording and amendments were made. 
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7.3.4. Methods of sampling and interviewing 
Due to the limited number of healthcare professionals, managers and pharmacists in 
Abha city, purposive sampling was used to identify those who were involved either 
directly or indirectly in providing healthcare services to people with diabetes. These 
groups of key informants were interviewed face-to-face by the main researcher (AA).  
The physicians, who joined the research team as interviewers, were responsible for 
interviewing a systematic sample of patients with diabetes who attended their clinics 
during the study period which lasted for 2 months. Because of the limited number of 
physicians who work in each PHCC, it was difficult to arrange free hours or days for 
physicians to work solely on interviewing patients. This would disturb and interrupt 
their working duties and have negative effects on the service delivery. Further, due to 
variation among PHCCs in the number of interviewers, workload and patient 
overcrowding, each PHCC selected the “every Nth patient” to be interviewed from the 
visiting patients. This technique of sampling was used to reduce the negative effects of 
conducting interviews during the working hours. The target number to interview in 
each PHCC was at least 10% of the total number of registered patients with diabetes. 
The interviews with patients were face-to-face interviews. The interviewers were 
asked to stick with the sampling procedure and ignore their personal opinion or 
knowledge of patients’ past history when recruiting participants. Children under 15 
years old or people with learning and communication difficulties were excluded. The 
interviewers did not collect any data on the number of patients who refused to 
participate or the reasons for their inability to participate.  
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Interview recording is culturally unfamiliar in Saudi Arabia and could make participants 
more reluctant to freely express their views. Therefore, note taking was used to 
summarise the answers of the interviewees. The notes were written during the 
interviews. The duration of each interview was between 20 to 40 minutes. The 
interviewer was allowed to re-word, re-order or clarify the questions to further 
investigate topics introduced by the participant. After each question or at the end of 
the interview, the interviewers read the written notes on the participants to receive 
any comments or corrections.  
 
7.3.5. Ethical consideration 
The study was approved by the research ethics committee of the University of Dundee 
and that of the Ministry of Health (MOH) in Saudi Arabia where the interviews were 
conducted. Interviewees were given written information about the study which 
explained clearly the objectives and reasons of seeking their views and doing the 
research (Appendix 17). Informed consent was obtained from all participants 
(Appendix 18). For children between 15 and 18, informed consent was obtained from 
both the child and the accompanying parents. 
 
7.3.6. Methods of analysis 
In this exploratory analysis, the aim was to gather lists of major categories or themes 
on key informants’ perceptions of health needs, healthcare needs and problems, needs 
for healthcare services and barriers to improvements of diabetes care. All data were 
entered and analysed using the Statistical Package for the Social Sciences (SPSS) 
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statistical software, version 20. Most of the interview questions asked for a list of 
items for perceived needs, problems, services or barriers to improvement. Descriptive 
coding was used first to describe and code each specific response (note) by one coder 
(AA). Then under each question, related inductive codes were grouped into different 
themes which in turn aggregated into categories by three coders (AA, IC, LI). With this 
analytic coding, several themes were derived from the data analysis. The perceived 
needs and problems were similar and therefore, the same codes, themes and 
categories were applied to needs and problems. The lists of codes and the derived 
themes and categories for all the responses to the questions about needs, problems, 
services and barriers for all key informants interviewed are shown in appendix 19.  
Counting the frequency based on the number of individual participants who 
mentioned a particular response (code) rather than the total number of times a 
response appeared in the text was used. This approach helps to identify which themes 
and responses were common and which rarely perceived.  
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7.4. Results 
7.4.1. Patient views 
Demographics:  
In total, 235 people with diabetes were interviewed. The participant physicians 
interviewed 211 patients across all the PHCCs in Abha while the main researcher (AA) 
interviewed 24 patients, including 6 patients in the PHCCs and 18 patients in the ADC. 
More male patients 70.6% (166) were interviewed than female. Although the majority 
(132) were middle aged (45-64 years), 4.3% (10) were youths aged between 15 to 24 
years and 10.6% were adults (25-44 years old). More than one third of patients 39.6% 
(93) were retired; 26.4% (62) were employed while 28.5% (67) were unemployed. 
More than one fifth (52) of patients were illiterate; one third (79) can read and write. 
Of educated patients, 14% (33) had a bachelor degree and only 3 patients had a 
postgraduate degree. 
Approximately 13% (30) were smokers, 5% (11) were ex-smokers, 78% (183) were non-
smokers and the smoking status of the remainder was unknown. The majority of 
patients (85%) had T2DM. Almost two thirds of the patients (65.5%) were on oral 
antidiabetic drugs and one third (32.3%) on insulin or insulin plus oral antidiabetic 
drugs. 
Most of the patients 70% (165) reported that they have not had any diabetes 
complications. Among patients who reported having complications, 24 had ischemic 
heart disease, 6 had cerebrovascular disease, 7 had peripheral arterial disease, 31 had 
retinopathy, 11 had nephropathy, 21 had neuropathy and 16 had foot problems. 
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Thirteen patients (5.5%) reported that they live alone and half (121) of the patients 
(51.5%) recalled having glucometer at home. 
The majority (57.4%) of patients recalled that their diabetes was diagnosed because of 
diabetes symptoms while 29.4% were diagnosed by chance. Only 5.5% reported that 
their diabetes was diagnosed because of the screening programmes. Most of the 
patients (93%) reported that at the time of diagnosis, they did not have any 
complications. 
 
Perceived health needs and problems:  
Overall, most of the issues raised were identified both as needs and problems. 
Common themes that emerged from interviews with patients were (Table 42): 
laboratory services and resources are not always available; insufficient availability of 
antidiabetic drugs; insufficient availability of insulin syringes and alcohol swabs; 
unavailability of supportive tools such as glucometer with its strips and needles; 
insufficient number of healthcare staff particularly trained and specialist professionals 
including diabetologists, ophthalmologists and dieticians; inappropriate appointment 
system and crowding particularly in hospitals; inappropriate annual referral system to 
hospitals; staff attitude problems such as carelessness and lack of good 
communication with patients; inadequate health education; and home care.  
A quarter (25.5%) of patients felt that more laboratory resources and tests are needed. 
The same theme was reported by 23% of patients as a problem encountered in the 
PHCCs; however, only 7% perceived that as a problem in hospitals. Insufficient 
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availability of antidiabetic drugs was perceived as a problem in the PHCCs more than in 
hospitals. On the other hand, insufficient numbers of healthcare staff and 
inappropriate appointment and referral systems were perceived mainly as problems in 
hospitals (Table 42).   
Patients were asked to suggest solutions that met the identified needs or solved the 
identified problems. The overall response to this question was poor. The patients’ 
responses were simply to remedy the deficiencies. Further, when the patients were 
asked what the differences their suggested solutions would make, the most frequent 
answers were that health would improve and patient’s satisfaction would be better. 
Therefore, because the responses were not informative, the data were not presented.         
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Table 42: Issues of concern raised by people with diabetes in Abha city. 
Theme  Issue of concern Needs 
N=235 
Problems 
N=235 
PHCCs
 
Hospit
als 
Laboratory resources Availability of laboratory investigations 60 54 17 Availability of ECG test 8 3 0 Availability of X-ray machine 6 6 0 Pharmacy resources Insufficient availability of drugs 52 56 12 New anti-diabetes drugs 7 2 0 Availability of Insulin (Lantus, Mixtard) 5 1 0 Statins 16 1 1 Glucometer, its strips & needles 54 8 3 Insulin syringes 6 1 2 Alcohol swabs 12 1 1 Manpower Sufficient working staff 11 12 27 Sufficient trained staff 8 10 6 Dietician clinic (dietician) 9 3 4 Ophthalmology clinic (ophthalmologist) 8 3 2 Diabetologist clinic (diabetologist) 11 11 6 Specialist trained physicians 10 6 4 Clinic system Keeping clinicians work in their clinics all the time (not to change them frequently ) 2 8 1 System for organizing the clinic and patients entrance to the clinic 0 3 9 Health insurance system/ financial support 6 0 1 Appointment system Inappropriate appointment system & times 4 11 26 Long appointment waiting list 1 0 31 Patient overcrowding 4 10 90 Long waiting time (while fasting) 0 2 21 Long appointment time with ophthalmology clinics 0 0 12 Referral system Inappropriate annual referral system to hospitals (difficulties) 6 1 10 Staff attitude Careless healthcare staff 1 5 8 Lack of good communication with patients 1 7 8 Education Lack of health education materials, systems,  programs and clinics 9 6 4 Home care Home care  12 3 1 
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Patient perception of important diabetes services that are not available or 
need to be improved:  
The same themes that emerged from the answers to the questions about unmet needs 
and problems were also identified here (Table 43). However, some differences were 
noted. Laboratory services were the most commonly reported unavailable services or 
services that need to be improved. Some specific unavailable laboratory services in 
PHCCs were identified such as ECG test, lipid profile tests, HbA1c test, renal function 
tests (RFT), liver function tests (LFT) and x-ray machine. Regarding insufficient 
availability of healthcare staff, some patients perceived podiatry services as 
unavailable services and some as services that need to be improved in the primary 
healthcare.  
In the appointment system theme, while long appointment waiting list was perceived 
as a problem, the need for an electronic appointment system and recalling system was 
considered as an important unavailable service that might resolve the long waiting 
problem. Moreover, opening new diabetes clinics which would be open every day was 
perceived as a way of improving diabetes services.    
Although few patients perceived health education as a need or its lack as a problem, 
32 patients (13.6%) perceived it as an important unavailable service. Diet and weight 
reduction programmes were also reported as unavailable services.        
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Table 43: Important, unavailable services and areas for improvement in primary 
healthcare raised by people with diabetes. 
Theme Issue of concern Unavailable 
services  
N=235 
Services 
need to be 
improved 
N=235 
Laboratory resources 
Some laboratory services in PHCC (a laboratory  with all investigations) 91 87 ECG machine/ ECG test 18 3 Lipid profile tests 10 0 HbA1c test 8 0 X-ray machine 7 2 RFT and LFT 4 0 
Pharmacy resources 
Some drugs (all drugs to be available) 62 62 Glucometer, its strips & needles 20 6 Availability of Insulin (Lantus, Mixtard) 16 0 Statins 6 2 Insulin syringes 5 0 Alcohol swabs 4 0 
Manpower 
Diabetologist clinic (diabetologist) 21 6 Dietician clinic (dietician) 19 21 Specialist trained physicians 18 12 Ophthalmology clinic (ophthalmologist) 17 5 Podiatrist clinic 4 10 Sufficient working staff 3 14 
Appointment system 
Appointment and follow up system 34 21 Electronic appointment system 5 0 Appointment reminder by calling or SMS 4 0 System for defaulter follow up 3 1 More clinics for diabetes, to open mini-clinics many times per week 3 22 Education and promotion Health education/ educator, materials/ place/ screens/programs/lectures 32 7 Program for weight reduction and diet 4 0 Home care Home care  10 3 
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Perceived barriers to service improvement: 
Common themes that emerged from interviews with patients regarding barriers to 
service improvement are shown in table 44. The most common barrier mentioned by 
patients (22.5%) was insufficient staff availability. Inadequate services such as 
laboratory services and pharmacy services were the second most common perceived 
barrier. The patients perceived that primary healthcare is ignored by higher authorities 
in MOH and its administration is poor. These were reported as barriers to improving 
services. In addition, lack of health education and appropriate appointment systems 
were perceived as barriers to service improvement by 5% of patients.  
Table 44: Patient views on barriers to improvement of healthcare services 
Theme Top barriers to improvement Frequency  
N=235 
Organizational 
barriers 
PHCCs are ignored by higher authorities of MOH and managers/ Weak commitment of higher authorities/ Higher authorities do not respond to the PHCCs requests/  Lack of attention to PHCCs by higher authorities 
16 
Patient overcrowding 16 Lack of financial support for healthcare services 8 
Administrative 
barriers 
Careless administrators and managers/ administrative problems/  Lack of primary health care administration and communication system/ Poor management 11 
Staff 
availability 
Lack of diabetologists (clinics) 14 Insufficient staff/ Shortage of trained healthcare staff (specialists)/  Difficulties of employing more staff 53 
Staff training 
and 
performance 
Lack of good communication with patients 7 
Unavailable 
services 
Lack of good health education/ lectures, campaigns 13 Lack of appointment system & reminder 12 Lack of diabetes centres 8 
Inadequate 
services 
Inadequate lab investigations and devices/ resources/  Insufficient lab services (lab support) 33 Incomplete pharmacy resources/ lack of some drugs 28 Limited resources in PHCCs /  Shortage of supportive services/  Lack of enough resources 21 
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7.4.2. Healthcare professional views 
Demographics: 
A total of 29 healthcare professionals were interviewed; in more detail, 21 were males, 
17 were Saudi professionals, 22 were from the 10 PHCCs and 7 were from both ADC 
and AGH, 19 were physicians and 10 were nurses. Twenty three have received training 
on management of diabetes; however, 28 perceived that they need more training on 
diabetes management. 
      
Perceived health needs and problems: 
Compared to patients, similar themes emerged from the responses of healthcare 
professionals (Table 45). However, while patients made complaints about staff attitude 
and behaviours, the health professionals also made complaints about patient 
compliance and knowledge. Half of the healthcare professionals (14) perceived that 
poor patient compliance is a problem in PHCCs. Lack of health education resources, 
insufficient availability of drugs and provision of glucometers for patients were the 
most frequent perceived needs. The professionals also felt that there is a need for 
more laboratory resources and tests to be available, particularly the HbA1c test.  
The professionals suggested a variety of solutions to meet the identified needs or to 
solve the identified problems. The themes that emerged from the suggested solutions 
were to: increase the number of staff employed, provide health education and health 
promotion programmes, provide more training opportunities, improve the current 
system of care by establishing electronic systems, increase number of diabetes clinics 
and centres, improve the administration systems, open a central laboratory for each 
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healthcare sector, update the essential drug list, assess needs by consulting experts 
and patients and finally to improve the communication system between different 
healthcare level.  
Further, healthcare professionals were asked what the differences their suggested 
solutions would make. The most frequent answers were that the patients’ health, 
satisfaction, compliance with appointments and drugs and control of diabetes would 
improve. In addition, the professionals indicated that the quality, availability and 
efficiency of healthcare services would improve and diabetes complications would be 
lower.            
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Table 45: Issues of concern raised by healthcare professionals in Abha city. 
Theme  Issue of concern Needs 
N=29 
Problems 
N=29 
PHCCs
 
Hospit
als 
Laboratory resources Availability of laboratory investigations 6 7 1 Availability of HbA1c test 5 0 1 
Pharmacy resources 
Insufficient availability of drugs 10 7 3 ARBs drug 2 0 0 Availability of Insulin (Lantus, Mixtard, Apidra) 7 0 0 Statins 2 1 0 Glucometer, its strips & needles 9 0 1 A pharmacy in the ADC 0 0 2 
Manpower 
Sufficient working staff 4 2 4 Sufficient trained staff 1 0 0 Dietician clinic (dietician) 3 2 2 Ophthalmology clinic (ophthalmologist) 1 0 0 Diabetologist clinic (diabetologist) 2 0 0 Specialist trained physicians 0 3 0 Health educator 2 1 1 Social worker 2 0 0 Podiatrist clinic (podiatrist) 1 0 2 
Other resources 
Diabetes centres (more than one) 4 0 0 Underdeveloped PHCCs/ Modern & good PHCCs/ PHCCs with insufficient resources 2 4 0 Lack of electronic & computer system 0 3 0 Keeping clinicians work in their clinics all the time (not to change them frequently ) 0 3 0 
Appointment system 
Inappropriate appointment system & times 1 2 0 Long appointment waiting list 3 2 2 Patient overcrowding 1 2 4 System for defaulter follow up 2 0 0 High defaulter rate 0 2 0 Referral system Inappropriate annual referral system to hospitals (difficulties) 2 3 0 Lack of proper communication/coordination between healthcare levels 0 2 0 Education Lack of health education materials, systems,  programs and clinics 11 6 1 Health promotion Effective diet & nutrition programs 1 0 0 Reducing weight programs 2 0 0 Lifestyle management programs 1 0 0 Patient knowledge & attitude Weak/Lack of health awareness 0 3 0 Poor compliance 0 14 1 Home care Home care  5 0 0 
 
 
238 
 
Perception of important diabetes services that are not available or need to be 
improved:  
Table 46 presents the themes that emerged from the responses of healthcare 
professionals. Laboratory services, drugs, and health education resources were the 
common perceived services that are sometimes unavailable and need to be improved. 
HbA1c test was identified as unavailable laboratory services by 6 professionals. 
Dietetic services and podiatry services were perceived as unavailable services by 7 and 
4 professionals respectively.   
Table 46: Important, unavailable services and areas for improvement in primary 
healthcare raised by healthcare professionals. 
Theme  Issue of concern Unavailable 
services 
N=29 
Services 
need to be 
improved 
N=29 
Laboratory resources 
Some laboratory services in PHCC (a lab with all investigations) 8 15 ECG machine/ ECG test 3 0 HbA1c test 6 0 RFT and LFT 1 0 Pharmacy resources Some drugs (all drugs to be available) 8 8 Other resources Opening more than 1 diabetes centre 3 0 
Manpower 
Dietician clinic (dietician) 7 3 Specialist trained physicians 1 1 Ophthalmology clinic (ophthalmologist) 1 1 Podiatrist clinic 4 2 Sufficient working staff 0 3 Appointment system Appointment and follow up system 1 2 More clinics for diabetes, to open mini-clinics many times per week 0 3 Education and promotion Health education/ educator, materials/ place/ screens/programs/lectures 7 9 Referral system Effective referral system 1 1 Health records Health records/ electronic 0 3 Home care Home care  0 1 
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Perceived barriers to service improvement: 
As shown in table 47, the perceived barriers to improvement were mainly 
organizational and administrative. Some professionals felt that low patient knowledge 
and awareness is a barrier to service improvement. Six healthcare professionals 
perceived that weak commitment of higher authorities of MOH towards PHCCs needs 
is an important barrier in addition to lack of financial support for healthcare services.     
Table 47: Healthcare professionals’ views on barriers to improvement of healthcare 
services 
Theme  Top barriers to improvement Frequency  
N=29 
Organizational 
barriers 
PHCCs are ignored by higher authorities of MOH and managers/ Weak commitment of higher authorities/ Higher authorities do not respond to the PHCCs requests/  Lack of attention to PHCCs by higher authorities 
6 
Lack of financial support for healthcare services 5 Lack of efficient system 4 Routine work 3 Lack of cooperation, communication between healthcare levels 2 Lack of financial incentives 2 Patient overcrowding 1 
Administrative 
barriers 
Careless administrators and managers/ administrative problems/  Lack of primary health care administration and communication system/ Poor management 4 Bureaucracy 2 Old managers in charge who are unwilling to improve or change the current system 2 
Staff 
availability 
Insufficient staff/ Shortage of trained healthcare staff (specialists)/  Difficulties of employing more staff 3 
Staff training 
and 
performance 
Low staff awareness of what patients need 2 Lack of training & specialization 1 
Patient 
knowledge 
and awareness 
Patient's awareness /  Low patient's health awareness 2 
Inadequate 
services 
Inadequate lab investigations and devices/ resources/  Insufficient lab services (lab support) 1 Limited resources in PHCCs /  Shortage of supportive services/  Lack of enough resources 1 
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Groups in needs:  
Healthcare professionals identified several groups of the population whose health 
needs are not being currently met. These groups included older people, school age 
children, expatriates, patients with T1DM and disabled patients.  
 
Perception of importance of prevention:  
The majority of healthcare professionals rated preventing diabetes, early diagnosis by 
screening and preventing its complications as very important, (27, 26 and 27 
respectively). 
 
Perception of the barriers to the use of preventive services by high risk 
population:  
Lack of patient health knowledge and awareness, incorrect patient beliefs, low health 
education and apprehensions about having diabetes were the common barriers 
perceived by healthcare professionals (11, 4, 4 and 5 respectively). A small number of 
healthcare professionals (2-3) perceived that difficult access to services, lack of 
transport facilities and lack of motivation to participate are also barriers for high risk 
populations in utilizing the available preventive services. 
 
 
 
241 
 
Healthcare professionals’ views on facilitators and barriers to the 
implementation of the referral system:  
The five most frequent reported facilitators to the implementation of the referral 
system were: establishing an electronic referral system, proper cooperation and 
coordination between PHCCs and hospitals, involving patients in the referral process 
by taking back and forth the referral and feedback sheets, when the hospital and the 
PHCC are near to the patient and involving trained healthcare professionals in the 
referral process. 
The five most frequent reported barriers to the implementation of the referral system 
were: patient overcrowding in hospitals, long waiting time to enter the clinic, unclear 
referral system, incomplete or missing feedback and lack of cooperation and 
coordination between PHCCs and hospitals. 
 
Perception of service evaluation and clinic audit:         
Fifteen out of 29 healthcare professionals perceived that the current healthcare 
services they provide are evaluated and audited in a continuous manner. However, 
when they were asked how the services are audited, they reported different audit 
methods. For example, in ADC, a meeting every week for the staff to discuss any 
problems was perceived as an audit system. In the PHCCs, reviewing monthly and 
annually the routinely collected data was perceived as an audit system. Some 
professionals reported that auditing services is the responsibility of higher authorities 
not the clinical staff. Those who indicated that the healthcare services they provide are 
not evaluated or audited indicated that the healthcare services should be audited. 
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7.4.3. Healthcare manager views 
Demographics:  
A total of 13 healthcare managers were interviewed; in more detail, all were males, 11 
were Saudi managers, 8 were from the PHCCs, 2 were from both ADC and AGH and 3 
were from the Regional Health Affairs (RHA), 4 were executive physicians, 4 were 
executive nurses and 5 were health administrators. Six have received training on the 
management of diabetes; however, all perceived that they need more training on 
diabetes management.  
     
Perceived health needs and problems:  
Similar themes and concerns were raised from the responses of healthcare managers 
(Table 48). However, some differences were identified. The managers showed more 
concerns regarding patient knowledge and behaviours and provided more informative 
responses. They also indicated that health education and promotion programmes are 
important needs for people with diabetes. Moreover, the managers reported some 
administrative needs such as the need for the higher authorities to pay more attention 
to PHCCs. Managers suggested that they should also address lack of motivation and 
provide incentives for the primary healthcare staff.        
The managers suggested a variety of solutions to meet the identified needs or to solve 
the identified problems. These solutions were similar to what have been suggested by 
the healthcare professionals. However, some administrative solutions were suggested 
such as to improve the policy of providing drugs to PHCCs, build new PHCC buildings 
and increase the commitment of the higher authorities.  
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Further, healthcare managers were asked what the differences their suggested 
solutions will make. The overall responses to this question were similar to what have 
been reported by the healthcare professionals.            
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Table 48: Issues of concern raised by healthcare managers in Abha city. 
Theme  Issue of concern Needs 
N=13 
Problems 
N=13 
PHCCs
 
Hospit
al
s Laboratory resources Availability of laboratory investigations 3 4 0 Availability of HbA1c test 1 1 0 
Pharmacy resources 
Insufficient availability of drugs 3 4 2 Insulin pens 2 0 0 Glucometer, its strips & needles 5 1 0 Insulin syringes  1 0 0 Alcohol swabs 1 0 0 
Manpower 
Sufficient working staff 4 1 1 Sufficient trained staff 0 2 1 Podiatrist clinic (podiatrist) 1 0 0 Diabetologist clinic (diabetologist) 1 0 0 Specialist trained physicians 2 0 0 Biomechanics 1 0 0 Laboratory technician 0 2 0 
Other resources 
Dressing materials 1 0 0 10g monofilaments 1 0 0 Lack of electronic & computer system 1 0 1 Underdeveloped PHCCs/ Modern and good PHCCs/ PHCCs with insufficient resources 0 3 3 Training courses for all HCPs/ lack of 0 2 2 Clinic system Opening diabetes clinic many days/ all days per week 1 0 0 More care , attention, concern from higher authorities 0 2 0 Appointment system Appointment system for follow-up 2 0 0 Inappropriate appointment system & times 1 0 1 Crowding 0 1 1 Referral system Inappropriate annual referral system to hospitals  0 1 1 Lack of proper communication/coordination between healthcare levels 0 0 2 Staff attitude Lack of good communication with patients 1 0 0 Lack of motivation/ incentives 0 2 0 Education Lack of health education materials, systems,  programs and clinics 4 1 0 Health promotion Effective diet & nutrition programs 2 0 0 Exercise programmes 2 0 0 Reducing weight programs 2 0 0 
Patient knowledge & attitude 
Weak/Lack of health awareness 0 2 0 Poor compliance 0 2 2 Don't like to wait 0 1 0 Refusing to be annually referred to hospitals 0 1 0 Requesting drugs without prescription and without visiting the clinic 0 1 0 Poor patient communications/ behaviour inside PHCCs 0 2 0 Home care Home care  2 0 0 
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Perception of important diabetes services that are not available or need to be 
improved:  
Table 49 shows the themes that emerged from the responses of healthcare managers 
to the questions about important diabetes services that are not available or need to be 
improved. The responses were similar to what healthcare professionals indicated. 
However, a small number of those managers who were interviewed indicated different 
perceptions such as the need for new governmental buildings for the PHCCs and 
perception of unavailable screening services for diabetes in Abha. 
Table 49: Important, unavailable services and areas for improvement in primary 
healthcare raised by healthcare managers. 
Theme  Issue of concern Unavailable 
services 
N=13 
Services 
need to be 
improved 
N=13 Laboratory resources Some laboratory services in PHCC (a lab with all investigations) 5 4 HbA1c test 1 0 Pharmacy resources Some drugs (all drugs to be available) 2 1 Glucometers for patients/ with it strips & needles 1 0 Other resources PHCC buildings 1 1 
Manpower Dietician clinic (dietician) 2 1 Ophthalmology clinic (ophthalmologist) 1 1 Podiatrist clinic 0 1 Sufficient working staff 1 1 Appointment system Appointment and follow up system 0 4 More clinics for diabetes, to open mini-clinics many times per week 0 2 Referral system Annual referral and examination 0 1 All services All services need to be improved 0 3 Education and promotion Health education/ educator, materials/ place/ screens/programs/lectures 5 2 Clinic system Early diagnosis and screening services 1 1 Home care Home care  2 0 
 
 
 
246 
 
Perceived barriers to service improvement:  
The managers who were interviewed suggested several barriers which were similar to 
the suggestions of healthcare professionals (Table 50). However, some different 
organizational barriers and inadequate services were reported. Three managers 
indicated that there are problems with the administration system which were 
perceived as barriers to service improvement. One manager stated that lack of team 
work is an important barrier to service improvement and another indicated that the 
rented houses for most of the PHCCs in Abha is an important barrier.    
Table 50: Healthcare managers’ views on barriers to improvement of healthcare 
services 
Theme  Top barriers to improvement Frequency  
N=13 
Organizational 
barriers 
PHCCs are ignored by higher authorities of MOH and managers/ Weak commitment of higher authorities/ Higher authorities do not respond to the PHCCs requests/  Lack of attention to PHCCs by higher authorities 
2 
Lack of financial support for healthcare services 3 Lack of efficient system 2 Lack of cooperation, communication between healthcare levels 1 Weak governmental  inter-sectoral coordination 1 Lack of leadership  1 
Administrative 
barriers 
Careless administrators and managers/ administrative problems/  Lack of primary health care administration and communication system/ Poor management 3 Bureaucracy 1 
Staff 
availability 
Insufficient staff/ Shortage of trained healthcare staff (specialists)/  Difficulties of employing more staff 5 
Staff training 
and 
performance 
Lack of team work 1 
Inadequate 
services 
Inadequate lab investigations and devices/ resources/  Insufficient lab services (lab support) 1 Limited resources in PHCCs /  Shortage of supportive services/  Lack of enough resources 3 Lack of governmental buildings/ good buildings 1 Incomplete pharmacy resources/ lack of some drugs 1 
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Groups in need:  
Healthcare managers reported that older people, disabled patients and school age 
children were the groups of population whose health needs are not being currently 
met.  
 
Perception of importance of prevention: 
The majority of healthcare managers rated preventing diabetes, early diagnosis by 
screening and preventing its complications as very important, (11, 11 and 13 
respectively). 
 
Perception of the barriers to the use of preventive services by high risk 
population:  
Lack of patient health knowledge and awareness was the common barrier perceived by 
7 healthcare managers. Incorrect patient beliefs, low health education, difficult access 
to services, lack of transport facilities and lack of motivation to participate were also 
perceived as barriers for high risk population to utilize the available preventive 
services. 
 
Healthcare managers’ views on facilitators and barriers to the implementation 
of the referral system: 
The reported facilitators to the implementation of the referral system were: proper 
cooperation and coordination between PHCCs and hospitals, establishing an electronic 
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referral system, involving patients in the referral process by taking back and forth the 
referral and feedback sheets, auditing the referral system, and employing more 
healthcare staff.  
The five most frequent reported barriers to the implementation of the referral system 
were: lack of cooperation and coordination between PHCCs and hospitals, negative 
staff attitude, long waiting time to enter the clinic, uncompleted and missed feedbacks 
and negative patient behaviours e.g. refusing to be referred and leaving before 
conducting all the required investigations. 
  
Perception of service evaluation and clinic audit:         
Nine out of 13 healthcare managers perceived that the current healthcare services 
they provide are evaluated and audited in a continuous manner. However, when they 
were asked how the services are audited, they reported different audit methods. For 
example, the managers from Regional Health Affairs who were interviewed reported 
that there is an annual standard form for collecting data which is used to audit the 
healthcare services at the sectoral and regional level. In the PHCCs, reviewing monthly 
and annually the routinely collected data was perceived also by the managers as an 
audit system. Three of those who indicated that the healthcare services they provide 
are not evaluated or audited indicated that the healthcare services should be audited 
while one reported that he does not know if the healthcare services should be audited 
or not. 
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7.4.4. Perception of needs prioritization for patients with diabetes, 
healthcare professionals and managers  
By asking about what the greatest needs were for people with diabetes in terms of the 
size of the need, its urgency, severity, impact and availability of solutions, both 
patients and healthcare professionals were remarkably similar (Table 51). They 
perceived that more drugs, laboratory services, and working staff as well as 
glucometers are needed. However, patients would like home care for older people 
while professionals prioritized having more health education materials and programs. 
Healthcare managers, on the other hand, were more interested to say we need first to 
prevent diabetes and promote health. In addition, the managers prioritized needs 
which are related more to their administrative responsibilities such as having 
computers, new governmental buildings and opening diabetes clinics on more days per 
week. 
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Table 51: The top 10 priority needs (ranked as 1) by patients, healthcare 
professionals and healthcare managers 
People with diabetes  
N=235 
n Healthcare professionals 
N=29 
n 
 
Healthcare 
managers 
N=13 
n 
Insufficient availability of drugs (including anti-diabetes) 
35 Insufficient availability of drugs (including anti-diabetes) 3 Lack of health education materials, systems,  programs, clinics 
3 
Glucometer, its strips and needles 33 Lack of health education materials, systems,  programs, clinics 3 Effective diet & nutrition programs/ control of dyslipidemia 
2 
Availability of Laboratory and all laboratory investigations 
22 Availability of Laboratory and all laboratory investigations 2 Availability of HbA1C test 1 Home care 7 Increase range of insulin types available 2 Insufficient availability of drugs (including anti-diabetes) 
1 
Diabetologist clinic (diabetologist) 6 Glucometer, its strips & needles 2 Glucometer, its strips and needles 1 Specialist clinics (Family medicine physicians, specialists, trained physicians) 
5 Insufficient working staff 2 Dressing materials 1 
Health insurance system and financial support 5 Diabetologist clinic (diabetologist) 2 Computer and printer 1 Increase range of insulin types available 4 Diabetes centres (more than one) 2 Governmental PHCC buildings 1 Statins 4 Underdeveloped PHCCs/ modern PHCCs/ PHCCs with insufficient resources 2 Opening diabetes clinic many days per week 1 New anti-diabetes drugs 3 Availability of HbA1C test 1 Lack of good communication with patients 1 
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7.4.5. Pharmacist views 
Demographics:  
A total number of 13 pharmacists were interviewed. One pharmacist was interviewed 
from each PHCC and the other three were from AGH and ACH. In more detail, ten 
pharmacists were males, 12 were Saudis, three had a bachelor degree in pharmacy and 
the others had a diploma. Only three pharmacists received training courses related to 
diabetes and 12 perceived that they need to attend training courses on healthcare of 
patients with diabetes. 
     
Perceived supply problems and their priorities:  
Insufficient availability of drugs and provision of drugs close to the expiry dates were 
cited by 5 and 6 pharmacists respectively. Three pharmacists indicated that they 
should not themselves go to the drug supply centre and leave the PHCC pharmacy 
during working hours in order to bring the next instalment of drugs. They said that 
transferring the drugs from the supply centre to the PHCC pharmacy is not their 
responsibility. Delayed provision of drugs to the pharmacy and insufficient quantities 
of drugs supplied was reported by three pharmacists. Two pharmacists from the PHCCs 
suggested increasing the range of insulin types available in PHCC pharmacies to include 
the long-acting form of insulin (Lantus) and the dual-acting, biphasic formulation which 
consists of a premix of soluble fast-acting insulin human and isophane long-acting 
insulin (Mixtard). 
 Insufficient availability of drugs, provision of drugs close to the expiry dates and 
limited range of insulin types available for PHCC were cited as high priority problems.  
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Perception of other pharmacy problems and their priorities:  
The need for female pharmacists, electronic systems, and regular updates of the drug 
dosage in the patients’ cards were cited by 2, 2 and 3 pharmacists respectively. In 
addition two pharmacists mentioned that some patients ask for and insist on collecting 
drugs from the pharmacy without a prescription or insist on receiving a larger amount 
than prescribed. 
The need for female pharmacists, trained pharmacists and keeping a regular update of 
the drug dosage in the patients’ cards were cited as high priority problems. 
    
Perception of solutions:   
 The pharmacists suggested a variety of solutions for the identified problems. 
Remedying the identified deficiencies, providing large amount of drugs with a long 
expiration dates and educating patients were the commonly mentioned solutions. 
Establishing electronic systems for the pharmacy, increasing the number of employed 
pharmacists and further support from the MOH for the PHCC pharmacies were 
mentioned by some pharmacists. 
 
Drug availability: 
As shown in table 52, some pharmacists indicated that some drugs such as 
glibenclamide tablets, gliclazide, regular and NPH insulin are always available in the 
pharmacy. On the other hand, some drugs were not always available in all the 
pharmacies in Abha such as metformin tablets, rapid acting and mixed insulin 
formulations as well as insulin syringes and test strips.  
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Table 52: Availability of some drugs in the pharmacy 
Drug Always 
available 
Sometimes 
available 
Not 
available 
Total  
Metformin 10 3 0 13 Glibenclamide 13 0 0 13 Gliclazide 13 0 0 13 Glipizide 4 0 9 13 Glinide 0 0 13 13 Aspart or Lispro (Rapid-acting) 2 2 9 13 Regular insulin (Short-acting) 13 0 0 13 NPH insulin (Intermediate-acting) 13 0 0 13 A mixture of NPH and regular insulin 10 3 0 13 Anti-hypertensive drugs: Angiotensin-Converting Enzyme Inhibitors, Beta-blockers, diuretics 12 1 0 13 Cholesterol-lowering drugs: statins 6 1 6 13 Consumables: needles, syringes, urine test strips, capillary blood glucose test strips 9 1 3 13 I.V. Glucose solution  10 2 1 13 
 
Methods of drug supply:  
The pharmacists in the PHCCs reported consistent procedures for drug supply which 
include:  
1. The nurse of the diabetes mini-clinic calculates the total amount of 
antidiabetic drugs and insulin needed for each patient by reviewing patients’ 
files. 
2. The nurse then sends the total amount of drugs required for all patients to the 
pharmacist. 
3. The pharmacist sends a request for the required amount to the health sector 
administration. 
4. The health sector then sends the request to the drug supply centre. 
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5. The pharmacist then goes to the drug supply centre to collect the required 
amount. 
In hospitals, the steps of drug supply are slightly different where the pharmacy 
coordinator requests every month the required amount from the drug store of the 
hospital. It is the responsibility of the drug store to make sure that there are drugs 
available by requesting them every month from the drug supply centre or buying them 
directly from the drug companies. In the same way, the pharmacists in hospitals are 
responsible for collecting the requested amounts of drugs from the drug supply centre. 
 
Methods of dispensing drugs:     
The pharmacists reported similar methods for dispensing diabetes drugs to patients. 
First, the patient should bring a prescription from a physician and his/her diabetes card 
which contains information about the dosage and amount of drugs needed. The 
pharmacist then dispenses medication to patients every 2 or 3 months in PHCCs and 
every month in hospitals or as requested in the prescription. The pharmacists are 
responsible for recording the amount dispensed in the diabetes card of the patient. 
Drugs close to the expiry date are dispensed first.  
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Training needs:       
The pharmacists indicated that they would like to attend several training courses. Six 
of them reported that they need to attend courses on quality assurance and drugs 
update. Some pharmacists reported the need for courses on methods of drug 
dispensing, drug safety, drug preparation and healthcare management. Some 
pharmacists showed interest in attending courses on how to communicate with and 
educate patients about drugs. 
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7.5. Discussion 
7.5.1. Principal findings  
This study is the first exploratory description in Saudi Arabia for the views of diabetes 
patients, healthcare professionals and managers from the primary and secondary 
healthcare on the unmet needs of patients, the unavailable healthcare services that 
the MOH should provide and how services could improve. There was agreement 
between patients, professionals and managers that there is a need for more laboratory 
services, drugs and working staff. Insufficient availability of these needs was also 
perceived as healthcare problems. This would indicate that these are real problems 
and should be given a priority for action.  
However, there were also some important differences between patients, professionals 
and managers. For example, the patients made complaints about staff attitude and 
behaviours while the professionals in contrast made complaints about patient 
compliance and knowledge. On the other hand, the managers were interested in 
provision of health education and promotion as well as reporting administrative 
problems such as the need of the PHCCs for more support and commitment from 
higher authorities and lack of motivation and incentives for the primary healthcare 
staff. The pharmacists also reported that there is insufficient provision of drugs and 
raised different concerns such as provision of drugs which will expire soon and 
provision of limited types of insulin. These differences show the importance of 
interviewing different key informants where different definitions of need correspond 
with different groups of the population.(282)  
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The insufficient availability of laboratory, pharmacy (drugs) and health education 
resources for diabetes care in primary healthcare settings was consistent with what 
has been reported by several studies in Aseer region.(256-257, 270, 283) These insufficiencies 
were thought to play an important role in making programmes targeting chronic 
diseases such as diabetes less effective.(138, 256-257, 269-271) Therefore, it is important to 
address these insufficiencies and provide all PHCCs with adequate resources according 
to their actual needs; particularly for important services such as HbA1c test, podiatry 
services and dietetic services which were perceived to be unavailable.      
Inappropriate referral and appointment systems particularly in hospitals were 
perceived as a problem by most of patients and professionals and some managers. 
This confirms what previous studies reported about the need to improve the referral 
and appointment systems.(138, 265, 270) Further research is needed to evaluate the 
current referral and appointment systems and to identify interventions that are 
effective in improving these systems.          
While there was some agreement between patients, professionals and managers 
about the barriers to service improvement, there were also some important 
differences. For example, some professionals reported barriers which are related to 
their work experience such as bureaucracy, inefficient systems, routine work and lack 
of cooperation between healthcare levels. In the same way, some healthcare 
managers reported different barriers such as lack of leadership, lack of team work and 
weak coordination between different governmental sectors. Further exploration of 
barriers to service improvement is needed in order to be able to develop interventions 
that can overcome these barriers and successfully improve diabetes care.                 
 
 
258 
 
It was important to ask about health needs of people with diabetes in different ways. 
This is because the informants perceive some issues as needs while others perceive 
them as problems.  For example, 31 patients perceived that long appointment waiting 
list is a problem in hospitals while only 1 patient out of 235 patients perceived this 
issue as a need. In the same way, 54 patients perceived that they need free 
glucometers from the PHCC while only 8 patients perceived unavailability of free 
glucometers as a problem in PHCCs. Therefore, asking in different ways helped to 
gather a comprehensive list of needs and problems as shown in appendix 19.     
The similarity among key informants in reporting needs, problems and even priorities 
could be due to some of the following factors. First, patients with diabetes have a wide 
experience of service use because of their need to frequently use the healthcare 
services. This will help patients to be able to provide insight into the type of needs that 
other patients would have and identify deficiencies similar to healthcare professionals. 
Second, it is still possible that the views of physicians who interviewed patients might 
influence the views of patients. 
Overall, this study shows that patients with diabetes have a high level of healthcare 
needs. It shows also that patients are concerned about their management and 
reported insightful responses. Their perception that the primary healthcare services 
they receive are underdeveloped and inappropriate might affect their self-care and 
self-management and consequently their diabetes control. In addition, the low priority 
for disease prevention by patients may suggest that preventive interventions will 
struggle to succeed and education is a challenge. 
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7.5.2. Limitations 
The study is a step forward in using the views of key informants to understand the 
current deficiencies and how to meet needs and improve services. It involves eliciting 
the views of local key informants which is the most appropriate method sensitive to 
local concerns and circumstances.(228, 284) However, the representativeness of the 
interviewed sample of stakeholders might be limited by the methods of recruiting 
participants and the characteristics of the obtained samples.  
For patients, the views of local patients who did not access or were unable to access 
the healthcare services during the study period were not sought. This might 
particularly lead to under reporting the barriers to accessing services. Further, more 
male patients (70%) were interviewed than female which might cause under reporting 
of female related issues.  Although, the use of systematic sampling technique would 
result in a representative sample of patients, it would have been better to take a 
separate sample from men and women subgroups of patients. Recruiting a sample of 
patients with a majority of male patients might be due to having few female 
interviewers. The female patients might prefer to be interviewed by female 
interviewer and because 11 out of 14 interviewers in the research team were male, 
this perhaps leads female patients to refuse to participate. This interpretation however 
is difficult to confirm because the researchers did not collect data about those who 
refused to participate.   
Additionally, it is possible that some patients may be reluctant to explicitly state their 
views, either because they don’t believe that their views will be taken seriously or 
because they think this may have a negative impact on the services they receive. In 
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spite of this, the participant’s information sheet was designed to explain the benefits 
of the study in a way to encourage patients to give clear and honest responses.   
Small purposive samples of professionals, managers and pharmacists were 
interviewed. This reliance on a small number of participants who may be biased in 
their perceptions and may not represent the views of the more general population is 
one of the disadvantages of this study. Moreover, the health professionals, managers 
and pharmacists have a personal stake in the outcome of the healthcare which might 
bias the reported needs and problems. However, they are presumed to have the 
broadest experience and knowledge of needs, problems and current service provision 
which make them the best representative sample that can provide informative 
answers.   
The study also sought the views of key informants in prioritizing needs and problems. 
The views of informants and their priorities are important to consider in planning for 
solutions. However, local priorities identified are linked with other considerations like 
equity, effectiveness and costs which should also be considered for decision making. 
Inability to record the interviews can be considered as an advantage and disadvantage 
at the same time. It is an advantage because, culturally, taking notes instead of 
recording gives participants more willingness, freedom and comfort to answer the 
questions while recording might lead them to be more reluctant and conservative. On 
the other hand, it is a disadvantage because it requires the interviewer to think, 
interpret and understand what the interviewee said before writing the notes. This 
process of listening, interpreting and writing might involve interviewer’s bias in writing 
the correct responses. To minimize this bias, the interviewers were asked, at the end 
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of each interview, to give the interviewee the chance to review the notes taken and 
correct or change any response. In addition, it is possible that interviewers might miss 
some responses during writing notes due to several reasons.  
               
7.6. Conclusion  
In summary, a number of areas for improvement were identified. These included the 
need for:  
• Adequate provision of all diabetes care resources which include laboratory, 
pharmacy and manpower resources.  
• Adequate, flexible and responsive healthcare system to meet patients’ needs. 
• Improved and efficient system for drug provision that ensure continuous 
availability of antidiabetic drugs and standard equipment in PHCC pharmacies. 
• Well organized diabetes care pathway at the PHCCs and at the level of 
secondary and tertiary healthcare. 
• Commitment and support from higher authorities in the MOH. 
• Well implemented diabetes mini-clinic programme in PHCCs. 
• Provision of adequate and easy accessible podiatry and dietetic services  
• Adequate referral and appointment systems which should improve the 
communication and coordination between healthcare professionals and 
patients, and between primary care and hospital clinicians.  
• Healthcare staff to enhance their attitude and skills in managing people with 
diabetes through staff training and continuous professional development. 
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• Easy access to health education and promotion programmes, materials and 
clinics that provide regular information and support according to the patient’s 
needs and capabilities. 
• Designing interventions to improve patients’ compliance.  
• Establishing electronic healthcare systems which should include electronic 
health records, electronic appointment and referral system, electronic 
pharmacy system. 
• Adequate home care for bedridden patients and those with difficult 
accessibility. 
• Establishing adequate facilities for physical activities such as boardwalks and 
gyms. 
• Adequate auditing system for healthcare services. 
Many of the needs and problems identified in this study could be addressed by 
establishing a managed clinical network and quality assessment and improvement 
system in the primary health care. The knowledge and experience of patients should 
be involved in the process of planning for improvement. Further large studies at the 
regional and national levels are needed as well as annual patient satisfaction audits. 
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  CHAPTER EIGHT 
 
  
Healthcare leaders’ 
priorities  
 
This chapter reports the results of a survey with healthcare leaders to explore 
their perceived priorities for a number of recommendations to improve diabetes 
care in Abha city. The principal findings and limitations of the survey are 
discussed. 
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Chapter 8: Healthcare leaders’ priorities 
 
8.1. Introduction 
Need and demand for healthcare always exceeds the funding that is available to the 
Ministry of Health (MOH). It is important to involve different stakeholders in priority 
setting. Several methods have been proposed for establishing needs priorities. One 
approach is to ask the participants to give each need area a numeric rank score.(285) In 
the previous chapter, people with diabetes, healthcare professionals and healthcare 
mangers were asked to prioritize the needs they perceived by ranking them from one 
to five where one was the first priority. In this chapter, the healthcare leaders will be 
involved in priority setting.  
The role of leaders in health services priority setting was described and explored by 
Reeleder and his colleagues in 2006.(286) They emphasized the key role of healthcare 
leaders in priority setting. They also prescribed several leadership practices for priority 
setting and its benefits to achieve proper and fair prioritization. The healthcare leaders 
are in a position to identify the changes that have the greatest impact on patient 
wellbeing. Their role is also central to implementing the changes identified or the 
recommendations made.  
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8.2. Objectives 
In this study, the aim was to explore the views of healthcare leaders on the priority of 
specific recommendations to meet the identified needs and gaps in service provision 
which were reported in the previous chapters. 
  
8.3. Methods 
8.3.1. Methods of constructing the questionnaire  
A questionnaire for healthcare leaders to explore their prioritization on some 
suggested recommendations was developed (Appendix 20). The identified health 
needs and gaps in service provision that were reported in the previous chapters (7-9) 
were listed. By reviewing this list, the findings were then categorized into different 
groups which resulted in the following 12 groups: 
1. National policies and strategies of diabetes care  
2. Clinical practice guidelines 
3. Health care service computerization 
4. Occurrence of diabetes 
5. Demographic issues 
6. Diabetes risk factors  
7. Population health status 
8. Healthcare utilization 
9. Current diabetes service provision 
10. Mini-clinic resource evaluation 
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11. Health Education 
12. Preventive services 
The suggested solutions to meet the identified needs that were reported by patients, 
healthcare professionals and managers in chapter 7 were reviewed by the researcher 
(AA). Based on these suggested solutions, several recommendations to meet the 
identified needs or to close the identified gaps were suggested by the researcher (AA), 
at least one for each group of findings. This analysis was completed after the first field 
work. The researcher (AA) then return to Saudi Arabia for the second phase of field 
work to ask the healthcare leaders to prioritize the suggested recommendations. The 
healthcare leaders were asked to rate the priority of each recommendation on a rating 
scale of 0-100%, where 0% was the lowest priority and 100% was the highest priority. 
 
8.3.2. Methods of sampling and questionnaire administration 
Purposive sampling was used to identify those healthcare leaders who are involved in 
planning, commissioning or supervising diabetes care in Abha city. A printed copy of 
the questionnaire was given in person to each participant to be completed within 7 
days. The completed questionnaires were then collected by the researcher (AA) after 
one to two weeks. 
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8.3.3. Methods of analysis 
The data were entered and analysed using the Statistical Package for Social Sciences 
(SPSS) software, version 20. The mean priority rate was calculated for each 
recommendation by adding up all the 16 scores then dividing the sum by 16. For 
analysis purposes, the recommendations were reviewed by 3 independent reviewers 
(AA, IC, LI) and a consensus was reached to categorize the recommendations into 7 
themes. These themes were related to:  
1. Prevention of diabetes 
2. National policies and strategies of diabetes care 
3. Healthcare process and utilization 
4. Data availability 
5. Diabetes service provision (resources, workforce) 
6. Auditing and evaluating healthcare services 
7. Health care service computerization 
The mean priority scores for the recommendations of each derived theme were then 
compared to the median for all the mean scores of the recommendations. 
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8.4. Results 
The questionnaire was given to 18 healthcare leaders. Sixteen healthcare leaders 
responded and completed the questionnaires and two did not return the 
questionnaire.  All the respondents were male leaders who work in the Regional 
Health Affairs (RHA). 
Figure 31 shows that most of the recommendations were rated of high priority (70-
100%); 94.7% of all the scores (1104) were 70% or above. The median score was 95%.  
The lower and upper quartiles were 80% and 100% respectively.  
 
Figure 31: The frequency of reported priority scores for all the recommendations 
 
 
 
The themes and recommendations with their mean priority scores are presented in 
appendix 21.  The mean priority scores for each recommendation are presented in 
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figure 32 by themes. As shown, the median for the means was 90.94% (red line). 
Almost all the mean scores of the recommendations in the prevention and service 
auditing themes were above the median. The mean scores of the recommendations 
regarding the computerization of healthcare services were all below the median. 
   
Figure 32: The mean priority rate for all recommendations within each theme 
 
Red line is the median=90.937%  
 
The mean priority scores of the recommendations of other themes such as policies and 
strategies, healthcare utilization and diabetes service provision had a wider range. For 
example, within the theme of policies and strategies for diabetes care, the top priority 
was the need for a national quality assurance manual for diabetes care at hospital and 
diabetes centre (96.8%). In contrast, the lowest priority was for the need to 
implement, monitor and evaluate the Gulf Executive Plan for Diabetes Control (80.6%). 
For the theme of healthcare processes and utilization, the top priority 
recommendation was for the need for high quality diabetes care to reduce the burden 
of diabetes complications (95.9%). In the same theme, the bottom priority 
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recommendation was about the need to increase referral rate to hospital for annual 
review and hospital feedback to 100% (77.8%). 
 For the diabetes service provision theme, the top priority was for a tertiary care 
hospital in Abha city for eye care (94.1%) and the lowest priority was for employing 
more x-ray technicians (62.8%). For the data availability theme, the top priority 
recommendation was about the need for recording routinely the number of diabetes 
related follow-up visits in Almansak PHCC (94.1%); the lowest priority was about 
recommending that data on gestational diabetes be made available (85.3%). 
  
The top 20 priority recommendations are shown in table 53. Most (eleven) of these 
recommendations were related to the prevention theme, 3 related to service audit 
and evaluation, 2 related to diabetes service provision theme, 2 related to healthcare 
processes and utilization, 1 related to data availability and one related to policies and 
strategies for diabetes care.   
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Table 53: The top 20 priority recommendations according to the mean score 
Recommendations Mean 
score 
Activating and enhancing the mini-clinic screening program is needed to 
identify undiagnosed diabetes. 
97.81 
There is a need to promote physical activity and diet control. 97.19 
National quality assurance manual for diabetes care at hospital and diabetes 
centres is needed. 
96.88 
 Annual review and examination needs to be implemented effectively and 
completely. 
96.56 
Effective public health interventions are needed to reduce the burden of 
diabetes. 
95.94 
Effective interventions to improve monitoring of blood glucose and its control 
is needed. 
95.94 
High quality of diabetes care is needed to reduce the burden of diabetes 
complications. 
95.94 
Foot screening for those patients with diabetes at high risk is needed. 95.31 
Effective national and local action to tackle obesity is urgently needed. 94.69 
Health education program need to be implemented efficiently and effectively.  94.69 
The programmes of screening for diabetes and its complications need to be 
enhanced and implemented effectively and also evaluated for its effectiveness. 
94.69 
Retinopathy screening program for all patients with diabetes is needed. 94.69 
The gap between estimated prevalence and actual (registered) prevalence of 
diabetes need to be closed. 
94.69 
Almansak PHCC must record routinely the number of diabetes related follow-
up visits.  
94.06 
There is a need for tertiary care hospital in Abha city especially for eye care. 94.06 
Need to audit diabetes services at the national and regional level. 93.75 
MOH Diabetes centre services need to be audited and evaluated. 93.75 
There is a need for provision of HbA1C machine at all PHCCs and ADC. 93.44 
Mini-clinic program for chronic diseases at PHC need to be audited and 
evaluated to measure its implementation and effectiveness. 
93.13 
Enhancing and supporting the new health promotion initiative and merging 
the mini-clinic screening program within its activity should be considered. 
92.81 
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8.5. Discussion 
8.5.1. Principal findings 
The healthcare leaders perceived most of the recommended solutions and 
interventions as high priority. This could be because the researcher identified the 
important needs and gaps which should be tackled. This led healthcare leaders to give 
high priority to most of the recommendations. It also confirms that there are many 
issues need to be addressed.  
The healthcare leaders rated the recommendations on prevention or health promotion 
perspectives as the highest. Healthcare managers gave similar responses (previous 
chapter).  This could indicate that those who work in managing and commissioning 
healthcare services, whether they work in the RHA or as managers in local hospitals 
and PHCCs, have more interest in improving the preventive services and promoting 
health. It is possible that they both have a long term views on the scale of the problem 
of diabetes in Saudi Arabia. Thus, their concern is to try to prevent the future rise in 
demand for diabetes care by focusing on prevention rather than on increasing service 
provision.   
Moreover, the leaders gave consistently high priority to auditing and evaluation of 
diabetes care. This might be because they perceived that auditing diabetes services 
would help them in commissioning, planning and improving diabetes care. This 
perception was supported by some of their quotes. For example, one leader wrote 
“auditing would help for proper planning and improvement”. Another leader wrote 
“continuous audit means continuous improvement” and “audit would help for 
planning and decision making”.  
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The recommendations to computerize the healthcare services were given lower 
priority scores. This could be due to the previous failed attempt to computerize the 
primary healthcare services. However, it is important to computerize the healthcare 
systems because this will help to provide proper administration and collect accurate 
and easy accessible data which in turn will support conducting service audit and 
evaluation. A participant when asked why he gave computerization of healthcare 
system 100% priority wrote “because it will be easier to follow and collect data”.   
     
8.5.2. Limitations 
This study is not a formal priority setting exercise and did not aim to prioritize needs by 
conducting a robust priority setting processes. It just describes the participants’ views 
on perceived priority of specific recommendations to improve diabetes care. One of 
the weaknesses of this study was that it did not determine specific criteria to consider 
for prioritizing the recommendations. Therefore, each participant might have used 
different considerations for priority rating. For example, the cost of the 
recommendation was not explicitly taken into account.   
Another weakness was the involvement of a small sample size which limits the 
interpretation and generalizability of the findings.        
Although, some recommendations were given higher priority mean scores than others, 
the small differences between mean scores limit the prioritization process. Therefore, 
the interpretations should be cautious.  
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8.6. Conclusion  
The healthcare leaders in Abha city attached high priority to meeting identified needs 
and closing identified gaps in service provision.  Improving the preventive services and 
establishing an audit system for diabetes care were given particularly high priority. 
    
Need and demand for healthcare always exceed the funding available. Therefore, 
proper priority setting is required to prioritize the identified needs into those that will 
be met and those that will not. Achieving this is a challenging task which requires 
robust and fair priority setting processes. These should balance competing needs and 
achieve rational resource allocation. The next step, which includes developing effective 
interventions, planning for effective implementation and overcoming barriers, is also a 
challenge. 
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CHAPTER NINE 
 
  
Overall discussion and 
conclusion  
 
This chapter discusses the key findings of the whole research project and the 
implications of these findings for service improvement. Recommendations are 
made for future developments in diabetes care. Major priorities for research are 
identified. 
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Chapter 9: Overall discussion and 
conclusion 
 
9.1. Principal findings 
The findings of this research showed suboptimal achievement of several targets and 
indicators of quality of care covering measures of structures, processes and outcomes 
of diabetes care. This chapter will discuss some of the key findings of this thesis.  
 
9.1.1. Assessment of diabetes outcome measures 
This study in Abha city found that a large number of Saudi patients with diabetes are 
not achieving recommended levels of glycemic, lipid and BMI control and are therefore 
at high risk of diabetes complications. The analysis of patient case notes showed that 
80% of patients, who had their FBG measured within the preceding 12 months, did not 
achieve the target of FBG ≤ 126 mg/dl (7 mmol/l). In addition, more than 40% had poor 
glycemic control of ˃ 180 mg/dl (10 mmol/l). These results are consistent with those of 
previous studies across different regions of Saudi Arabia.(104-107) Although HbA1c has 
become the standard assay for managing and monitoring glycemic control, few 
patients (4%) in the PHCCs of Abha city had a record of HbA1c. In Aseer Diabetes 
Centre (ADC), 403 patients (73%) had a record of HbA1c and more than 83% of them 
had HbA1c values higher than 7% while 76% had HbA1c values higher than 7.5%. In all 
the neighbouring gulf countries, inadequate glycemic control of having HbA1c > 7% 
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was consistently reported in more than half of patients with T2DM.(110) A lower 
proportion was reported in Jordan where almost 44% of T2DM patients had HbA1c 
values of more than 7%.(287) In developed countries such as Scotland and England, 44% 
and 33% of patients with a record of HbA1c had values of more than 7.5% 
respectively.(288-289) 
The proportions of overweight and obese people with diabetes in Abha city were 
similar to what has been reported recently in Scotland. More than 85% of adult 
patients (≥ 20 years) with diabetes in Abha city were either overweight (33%) or obese 
(53%). A recent study which included 61% (14252) of all patients with diabetes in Aseer 
region showed similar proportions of overweight and obesity among people with 
diabetes (36% and 46% respectively).(290) Similarly, in Scotland almost 85% of adults (≥ 
18 years) with diabetes were either overweight (32.3%) or obese (52.5%).(288) However, 
for those patients who have their total cholesterol measured and recorded, almost half 
of patients (47.3%) in Abha compared with 20.5% in Scotland had total cholesterol 
level higher than 195 mg/dl (5 mmol/l).    
Another assessed outcome indicator was blood pressure (BP) control. This study found 
that 22% of patients with diabetes had BP readings (the most recent) higher than 
130/80 mmHg. In Scotland however, the Scottish Diabetes Survey in 2012 showed that 
a higher proportion of almost two thirds (66%) of patients with diabetes had BP 
readings higher than 130/80 mmHg. This thesis also found that only 22.5% of the 
patients with diabetes had a diagnosis of hypertension. This proportion was also lower 
than what has been reported from other studies in different regions of Saudi Arabia 
which range from 33 to 37%.(85, 291) 
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These findings raise concerns on the measurement and recording BP readings for 
people with diabetes in Abha city. For example, in Scotland, 93.6% of people with 
diabetes had their BP recorded within the preceding 15 months while in Abha city only 
65% had their BP recorded within the preceding 12 months. It is expected that those 
patients who did not have their BP measured in the preceding 12 months would have 
higher readings than those who were compliant with their follow-up appointment. This 
could explain in part why, in comparison to Scotland, a smaller proportion of patients 
with diabetes in Abha had BP readings higher than 130/80 mmHg. Another possible 
explanation for this might be that BP is not measured routinely for all patients either 
during their follow-up visits to the PHCCs or annual review in hospitals (only 54% of 
patients have their BP measured during the most recent hospital review). This would 
lead to missing more patients with high BP readings.        
 
Despite these inadequacies in the health status of people with diabetes in Abha city, 
one unanticipated finding was that most of the interviewed patients did not perceive 
that good glycemic control, weight reduction or lipid control are unmet needs or a 
problem that should be given a priority to tackle. This would indicate that the patients, 
when asked about their health needs and diabetes management problems, usually do 
not think about themselves and their diabetes control but rather about other issues 
related to the availability of services and processes of care. This might be because they 
think that if all the resources were available and the processes of care were 
appropriate, control of their diabetes would improve. On the other hand, the low level 
of concern might be instead a result of patients’ lack of awareness of the importance 
of achieving good glycemic, lipid and weight control. The finding that health education 
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was not frequently given could partly explain this lack of patients’ awareness. In 
addition, the healthcare professionals’ responses supported that by frequently 
reporting poor patient compliance and lack of patient knowledge as problems in 
diabetes care. This is consistent with the findings of a recent survey among physicians 
in the Middle East and North Africa which showed that physicians identified the 
patient factors  as the most important barriers to optimal diabetes care.(292)       
Poor glycemic control has been shown to increase the risk of diabetes 
complications.(13, 293) Contrary to expectations, the reported inadequate glycemic and 
lipid control in Abha city was accompanied by lower than expected prevalence of 
diabetes complications. Of reviewed patients (4458), 22.5% had hypertension, 10.5% 
had retinopathy, 2.9% had ischemic heart disease, 1.8% had nephropathy and only 
1.4% had cerebrovascular disease. In addition, the proportions of peripheral arterial 
disease, neuropathy and foot problems were almost lower than 1%. By comparing with 
the prevalence of diabetes complications in developed countries with high quality 
diabetes care,(261) it is clear that the prevalence of diabetes complications in this study 
was lower than would be expected. This poor identification of diabetes complications 
is probably attributed mainly to several inadequacies of the care processes of 
identifying these complications. Low referral rate to hospital for annual review and the 
lack of performing or recording some clinical examinations such as foot examination 
are examples of these process inadequacies. On the other hand, a multi-faceted 
approach involving issuing guidelines, staff training, service evaluation and frequent 
auditing could increase examination frequency. For instance, an evidence based 
diabetic foot examination reminder, which was implemented in a PHCC in Saudi 
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Arabia, showed a dramatic improvement in performing foot examination from 7.8% to 
52.7%.(294)  
Although it is not possible to prevent T1DM, there is evidence suggesting that it is 
possible to prevent T2DM, or at least delay its onset, by preventing obesity and 
promoting physical activity.(295-296) Therefore, in Saudi Arabia, it is necessary to 
implement interventions to reduce the incidence of T2DM which aim to increase 
physical activity, promote healthy eating and prevent or at least reduce overweight 
and obesity. Research is needed to help in developing and identifying the most 
effective and efficient interventions that is suitable for the Saudi populations and 
circumstances.    
It is now generally accepted that early diagnosis and treatment of people with T2DM 
can help reduce their risk of developing complications and the costs associated with 
diabetes management. Therefore, it is recommended to screen for T2DM those 
asymptomatic, undiagnosed individuals who are at increased risk of developing 
diabetes.(14, 37, 250, 297) It should become a routine part of diabetes services once a 
working system of care is in place. Although the screening of those at increased risk of 
developing diabetes is one of the components of the diabetes mini-clinic programme, 
few patients were diagnosed annually due to the implementation of this programme 
(5% of the interviewed patients). The study estimated that in 2011, 73% (12988) of 
people with diabetes in Abha city are still undiagnosed. This large number of people 
with undiagnosed diabetes will increase the likelihood of presenting with long-term 
complications at time of diagnosis, which will increase the cost of their management. 
Therefore, improving the implementation of the screening programme should be 
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considered. At the national level, the estimated proportion of undiagnosed diabetes is 
77.4%.(37) In the high-income countries of the Middle East and North Africa region, the 
proportion of undiagnosed diabetes was estimated to be 40.7%.(298) Globally, the IDF 
estimated that close to half (45.8%) of those who have diabetes are undiagnosed; 
ranging from 24-75% across IDF region and income groups.(298) This shows that Saudi 
Arabia had a higher proportion of undiagnosed diabetes than neighbouring countries 
with similar high income.  
In addition, although the population-wide screening for diabetes in not recommended 
in some developed countries, (14, 37, 250, 297) its implementation in Saudi Arabia might be 
effective due to the high prevalence of diabetes and undiagnosed diabetes in the 
country. Some statistical models showed that identifying each case of undiagnosed 
diabetes in Taiwan was more cost-effective than in the USA.(299) The proportion of 
undiagnosed diabetes was higher in Taiwan than in the USA (46.7% versus 27.7%).(37) 
In Taiwan, the cost per quality-adjusted life-year (QALY) gained from earlier detection 
and treatment of each case of undiagnosed diabetes was estimated to be around US$ 
17,800, which compares favourably to the USA where the cost was US$ 56,600 per 
QALY gained.(299) This comparison between Taiwan and the USA emphasize that the 
cost-effectiveness of population-wide screening is sensitive to the prevalence of 
undiagnosed diabetes. Therefore, population screening for T2DM should be studied 
for its cost-effectiveness and clinical benefits within the Saudi community. Another 
important consideration is whether the capacity of the healthcare system is sufficiently 
able to treat the newly identified patients.(299)  
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9.1.2. Assessment of service resources and process of care 
A wide gap exists between our standards and knowledge of effective diabetes 
interventions and their implementation in practice. Several deficiencies in service 
provision were identified and several related concerns were raised by the key 
stakeholders. These deficiencies were related to either the issue of availability of 
specific resources and services or the issue of poor implementation of some care 
services. Table 54 shows the main consistent deficiencies in care across the different 
methods used. Inadequacies of the process measures of diabetes care were found in 
all the PHCCs with marked variation between them. 
Table 54: Triangulation of key findings across different methods 
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Insufficient availability of medications, healthcare staff and laboratory resources were 
findings of most of the approaches used. For example, reviewing the patient case 
notes showed inequity in prescribing of some drugs such as aspirin and statins. 
Evaluating what medications are available in each PHCC showed that mixed insulin 
(Mixtard) was available in Almanhal and Wasat Abha PHCCs while the Lantus pen was 
only available in Almanhal PHCC. At the same time, patients and healthcare 
professionals as well as pharmacists frequently perceived that the availability of 
medications in the PHCCs is insufficient. 
In the same way, the insufficient availability of laboratory resources was reported by 
most of the different approaches used in this research. For example, evaluating service 
provision showed that there is no laboratory in Johaan PHCC and that HbA1c test and 
blood electrolytes were not available in any of the PHCCs. Reviewing the patient case 
notes showed for example that HbA1c was measured for only 4% of patients and FBG 
was measured for 60% of patients. Insufficient or unavailable laboratory services were 
one of the most frequent perceived needs reported by interviewed patients, 
healthcare professionals and managers. A recent survey of 1082 physicians in five 
countries including Saudi Arabia showed that the Saudi physicians perceived a lack of 
laboratory facilities as a problem and identified inadequate laboratory facilities as a 
potential barrier to optimal diabetes care.(292)  
Availability of well trained staff was also an important issue of diabetes care in Abha 
city. Reviewing the current provision of care services showed that, in Abha city, there 
are no specialists in podiatry, nutrition and diet or health education. The foot clinic and 
health education clinic in ADC are run by interested nurses who have had limited 
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training while the dietetic clinic is run by two dieticians. The numbers of specialist 
general physicians, laboratory technicians and x-ray technicians are not sufficient. In 
addition, there was a need for equitable redistribution of the working staff based on 
the number of people registered at each PHCC. Moreover, when the patients, 
healthcare professionals and managers were asked about the healthcare needs of 
patients with diabetes, they all perceived that the current number of staff is not 
sufficient and there is a need for more well-trained staff in different specialities at both 
primary and secondary healthcare.            
The need to improve the annual referral of patients to hospitals for checkups was also 
indentified by three approaches used in this study (Table 54). Reviewing how the 
diabetes care was delivered showed that there are no explicit criteria and guidelines 
for organizing the methods of referring patients to hospitals and receiving feedback. 
On the other hand, the analysis of patients’ case notes showed that only 45% of people 
with diabetes were referred to the hospital for annual checkups in the preceding 12 
months with marked variation between the PHCCs. Additionally, many patients, 
healthcare professionals and managers who were interviewed repeatedly reported 
concerns and difficulties in this system particularly in hospitals. Further studies are 
needed to explain why this variation in referral rates exists and what effective 
interventions could help to improve the referral system.        
Reviewing the current provision of diabetes care showed that there is a need for 
national policy statements, strategies, action plans and updated quality assurance 
guidelines in order to improve the organization and delivery of diabetes care. 
Developing effective interventions to improve all the components of diabetes care 
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including prevention of T2DM; diagnosis; initial management; education; follow-up 
care; and regular screening for and treatment of complications are needed. Some 
interventions have shown promising effects in improving the processes of diabetes 
care in Saudi Arabia. For example, developing a computer programme for physicians to 
generate an evidence-based checklist of clinical and biochemical screening tests 
needed for patients with diabetes at each visit showed significant improvement in 
screening for diabetes complications. This intervention significantly improved the 
percentage of patients being screened for diabetic retinopathy from 24.7 to 98.5%, 
neuropathy from 25.9 to 92%, and nephropathy from 37.8 to 73.7% in a primary 
healthcare setting in Riyadh. However, this intervention did not show any 
improvement in the glycemic control.(300) Moreover, using an evidence-based diabetic 
flow sheet in the patient records improved performance on 7 out of 9 process 
indicators of diabetes care. The difference in improvement was 40% for measuring the 
BMI, 36% for testing lipid profile, 29% for HbA1c, 24% for peripheral neuropathy 
examination, 23% for examining foot, 18% for retinoscopy and 14% for microalbumin 
testing.(301)  
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9.2. Challenges of the field work 
Assessment of diabetes care in a developing country was a major undertaking. 
Designing and conducting the research project required to consider the complexity of 
diabetes care and the lack of electronic healthcare systems and records in Saudi 
Arabia. Therefore, several methods of research were designed to collect data on 
diabetes care from different sources. These methods included semi-structured 
interviews with key stakeholders encompassing patients, healthcare professionals, 
managers and pharmacists; standard checklist for evaluating available resources; 
analysis of routine healthcare data; questionnaires to medical directors and healthcare 
leaders; and examination of the case notes of patients with diabetes. These methods 
were designed to be culturally acceptable, fit the nature of the paper-based healthcare 
system and ensure feasible, doable and successful conduction. Getting access, 
constructing the research teams and getting approval required extensive efforts. In 
addition, limited fund, resources, available time and limited available data were all 
major difficulties. The approval and support of the Saudi MOH was essential in 
obtaining access to different data sources and developing the research teams. 
Conducting the research project during the working hours was also a difficult task. The 
working staff was busy with their daily work duties. With the support of the MOH, 
which offered the nurses who worked in the team 2 free days per week for 2 months, 
this task was achieved well. 97% of the case notes were reviewed by nurses and 290 
key informants were interviewed by the physicians. In the first two weeks, the main 
researcher and the supervision teams double checked the filled forms to ensure the 
data were extracted accurately and the forms were filled in completely. The project 
was interrupted by two measles vaccination campaigns and the hajj holiday. However, 
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with this recruited enthusiastic teams, we were able to overcome these difficulties. 
More members were recruited in the PHCCs with high workload and one nurse was 
moved to help any PHCC team when needed. Doing this kind of research is difficult; 
however, with advanced planning and using modified feasible research techniques, 
this help to conduct the project successfully.   
 
9.3. Strengths and limitations 
9.3.1. Methods used 
This is the first study that has used multiple approaches to assess diabetes care at both 
the primary and secondary healthcare level in a whole city in the Kingdom of Saudi 
Arabia. It is the first study that has assessed diabetes care by analysis of the routine 
healthcare data in conjunction with data from patient case notes and interviews with 
key stakeholders. The methods included first evaluating the current diabetes services 
through assessing the availability of the resources of diabetes care and whether 
specific diabetes services are delivered or not. A standard service checklist and service 
provision questionnaires were used in addition to collecting and analysing routine 
healthcare data to achieve a comprehensive assessment. Second, the records of 
patients with diabetes were reviewed using specific developed form to evaluate 
several process and outcome measures of diabetes care. Third, interviews with key 
informants including users, providers and managers of diabetes care were undertaken 
to gain insight into their views and priorities regarding patient needs and deficiencies 
in diabetes care. Four specific semi-structured interview schedules were developed 
and used for this purpose. 
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9.3.2. Rationale and limitations of each method 
Each of the methods used has its own strengths and limitations. The first approach, 
which aimed to assess the availability of specific checklist of diabetes care resources 
and services, used both direct inspections of the PHCCs resources and asking by face-
to-face interviews the best placed clinicians whether specific diabetes services and 
resources are available or not. This approach was used because of the lack of routine 
data or reports that can provide information on the available resources. However, the 
methods used did not assess whether the available resources are adequate in terms of 
their amount, type and condition. Also, they did not assess whether these resources 
have been used appropriately.  
Interviewing the lead clinicians about resource availability might involve response bias. 
The clinicians might underestimate or overestimate the available resources. They 
might think that underestimating what is available might bring more resources. 
Conversely, they might think that they will be held responsible for any deficiency 
identified which might lead them to overestimate what is available. It was difficult to 
know if response bias was a problem. In addition, interviewing small purposive sample 
of clinicians (16 medical directors) might not represent the whole population. 
However, it was used because the researcher aimed to collect informative and 
accurate answers on which is available and which is not. This is best achieved by asking 
only those clinicians who were designing, giving or administering the diabetes services. 
These clinicians are best placed to answer the research questions. It has been thought 
that asking patients or those clinicians who do not have experience or knowledge 
about diabetes care might be misleading. In addition, the aim was not to assess what 
the population think about the available resources but rather to assess what are 
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actually available. Therefore, using small purposive sample might be one of the best 
approaches to achieve this aim.       
Collection and analysis of the available routine data was one of the methods used to 
assess diabetes care in this study. The availability of routine data on diabetes care was 
limited particularly for hospitals. Therefore, it was not possible to describe and assess 
all the components of diabetes care such as hospital admissions, waiting time for 
services and length of hospital stay. Moreover, routine data for some health 
determinants such as deprivation and socio-economic status were not available. In 
addition, the validity of the available routine data depends on the accuracy and 
completeness of coding and recording these data.(238)  Although the Saudi MOH uses 
these data, its validity has not been assessed in published research.  
Moreover, the validity of the data that were obtained from case note review depends 
also on the accuracy and completeness of the patients’ records. The paper-based 
records of patients with diabetes in Saudi Arabia were reviewed by many researchers 
to assess some aspects of diabetes care.(138, 180, 256-258) However, these data have not 
been assessed for validity in published research. One of the limitations of the case note 
reviews is the assumption that absence of recorded results for a process measure 
means that the measure was not conducted. This might lead to underestimated 
measures due to missed recording.  
Another limitation is lack of consistent recording of some data items among the 
PHCCs. This makes it unfeasible to assess patient compliance for example. Further, the 
case notes were reviewed by a team of nurses. Using different type of healthcare staff 
might result in different interpretations of the recorded care, which might in turn lead 
to variation in reporting the performance measures. Using clear, simple and easy-to-
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answer questions with specific lists of answers, mostly yes or no, was a strategy used 
to overcome this limitation. In addition, the teams were trained on how to fill in the 
forms correctly and a sample of the completed forms were double checked and return 
to the nurses for correct and complete filling.    
 
The third approach which involved interviewing samples of different stakeholders has 
some limitations. First, interviewing a systematic sample of patients who attended 
their appointment means that the views of local patients who did not access or were 
unable to access the healthcare services during the study period were not sought. This 
would also means that the views of those patients who are not compliant with 
attending their follow-up appointments were not sought. Therefore, the healthcare 
needs and problems of this type of patients might be under reported. Second, the 
majority of interviewed patients were male patients. This might lead to under 
reporting the healthcare needs and problems of female patients.     
 
In addition, interviewing small purposive samples of healthcare professionals, 
managers and pharmacists might not represent the views of the more general 
population. However, they are presumed to have a broad experience and knowledge 
about the local diabetes care. Therefore, eliciting their views is the most appropriate 
method sensitive to local concerns and circumstances.(228, 284)  
 
Moreover, taking notes instead of recording the interviews might involve interviewer’s 
views and bias in writing the correct responses. Culturally, it gives the participants 
more willingness and freedom to express their views while recording the interviews 
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might lead the participants to be more reluctant and conservative. However, to 
minimize this bias, the participants were given the chance to review the notes taken 
and correct or change any responses.  
 
9.3.3. Strengths 
Despite these limitations, this study still provides valuable evaluation and information 
about one of the important chronic disease conditions in Saudi Arabia. Triangulation of 
the findings of each approach showed consistent results with other methods used.  
Using all these approaches together in one study to assess diabetes care is one of the 
advantages of this study. This combination of approaches was used because first, the 
inherently complex nature of diabetes care which involves different professions, 
different aspects of care at different healthcare levels. Second, assessing the quality of 
care involves measuring different dimensions of quality such as structure, processes 
and outcomes of care and different areas of quality such as effectiveness, efficiency, 
acceptability, access, and equity of care.(192-193, 199) Third, the combination of 
approaches was used to help in achieving our research objectives and to assess as 
comprehensively as possible the diabetes care in Saudi Arabia. It was also considered 
that the use of only one approach, the research may suffer from associated limitations 
while using more than one approach would usefully supplement and extend the 
research findings and enhance confidence in them. Therefore, the consistency of 
findings across these approaches was a major strength of this study. 
For example, when the routine data were checked (triangulated) against other sources 
of data in this thesis, they showed similar findings. The data on registered diabetes 
prevalence were similar to what has been reported by the structured questionnaire to 
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the medical directors and the case notes reviewed. Insufficient medications, staff, 
laboratory resources and health education resources were also reported or identified 
by most of the research methods used in this study. This would enhance the 
confidence in the findings of this thesis. 
The other advantage of this study is the coverage of all the PHCCs and the diabetes 
centre in one city. This gives us a complete coverage of a typical city in Saudi Arabia. 
Many previous studies have had limited coverage. (138, 179, 246, 256-257, 269) Abha city is 
similar to most of the cities and large towns in Saudi Arabia in terms of population size, 
demographic characteristics and availability of healthcare and public services. 
However, Abha is different from the capital city and rural areas. The capital city is 
expected to have more, better and advanced healthcare services as well as public 
services. Conversely, the rural areas and remote villages are expected to have less 
healthcare and public services and the diabetes care is expected to be worse due to 
several difficulties such as lack of facilities, inadequate staff numbers, language 
barriers and rough roads.(302) Therefore, the findings of this study can be generalized to 
many cities and large towns but for rural areas and the capital city, this study might 
need to be replicated.  
The private healthcare sector was not included in this study which might lead to 
missing those patients with good financial status. Although it is possible that they 
might receive better healthcare in the private clinics; but in the other hand, the 
outcomes of care might be not satisfactory because of other care issues such as lack of 
physical activity and unhealthy eating habits. The patients with diabetes who were 
attending a private hospital received more prescriptions for rosiglitazone, pioglitazone, 
ARBs, statins and aspirin than the patients in a governmental hospital. (108) However, 
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the targets of glycemic and blood pressure control were reported to be similar in both. 
Only the LDL-cholesterol control was achieved well among the private hospital patients 
due to the fact that 40% of them were treated with statins versus 29% of patients at 
the governmental hospital.(108)  
 
9.3.4. Implications for the interpretation of the findings 
The limitations of the data that were collected will influence the interpretation of the 
findings of this study, particularly in having precise estimates for the scale of the 
identified deficiencies. Thus, small deficiencies in diabetes care would be difficult to 
identify reliably. However, most of the identified deficiencies were large or very large 
which would strongly indicate that these deficiencies are real. This is unlikely to be due 
to bias unless it was of extreme form. In addition, the consistency of findings across 
the different methods used gives more confidence in the study findings.  
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9.4. Conclusion 
Improving the structure and processes of diabetes care in Saudi Arabia is essential and 
urgent actions need to be taken. But this may not be enough to substantially improve 
the outcome indicators of diabetes care. In other words, the identified inadequacies of 
outcome indicators cannot be attributed only to the deficiencies and gaps in service 
provision. They resulted from complex and multidimensional interacting factors which 
related to the patients, the care providers, the healthcare system and the policy and 
organization of diabetes care. This study found that increasing intensity of diabetes 
therapy or receiving health education on more topics for example was not associated 
with improved glycemic control. Therefore, promoting patients’ health-related 
behaviours such as patients’ adherence to therapy prescribed, healthy eating and 
physical activity is also an essential part of good diabetes care.        
Optimal diabetes services should be organized and delivered in a collaborative and 
coordinated way using effective and efficient integrated and systematic approaches 
with involvement of collaborative, well-trained and multidisciplinary teams. Achieving 
this is a huge challenge to the government in Saudi Arabia. All the identified barriers to 
service improvement should be tackled using effective interventions. This thesis 
recommends that the higher healthcare authorities in Saudi Arabia should start 
urgently with two national projects. The first one is a research project which aims to:  
1. Replicate this study in Saudi Arabia at the national level, 
2. Identify effective strategies to improve the quality of care in Saudi Arabia. For 
example: 
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 Test the Chronic Care Model (CCM) which has been shown to be an 
effective framework for improving the quality of diabetes care in some 
developed countries,(14, 303-304) 
 Develop and test interventions appropriate to close the identified gaps 
in service provision and improve adherence to the recommended 
standards. 
3. Identify the priorities for improving diabetes care through conducting a robust 
priority setting research project at the national level. 
4. Identify effective strategies to prevent diabetes by controlling its risk factors 
and identifying high risk individuals for screening. This would include 
developing effective behavioural change interventions to promote healthy 
diet, physical activity and weight control.  
5. Take into account the knowledge and experience of both the users and the 
providers of diabetes care when developing a research project or planning for 
service improvement. 
6. Assess the cost-effectiveness of the current system of health care delivery and 
screening for diabetes and its complications.        
The second project is a national diabetes care improvement programme which will 
aim, in light of the research project, to: 
1. Develop all the required policy statements, guidelines, protocols, strategies 
and action plans for diabetes care, 
2. Implement the required interventions to optimize diabetes care,  
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3. Coordinate, organize and facilitate the processes of changing and improving 
diabetes care, 
4. Implement an audit programme for diabetes care, 
5. Insure that the research findings are acted upon by maintaining high quality 
communication with the research project teams.  
 
Diabetes mellitus has become an epidemic disease in Saudi Arabia. One in five Saudi 
Arabians beyond the age of 30 has diabetes mellitus. It is the third most common 
cause of visiting the primary healthcare centres and accounts for 6% of all deaths in 
the Kingdom. It currently imposes a large economic burden on the national healthcare 
system. Healthcare expenditure due to diabetes accounts for more than one fifth 
(21%) of the total national healthcare expenditure in Saudi Arabia. The percentage of 
the Saudi young population (< 45 years old) is almost 85% of the total population. The 
population is undergoing rapid demographic transition which will substantially 
increase the burden of diabetes if no action is taken to implement prevention 
programmes and improve the quality of diabetes care. The size of the diabetes 
problem, its burden, the quality of its care and where the deficiencies lie have been 
reported in this thesis. The views of patients, healthcare providers were explored. As a 
result, several recommendations were suggested and highly prioritized by a group of 
healthcare leaders in Abha city. These recommendations should be urgently 
considered and investigated for its applicability in improving diabetes care and 
reducing its burden. Further research is required and further actions are urgently 
needed. 
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Appendix 1: Prevalence studies of diabetes in Saudi Arabia, 1982-2012*  
 
* See the list of abbreviations for appendices 1, 2 and 3 at the end of appendix 3.  
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Appendix 2: Prevalence studies of Gestational Diabetes Mellitus in Saudi Arabia, 1982-2012 
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Appendix 3: Prevalence studies of T1DM in Saudi Arabia, 1982-2012  
 
WP: working population, GP: general population, ACH: attendees of a clinic or hospital, SP: sub-population, PHC: primary healthcare registered population, PW: pregnant 
women. NR: not reported, FBG: fasting blood glucose, FPG: fasting plasma glucose, FPMCBG: fasting post meal capillary blood glucose, RBG: random blood glucose, OGTT: 
oral glucose tolerance test, GCT: glucose challenge test, IR: incidence rate. DM: diabetes mellitus, T1DM: type 1 diabetes mellitus, T2DM: type 2 diabetes mellitus, GDM: 
gestational diabetes mellitus, MODY: maturity onset diabetes of youth. WHO: world health organization, ADA: American diabetes association, NDDG:  National Diabetes 
Data Group, ISPAD: International Society for Paediatric and Adolescent Diabetes.   
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Appendix 7: Evaluation checklist for resources of mini-clinic at PHCCs 
MINISTRY OF HEALTH 
DIRECTORATE GENERAL OF HEALTH  AFFAIRS 
PRIMARY HEALTH CARE AND PREVENTIVE MEDICINE DEPARTMENT 
PROGRAM  IMPLEMENTATION  DEPARTMENT 
ASEER REGION , KSA 
EVALUATION  CHECK-LIST  FOR  ORGANIZATION OF MINI-CLINIC FOR NON-
COMMUNICALE CHRONIC DISEASES AT PHCC * SECTOR : * PHCC : 
IMPORTANT  FUNCTIONAL  UNITS 
1 
TYPE OF PHCC building 
: GOV. 10* RENTED 0 DONATED 0 
2 MAN POWER: (≥ 1)   F.M.  Consult./Phys. 5 Male Nurse 1 Director 1   Specialist 5 Female Nurse 1 H. Inspector 1   Male GP 1 Lab. Technician 1 H. Educator 1   Female GP 1 X-Ray Technician 1 Dental Assistant 1   Dentist 1 Pharmacist 1 Nutritionist 1   Social worker 1         
3 Other important functional units AVAILABLE (Priority score)* NOT  AVAILABLE 1 Waiting space. 7 0 2 Consultation room. 10 0 3 Room for the nurse. 10 0 4 Laboratory. 10 0 5 Health education room. 7 0 6 Pharmacy. 10 0 7 Dental clinic. 8 0 8 X-ray. 5 0 9 Ambulance. 10 0 10 Telephone. 5 0 
*Bold red numbers represent the priority (importance) scores. 
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WAITING  SPACE 
  AVAILABLE 
NOT  
AVAILABLE 
1 Separate waiting space for male patients. 4 0 2 Separate waiting space for female patients. 4 0 3 One waiting space for all. 4 0 4 Health education materials (Leaflets, Posters, Video projection). 5 0 5 Health waste disposal container with black plastic bag. 4 0 6 Nearby toilet. 5 0 
 
CONSULTATION  ROOM 
  AVAILABLE NOT  AVAILABLE 1 Stethoscope. 1 0 2 BP instrument. 1 0 3 Hammer. 1 0 4 Torch light. 1 0 5 Patient examination light with stand. 1 0 6 Ophthalmoscope. 1 0 7 ENT set. 1 0 8 Magnifying glass. 1 0 9 Tuning fork. 1 0 10 Monofilament. 1 0 11 PEF meter. 1 0 12 MDI. 1 0 13 Spacer (Adult and children). 1 0 14 Snellen's chart. 1 0 15 Working table for doctor. 1 0 16 Chair for doctor. 1 0 17 Chair or revolving stool for patient. 1 0 18 Chair for attendant. 1 0 19 Patient examination couch. 1 0 20 Foot step. 1 0 21 Screen. 1 0 22 Cabinet. 1 0 23 X-Ray illuminator. 1 0 24 White bed sheet. 1 0 25 Pillow. 1 0 
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 26 Pillow cover. 1 0 27 Blanket. 1 0 28 Wall calenderer. 1 0 29 Desk calendar. 1 0 30 Bulletin board. 1 0 31 Board for statistics. 1 0 32 Board for memos and circular. 1 0 33 File for concerned circular. 1 0 34 Telephone. 1 0 35 Patient' register. 1 0 36 Prescription form. 1 0 37 Requisition form for laboratory investigation. 1 0 38 Requisition form for X-ray. 1 0 39 Referral sheet. 1 0 40 Annual evaluation sheet. 1 0 41 Data collection sheet. 1 0 42 Health education material (Life style management). 1 0 43 MOH protocol, guidelines and manuals for Hypertension, Diabetes and Bronchial asthma. 1 0 44 Guidelines for Hypertension, DM, Dyslipidemia and Health promotion from Joint program of Family medicine, Aseer.  1 0 45 Sample of medicines: Oral, parentral & inhaler (Hypertension, Diabetes and B. asthma). 1 0 46 Wash basin with running water. 1 0 47 Soap for hand washing. 1 0 48 Tissue papers. 1 0 49 Dispenser for antiseptic hand rub. 1 0 50 HC waste disposal container with black plastic bag. 1 0 51 HC waste disposal container with yellow plastic bag. 1 0 52 Visible signage (Mini-clinic for Chronic dis.). 1 0 
 
NURSING  ROOM 
  AVAILABLE NOT  AVAILABLE 1 Working table for the nurse. 1 0 2 Chair for the nurse. 1 0 3 Revolving stool or chair for the patient. 1 0 4 Chair for the attendant. 1 0 5 Patient examination bed. 1 0 6 Foot step. 1 0 7 Screen. 1 0 
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 8 Bed sheet. 1 0 9 Pillow. 1 0 10 Pillow cover. 1 0 11 Blanket. 1 0 12 Bulletin board. 1 0 13 Board for statistics. 1 0 14 Board for memos and remainder. 1 0 15 Standard weighing scale. 1 0 16 Standard Height measuring scale. 1 0 17 Patient examination light with stand. 1 0 18 Calculator. 1 0 19 Wall clock. 1 0 20 Wall Calendar with Hijri and Gregorian date. 1 0 21 Desk calendar with Hijri and Gregorian date. 1 0 22 Telephone with external line. 1 0 23 Computer with printer. 1 0 24 Instrument trolley having two shelves. 1 0 25 Stethoscope. 1 0 26 BP instrument. 1 0 27 Thermometer. 1 0 28 ECG machine with movable trolley. 1 0 29 Sufficient tracing papers for ECG. 1 0 30 ECG reporting form. 1 0 31 Glucometer with regular supply of Strip. 1 0 32 Filled oxygen cylinder. 1 0 33 Oxygen trolley. 1 0 34 I.V. Stand. 1 0 35 Suction machine. 1 0 36 Disposal oxygen masks. 1 0 37 Standard emergency drug list. 1 0 38 Standard emergency drugs. 1 0 39 Insulin syringes. 1 0 40 Disposables (Cotton, Sterile and non sterile gloves, alcohol strip, I/V infusion set etc.). 1 0 41 Containers for thermometer. 1 0 
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 42 Containers for cotton, syringes, Alcohol strips 1 0 43 Shelf / cabinet for the Patient's m. record (File). 1 0 44 Cabinet for medical and non medical materials. 1 0 45 Snellen's chart. 1 0 46 Glucose drink. 1 0 47 Screening register Hypertension. 1 0 48 Screening register for Diabetes. 1 0 49 Screening register for Bronchial asthma. 1 0 50 Master book for hypertensive patient. 1 0 51 Master book for Diabetic patient. 1 0 52 Master book for Bronchial asthma patient. 1 0 53 Master book for other types of NCD. 1 0 54 Patient referrals register. 1 0 55 Patient ID card for Hypertensive patient. 1 0 56 Patient ID card for Diabetic patient. 1 0 57 Patient ID card for Bronchial asthma patient. 1 0 58 File and folder for patient. 1 0 59 Required Performa for patient's file. 1 0 60 Appointment card for patient. 1 0 61 Patient flow card (Serial number). 1 0 62 Case follow-up register for Hypertension. 1 0 63 Case follow-up register for Diabetes. 1 0 64 Case follow-up register for Obesity. 1 0 65 Case follow-up register for dyslipidemia. 1 0 66 Standard Performa of defaulters. 1 0 67 Appointment dairy. 1 0 68 Standard monthly data collection sheet. 1 0 69 Standard yearly data collection sheet. 1 0 70 File for circular in relation to Mini-clinic and non-communicable chronic disease activity. 1 0 71 File for important reference papers. 1 0 72 Health education material. 1 0 73 Posters displaying target groups for screening. 1 0 
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 74 Washing basin with running water supply. 1 0 75 Hand washing soap. 1 0 76 Tissue papers. 1 0 77 H. waste disposal container with black plastic bags. 1 0 
78 H. waste disposal container with yellow plastic bags. 1 0 
79 Health waste disposal container for sharps. 1 0 
80 Manual for DM, Hypertension, Bronchial asthma, obesity and dyslipidemia. 1 0 
81 Policy & procedure for DM, Hypertension, Bronchial asthma, Obesity & Dyslipidemia. 1 0 82 Register for obesity. 1 0 83 Dispensers for antiseptic hand rub solution. 1 0 
 
LABORATORY 
PHCC  HAVING  LABORATORY 
  AVAILABLE NOT  AVAILABLE 1 Haematology : *  CBC 1 0 *  ESR 1 0 2 Biochemistry : *  Blood glucose ( Fasting , P.Prandial, Random & OGTT ) 1 0 *  HA1C 1 0 *  Renal Function Test 1 0 *  Uric Acid 1 0 *  Lipid Profile 1 0 * Calcium 1 0 *  LFT 1 0 * Alb/Creatinine ratio 1 0 3 Urine *  Routine 1 0 *  microscopic 1 0 
PHCC  WITHOUT  LABORATORY 
  AVAILABLE NOT  AVAILABLE 1 Glucometer for blood glucose 1 0 2 Urine dipstick 1 0 
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 HEALTH PROMOTION/ HEALTH  EDUCATION  ROOM 
  AVAILABLE NOT  AVAILABLE 1 Defined room. 1 0 2 Table for the health educator. 1 0 3 Chair for the health educator. 1 0 4 Chair for the patients (15-20 Chairs). 1 0 5 Shelf for health education material. 1 0 6 Health education materials for general and life style modification. 1 0 7 Cabinet. 1 0 8 Flip chart. 1 0 9 White board. 1 0 10 Pental pen for white board (Different colour). 1 0 11 Duster. 1 0 12 Projector. 1 0 13 Screen. 1 0 14 LCD/LED. 1 0 15 Health promotion register. 1 0 16 Health promotion record. 1 0 17 Health promotion file. 1 0 18 Diary for appointment, defaulter detection and follow-up for defaulter. 1 0 19 BMI chart. 1 0 20 Guideline for Health Promotion and periodic Health Maintenance in Family Practice. 1 0 21 Computer. 1 0 22 Health waste disposal container with black bag. 1 0 
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 PHARMACY 
a - Following drugs should be available according to MOH essential drug list 
for PHCC:  
  AVAILABLE NOT  AVAILABLE 1 Tab. Glibenclamide 5mg. 1 0 2 Tab. Metformin 500mg. 1 0 3 Tab. Gliclazide 80mg. 1 0 4  Insulin Human isophan Vial  100 units/1ml. 1 0 5 Insulin Human Regular Vail 100 units/1ml 1 0 6 Mixed Human Insulin Vail 100 units/1ml 1 0 7 Tab. Atenolol 100mg. 1 0 8 Tab. Captopril 25mg. 1 0 9 Tab. Enalapril maleate 10mg. 1 0 10 Tab. Linsinopril dehydrate 10mg. 1 0 11 Tab. Fosinopril 10mg. 1 0 12 Tab. Amlodipine besilate 5mg. or Felodepine 5mg. 1 0 13 Tab. Tab. Nitroglycerine 0.5mg. Sublingual. 1 0 14 Tab. Isosorbide Dinitrate 5mg Sublingual. 1 0 15 Tab. Isosorbide Dinitrate 20mg Sustained release. 1 0 16 Tab. Propranolol HCL 40mg. 1 0 17 Tab. Losartan 50mg. 1 0 18 Tab. Methyldopa 250mg. 1 0 19 Tab. Aspirin 75-100mg.  1 0 20 Tab. Simvastatin 10mg. 1 0 21 Tab. Pravastatin 20mg. 1 0 22 Tab. Atrovastatin 10mg. 1 0 23 Inj. Frusemide 20mg/2ml. Ampoule. 1 0 24 Tab. Frusemide 25mg. 1 0 25 Tab. Frusemide 40mg. 1 0 26 Tab. Hydroclorothiazide 25mg.  1 0 27 Inhaler Salbutamol 100 microgram. 1 0 28 Salbutamol Solution 0.5% for nebulizer. 1 0 29 Inhaler Beclomethazone 100 microgram. 1 0 30 Turbuhaler Budesonide 200 microgram. 1 0 31 Salmeterol xinafoate 25Mcg Inhaler / Fluticasone 125Mcg Evohaler. 1 0 32 Tab. Spironolactone 25mg. 1 0 
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b - Emergency Drugs: (Nurse room)  
  AVAILABLE NOT  AVAILABLE 1 Inj. Frusemide 20mg. 1 0 2 Inhaler Salbutamol. 1 0 3 Salbutamol solution. 1 0 4 Inhaler Beclomethazone. 1 0 5 Tab. Atenolol 100mg. 1 0 6 Tab. Captopril 25mg. 1 0 7 Dextrose 50% 50ml. 1 0 8 Dextrose 5% 250ml. 1 0 9 Na Chloride 0.9% 500ml. 1 0 10 Dextrose 5%+Na chloride 0.9% 500ml. 1 0 11 Ringer lactate 500ml. 1 0 12 Inj. Human regular 100units/ml. 1 0 13 Inj. Adrenaline 1:1,000  1 0 14 Inj. Calcium Chloride 10% 10ml syringe. 1 0 15 Inj. Sodium Bicarbonate 8.4% in 50ml. Vials. 1 0 16 Inj. Hydrocortisone 100mg/Vial. 1 0 17 Inj. Atropine sulphate 0.6mg/ampoule. 1 0 18 Inj. Antihistaminic. 1 0 19 Tab. Aspirine (Acetylsalicylic Acid) 500mg. 1 0 20 Inj. Morphin sulphate 10mg./ampoule. 1 0 21 Inj. Lidocain HCL 1% 100mg/vial. 1 0 22 Inj. Diazepam 10mg/ampoule. 1 0 23 Tab. Nitroglycerin 0.5mg Saublingual. 1 0 24 Tab. Isosorbide Dinitrate 20mg. Sublingual. 1 0 
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Appendix 8: Service provision questionnaire for primary healthcare centres  
 The data items will be collected from each primary healthcare centre (PHCC) by interviewing the technical supervisor of each PHCC.   Indicators of process and structure Questions/data items Answers Sources/notes 
1. Is there a computer system in this centre?   Yes (1)   No (2)  
2. Is there a diabetes mini-clinic?    Yes (1) 
  No (2)  
3. Is there an appointment system for people with diabetes to be seen every 2-3 months?    Yes (1)   No (2) If yes, what is this system? 
4. Is there a well-being clinic   Yes (1) 
  No (2) Health promotion clinic 
5. Is there a trained physician for caring & educating patients with diabetes?   Yes (1)   No (2)  
6. Is there a trained nurse for caring & educating patients with diabetes?   Yes (1)   No (2)  
7. Is referral to hospital specialists available (referral system)?   Yes (1)   No (2)  
8. Is there a guideline explaining in details the referral system?   Yes (1)   No (2)  
9. Do you receive feedback from hospitals for each referred patient?   Yes (1)   No (2)  
10. Is there a specific form for feedback?   Yes (1)   No (2)  
11. Is there a system for identification of the records of diabetic patients?  E.g tagging records or using a disease index. 
  Yes (1) 
  No (2)  
12. Does each patient with diabetes have a diabetic records separated from the family records?   Yes (1)   No (2)  
13. Is there a system for diabetes data collection?   Yes (1)   No (2)  
14. Is there a computer programme and database for diabetes?   Yes (1)   No (2)  
15. Is there a system for defaulter follow-up?   Yes (1)   No (2)  
Primary care data collection Form (A structured interview) 
Part 1 
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  Questions/data items Answers Sources/notes 
16. Is there a treatment protocol you follow (Diabetes clinical practice guideline) for managing diabetes?  
  Yes (1) 
  No (2)  
17. Are there emergency protocols (e.g. hypoglycaemic attack, ketoacidosis)   Yes (1)   No (2)  
18. What are the routine investigations carried out for each diabetic patient follow-up visit?   
  Blood glucose test (1) 
  Urine dipstick test (2) 
  HbA1C (3) 
  Lipid profile (4) 
  Others , what?  
19. How long is the routine follow-up period?   Every month (1)   Every 2 months (2) 
  Every 3 months (3) 
  Every 3-6 months (4) 
Why you have chosen this period? 
20. How is the annual routine referral organized for patients with diabetes?   
21. How do you receive feedback from hospitals?   Direct from 2nd care (1) 
  By patients (2) 
  Other (3) 
 
22. Do diabetic patients receive : 
• Education programme   Yes (1) 
  No (2) If ‘yes’ when, how & for how long? 
• Leaflets   Yes (1) 
  No (2)  
• Diabetic cards   Yes (1) 
  No (2)  
23. Do you provide services for patients with diabetes at home?   Yes (1)   No (2)  
24. What services are provided for management of patients with complications? 
• Ischaemic heart disease     
• Cerebrovascular disease     
• Peripheral arterial disease    
• Retinopathy    
 
 
336 
 
• Nephropathy    
• Neuropathy    
25. Do you deliver any of the following services for patients with diabetes in 
your centre: 
• A programme for tight control of blood glucose and blood pressure for diabetic patients.     Yes (1)   No (2)  
• Retinopathy screening for all diabetic patients.   Yes (1)   No (2)  
• Foot screening for those at high risk.   Yes (1)   No (2)  
• Screening obese people for IGT    Yes (1) 
  No (2)  
• Multiple risk factor management programmes.   Yes (1)   No (2)  
• A structured patient self-care education programme    Yes (1)   No (2)  
• Reduction of obesity and physical inactivity in high-risk groups   Yes (1)   No (2)  
26. What educational programmes and campaigns for diabetes have been carried out in last two years in your centre? 
  
 Workforce profile Questions/data items Answers Sources/notes 
27. What is the number of each of the following workers in your centre: 
o Diabetologists   
o Family physicians   
o GPs   
o Trained (diabetic ) nurses   
o General nurses   
o Dieticians   
o Podiatrists   
o Lab technicians   
o Pharmacists   
o Others      
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 Lab facilities Questions/data items Answers Sources/notes 
28. What are the ways used to measure blood glucose level?   Laboratory facilities (1)   Glucometer (2) 
  Other (3) 
 
29. Is there access to the hospital laboratory for the following tests:   
• Renal function   Yes (1) 
  No (2)  
• Hb A1C   Yes (1) 
  No (2)  
• Glomerular filtration rate (GFR)   Yes (1)   No (2)  
• Lipids profile   Yes (1) 
  No (2)   PHCC’s statistics Questions/data items Answers Sources/notes 
30. What is the total number of the registered population in this centre?    
31. What is the total number of registered diabetic patients? (registered prevalence) 
  
32. What is the total number of newly diagnosed and registered diabetic patients last year? (Incidence) 
  
33. What is the average number of diabetic patients who are seen per day, month?   
34. What is the default rate for the last six months?   
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Appendix 9: Service provision questionnaire for secondary care  
 This form is for collecting data from the secondary level of diabetes healthcare. The Diabetologists who are responsible about the management of diabetes in hospitals, diabetes centres will be interviewed to answer these questions. National & local strategies for tackling diabetes 
Questions/data items Answers Sources/notes  1. Is there a national service framework for managing diabetes?   Yes (1)   No (2)  2. Is there a national diabetes management guideline?   Yes (1)   No (2)  3. Is there a national strategy for tackling diabetes?   Yes (1)   No (2)  4. Is there a local managed clinical network for diabetes management?   Yes (1)   No (2)  5. Is there a local diabetes care pathway?   Yes (1)   No (2)  6. Is there a national dietary guideline?    Yes (1)   No (2)  7. Is there a national physical activity guideline?   Yes (1)   No (2)   Local health burden Questions/data items Answers Sources/notes 8. How many diabetes related hospitalisations in last year?  
 Number of patients admitted last year because of diabetes or one of its complications 9. How many diabetes related emergency admissions?  
 Number of patients visited the emergency department last year because of diabetes as a primary diagnosis or one of its complications 10. How many amputation surgeries have been carried out in last year for patients with diabetes?  
  
 
Secondary care data collection Form 
 
Part 2 
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 Indicators of structure Questions/data items Answers Sources/notes 11. Is there a computer system in this hospital/diabetes centre?   Yes (1)   No (2) If yes, what they are used for? 12. Is there a specific diabetes clinic?    Yes (1)   No (2)  13. Is there an appointment system for the people with diabetes to be seen routinely every 2-3 months?  
  Yes (1) 
  No (2)  
14. What is the routine follow-up period?   Once a month (1)   Twice a month (2) 
  Three times a month (3) 
  Not applicable (4)   
 
15. Is there a well-being clinic?   Yes (1) 
  No (2)  16. Is there a foot care clinic?   Yes (1) 
  No (2)  17. Is there a diabetes register?    Yes (1) 
  No (2)  18. Does each diabetic patient have a specific diabetes records?   Yes (1)   No (2)  19. Are there trained nurses for educating patients with diabetes?   Yes (1)   No (2)  20. Is referral to specialist’s clinic available (referral system)?   Yes (1)   No (2)  21. Is there a guideline explaining in details the referral system?   Yes (1)   No (2)  22. Is there a specific form for referral to specialists?   Yes (1)   No (2)  23. Do you receive feedback from specialist’s clinic for each referred patient?   Yes (1)   No (2)  24. Is there a specific form for feedback?   Yes (1)   No (2)  25. Is there a system for identification of the records of patients with diabetes? E.g tagging records or using a disease index. 
  Yes (1) 
  No (2)  
26. Are education leaflets for patients with diabetes available?   Yes (1)   No (2)  
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 27. Are there diabetic identification cards available for patients in the hospital?   Yes (1)   No (2)  28. What are the anti-diabetic drugs available in your hospital? Please list:    
 
29. Is there a system for diabetes data collection?   Yes (1)   No (2)  30. Is there a computer programme and database for diabetes?   Yes (1)   No (2)  31. Is there a list for defaulters?   Yes (1) 
  No (2) If yes, what are the procedures of recalling patient who default? 
 Workforce profile Questions/data items Answers Sources/notes 32. What is the number of each of the following workers in your hospital:  
o Diabetologists   
o Family physicians   
o Trained (diabetic ) nurses   
o General nurses   
o Dieticians   
o Podiatrists   
o Lab technicians   
o Pharmacists   
o Others   
 Secondary care’s statistics Questions/data items Answers Sources/notes 33. What is the total number of registered patients with diabetes? (registered prevalence)   34. What is the total number of newly diagnosed and registered patients with diabetes in the last year? (Incidence)   35. What is the average number of patients with diabetes who are seen per day, month?  Estimate? 36. What is the default rate for the last six months? (missed appointments)     
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 Indicators of process Questions/data items Answers Sources/notes 37. Is there a treatment protocol you follow (Diabetes clinical practice guideline) for managing diabetes? 
  Yes (1) 
  No (2)  
38. Are there any emergency protocols for managing diabetes? (e.g. hypoglycaemic attack, ketoacidosis) 
  Yes (1) 
  No (2)  
39. What are the routine investigations carried out for each diabetic patient’s follow-up visit?   
  Blood glucose test (1) 
  Urine dipstick test (2) 
  HbA1C (3) 
  Lipid profile (4) 
List any others: 
40. How long is the routine follow-up period?   Every month   Every 2 months 
  Every 3 months 
  Every 3-6 months 
Why you have chosen this period? 
41. Do you have annual routine check-ups for patients with diabetes?   Yes (1)   No (2)  42. Is referral to specialist clinic available such as ophthalmologist, podiatrist?   Yes (1)   No (2)  43. How do you receive feedback from specialist clinics?   Direct from 2nd care (1)   By patients (2) 
  Other (3) 
 
44. Do diabetic patients receive :   
• Education programme   Yes (1) 
  No (2) If ‘yes’ when , how & for how long? 
• Leaflets   Yes (1) 
  No (2)  
• Diabetic cards   Yes (1) 
  No (2)  45. Do you provide services for diabetic patients at home?   Yes (1)   No (2)  46. What services are provided for management of patients with complications?  
  
• Ischaemic heart disease   
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• Cerebrovascular disease    
• Peripheral arterial disease   
• Retinopathy   
• Nephropathy   
• Neuropathy   47. Do you deliver any of the following services for diabetic patients in your hospital:   
• A programme for tight control of blood glucose and blood pressure for diabetic patients.     Yes (1)   No (2)  
• Retinopathy screening for all diabetic patients.   Yes (1)   No (2)  
• Foot screening for those at high risk.   Yes (1)   No (2)  
• Screening obese people for IGT    Yes (1) 
  No (2)  
• Multiple risk factor management programmes.   Yes (1)   No (2)  
• A structured patient self-care education programme    Yes (1)   No (2)  
• Reduction of obesity and physical inactivity in high-risk groups   Yes (1)   No (2)  48. What services are provided for pregnant women who either have pre-existing diabetes or have developed diabetes during pregnancy? 
  
49. What educational programmes and campaigns for diabetes have been carried out in last two years in your centre? 
    
Use the back of this page if you need more space 
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Appendix 10: Patient record data collection form, PHCC’s version 
 
 
The data items will be collected from each diabetic patient’s record at the (PHCCs). 
1. Patient’s data 
 Questions/data 
items 
Answers Questions/data 
items 
Answers 
A PHC centre’s 
name: 
................................... File No. :----------
-------- 
Today date: ----/----/1432 
Date of birth or 
age:  
dd/mm/yyyy Nationality :   Saudi (1) 
  Non Saudi (2) 
Gender:   Male (1) 
  Female (2) 
Date of diagnosis: 
(Date of registration) 
dd/mm/yyyy 
Occupation:   Retired (1) 
  Unemployed (2) 
  Employed (3) 
  Irregular work (4) 
What is/was the 
main job? 
.................................... 
Education:   Illiterate (1) 
  Read & write (2) 
  Secondary school level or lower (3) 
  University level (Bachelor) (4) 
  Postgraduate level (master or higher) (5) 
Smoking status: 
  Smoker (1) 
  X-smoker (2) 
  Non-smoker (3) 
Marital status:   Single (1) 
  Married (2) 
  Divorced (3) 
  Widowed (4) 
  Other (5) 
What is the type 
of diabetes 
  Type 1 (1) 
  Type 2 (2) 
  Gestational DM (3) 
  Other (4) 
B Last measured Height: -------    cm BMI:................... Last 3 measured FBS: 
(1): -----  (2):-----  (3):---- 
 
(During last 12 months) 
Last 3 measured Weight : 
(1): ----  (2):-----  (3):--- 
(During last 12 months) 
Last 3 measured BP: 
(1): --------    (2):--------    (3):------
-- 
 
(During last 12 months) 
C The patient is 
treated currently 
with: 
  Diet & exercise only (1) 
  Metformin (2) 
  Glibenclamide (3) 
  Glicalazide (4) 
  Insulin (5) 
  Aspirin (6) 
  ACE (7) 
  Statin (8) 
  ARBs (9) 
  Others (10) 
Number of follow-up visits 
during the last 3 months 
   ...........visits Number of follow-up 
visits during the last 6 
months 
...........visits 
Is there an annual referral 
during the last 12 months: 
  Yes (1) 
   No (2) 
Is there a hospital 
feedback for the last 
annual referral 
  Yes (1) 
   No (2) 
Date of the last annual referral: ----/----/------ Date of the last hospital feedback: ------/------
/------- 
Patient’s record data collection Form 
 
Part 1.1 
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The last 3 recorded grades of patient’s 
compliance. P-Poor    F-Fair    G-Good 
(During last 12 months) 
Diet:   (1): ---------      (2):-------     (3):------- 
Exercise: (1): --------- (2):-------     (3):------- 
Appointment:(1): ---------(2):-------(3):------- 
Drugs: (1): -------    (2):-------      (3):------- 
 
2. Diabetic record’s components 
Questions Answers Questions  Answers 
Does the patient’s record contain completed (filled in) sheet of the following: 
o Bio-data information 
sheet 
  Completed (1) 
  Partly completed 
(2) 
  Absent sheet (3) 
o Complication 
(problem ) 
sheet 
  Completed (1) 
  Partly completed 
(2) 
  Absent sheet (3) 
o Last annual referral 
checklist sheet  
o How many referral 
sheets? ......... 
  Completed (1) 
  Partly completed 
(2) 
  Absent sheet (3) 
o Last Diabetes 
follow-up 
chart 
  Completed (1) 
  Partly completed 
(2) 
  Absent sheet (3) 
o Last Feedback 
information from 
hospitals 
o How many 
feedbacks were 
received?.......... 
  Completed (1) 
  Partly completed 
(2) 
  Absent sheet (3) 
o Education 
checklist sheet 
 Any date 
 Any sheet 
  Completed (1) 
  Partly completed 
(2) 
  Absent sheet (3) 
 
3. Diabetes complications/comorbidities 
Questions/data items Answers Notes 
From the complication (problem) sheet or any other relevant papers, does the patient have any 
of the following complications:   
• Hypertension   Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
• Ischaemic heart disease 
 
  Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
• Cerebrovascular disease 
 
  Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
• Peripheral arterial 
disease 
  Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
• Retinopathy   Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
• Nephropathy   Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
• Neuropathy   Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
• Depression   Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
• Foot problems or 
amputations 
  Yes (1) 
   No (2) 
If yes, when diagnosed     mm/yyyy 
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4. Education checklist 
Questions/data items Answers Notes  
From the education checklist sheet, what are the items that have been explained for the patients? 
1.Explanation of diabetes   Yes (1) 
   No (2) 
 
2. Diabetic card supplied   Yes (1) 
   No (2) 
 
3. Explanation of anti-diabetic drugs:-   Yes (1) 
   No (2) 
  Equipment (1) 
  Technique (2) 
  Action (3) 
  Storage (4) 
4. Understanding hypoglycemia and other 
side effects. 
  Yes (1) 
   No (2) 
 
5. Understanding diet   Yes (1) 
   No (2) 
 
6. Seeking medical aid in illness (stress 
importance of never omitting insulin) 
  Yes (1) 
   No (2) 
 
7. Urinalysis (All the patients should have 
urine dipsticks at home). 
  Yes (1) 
   No (2) 
 
8. Care of feet   Yes (1) 
   No (2) 
 
9. Risk of smoking   Yes (1) 
   No (2) 
 
10. Exercise   Yes (1) 
   No (2) 
 
11. Home blood glucose measurement 
technique (only if the patient has 
glucometer). Selected patients from Type 
1 should be advised to buy a glucometer. 
  Yes (1) 
   No (2) 
 
12. Patients' home monitoring chart   Yes (1) 
   No (2) 
 
13. Special circumstances such as shift 
work, contraception, driving, travel, 
Glucagon and complications. 
  Yes (1) 
   No (2) 
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5. Annual screening for complications 
Questions/data items Answers Notes  (If yes...) 
From the most recent annual referral checklist sheet (hospital 
feedback), were the following examinations and investigations 
carried out and recorded? 
Date of the last annual referral checklist sheet 
(feedback):   ........./....../............ 
Blood pressure    Yes (1) 
   No (2) 
What was the reading of BP: ------/------ 
Cardiovascular system examination   Yes (1) 
   No (2) 
  Normal (1) 
  Abnormal (2) 
Neuro-examination including (sensory, 
motor and reflexes)  
  Yes (all) (1) 
  Yes (some) (2) 
  No (all) (3) 
  Normal (1) 
  Abnormal (2) 
Eye examination  including (visual acuity, 
cataract, fundus examination) 
  Yes (all) (1) 
  Yes (some) (2) 
  No (all) (3) 
  Normal (1) 
  Abnormal (2) 
Foot examination including pulses   Yes (all) (1) 
  Yes (some) (2) 
  No (all) (3) 
  Normal (1) 
  Abnormal (2) 
Injection sites examination   Yes (1) 
   No (2) 
  Normal (1) 
  Abnormal (2) 
Smoking status   Yes (1) 
   No (2) 
 
HbA1C   Yes (1) 
   No (2) 
What was the reading of HbA1C: -------- 
Creatinine   Yes (1) 
   No (2) 
What was the reading of: Creatinine: ------------
- 
Cholesterol   Yes (1) 
   No (2) 
What was the reading of: Cholesterol: ----------
--- 
Triglycerides   Yes (1) 
   No (2) 
What was the reading of: Triglycerides: --------
----- 
Urine dipstick   Yes (1) 
   No (2) 
If yes, what was the reading of: Urine dipstick: 
------------ 
24 hours urine protein   Yes (1) 
   No (2) 
What was the reading of: Proteinuria:------------
--- 
Chest x-ray   Yes (1) 
   No (2) 
  Normal (1) 
  Abnormal (2) 
ECG   Yes (1) 
   No (2) 
  Normal (1) 
  Abnormal (2) 
Blood glucose   Yes (1) 
   No (2) 
If yes, what was the reading of: 
FBS:------                  RBS:------- 
Other!   Yes (1) 
   No (2) 
Other recorded tests but not mentioned here!  
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Appendix 11: Patient record data collection form, ADC version 
 
The data items will be collected from each diabetic patient’s record at the (Diabetes centre). 
1. Patient’s data 
Questions/data items Answers Questions/data items Answers 
Centre’s name: ........................... File No. :------------- Today date: ----/--
--/1432 
Date of birth or age:  dd/mm/yyyy Nationality :   Saudi (1) 
  Non Saudi (2) 
Gender:   Male (1) 
  Female (2) 
Date of registration: 
dd/mm/yyyy 
Date of 
diagnosis: 
dd/mm/yyyy 
Occupation:   Retired (1) 
  Unemployed (2) 
  Employed (3) 
  Irregular work (4) 
  Student (5) 
What is/was the 
main job? 
.............................
..... 
Referred from: 
...........................
......... 
The patient is treated 
currently with: 
  Diet & exercise only (1) 
  Metformin (2) 
  Glibenclamide (3) 
  Glicalazide (4) 
  Insulin (5) 
  Aspirin (6)       □ 
Others (11) 
  ACE (7) 
  Statin (8) 
  ARBs (9) 
  Insulin pump (10) 
Past Medical Hx: 
  HPN(1) 
  IHD(2) 
  MI(3) 
  Obesity(4) 
  CVA(5) 
  Dyslipidaemia(6) 
  PVD(7) 
  DKA(8) 
  Uncontrolled DM(9) 
  Hypoglycemia(10) 
Smoking status: 
  Smoker (1) 
  X-smoker (2) 
  Non-smoker (3) 
What is the type of 
diabetes: 
  Type 1 (1) 
  Type 2 (2) 
  Gestational DM (3) 
  Other (4) 
Last 3 measured 
FBS: 
(1): -------   
(2):--------   
(3):-------- 
(During last 12 
months) 
Last measured Height:  ------------    cm BMI:................... Injection site: 
  Normal(1) 
  Hypertrophy(2) 
  Atrophy(3) 
Last 3 measured Weight : 
(1): ---------        (2):----------        (3):--------- 
(During last 12 months) 
Last 3 measured BP: 
  (1): --------           (2):--------         (3):-------- 
(During last 12 months) 
Number of follow-up visits 
during the last 3 months 
  .........visits Number of follow-up visits 
during the last 6 months 
.......visits 
Number of follow-up visits during the last 12 months .............visits 
 
Patient’s record data collection Form  
 
Part 1.2 
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2. Diabetic record’s components 
Questions Answers Questions  Answers 
Does the patient’s record contain (filled in) sheet of the following: 
bio-data 
information sheet 
(patient’s record) 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Complication 
(problem ) sheet 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Progress note 
form 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Last Diabetes 
follow-up sheet 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Diabetic eye file  
All 3 sheets 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Diabetes 
Education 
programme 
Any date 
Any sheet 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Diabetic foot 
registry 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Diabetic foot 
clinic progress 
sheet 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Nursing diabetic 
assessment 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
Diet plan 
assessment 
  Completed (1) 
  Partly completed (2) 
  Absent sheet (3) 
 
3. Diabetes complications/comorbidities 
Questions/data items Answers Notes 
From the complication (problem) sheet or any other relevant papers, does the patient have any 
of the following complications:   
• Hypertension (HTN)   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Ischaemic heart disease (IHD) 
 
  Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Cerebrovascular disease 
(CVA) 
 
  Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Peripheral arterial disease   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Retinopathy   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Nephropathy   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Neuropathy   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Depression   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Foot problems or amputations   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
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• MI   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Dyslipidaemia   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
• Obesity   Yes (1) 
   No (2) 
If yes, when diagnosed     
mm/yyyy 
 
4. Education checklist 
Questions/data items Answers Notes  
From the education checklist sheet, what are the items that have been explained for the 
patients? 
1. What is diabetes?    Yes (1) 
   No (2) 
 
2. How to prevent & treat symptoms of 
hypoglycaemia & hyperglycemia 
  Yes (1) 
   No (2) 
 
3. Diabetic card supplied (available)   Yes (1) 
   No (2) 
 
4. Explanation of what is insulin?   Yes (1) 
   No (2) 
 
5. Diet explanation (Understanding diet)   Yes (1) 
   No (2) 
 
6. Exercise   Yes (1) 
   No (2) 
 
7. Explanation of oral hypoglycaemic 
(anti-diabetic drugs):- 
  Yes (1) 
   No (2) 
 
8. Self monitoring   Yes (1) 
   No (2) 
 
9. Special issues & circumstances such as 
Ramadan, hajj, parties, travelling.. 
  Yes (1) 
   No (2) 
 
10. Complications    Yes (1) 
   No (2) 
 
11. Bad habits (behaviours) smoking, 
overeating.. 
  Yes (1) 
   No (2) 
 
12. Hygiene: foot care, eye care, other 
hygiene 
  Yes (1) 
   No (2) 
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5. Annual screening for complications 
Questions/data items Answers Notes  (If yes...) 
From the last patient’s records or (progress notes of the last visit), were 
the following examinations and investigations carried out and recorded? 
Date of the last visit:........./....../............ 
Blood pressure    Yes (1) 
   No (2) 
What was the reading of BP: ------/------ 
Cardiovascular system examination   Yes (1) 
   No (2) 
  Normal (1) 
  Abnormal (2) 
Neuro-examination including (sensory, motor 
and reflexes)  
  Yes (all) (1) 
  Yes (some) (2) 
  No (all) (3) 
  Normal (1) 
  Abnormal (2) 
Eye examination  including (visual acuity, 
cataract, fundus examination) 
  Yes (all) (1) 
  Yes (some) (2) 
  No (all) (3) 
  Normal (1) 
  Abnormal (2) 
Foot examination including pulses   Yes (all) (1) 
  Yes (some) (2) 
  No (all) (3) 
  Normal (1) 
  Abnormal (2) 
Injection sites examination   Yes (1) 
   No (2) 
  Normal (1) 
  Abnormal (2) 
Smoking status   Yes (1) 
   No (2) 
 
HbA1C   Yes (1) 
   No (2) 
What was the reading of HbA1C: -------
- 
Creatinine   Yes (1) 
   No (2) 
What was the reading of: Creatinine: ---
---------- 
Cholesterol   Yes (1) 
   No (2) 
What was the reading of: 
 Cholesterol: ------------- 
Triglycerides   Yes (1) 
   No (2) 
What was the reading of: Triglycerides: 
------------- 
Urine dipstick   Yes (1) 
   No (2) 
If yes, what was the reading of: Urine 
dipstick: ------------ 
24 hours urine protein   Yes (1) 
   No (2) 
What was the reading of:  
Proteinuria:--------------- 
Chest x-ray   Yes (1) 
   No (2) 
  Normal (1) 
  Abnormal (2) 
ECG   Yes (1) 
   No (2) 
  Normal (1) 
  Abnormal (2) 
Blood glucose   Yes (1) 
   No (2) 
If yes, what was the reading of: 
FBS:------                  RBS:------- 
Other!   Yes (1) 
   No (2) 
Other recorded tests but not mentioned 
here!   
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اﻟﻣﻣﻠﻛﺔ اﻟﻌرﺑﯾﺔ اﻟﺳﻌودﯾﺔ و ﻛﯾﻔﯾﺔ ﺗﺣﺳﯾن  ﻓﻲ داء اﻟﺳﻛري ﻟﻣﺷﻛﻠﺔ اﻟﺗﺻدي ﻓﻲ ﻣﮭﺗم أﻧﺎ .أﺑﮭﺎ ﻓﻲ ﻣدﯾﻧﺔ وﻋن ﺧدﻣﺎت اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻣرض اﻟﺳﻛري اﻟذﯾن ﯾﻌﺎﻧون ﻣن اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻸﺷﺧﺎص إﻟﯾك ﻋن أرﯾد أن أﺗﺣدث
ھذا اﻟﻠﻘﺎء ﻟﻠﺑﺣث ﻓﻲ دورك اﻟﺧﺎص ﻓﻲ  ﯾﮭدف .ﻋﻠﻰ ﻧﺣو أﻓﺿل رﺿﻰ اﻟﺳﻛريﻣ ﺻﺣﺔ ﻣن ﺷﺄﻧﮭﺎ أن ﺗﺟﻌل واﻟﺗﻲ ﻟدﯾك أﻓﻛﺎر أي ﻋن أﺳﻣﻊ أرﯾد أن .ﻣرض اﻟﺳﻛري اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻸﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣن
 .أﻛﺑر ﻗدر ﻣن اﻟﻣﻌﻠوﻣﺎت إﻋطﺎء ﯾرﺟﻰ .ﻣرض اﻟﺳﻛري اﻷﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣن ﻟﺗﻠﺑﻲ ﺑطرﯾﻘﺔ أﻓﺿل إﺣﺗﯾﺎﺟﺎت ﺗﺳﺗﺷﻌر إﻣﻛﺎﻧﯾﺔ  ﺗﻐﯾﯾر اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ  وﻛﯾف ﻟدﯾﻧﺎ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﺧدﻣﺎت ﺗﺣﺳﯾن
 snoitseuq pu mraW
   ?setebaid evah uoy tuo dnif uoy did woH .1
  ﻛﯾف اﻛﺗﺷﻔت أو ﻋرﻓت أﻧك ﻣﺻﺎب ﺑﺎﻟﺳﻛري؟
 ﺑﺎﻟﺼﺪﻓﺔ  ecnahc yB )1(  
  ﻣﻦ ﺧﻼل أﻋﺮاض اﻟﺴﻜﺮي   smotpmys setebaid yB )2(  
  ﺑﻮاﺳﻄﺔ اﻟﺘﺸﺨﯿﺺ اﻟﻤﺒﻜﺮ    gnineercs yB )3(  
  ﺑﺴﺒﺐ ظﮭﻮر ﻣﻀﺎﻋﻔﺎت اﻟﺴﻜﺮي   snoitacilpmoc setebaid yB )4(  
 ............................... أﺧﺮى ﺣﺪد      yficepS  ?rehtO )5(  
 
 
 oN □ seY □  ?snoitacilpmoc setebaid yna evah uoy did ,sisongaid fo emit eht tA .2
 ﻋﻧدﻣﺎ أﻛد اﻷطﺑﺎء أﻧك ﻣﺻﺎب ﺑﺎﻟﺳﻛري ھل ﻛﻧت ﺗﻌﺎﻧﻲ ﻣن أي ﻣﺿﺎﻋﻔﺎت ﻟﻠﺳﻛري؟ 
 ﻻ□                   ﻧﻌﻢ□          
 
  setebaid htiw stneitap rof eludehcs weivretni derutcurts-imeS
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Perception of health needs 
3. What are the health needs 
that you currently need but 
have not been currently met 
for you?  
 ﻲﺗﻟا ﺔﯾﺣﺻﻟا تﺎﺟﺎﯾﺗﺣﻻا ﻲھ ﺎﻣ
؟كﻟ ﺎھرﯾﻓوﺗ مﺗﯾ مﻟ نﻛﻟ ًﺎﯾﻟﺎﺣ ﺎﮭﺟﺎﺗﺣﺗ 
4. Could you please rank from 1-5 (1 being the highest 
priority) what you think are the top five needs for your 
health?  (in terms of urgency, the seriousness of the 
need that the intervention may resolve) 
 ﻲﻐﺑﻧﯾ جﺎﯾﺗﺣا مھﺄﺑ ًأدﺑ تﺎﺟﺎﯾﺗﺣﻻا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
  اذﻛھو ﮫﯾﻠﯾ يذﻟا مﺛ كﺗﺣﺻﻟ ﺔﺑﺳﻧﻟﺎﺑ مﺎﻣﺗھﻻاو  ﺔﯾوﻟوﻷا ﺎھؤﺎطﻋإ نﻛﻣﯾ ؟
 جﺎﯾﺗﺣﻻا مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ذﺧﻷا ,ئرﺎط وھ لھ , هرﯾﺛﺄﺗو ﮫﺗروطﺧ ىدﻣ ,
  ﮫﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ.... 
5. From your point of 
view, what solutions 
could be implemented 
to meet these needs?   
كرظﻧ ﺔﮭﺟو نﻣ : لوﻠﺣﻟا ﻲھ ﺎﻣ
 هذھ دﺳﻟ ذﻔﻧﺗ نأ نﻛﻣﯾ ﻲﺗﻟا
 ؟تﺎﺟﺎﯾﺗﺣﻻا 
6. What are the differences these 
solutions will make? 
 هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
؟كرظﻧ ﺔﮭﺟو نﻣ لوﻠﺣﻟا 
Health Needs Need Priority                          جﺎﯾﺗﺣﻻا ﺔﯾوﻟوأ  Solutions                     لوﻠﺣﻟا رﯾﺛﺄﺗﻟاو قرﻔﻟا Difference made               
                              
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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Perception of healthcare needs 
7.What problems 
(difficulties) have you 
encountered during the 
management of your 
diabetes in the primary 
healthcare centre?  
 
 لﻛﺎﺷﻣﻟا ﻲھ ﺎﻣ)تﺎﺑوﻌﺻﻟا ( ﻲﺗﻟا
 ضرﻣﻟ كﺗﻌﺑﺎﺗﻣ ءﺎﻧﺛأ ﺎﮭﺗﮭﺟاو
 يرﻛﺳﻟا ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا زﻛرﻣﺑ
؟ﺔﯾﻟوﻷا 
8. Could you please rank from 1-5 (1 being the highest 
priority) what you think are the top five healthcare 
problems affecting your diabetes? (in terms of urgency, 
the seriousness of the problem that the intervention may 
resolve) 
 ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا ﻰﻠﻋ رﺛؤﺗ ﻲﺗﻟا  لﻛﺎﺷﻣﻟا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
 ﻲﺗﻟا مﺛ مﺎﻣﺗھﻻاو  ﺔﯾوﻟوﻷا ﺎھؤﺎطﻋإ ﻲﻐﺑﻧﯾ ﺔﻠﻛﺷﻣ مھﺄﺑ ًأدﺑ  كﯾدﻟ يرﻛﺳﻟا ضرﻣﻟ
مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ذﺧﻷا نﻛﻣﯾ ؟  اذﻛھو ﺎﮭﯾﻠﺗ  ﺔﻠﻛﺷﻣﻟا ,ﺔﺋرﺎط ﻲھ لھ , ىدﻣ
 رﻛﺳﻟا ﻰﺿرﻣ ﻰﻠﻋ ﺎھرﯾﺛﺄﺗو ﺎﮭﺗروطﺧ ,  ﺎﮭﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ.... 
9. From your point of 
view, what solutions are 
needed for these 
problems?   
 نﻣ ﺔﯾرورﺿﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
  ؟لﻛﺎﺷﻣﻟا هذﮭﻟ كرظﻧ ﺔﮭﺟو 
10. What are the differences 
these solutions will make? 
 هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
؟كرظﻧ ﺔﮭﺟو نﻣ لوﻠﺣﻟا 
Healthcare (problems)  Problem Priority                  لﻛﺎﺷﻣﻟا ﺔﯾوﻟوأ  Solutions                   لوﻠﺣﻟا قرﻔﻟاو رﯾﺛﺄﺗﻟا Difference made               
            
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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11. What problems 
(difficulties) have you 
encountered during the 
management of your 
diabetes in the hospitals & 
diabetes centres?  
 
 لﻛﺎﺷﻣﻟا ﻲھ ﺎﻣ)تﺎﺑوﻌﺻﻟا ( ﻲﺗﻟا
 ضرﻣﻟ كﺗﻌﺑﺎﺗﻣ ءﺎﻧﺛأ ﺎﮭﺗﮭﺟاو
 يرﻛﺳﻟاﺎﯾﻔﺷﺗﺳﻣﻟﺎﺑ زﻛارﻣو ت
؟يرﻛﺳﻟا 
12. Could you please rank from 1-5 (1 being the highest 
priority) what you think are the top five of these healthcare 
problems (difficulties) affecting your diabetes? (in terms of 
urgency, the seriousness of the problem that the 
intervention may resolve) 
 ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا ﻰﻠﻋ رﺛؤﺗ ﻲﺗﻟا  لﻛﺎﺷﻣﻟا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
 مﺛ مﺎﻣﺗھﻻاو  ﺔﯾوﻟوﻷا ﺎھؤﺎطﻋإ ﻲﻐﺑﻧﯾ ﺔﻠﻛﺷﻣ مھﺄﺑ ًأدﺑ  كﯾدﻟ يرﻛﺳﻟا ضرﻣﻟ
 ﺔﻠﻛﺷﻣﻟا مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ذﺧﻷا نﻛﻣﯾ ؟  اذﻛھو ﺎﮭﯾﻠﺗ ﻲﺗﻟا ,ﺔﺋرﺎط ﻲھ لھ ,
ﻰﺿرﻣ ﻰﻠﻋ ﺎھرﯾﺛﺄﺗو ﺎﮭﺗروطﺧ ىدﻣ  رﻛﺳﻟا ,  ﺎﮭﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ.... 
13. From your point of 
view, what solutions are 
needed for these 
problems?   
 ﺔﮭﺟو نﻣ ﺔﯾرورﺿﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
  ؟لﻛﺎﺷﻣﻟا هذﮭﻟ كرظﻧ 
14. What are the differences these 
solutions will make? 
 لوﻠﺣﻟا هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
نﻣ ؟كرظﻧ ﺔﮭﺟو 
Healthcare (problems) 
تﺎﺑوﻌﺻﻟا 
Problem Priority                      لﻛﺎﺷﻣﻟا ﺔﯾوﻟوأ  Solutions                 لوﻠﺣﻟا قرﻔﻟاو رﯾﺛﺄﺗﻟا Difference made                
           
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
 
 
 
 
355 
Perception of diabetes healthcare services 
 
15. What are the other primary healthcare services you think people with diabetes need to be available in each primary health care centre and currently are not 
available in your primary health care centre? E.g making appointment system, specific lab facilities, specific drugs, specific clinics... 
ﻼﺛﻣ ؟ﻲﺣﺻﻟا كزﻛرﻣ ﻲﻓ ًﺎﯾﻟﺎﺣ ةرﻓوﺗﻣ رﯾﻏ ﻲھو ﻲﺣﺻ زﻛرﻣ لﻛ ﻲﻓ ﺎھرﻓوﺗ نوﺟﺎﺗﺣﯾ رﻛﺳﻟا ﻰﺿرﻣ نأ دﻘﺗﻌﺗ ﻲﺗﻟا ﺔﯾﻟوﻷا ﺔﯾﺣﺻﻟا تﺎﻣدﺧﻟا ﻲھ ﺎﻣﺔﻧﯾﻌﻣ ﺞﻣارﺑ ،ﺔﻧﯾﻌﻣ ﺔﯾودأ ،ﺔﻧﯾﻌﻣ ﺔﯾرﺑﺗﺧﻣ تﺎﻣدﺧ ،دﯾﻋاوﻣ مﺎظﻧ ...  
1................................................................................................................................................................................................. 
2................................................................................................................................................................................................. 
3................................................................................................................................................................................................ 
4................................................................................................................................................................................................ 
5................................................................................................................................................................................................ 
16. What are the current primary healthcare services you think needs to be improved or changed? What are your suggestions to improve these services?  E.g 
making appointment system, mini-clinics for diabetes, more clinics for dietician or podiatrists ... 
 ؟ﮫﺣرﺗﻘﺗ يذﻟا رﯾﯾﻐﺗﻟا وا رﯾوطﺗﻟا عوﻧ وھ ﺎﻣو ؟رﯾﯾﻐﺗ وأ رﯾوطﺗ جﺎﺗﺣﺗ ﺎﮭﻧا دﻘﺗﻌﺗو ًﺎﯾﻟﺎﺣ ةرﻓوﺗﻣﻟا ﺔﯾﻟوﻷا ﺔﯾﺣﺻﻟا تﺎﻣدﺧﻟا ﻲھ ﺎﻣ  ﻲﺋﺎﺻﺧا وأ ﺔﯾذﻐﺗ ﻲﺋﺎﺻﺧا ﻊﻣ ﺔﺻﺻﺧﺗﻣ تادﺎﯾﻋ ،ﺔﻧﯾﻌﻣ ﺔﯾودأ ،ﺔﻧﯾﻌﻣ ﺔﯾرﺑﺧﻣ تﺎﻣدﺧ ﻼﺛﻣ
مدﻗ..  
رﯾﯾﻐﺗﻟا وأ رﯾوطﺗﻟا عوﻧ  Needed improvements                    تﺎﻣدﺧﻟا Services                                        
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Patient’s demographic details  
Questions/data items Answers Questions/data items Answers 
Healthcare centre’s name: 
............................................ 
  Primary level (1) 
  Secondary level (2) 
Gender:   Male (1) 
  Female (2) 
Do you have a diabetes identification 
card? 
  (1) Yes  if yes                    □ Completed (3) 
  (2) No                                □ Partly completed (4) 
Nationality :   Saudi (1) 
  Non Saudi (2) 
Age or date of birth: 
......../........./............ 
  (1) Youths (aged 15 – 24) 
  (2) Adults (aged 25 – 44) 
  (3) Middle aged (aged 45 – 64)  
  (4) Older People (aged 65+) 
Occupation:  
What is/was your main job? 
............................................. 
  Retired (1) 
  Unemployed (2) 
  Employed (3) 
  Irregular work (4) 
17. From your perspective, what are the barriers of improving health care for people with diabetes? 
  ؟يرﻛﺳﻟا ﻰﺿرﻣﻟ ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا رﯾوطﺗ ﻖﺋاوﻋ ﻲھ ﺎﻣ كرظﻧ ﺔﮭﺟو نﻣ 
1. 
2. 
3. 
4. 
5. 
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Education:   Illiterate (1) 
  Read & write (2) 
  Secondary school level or lower (3) 
  University level (Bachelor) (4) 
  Postgraduate level (master or higher) (5) 
When first diagnosed  (date) or 
............/................./................. 
How long have you had diabetes?  
 
Smoking status: 
  Smoker (1) 
  X-smoker (2) 
  Non-smoker (3) 
What is the type of diabetes you 
have? 
  Type 1 (1) 
  Type 2 (2) 
  Gestational DM (3) 
  Other! Specify................... (4) 
What is the type of treatment you are 
currently on: 
  Diet & exercise only (1) 
  Oral anti-diabetic drugs (2)  
  Insulin (3) 
 Who prepares syringe?  ........... 
 Who administers insulin?........ 
Type of accommodation: 
  Owned (4) 
  Rented (5) 
  Old traditional house (1) 
  Modern house (2) 
  Flat (3) 
Do you suffer from any of the following?  
Check all that apply: 
  Ischemic heart disease (1) 
  Cerebrovascular disease (2) 
  Peripheral arterial disease (3) 
  Retinopathy (4) 
  Nephropathy (5) 
  Neuropathy (6) 
  Depression (7) 
  Foot problems or amputations (8) 
Are you Living alone?   Yes (1) 
  With my wife/husband only (2)  
  With my wife/husband & children(3) 
  With my Family including children (4) 
  With my Family as a child (5) 
  With my brother & his family (6) 
  With my sons and their families (7) 
Do you have a glucometer?   Yes (1) 
  No (2) 
• Check up the notes taken with the patient, check up after you have written the notes: ‘What I have written down is… Have I noted that down OK, or do you want to change something? 
• Allows the interviewee to (re)consider what has been said while you write and expand the answers 
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ﺗﺣﺳﯾن  ﻛﯾﻔﯾﺔاﻟﻣﻣﻠﻛﺔ اﻟﻌرﺑﯾﺔ اﻟﺳﻌودﯾﺔ و  ﻓﻲ داء اﻟﺳﻛري ﻣﺷﻛﻠﺔﻟ اﻟﺗﺻدي ﻓﻲ ﻣﮭﺗم أﻧﺎ .أﺑﮭﺎ ﻓﻲ ﻣدﯾﻧﺔ ﺧدﻣﺎت اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔوﻋن  ﻣرض اﻟﺳﻛري ﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣناﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻸ إﻟﯾك ﻋن أرﯾد أن أﺗﺣدث
ھذا اﻟﻠﻘﺎء ﻟﻠﺑﺣث ﻓﻲ دورك اﻟﺧﺎص ﻓﻲ  ﯾﮭدف .ﻋﻠﻰ ﻧﺣو أﻓﺿل ﻣرﺿﻰ اﻟﺳﻛري ﺻﺣﺔ ﻣن ﺷﺄﻧﮭﺎ أن ﺗﺟﻌل واﻟﺗﻲ ﻟدﯾك أﻓﻛﺎر أي ﻋن أﺳﻣﻊ أرﯾد أن .ﻣرض اﻟﺳﻛري ﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣناﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻸ
 .أﻛﺑر ﻗدر ﻣن اﻟﻣﻌﻠوﻣﺎت إﻋطﺎء ﯾرﺟﻰ .ﻣرض اﻟﺳﻛري اﻷﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣن أﻓﺿل إﺣﺗﯾﺎﺟﺎتﺗﻠﺑﻲ ﺑطرﯾﻘﺔ ﻟ ﺗﺳﺗﺷﻌر إﻣﻛﺎﻧﯾﺔ  ﺗﻐﯾﯾر اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ  وﻛﯾف ﻟدﯾﻧﺎ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﺧدﻣﺎت ﺗﺣﺳﯾن
 noitseuq pu mraW
 deificeps eb ot deen seitilibisnopser dna selor kniht uoy oD  ?setebaid htiw elpoep ot erachtlaeh gnidivorp ni seitilibisnopser dna elor ruoy si tahW .1
 oN □ seY □ ?dezinagro dna
 ﻻ□ﻧﻌم  □   ار واﻟﻣﺳؤوﻟﯾﺎت ﺗﺣﺗﺎج ﻟﺗﺣدﯾد وﺗﻧظﯾم؟ھل ﺗﻌﺗﻘد أن اﻷدو ﻣﺎ ھو دورك وﻣﺳؤوﻟﯾﺎﺗك ﻓﻲ ﺗﻘدﯾم اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري؟
 elor noitatilibaheRدور ﺗﺄھﯿﻠﻲ   
 elor noitacudEدور ﺗﺜﻘﯿﻔﻲ   
 ?rehtOأﺧﺮى   
 elor evitneverPدور وﻗﺎﺋﻲ   
  elor noitartsinimdA  دور إداري  
 elor gnitaerTدور ﻋﻼﺟﻲ   
 elor gniraCدور ﻋﻨﺎﯾﺔ   
 
 smelborp htlaeh lanoitan fo noitpecreP
  ?level lanoitan eht ta htlaeh no tcapmi tsom evah smelborp hcihW ?smelborp htlaeh tnelaverp tsom eht era tahW .2
 اﻻﻛﺛر ﺗﺄﺛﯾرا ًﻋﻠﻰ اﻟﺻﺣﺔ ﻋﻠﻰ اﻟﻣﺳﺗوى اﻟوطﻧﻲ ؟ ﻣﺎھﻲ اﻟﻣﺷﺎﻛل اﻟﺻﺣﯾﺔ اﻻﻛﺛر اﻧﺗﺷﺎرا ًو  
 
 slanoisseforp erachtlaeH rof eludehcs weivretni derutcurts-imeS
 2 traP
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Perception of health needs 
3. What are the health 
needs that have not been 
currently met for patients 
with diabetes?  
 مﻟ ﻲﺗﻟا ﺔﯾﺣﺻﻟا تﺎﺟﺎﯾﺗﺣﻻا ﻲھ ﺎﻣ
 ﺎھرﯾﻓوﺗ وأ ﺎﮭﺗﯾطﻐﺗ ًﺎﯾﻟﺎﺣ مﺗﯾ
؟يرﻛﺳﻟا ﻰﺿرﻣﻟ 
4. Could you please rank from 1-5 (1 being the highest priority) what you 
think are the top five needs for health of people with diabetes? (in 
terms of urgency, the number of people affected, the seriousness of the 
need that the intervention may resolve) 
 ﺎھؤﺎطﻋإ ﻲﻐﺑﻧﯾ جﺎﯾﺗﺣا مھﺄﺑ ًأدﺑ تﺎﺟﺎﯾﺗﺣﻻا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
 ؟  اذﻛھو ﮫﯾﻠﯾ يذﻟا مﺛ مﺎﻣﺗھﻻاو  ﺔﯾوﻟوﻷا جﺎﯾﺗﺣﻻا مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ذﺧﻷا نﻛﻣﯾ ,
ئرﺎط وھ لھ , هرﯾﺛﺄﺗو ﮫﺗروطﺧ ىدﻣ ,  ﮫﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ.... 
5. From your point of view, 
what solutions could be 
implemented to meet 
these needs?   
كرظﻧ ﺔﮭﺟو نﻣ : ﻲﺗﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
  ؟تﺎﺟﺎﯾﺗﺣﻻا هذھ دﺳﻟ ذﻔﻧﺗ نأ نﻛﻣﯾ 
6. What are the differences these 
solutions will make? 
 لوﻠﺣﻟا هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
؟كرظﻧ ﺔﮭﺟو نﻣ 
Health Needs Need Priority                جﺎﯾﺗﺣﻻا ﺔﯾوﻟوأ  Solutions                     لوﻠﺣﻟا رﯾﺛﺄﺗﻟاو قرﻔﻟا Difference made               
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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Perception of healthcare needs 
7. What problems (difficulties) have you 
encountered during the management of 
patients with diabetes in the primary 
healthcare centre?  
 
Does the healthcare system face any problems 
in terms of management of patients with 
diabetes? 
 ﻰﺿرﻣﻟ كﺗﺟﻟﺎﻌﻣ ءﺎﻧﺛأ ﺎﮭﺗﮭﺟاو ﻲﺗﻟا لﻛﺎﺷﻣﻟا ﻲھ ﺎﻣ
 مﺎظﻧﻟا ﮫﺟاوﯾ لھ ؟ﺔﯾﻟوﻷا ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟﺎﺑ يرﻛﺳﻟا
؟رﻛﺳﻟا ﻰﺿرﻣ ﺔﯾﺎﻋرﺑ ﻖﻠﻌﺗﯾ ﺎﻣﯾﻓ لﻛﺎﺷﻣ يأ ﻲﺣﺻﻟا 
8. Could you please rank from 1-5 (1 being the highest 
priority) what you think are the top five healthcare 
problems affecting healthcare of patients with 
diabetes? (in terms of urgency, the seriousness of the 
problem that the intervention may resolve) 
 رﺛؤﺗ ﻲﺗﻟا  لﻛﺎﺷﻣﻟا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
 ﺔﻠﻛﺷﻣ مھﺄﺑ ًأدﺑ  يرﻛﺳﻟا ضرﻣﻟ ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا ﻰﻠﻋ
ﯾوﻟوﻷا ﺎھؤﺎطﻋإ ﻲﻐﺑﻧﯾ ؟  اذﻛھو ﺎﮭﯾﻠﺗ ﻲﺗﻟا مﺛ مﺎﻣﺗھﻻاو  ﺔ
 ﺔﻠﻛﺷﻣﻟا مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ذﺧﻷا نﻛﻣﯾ ,ﺔﺋرﺎط ﻲھ لھ ,
 رﻛﺳﻟا ﻰﺿرﻣ ﻰﻠﻋ ﺎھرﯾﺛﺄﺗو ﺎﮭﺗروطﺧ ىدﻣ , دﺟوﯾ لھ
  ﺎﮭﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ.... 
9. From your point of 
view, what solutions 
are needed for these 
problems?   
 نﻣ ﺔﯾرورﺿﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
ﺟو  ؟لﻛﺎﺷﻣﻟا هذﮭﻟ كرظﻧ ﺔﮭ 
10. What are the 
differences these 
solutions will make? 
 لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
؟كرظﻧ ﺔﮭﺟو نﻣ لوﻠﺣﻟا هذھ 
Healthcare (problems)  Problem Priority                  لﻛﺎﺷﻣﻟا ﺔﯾوﻟوأ  Solutions                  ﺣﻟا لوﻠ  قرﻔﻟاو رﯾﺛﺄﺗﻟا Difference 
made                           
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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11. What problems (difficulties) have 
you encountered during the 
management of patients with 
diabetes in the hospitals & diabetes 
centres?  
 
 لﻛﺎﺷﻣﻟا ﻲھ ﺎﻣ)تﺎﺑوﻌﺻﻟا ( ءﺎﻧﺛأ ﺎﮭﺗﮭﺟاو ﻲﺗﻟا
 يرﻛﺳﻟا ﻰﺿرﻣﻟ كﺗﻌﺑﺎﺗﻣ زﻛارﻣو تﺎﯾﻔﺷﺗﺳﻣﻟﺎﺑ
؟يرﻛﺳﻟا 
12. Could you please rank from 1-5 (1 being the highest priority) 
what you think are the top five healthcare problems affecting 
healthcare of patients with diabetes? (in terms of urgency, the 
seriousness of the problem that the intervention may resolve) 
 ﺔﯾﺎﻋرﻟا ﻰﻠﻋ رﺛؤﺗ ﻲﺗﻟا  لﻛﺎﺷﻣﻟا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
  ﺔﯾوﻟوﻷا ﺎھؤﺎطﻋإ ﻲﻐﺑﻧﯾ ﺔﻠﻛﺷﻣ مھﺄﺑ ًأدﺑ  يرﻛﺳﻟا ضرﻣﻟ ﺔﯾﺣﺻﻟا
ﺑ ذﺧﻷا نﻛﻣﯾ ؟  اذﻛھو ﺎﮭﯾﻠﺗ ﻲﺗﻟا مﺛ مﺎﻣﺗھﻻاو مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌ
 ﺔﻠﻛﺷﻣﻟا ,ﺔﺋرﺎط ﻲھ لھ , رﻛﺳﻟا ﻰﺿرﻣ ﻰﻠﻋ ﺎھرﯾﺛﺄﺗو ﺎﮭﺗروطﺧ ىدﻣ
 ,  ﺎﮭﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ.... 
13. From your point of 
view, what solutions 
are needed for these 
problems?   
 نﻣ ﺔﯾرورﺿﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
  ؟لﻛﺎﺷﻣﻟا هذﮭﻟ كرظﻧ ﺔﮭﺟو 
14. What are the 
differences these 
solutions will make? 
 لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
؟كرظﻧ ﺔﮭﺟو نﻣ لوﻠﺣﻟا هذھ 
Healthcare (problems) تﺎﺑوﻌﺻﻟا Problem Priority                      لﻛﺎﺷﻣﻟا ﺔﯾوﻟوأ  Solutions                 لوﻠﺣﻟا قرﻔﻟاو رﯾﺛﺄﺗﻟا Difference 
made                           
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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15. Please specify if there are any population groups with diabetes whose health needs are not being currently met? Please tell us who they are and 
why: e.g. an entire ethnic group?   
 ً ﺎﯾﻟﺎﺣ ﺎﮭﺗﯾطﻐﺗ مﺗﯾ مﻟ ﺔﯾﺣﺻﻟا مﮭﺗﺎﺟﺎﯾﺗﺣا رﺧآ ﻰﻧﻌﻣﺑ وا ﺔﯾﺣﺻﻟا ﺔﯾﺎﻧﻌﻠﻟ ﺔﺟﺎﺣﻟا سﻣﺄﺑ مھ رﻛﺳﻟا ﻰﺿرﻣ نﻣ ﺔﻧﯾﻌﻣ ﺔﻋوﻣﺟﻣ ددﺣﺗ نا نﻛﻣﯾ لھ  رﯾﻏ ،ﺔﻧﯾﻌﻣ ﺔﯾﻗرﻋ ﺔﻋوﻣﺟﻣ لﺎﺛﻣﻟا لﯾﺑﺳ ﻰﻠﻋ ؟دﯾﺟ لﻛﺷﺑ
ةروﺎﺟﻣﻟا ىرﻘﻟا لھا ،نﯾﯾدوﻌﺳﻟا .........؟ اذﺎﻣﻟ ﺢﺿوﺗ نا نﻛﻣﯾ لھ كﻟذﻛ  
 
 
Perception of diabetes healthcare services 
 
16. From your point of view, how important is prevention in preventing diabetes in Saudi Arabia? 
؟ ﺔﻛﻠﻣﻣﻟا ﻲﻓ يرﻛﺳﻟا ضرﻣ ثودﺣ ﻊﻧﻣ ﻲﻓ ﺔﯾﺎﻗوﻟا ﺔﯾﻣھأ ﺎﻣ كرظﻧ ﺔﮭﺟو نﻣ 
 
 
 □ مﻠﻋأ ﻻ) (Don’t Know 
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17. From your point of view, how important is early diagnosis of diabetes by the screening programme in preventing diabetes?  
  ؟ مدﻟا ﻲﻓ يرﻛﺳﻠﻟ يرودﻟا صﺣﻔﻟا لﻼﺧ نﻣ يرﻛﺳﻟا ضرﻣﻟ رﻛﺑﻣﻟا صﯾﺧﺷﺗﻟا ﺔﯾﻣھأ ﺎﻣ كرظﻧ ﺔﮭﺟو نﻣ 
 
 
□  مﻠﻋأ ﻻ) (Don’t Know 
18. From your point of view, how important is preventing diabetes complications in patients with diabetes?  
  ؟ يرﻛﺳﻟا ضرﻣ ىدﻟ يرﻛﺳﻟا ضرﻣ تﺎﻔﻋﺎﺿﻣ نﻣ دﺣﻟا ﺔﯾﻣھأ ﺎﻣ كرظﻧ ﺔﮭﺟو نﻣ 
 
 
□  مﻠﻋأ ﻻ) (Don’t Know 
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19. What are the barriers for high risk groups to participate and utilize the available preventive services?   
ﻣدﺧﻟا هذھ لﺛﻣ نﻣ ةدﺎﻔﺗﺳﻻاو ﺔﻛرﺎﺷﻣﻠﻟ يرﻛﺳﻟا ضرﻣﺑ ﺔﺑﺎﺻﻻا ﺔﯾﻟﺎﻣﺗﺣا نﻣ ﺔﯾﻟﺎﻋ ةروطﺧ ﺔﺟرد ﻰﻠﻋ نﯾذﻟا كﺋﻟوأ ﻊﻧﻣﺗ ﻲﺗﻟا ﻖﺋاوﻌﻟا ﻲھ ﺎﻣ ؟تﺎ  
 
20. What are the other primary healthcare services you think people with diabetes need to be available in each primary health care centre and currently 
are not available? E.g making appointment system, specific lab facilities, specific drugs, specific clinics... 
ً؟ﺎﯾﻟﺎﺣ ةرﻓوﺗﻣ رﯾﻏ ﻲھو ﻲﺣﺻ زﻛرﻣ لﻛ ﻲﻓ ﺎھرﻓوﺗ نوﺟﺎﺗﺣﯾ رﻛﺳﻟا ﻰﺿرﻣ نأ دﻘﺗﻌﺗ ﻲﺗﻟا ىرﺧﻷا ﺔﯾﻟوﻷا ﺔﯾﺣﺻﻟا تﺎﻣدﺧﻟا ﻲھ ﺎﻣ  ﺞﻣارﺑ ،ﺔﻧﯾﻌﻣ ﺔﯾودأ ،ﺔﻧﯾﻌﻣ ﺔﯾرﺑﺧﻣ تﺎﻣدﺧ ﻼﺛﻣ
ﺔﻧﯾﻌﻣ...  
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  ?secivres eseht evorpmi ot snoitseggus ruoy era tahW ?degnahc ro devorpmi eb ot sdeen kniht uoy secivres erachtlaeh yramirp tnerruc eht era tahW .12
 ... stsirtaidop ro naiciteid rof scinilc erom ,setebaid rof scinilc-inim ,metsys tnemtnioppa gnikam g.E
ﻼ ﺧدﻣﺎت ﻣﺧﺑرﯾﺔ ﻣﻌﯾﻧﺔ، أدوﯾﺔ ﻣﻌﯾﻧﺔ، ﻋﯾﺎدات ﻣﺎ ھﻲ اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ اﻷوﻟﯾﺔ اﻟﻣﺗوﻓرة ﺣﺎﻟﯾﺎ ًوﺗﻌﺗﻘد اﻧﮭﺎ ﺗﺣﺗﺎج ﺗطوﯾر أو ﺗﻐﯾﯾر؟ وﻣﺎ ھو ﻧوع اﻟﺗطوﯾر او اﻟﺗﻐﯾﯾر اﻟذي ﺗﻘﺗرﺣﮫ؟  ﻣﺛ
  ..ﻣﺗﺧﺻﺻﺔ ﻣﻊ اﺧﺻﺎﺋﻲ ﺗﻐذﯾﺔ أو اﺧﺻﺎﺋﻲ ﻗدم
                                                                                    secivreS اﻟﺧدﻣﺎت                                                     stnemevorpmi dedeeN  ﻧوع اﻟﺗطوﯾر أو اﻟﺗﻐﯾﯾر
  
  ?metsys larrefer eht rof srotatilicaf dna )sreirrab( selcatsbo eht era tahW .22
ﻋﻣﻠﯾﺔ ﺳﯾر ﻧظﺎم اﻹﺣﺎﻟﺔ ﺑﺷﻛل ﺟﯾد؟          ﻛﯾف ﯾﻌﻣل ﻧظﺎم اﻻﺣﺎﻟﺔ واﻟﺗﻐذﯾﺔ اﻻرﺟﺎﻋﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري ؟ ﻣﺎ اﻟﻌواﻣل اﻟﺗﻲ ﺗﺳﮭل ﻋﻣﻠﯾﺔ ﺳﯾر ھذا اﻟﻧظﺎم؟  وﻣﺎ ھﻲ اﻟﻌواﺋﻖ اﻟﺗﻲ ﺗﻌﯾﻖ   
                        
 srotcaF gnitatilicaFرة   اﻟﻌواﻣل اﻟﻣﯾﺳ selcatsbOاﻟﻌواﺋﻖ      
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 ?stnemevorpmi ecivres ot segnellahc dna sreirrab eht era tahw ,evitcepsrep ruoy morF .32
                         ﻣن وﺟﮭﺔ ﻧظرك ﻣﺎ ھﻲ اﻟﺗﺣدﯾﺎت اﻟﺗﻲ ﺗﻘف أﻣﺎم ﺗﻧﻔﯾذ ھذه اﻻﻗﺗراﺣﺎت واﻟﺗطورات ﻟﻠرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري؟                         
 
 seugaelloc ruoy dna uoy secivres eht era woH :sey fI    oN □ seY □ ?edivorp uoy secivres erachtlaeh eht rof metsys gnitidua suounitnoc a ereht sI .42
     oN □ seY □ ?detidua eb dluohs secivres htlaeh eht kniht uoy od ,on fI ?detidua edivorp
ھل ھﻧﺎك ﺗﻘﯾﯾم وﻣراﺟﻌﺔ ﻣﺳﺗﻣرة ﻟﻠﺧدﻣﺎت اﻟﺻﺣﯾﺔ اﻟﺗﻲ ﺗﻘدﻣوﻧﮭﺎ؟ □ ﻧﻌم  □ﻻ  ﻓﻲ ﺣﺎل اﻹﺟﺎﺑﺔ ﺑﻧﻌم ﻛﯾف ﯾﺗم ﺗﻘﯾﯾم وﻣراﺟﻌﺔ اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ اﻟﺗﻲ ﺗﻘدﻣوﻧﮭﺎ؟ إذا ﻛﺎﻧت اﻟﺧدﻣﺎت ﻻ ﺗُﻘَﯾم ﻓﮭل ﺗﻌﺗﻘد اﻧﮫ 
 ﯾﺟب ﺗﻘﯾﯾم ﻣدى ﺟودة اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ ﻣن اﺟل ﺗﺣدﯾد ﺳﺑل ﺗطوﯾرھﺎ ﺑﺷﻛل ﻣﺳﺗﻣر؟ □ ﻧﻌم  □ﻻ 
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Professional’s details  
Questions/data items Answers Notes  
Healthcare centre’s name: 
............................................................. 
  Primary level 
  Secondary level 
 
Age or date of birth:    Youth (aged < 24) 
  Adults (aged 25 – 64)   
  Older People (aged 65+) 
 
Gender:   Male  
  Female 
 
Nationality :   Saudi  
  Non Saudi 
 
What is your current occupation and 
specialty: 
 Work period/day: □ 0-5 hours    □ 6-10 hours    □ >10 hours 
Have you received any training on the 
management of diabetes? 
  Yes.. if yes specify.... 
  No  
 
Would you like to attend training courses 
on healthcare of people with diabetes? 
  Yes.. if yes specify....  
  No  
 
• Check up the notes taken with the interviewee, check up after you have written the notes: ‘What I have written down is… Have I noted that down OK, or do you want to change 
something?  Allows the interviewee to (re)consider what has been said while you write and expand the answers 
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 sreganam erachtlaeh rof eludehcs weivretni derutcurts-imeS :41 xidneppA
 
 
 elbmaerP
ﺷﺧﺎص ﺗﺣﺳﯾن اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻸ ﻛﯾﻔﯾﺔاﻟﻣﻣﻠﻛﺔ اﻟﻌرﺑﯾﺔ اﻟﺳﻌودﯾﺔ و  ﻓﻲ داء اﻟﺳﻛري ﻣﺷﻛﻠﺔﻟ اﻟﺗﺻدي ﻓﻲ ﻣﮭﺗم أﻧﺎ .أﺑﮭﺎ ﻓﻲ ﻣدﯾﻧﺔ ﺧدﻣﺎت اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔوﻋن  ﻣرض اﻟﺳﻛري ﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣناﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻸ إﻟﯾك ﻋن أرﯾد أن أﺗﺣدث
ﺗﺳﺗﺷﻌر إﻣﻛﺎﻧﯾﺔ  ﺗﻐﯾﯾر  وﻛﯾف ﻟدﯾﻧﺎ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﺧدﻣﺎت ھذا اﻟﻠﻘﺎء ﻟﻠﺑﺣث ﻓﻲ دورك اﻟﺧﺎص ﻓﻲ ﺗﺣﺳﯾن ﯾﮭدف .ﻋﻠﻰ ﻧﺣو أﻓﺿل ﻣرﺿﻰ اﻟﺳﻛري ﺻﺣﺔ ﻣن ﺷﺄﻧﮭﺎ أن ﺗﺟﻌل واﻟﺗﻲ ﻟدﯾك أﻓﻛﺎر أي ﻋن أﺳﻣﻊ أرﯾد أن .رض اﻟﺳﻛريﻣ اﻟذﯾن ﯾﻌﺎﻧون ﻣن
 .أﻛﺑر ﻗدر ﻣن اﻟﻣﻌﻠوﻣﺎت إﻋطﺎء ﯾرﺟﻰ .ﻣرض اﻟﺳﻛري ﻣن اﻷﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون أﻓﺿل إﺣﺗﯾﺎﺟﺎتﺗﻠﺑﻲ ﺑطرﯾﻘﺔ ﻟ اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ 
 noitseuq pu mraW
 deificeps eb ot deen seitilibisnopser dna selor kniht uoy oD  ?setebaid htiw elpoep ot erachtlaeh gnidivorp ni seitilibisnopser dna elor ruoy si tahW .1
 oN □ seY □ ?dezinagro dna
 ﻻ□ﻧﻌم  □   ھل ﺗﻌﺗﻘد أن اﻷدوار واﻟﻣﺳؤوﻟﯾﺎت ﺗﺣﺗﺎج ﻟﺗﺣدﯾد وﺗﻧظﯾم؟ ﺳؤوﻟﯾﺎﺗك ﻓﻲ ﺗﻘدﯾم اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري؟ﻣﺎ ھو دورك وﻣ
 elor noitatilibaheRدور ﺗﺄھﯿﻠﻲ   
 elor noitacudEدور ﺗﺜﻘﯿﻔﻲ   
 ?rehtOأﺧﺮى   
 elor evitneverPدور وﻗﺎﺋﻲ   
  elor noitartsinimdA  دور إداري  
 elor gnitaerTدور ﻋﻼﺟﻲ   
 elor gniraCدور ﻋﻨﺎﯾﺔ   
 
 smelborp htlaeh lanoitan fo noitpecreP
  ?level lanoitan eht ta htlaeh no tcapmi tsom evah smelborp hcihW ?smelborp htlaeh tnelaverp tsom eht era tahW .2
 ﺗوى اﻟوطﻧﻲ ؟اﻷﻛﺛر ﺗﺄﺛﯾرا ًﻋﻠﻰ اﻟﺻﺣﺔ ﻋﻠﻰ اﻟﻣﺳ ﻣﺎ ھﻲ اﻟﻣﺷﺎﻛل اﻟﺻﺣﯾﺔ اﻷﻛﺛر اﻧﺗﺷﺎرا ًو  
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Perception of health needs 
3. What are the health 
needs that have not been 
currently met for patients 
with diabetes?  
 مﻟ ﻲﺗﻟا ﺔﯾﺣﺻﻟا تﺎﺟﺎﯾﺗﺣﻻا ﻲھ ﺎﻣ
 ﺎھرﯾﻓوﺗ وأ ﺎﮭﺗﯾطﻐﺗ ًﺎﯾﻟﺎﺣ مﺗﯾ
؟يرﻛﺳﻟا ﻰﺿرﻣﻟ 
4. Could you please rank from 1-5 (1 being the highest priority) what you 
think are the top five needs for health of people with diabetes? (in 
terms of urgency, the number of people affected, the seriousness of 
the need that the intervention may resolve) 
ھﺄﺑ ًأدﺑ تﺎﺟﺎﯾﺗﺣﻻا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ ﺎھؤﺎطﻋإ ﻲﻐﺑﻧﯾ جﺎﯾﺗﺣا م
 جﺎﯾﺗﺣﻻا مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ذﺧﻷا نﻛﻣﯾ ؟  اذﻛھو ﮫﯾﻠﯾ يذﻟا مﺛ مﺎﻣﺗھﻻاو  ﺔﯾوﻟوﻷا
 ,ئرﺎط وھ لھ , هرﯾﺛﺄﺗو ﮫﺗروطﺧ ىدﻣ ,  ﮫﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ.... 
5. From your point of view, 
what solutions could be 
implemented to meet 
these needs?   
ﺟو نﻣكرظﻧ ﺔﮭ : ﻲﺗﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
  ؟تﺎﺟﺎﯾﺗﺣﻻا هذھ دﺳﻟ ذﻔﻧﺗ نأ نﻛﻣﯾ 
6. What are the differences these 
solutions will make? 
 لوﻠﺣﻟا هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
؟كرظﻧ ﺔﮭﺟو نﻣ 
Health Needs Need Priority                جﺎﯾﺗﺣﻻا ﺔﯾوﻟوأ  Solutions                     لوﻠﺣﻟا رﯾﺛﺄﺗﻟاو قرﻔﻟا Difference made               
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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Perception of healthcare needs 
7. What problems (difficulties) have you 
encountered during the management 
of patients with diabetes in the 
primary healthcare centre?  
 
Does the healthcare system face any 
problems in terms of management of 
patients with diabetes? 
 كﺗﺟﻟﺎﻌﻣ ءﺎﻧﺛأ ﺎﮭﺗﮭﺟاو ﻲﺗﻟا لﻛﺎﺷﻣﻟا ﻲھ ﺎﻣ
 لھ ؟ﺔﯾﻟوﻷا ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟﺎﺑ يرﻛﺳﻟا ﻰﺿرﻣﻟ
ﻖﻠﻌﺗﯾ ﺎﻣﯾﻓ لﻛﺎﺷﻣ يأ ﻲﺣﺻﻟا مﺎظﻧﻟا ﮫﺟاوﯾ 
؟رﻛﺳﻟا ﻰﺿرﻣ ﺔﯾﺎﻋرﺑ 
8. Could you please rank from 1-5 (1 being the highest 
priority) what you think are the top five healthcare 
problems affecting healthcare of patients with diabetes? (in 
terms of urgency, the seriousness of the problem that the 
intervention may resolve) 
 ﻰﻠﻋ رﺛؤﺗ ﻲﺗﻟا  لﻛﺎﺷﻣﻟا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
 ﻲﻐﺑﻧﯾ ﺔﻠﻛﺷﻣ مھﺄﺑ ًأدﺑ  يرﻛﺳﻟا ضرﻣﻟ ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا
 ذﺧﻷا نﻛﻣﯾ ؟  اذﻛھو ﺎﮭﯾﻠﺗ ﻲﺗﻟا مﺛ مﺎﻣﺗھﻻاو  ﺔﯾوﻟوﻷا ﺎھؤﺎطﻋإ
 ﺔﻠﻛﺷﻣﻟا مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ,ﺔﺋرﺎط ﻲھ لھ , ﺎﮭﺗروطﺧ ىدﻣ
ﻟا ﻰﺿرﻣ ﻰﻠﻋ ﺎھرﯾﺛﺄﺗو رﻛﺳ ,  ﺎﮭﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ.... 
9. From your point of 
view, what solutions 
are needed for these 
problems?   
 نﻣ ﺔﯾرورﺿﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
  ؟لﻛﺎﺷﻣﻟا هذﮭﻟ كرظﻧ ﺔﮭﺟو 
10. What are the 
differences these 
solutions will make? 
 هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
ﺟو نﻣ لوﻠﺣﻟا؟كرظﻧ ﺔﮭ 
Healthcare (problems)  Problem Priority                  لﻛﺎﺷﻣﻟا ﺔﯾوﻟوأ  Solutions                   لوﻠﺣﻟا قرﻔﻟاو رﯾﺛﺄﺗﻟا Difference made 
                          
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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11. What problems (difficulties) 
have you encountered during the 
management of patients with 
diabetes in the hospitals & 
diabetes centres?  
 
 لﻛﺎﺷﻣﻟا ﻲھ ﺎﻣ)تﺎﺑوﻌﺻﻟا ( ﺎﮭﺗﮭﺟاو ﻲﺗﻟا
 يرﻛﺳﻟا ﻰﺿرﻣﻟ كﺗﻌﺑﺎﺗﻣ ءﺎﻧﺛأ تﺎﯾﻔﺷﺗﺳﻣﻟﺎﺑ
؟يرﻛﺳﻟا زﻛارﻣو 
12. Could you please rank from 1-5 (1 being the highest priority) 
what you think are the top five healthcare problems affecting 
healthcare of patients with diabetes? (in terms of urgency, the 
seriousness of the problem that the intervention may resolve) 
 هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ ﺔﯾﺎﻋرﻟا ﻰﻠﻋ رﺛؤﺗ ﻲﺗﻟا  لﻛﺎﺷﻣﻟا
  ﺔﯾوﻟوﻷا ﺎھؤﺎطﻋإ ﻲﻐﺑﻧﯾ ﺔﻠﻛﺷﻣ مھﺄﺑ ًأدﺑ  يرﻛﺳﻟا ضرﻣﻟ ﺔﯾﺣﺻﻟا
 مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ذﺧﻷا نﻛﻣﯾ ؟  اذﻛھو ﺎﮭﯾﻠﺗ ﻲﺗﻟا مﺛ مﺎﻣﺗھﻻاو
 ﺔﻠﻛﺷﻣﻟا ,ﺔﺋرﺎط ﻲھ لھ , رﻛﺳﻟا ﻰﺿرﻣ ﻰﻠﻋ ﺎھرﯾﺛﺄﺗو ﺎﮭﺗروطﺧ ىدﻣ ,
  ﺎﮭﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ.... 
13. From your point of 
view, what solutions 
are needed for these 
problems?   
 نﻣ ﺔﯾرورﺿﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
  ؟لﻛﺎﺷﻣﻟا هذﮭﻟ كرظﻧ ﺔﮭﺟو 
14. What are the differences 
these solutions will make? 
 هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
؟كرظﻧ ﺔﮭﺟو نﻣ لوﻠﺣﻟا 
Healthcare (problems) تﺎﺑوﻌﺻﻟا Problem Priority                      لﻛﺎﺷﻣﻟا ﺔﯾوﻟوأ  Solutions                 لوﻠﺣﻟا قرﻔﻟاو رﯾﺛﺄﺗﻟا Difference made    
                       
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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15. Please specify if there are any population groups with diabetes whose health needs are not being currently met? Please tell us who they are and 
why: e.g. an entire ethnic group?   
ﯾطﻐﺗ مﺗﯾ مﻟ ﺔﯾﺣﺻﻟا مﮭﺗﺎﺟﺎﯾﺗﺣا رﺧآ ﻰﻧﻌﻣﺑ وأ ﺔﯾﺣﺻﻟا ﺔﯾﺎﻧﻌﻠﻟ ﺔﺟﺎﺣﻟا سﻣﺄﺑ مھ رﻛﺳﻟا ﻰﺿرﻣ نﻣ ﺔﻧﯾﻌﻣ ﺔﻋوﻣﺟﻣ ددﺣﺗ نأ نﻛﻣﯾ لھ رﯾﻏ ،ﺔﻧﯾﻌﻣ ﺔﯾﻗرﻋ ﺔﻋوﻣﺟﻣ لﺎﺛﻣﻟا لﯾﺑﺳ ﻰﻠﻋ ؟دﯾﺟ لﻛﺷﺑ ًﺎﯾﻟﺎﺣ ﺎﮭﺗ
ةروﺎﺟﻣﻟا ىرﻘﻟا لھأ ،نﯾﯾدوﻌﺳﻟا .........؟ اذﺎﻣﻟ ﺢﺿوﺗ نأ نﻛﻣﯾ لھ كﻟذﻛ  
 
 
 
 
Perception of diabetes healthcare services 
16. From your point of view, how important is prevention in preventing diabetes in Saudi Arabia? 
؟ ﺔﻛﻠﻣﻣﻟا ﻲﻓ يرﻛﺳﻟا ضرﻣ ثودﺣ ﻊﻧﻣ ﻲﻓ ﺔﯾﺎﻗوﻟا ﺔﯾﻣھأ ﺎﻣ كرظﻧ ﺔﮭﺟو نﻣ 
 
 
□  مﻠﻋأ ﻻ) (Don’t Know 
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17. From your point of view, how important is early diagnosis of diabetes by the screening programme in preventing diabetes?  
  ﺔﯾﻣھأ ﺎﻣ كرظﻧ ﺔﮭﺟو نﻣ ؟ مدﻟا ﻲﻓ يرﻛﺳﻠﻟ يرودﻟا صﺣﻔﻟا لﻼﺧ نﻣ يرﻛﺳﻟا ضرﻣﻟ رﻛﺑﻣﻟا صﯾﺧﺷﺗﻟا 
 
□  مﻠﻋأ ﻻ) (Don’t Know 
18. From your point of view, how important is preventing diabetes complications in patients with diabetes?  
  رﻣ ىدﻟ يرﻛﺳﻟا ضرﻣ تﺎﻔﻋﺎﺿﻣ نﻣ دﺣﻟا ﺔﯾﻣھأ ﺎﻣ كرظﻧ ﺔﮭﺟو نﻣ؟ يرﻛﺳﻟا ض 
 
□  مﻠﻋأ ﻻ) (Don’t Know 
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19. What are the barriers for high risk groups to participate and utilize the available preventive services?   
 ةدﺎﻔﺗﺳﻻاو ﺔﻛرﺎﺷﻣﻠﻟ يرﻛﺳﻟا ضرﻣﺑ ﺔﺑﺎﺻﻹا ﺔﯾﻟﺎﻣﺗﺣا نﻣ ﺔﯾﻟﺎﻋ ةروطﺧ ﺔﺟرد ﻰﻠﻋ نﯾذﻟا كﺋﻟوأ ﻊﻧﻣﺗ ﻲﺗﻟا ﻖﺋاوﻌﻟا ﻲھ ﺎﻣ ؟تﺎﻣدﺧﻟا هذھ لﺛﻣ نﻣ  
 
20. What are the other primary healthcare services you think people with diabetes need to be available in each primary health care centre and currently 
are not available? E.g making appointment system, specific lab facilities, specific drugs, specific clinics... 
 تﺎﻣدﺧ ﻼﺛﻣ ً؟ﺎﯾﻟﺎﺣ ةرﻓوﺗﻣ رﯾﻏ ﻲھو ﻲﺣﺻ زﻛرﻣ لﻛ ﻲﻓ ﺎھرﻓوﺗ نوﺟﺎﺗﺣﯾ رﻛﺳﻟا ﻰﺿرﻣ نأ دﻘﺗﻌﺗ ﻲﺗﻟا ىرﺧﻷا ﺔﯾﻟوﻷا ﺔﯾﺣﺻﻟا تﺎﻣدﺧﻟا ﻲھ ﺎﻣ ﺞﻣارﺑ ،ﺔﻧﯾﻌﻣ ﺔﯾودأ ،ﺔﻧﯾﻌﻣ ﺔﯾرﺑﺧﻣ
ﺔﻧﯾﻌﻣ...  
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  ?secivres eseht evorpmi ot snoitseggus ruoy era tahW ?degnahc ro devorpmi eb ot sdeen kniht uoy secivres erachtlaeh yramirp tnerruc eht era tahW .12
 ... stsirtaidop ro naiciteid rof scinilc erom ,setebaid rof scinilc-inim ,metsys tnemtnioppa gnikam g.E
ﺗطوﯾر أو ﺗﻐﯾﯾر؟ وﻣﺎ ھو ﻧوع اﻟﺗطوﯾر أو اﻟﺗﻐﯾﯾر اﻟذي ﺗﻘﺗرﺣﮫ؟  ﻣﺛﻼ ﺧدﻣﺎت ﻣﺧﺑرﯾﺔ ﻣﻌﯾﻧﺔ، أدوﯾﺔ ﻣﻌﯾﻧﺔ، ﻋﯾﺎدات ﻣﺎ ھﻲ اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ اﻷوﻟﯾﺔ اﻟﻣﺗوﻓرة ﺣﺎﻟﯾﺎ ًوﺗﻌﺗﻘد أﻧﮭﺎ ﺗﺣﺗﺎج 
  ..ﻣﺗﺧﺻﺻﺔ ﻣﻊ أﺧﺻﺎﺋﻲ ﺗﻐذﯾﺔ أو أﺧﺻﺎﺋﻲ ﻗدم
                                                                                    secivreS اﻟﺧدﻣﺎت                                                     stnemevorpmi dedeeN  ﻧوع اﻟﺗطوﯾر أو اﻟﺗﻐﯾﯾر
  
  ?metsys larrefer eht rof srotatilicaf dna )sreirrab( selcatsbo eht era tahW .22
ھذا اﻟﻧظﺎم؟  وﻣﺎ ھﻲ اﻟﻌواﺋﻖ اﻟﺗﻲ ﺗﻌﯾﻖ ﻋﻣﻠﯾﺔ ﺳﯾر ﻧظﺎم اﻹﺣﺎﻟﺔ ﺑﺷﻛل ﺟﯾد؟          ﻛﯾف ﯾﻌﻣل ﻧظﺎم اﻹﺣﺎﻟﺔ واﻟﺗﻐذﯾﺔ اﻻرﺗﺟﺎﻋﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري ؟ ﻣﺎ اﻟﻌواﻣل اﻟﺗﻲ ﺗﺳﮭل ﻋﻣﻠﯾﺔ ﺳﯾر  
            
 srotcaF gnitatilicaFاﻟﻌواﻣل اﻟﻣﯾﺳرة    selcatsbOاﻟﻌواﺋﻖ      
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 ?tnemevorpmi secivres ot segnellahc dna sreirrab eht era tahw ,evitcepsrep ruoy morF .32
               رك ﻣﺎ ھﻲ اﻟﺗﺣدﯾﺎت اﻟﺗﻲ ﺗﻘف أﻣﺎم ﺗﻧﻔﯾذ ھذه اﻻﻗﺗراﺣﺎت واﻟﺗطورات ﻟﻠرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري؟                                  ﻣن وﺟﮭﺔ ﻧظ 
 
 seugaelloc ruoy dna uoy secivres eht era woH :sey fI    oN □ seY □ ?edivorp uoy secivres erachtlaeh eht rof metsys gnitidua suounitnoc a ereht sI .42
     oN □ seY □ ?detidua eb dluohs secivres htlaeh eht kniht uoy od ,on fI ?detidua edivorp
ھل ھﻧﺎك ﺗﻘﯾﯾم وﻣراﺟﻌﺔ ﻣﺳﺗﻣرة ﻟﻠﺧدﻣﺎت اﻟﺻﺣﯾﺔ اﻟﺗﻲ ﺗﻘدﻣوﻧﮭﺎ؟ □ ﻧﻌم  □ﻻ  ﻓﻲ ﺣﺎل اﻹﺟﺎﺑﺔ ﺑﻧﻌم ﻛﯾف ﯾﺗم ﺗﻘﯾﯾم وﻣراﺟﻌﺔ اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ اﻟﺗﻲ ﺗﻘدﻣوﻧﮭﺎ؟ إذا ﻛﺎﻧت اﻟﺧدﻣﺎت ﻻ ﺗُﻘَﯾم ﻓﮭل ﺗﻌﺗﻘد اﻧﮫ 
 ﯾﺟب ﺗﻘﯾﯾم ﻣدى ﺟودة اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ ﻣن اﺟل ﺗﺣدﯾد ﺳﺑل ﺗطوﯾرھﺎ ﺑﺷﻛل ﻣﺳﺗﻣر؟ □ ﻧﻌم  □ﻻ 
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Manager’s details  
Questions/data items Answers Notes  
Healthcare centre’s name: 
............................................................. 
  Primary level 
  Secondary level 
 
Age or date of birth:    Youth (aged < 24) 
  Adults (aged 25 – 64)   
  Older People (aged 65+) 
 
Gender:   Male  
  Female 
 
Nationality :   Saudi  
  Non Saudi 
 
What is your current occupation and 
specialty: 
 Work period/day: □ 0-5 hours    □ 6-10 hours    □ >10 hours 
Have you received any training on the 
management of diabetes? 
  Yes.. if yes specify.... 
  No  
 
Would you like to attend training courses 
on healthcare of people with diabetes? 
  Yes.. if yes specify....  
  No  
 
• Check up the notes taken with the interviewee, check up after you have written the notes: ‘What I have written down is… Have I noted that down OK, or do you want to change something? 
• Allows the interviewee to (re)consider what has been said while you write and expand the answers. 
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 elbmaerP
ﺗﺣﺳﯾن  ﻛﯾﻔﯾﺔاﻟﻣﻣﻠﻛﺔ اﻟﻌرﺑﯾﺔ اﻟﺳﻌودﯾﺔ و  ﻓﻲ داء اﻟﺳﻛري ﻣﺷﻛﻠﺔﻟ اﻟﺗﺻدي ﻓﻲ ﻣﮭﺗم أﻧﺎ .أﺑﮭﺎ ﻓﻲ ﻣدﯾﻧﺔ ﺧدﻣﺎت اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔوﻋن  ﻣرض اﻟﺳﻛري ﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣناﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻸ إﻟﯾك ﻋن أرﯾد أن أﺗﺣدث
ھذا اﻟﻠﻘﺎء ﻟﻠﺑﺣث ﻓﻲ دورك اﻟﺧﺎص ﻓﻲ  ﯾﮭدف .ﻋﻠﻰ ﻧﺣو أﻓﺿل ﻣرﺿﻰ اﻟﺳﻛري ﺻﺣﺔ ﻣن ﺷﺄﻧﮭﺎ أن ﺗﺟﻌل واﻟﺗﻲ ﻟدﯾك أﻓﻛﺎر أي ﻋن ﻊأﺳﻣ أرﯾد أن .ﻣرض اﻟﺳﻛري ﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣناﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻸ
 .أﻛﺑر ﻗدر ﻣن اﻟﻣﻌﻠوﻣﺎت ﻋطﺎءإ ﯾرﺟﻰ .ﻣرض اﻟﺳﻛري اﻷﺷﺧﺎص اﻟذﯾن ﯾﻌﺎﻧون ﻣن أﻓﺿل إﺣﺗﯾﺎﺟﺎتﺗﻠﺑﻲ ﺑطرﯾﻘﺔ ﻟ ﺗﺳﺗﺷﻌر إﻣﻛﺎﻧﯾﺔ  ﺗﻐﯾﯾر اﻟﺧدﻣﺎت اﻟﺻﺣﯾﺔ  وﻛﯾف ﻟدﯾﻧﺎ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﺧدﻣﺎت ﺗﺣﺳﯾن
 noitseuq pu mraW
 deificeps eb ot deen seitilibisnopser dna selor kniht uoy oD  ?setebaid htiw elpoep ot erachtlaeh gnidivorp ni seitilibisnopser dna elor ruoy si tahW .1
 oN □ seY □ ?dezinagro dna
 ﻻ□ﻧﻌم  □   ھل ﺗﻌﺗﻘد أن اﻷدوار واﻟﻣﺳؤوﻟﯾﺎت ﺗﺣﺗﺎج ﻟﺗﺣدﯾد وﺗﻧظﯾم؟ ﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري؟ﻣﺎ ھو دورك وﻣﺳؤوﻟﯾﺎﺗك ﻓﻲ ﺗﻘدﯾم اﻟرﻋ
 elor evitneverPدور وﻗﺎﺋﻲ   
  elor noitartsinimdA  دور إداري  
 elor gnitaerTدور ﻋﻼﺟﻲ   
 elor gniraCدور ﻋﻨﺎﯾﺔ   
 elor noitatilibaheRدور ﺗﺄھﯿﻠﻲ   
 elor noitacudEدور ﺗﺜﻘﯿﻔﻲ   
 ?rehtO أﺧﺮى  
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Perception of pharmacy problems 
2. Does the centre’s pharmacy 
experience supply problems? If yes, 
what are these problems and what 
are the suggested solutions for 
these problems? 
  صوﺻﺧﺑ لﻛﺎﺷﻣ نﻣ ﻲﻧﺎﻌﺗ زﻛرﻣﻟا ﺔﯾﻟدﯾﺻ لھ
 ؟ﺔﯾودﻷﺎﺑ مﻛدﯾوزﺗ □  مﻌﻧ□ﻻ  ﻣ هذھ ﻲھ ﺎ
 ؟ لﻛﺎﺷﻣﻟا 
3. Could you please rank from 1-5 (1 being the 
highest priority) what you think are the top five 
healthcare problems affecting healthcare of 
patients with diabetes? (in terms of urgency, the 
seriousness of the problem that the intervention 
may resolve) 
 ﻰﻠﻋ رﺛؤﺗ ﻲﺗﻟا  لﻛﺎﺷﻣﻟا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
 ﺎھؤﺎطﻋإ ﻲﻐﺑﻧﯾ ﺔﻠﻛﺷﻣ مھﺄﺑ ًأدﺑ  يرﻛﺳﻟا ضرﻣﻟ ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا
 نﯾﻌﺑ ذﺧﻷا نﻛﻣﯾ ؟  اذﻛھو ﺎﮭﯾﻠﺗ ﻲﺗﻟا مﺛ مﺎﻣﺗھﻻاو  ﺔﯾوﻟوﻷا
 ﺔﻠﻛﺷﻣﻟا مﺟﺣ رﺎﺑﺗﻋﻻا ,ﺔﺋرﺎط ﻲھ لھ , ﺎھرﯾﺛﺄﺗو ﺎﮭﺗروطﺧ ىدﻣ
ﻟا ﻰﺿرﻣ ﻰﻠﻋ رﻛﺳ , ﺎﮭﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ 
4. From your point of 
view, What solutions 
are needed for these 
problems?   
 نﻣ ﺔﯾرورﺿﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ
  ؟لﻛﺎﺷﻣﻟا هذﮭﻟ كرظﻧ ﺔﮭﺟو 
5. What are the differences these 
solutions will make? 
 نﻣ لوﻠﺣﻟا هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
ظﻧ ﺔﮭﺟو؟كر 
Supply problems    ﺔﯾودﻷا رﯾﻓوﺗ لﻛﺎﺷﻣ Problem Priority        لﻛﺎﺷﻣﻟا ﺔﯾوﻟوأ  Solutions                         
لوﻠﺣﻟا 
قرﻔﻟاو رﯾﺛﺄﺗﻟا Difference made          
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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6. Are there any other problems in 
your pharmacy that might affect 
people with diabetes? 
 
   ﺎﮭﻧﻣ ﻲﻧﺎﻌﺗ ىرﺧأ لﻛﺎﺷﻣ يأ كﺎﻧھ لھ
؟يرﻛﺳﻟا ﻰﺿرﻣ ﻰﻠﻋ رﺛؤﺗ وأ نﻛﻣﯾ ﺔﯾﻟدﯾﺻﻟا   
7. Could you please rank from 1-5 (1 being the 
highest priority) what you think are the top five 
pharmacy problems affecting healthcare of 
patients with diabetes? (in terms of urgency, the 
seriousness of the problem that the intervention 
may resolve) 
 رﺛؤﺗ ﻲﺗﻟا  لﻛﺎﺷﻣﻟا هذھ بﯾﺗرﺗﺑ موﻘﺗو لﺿﻔﺗﺗ نأ نﻛﻣﻣ لھ
 ﺔﻠﻛﺷﻣ مھﺄﺑ ًأدﺑ  يرﻛﺳﻟا ضرﻣﻟ ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا ﻰﻠﻋ
ﺎطﻋإ ﻲﻐﺑﻧﯾ  اذﻛھو ﺎﮭﯾﻠﺗ ﻲﺗﻟا مﺛ مﺎﻣﺗھﻻاو  ﺔﯾوﻟوﻷا ﺎھؤ
 ﺔﻠﻛﺷﻣﻟا مﺟﺣ رﺎﺑﺗﻋﻻا نﯾﻌﺑ ذﺧﻷا نﻛﻣﯾ ؟ , ﻲھ لھ
ﺔﺋرﺎط , رﻛﺳﻟا ﻰﺿرﻣ ﻰﻠﻋ ﺎھرﯾﺛﺄﺗو ﺎﮭﺗروطﺧ ىدﻣ ,
 ﺎﮭﻟ ﺔﺑﺳﺎﻧﻣ لوﻠﺣ دﺟوﯾ لھ 
8. From your point of view, 
What solutions are 
needed for these 
problems?   
ﺔﯾرورﺿﻟا لوﻠﺣﻟا ﻲھ ﺎﻣ  ﺔﮭﺟو نﻣ
  ؟لﻛﺎﺷﻣﻟا هذﮭﻟ كرظﻧ 
9. What are the differences 
these solutions will make? 
 لوﻠﺣﻟا هذھ لﺛﻣ ﮫﻘﻘﺣﺗﺳ يذﻟا قرﻔﻟا وھ ﺎﻣ
؟كرظﻧ ﺔﮭﺟو نﻣ 
Other problems    ىرﺧأ لﻛﺎﺷﻣ Problem Priority        لﻛﺎﺷﻣﻟا ﺔﯾوﻟوأ  Solutions                         لوﻠﺣﻟا قرﻔﻟاو رﯾﺛﺄﺗﻟا Difference made          
 1. 1. 1. 
 2. 2. 2. 
 3. 3. 3. 
 4. 4. 4. 
 5. 5. 5. 
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10. Could you please explain how the diabetes drugs are supplied?                                                                    ﻞﻀﻔﺘﺗ نا ﻦﻜﻤﻣ ﻞھ؟ يﺮﻜﺴﻟا ﺔﯾودﺄﺑ ﻢﻛﺪﯾوﺰﺗ ﻢﺘﯾ ﻒﯿﻛ حﺮﺸﺗو  
 
 
Drug availability 
11. For each drug below, what is their availability in this pharmacy?                                                                            ؟ ﺎھﺮﻓﻮﺗ ىﻮﺘﺴﻣ ﻮھ ﺎﻣ ،هﺎﻧدأ ﺔﯾودﻷا ﻦﻣ ﻞﻜﻟ 
Drugs Its availability Notes 
Metformin   Always available 
  Sometimes available 
  Not available 
 
Glibenclamide   Always available 
  Sometimes available 
  Not available 
 
Gliclazide   Always available 
  Sometimes available 
  Not available 
 
Glipizide   Always available  
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  Sometimes available 
  Not available 
Glinide   Always available 
  Sometimes available 
  Not available 
 
Aspart or Lispro 
(Rapid-acting) 
  Always available 
  Sometimes available 
  Not available 
 
Regular insulin (Short-acting)   Always available 
  Sometimes available 
  Not available 
 
NPH insulin 
(Intermediate-acting) 
  Always available 
  Sometimes available 
  Not available 
 
A mixture of NPH and regular insulin   Always available 
  Sometimes available 
  Not available 
 
Antihypertensives: ACEIs (Angiotensin-Converting 
Enzyme Inhibitors), Beta-blockers diuretics, etc. 
  Always available 
  Sometimes available 
  Not available 
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Cholesterol-lowering drugs: statins   Always available 
  Sometimes available 
  Not available 
 
Consumables: needles, syringes, urine test strips, 
capillary blood glucose test strips, 
  Always available 
  Sometimes available 
  Not available 
 
I.V. Glucose solution    Always available 
  Sometimes available 
  Not available 
 
Others   Always available 
  Sometimes available 
  Not available 
 
 
  
 
 
 
 
384 
Dispensing drugs to patients 
 
Pharmacy team 
12. Do you have a dispensing mechanism or protocol for delivering diabetes drugs? If yes, what is it and how it works? 
؟لﻣﻌﺗ فﯾﻛو ﻲھ ﺎﻣ ؟يرﻛﺳﻟا ﺔﯾودأ فرﺻﻟ ﺔﯾﻟآ مﻛﯾدﻟ لھ 
 
13. Who is the pharmacy team composed of? What training have they had? 
؟ﺎﮭﯾﻠﻋ نﯾﻠﺻﺎﺣﻟا تادﺎﮭﺷﻟاو بﯾردﺗﻟا تﺎﯾوﺗﺳﻣ ﺎﻣو ؟ﺔﯾﻟدﯾﺻﻟا ﻖﯾرﻓ نوﻛﺗﯾ نﻣﻣ 
Team member                                                                Training level                                                                                      
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Training needs 
 
 
  
14. What training courses would you like to attend?  
 ؟ﺎھروﺿﺣﺑ بﻏرﺗ ﻲﺗﻟا ﺔﯾﺑﯾردﺗﻟا ﺞھﺎﻧﻣﻟا ﻲھﺎﻣ 
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Pharmacist’s details  
Questions/data items Answers Notes  
Healthcare centre’s name: 
............................................................. 
  Primary level 
  Secondary level 
 
Age or date of birth:    Youth (aged < 24) 
  Adults (aged 25 – 64)   
  Older People (aged 65+) 
 
Gender:   Male  
  Female 
 
Nationality :   Saudi  
  Non Saudi 
 
What is your current occupation and 
specialty: 
 Work period/day: □ 0-5 hours    □ 6-10 hours    □ >10 hours 
Have you received any training on the drug 
management of diabetes? 
  Yes.. if yes specify.... 
  No  
 
Would you like to attend training courses on 
healthcare of people with diabetes? 
  Yes.. if yes specify....  
  No  
 
• Check up the notes taken with the interviewee, check up after you have written the notes: ‘What I have written down is… Have I noted that down OK, or do you want to change something? 
• Allows the interviewee to (re)consider what has been said while you write and expand the answers. 
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Appendix 16: Invitation letter for healthcare staff to join the research team 
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Appendix 17: Participant information sheets for patients and healthcare 
professionals, English and Arabic versions 
PARTICIPANT INFORMATION SHEET (for patients) 
DIABETES HEALTH NEEDS ASSESSMENT IN ABHA CITY, SAUDI ARABIA 
INVITATION TO TAKE PART IN A RESEARCH STUDY 
You are being asked to take part in a research project, which aims to identify the health and 
healthcare needs of patients with diabetes. We are a group of healthcare professionals who 
are interested in improving the healthcare management of patients with diabetes in Abha city. 
The team leader is Dr Abdullah Alshehri and the supervisor is Professor Iain Crombie.   
 
PURPOSE OF THE RESEARCH STUDY 
In this study, the research team will interview patients, healthcare providers and managers 
and ask them about their perceptions of what patients with diabetes need in terms of health 
and healthcare. During this project you will be asked to complete a questionnaire asking about 
your health, the health needs of patients with diabetes and the health care services they are 
currently receiving. You may also be invited to a meeting in order to give your view about 
health needs of patients with diabetes. 
Participation in this research would benefit first our government, represented by the Ministry 
of Health, to improve the delivery of healthcare services based on understanding what 
patients need. Second, people with diabetes would benefit by receiving better healthcare that 
meets their needs. Third, Healthcare professionals would also benefit from this project by in-
depth understanding of what people with diabetes need.      
TIME COMMITMENT 
The study will involve interview of about 30 minutes, for those invited to a meeting, the 
duration will be less than 1 hour. The meeting will be held at your primary healthcare centre, 
hospital or diabetes centre. 
TERMINATION OF PARTICIPATION 
Participation in this research is completely voluntary. You may decide to stop being a part of 
the research study at any time without explanation.  
RISKS 
There are no known risks for you in this study.  
 
CONFIDENTIALITY/ANONYMITY 
The data we collect do not contain any personal information about you. No one will link the 
data you provided to your identity and name. It is anticipated that the findings of the study will 
be written up for publication in a peer reviewed journal and presented at international 
conferences. All results will be anonymised and it will not be possible to identify individual 
participant’s data. 
 
FOR FURTHER INFORMATION ABOUT THIS RESEARCH STUDY 
Dr Abdullah Alshehri will be glad to answer your questions about this study at any time. If you 
want to find out about the final results of this study, you can just send an email to Dr Abdullah 
Alshehri at dr.alsabaani@hotmail.com or  A.Alshehri@cpse.dundee.ac.uk. You may also contact: 
Department of Public Health 
School of Medicine  
University of Dundee 
Mackenzie Building 
Kirsty Semple Way 
Dundee 
Scotland 
DD2 4BF 
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PARTICIPANT INFORMATION SHEET (for healthcare professional) 
 
DIABETES HEALTH NEEDS ASSESSMENT IN ABHA CITY, SAUDI ARABIA 
INVITATION TO TAKE PART IN A RESEARCH STUDY 
You are being asked to take part in a research project, which aims to identify the health and 
healthcare needs of patients with diabetes. We are a group of healthcare professionals who 
are interested in improving the healthcare management of patients with diabetes in Abha city. 
The team leader is Dr Abdullah Alshehri and the supervisor is Professor Iain Crombie.   
 
PURPOSE OF THE RESEARCH STUDY 
In this study, the research team will interview patients, healthcare providers and managers 
and ask them about their perceptions of what patients with diabetes need in terms of health 
and healthcare. Meetings & discussions will then be conducted to prioritize the identified 
needs. Actions will be planned to meet the most significant needs. A set of recommendations 
will then be developed to guide and influence the health policy of delivering healthcare 
services to patients with diabetes. During this project you will be asked to complete a 
questionnaire asking about your health, the health needs of patients with diabetes and the 
health care services they are currently receiving. You may also be invited to a meeting in order 
to give your view about health needs of patients with diabetes.     
 
Participation in this research would benefit first our government, represented by the ministry 
of health, to improve the delivery of healthcare services based on understanding what patients 
need. Second, people with diabetes would benefit by receiving better healthcare that meets 
their needs. Third, Healthcare professionals would also benefit from this project by in-depth 
understanding of what people with diabetes need.      
 
TIME COMMITMENT 
The study will involve interview of about 30 minutes, for those invited to a meeting, the 
duration will be less than 1 hour. The meeting will be held at your primary healthcare centre, 
hospital or diabetes centre. 
 
TERMINATION OF PARTICIPATION 
Participation in this research is completely voluntary. You may decide to stop being a part of 
the research study at any time without explanation.  
 
RISKS 
There are no known risks for you in this study.  
 
CONFIDENTIALITY/ANONYMITY 
The data we collect do not contain any personal information about you. No one will link the 
data you provided to your identity and name. It is anticipated that the findings of the study will 
be written up for publication in a peer reviewed journal and presented at international 
conferences. All results will be anonymised and it will not be possible to identify individual 
participant’s data. 
 
FOR FURTHER INFORMATION ABOUT THIS RESEARCH STUDY 
Dr Abdullah Alshehri will be glad to answer your questions about this study at any time. If you 
want to find out about the final results of this study, you can just send an email to Dr Abdullah 
Alshehri at dr.alsabaani@hotmail.com or  A.Alshehri@cpse.dundee.ac.uk. You may also contact: 
Department of Public Health, School of Medicine, University of Dundee 
Mackenzie Building 
Kirsty Semple Way 
Dundee/Scotland 
DD2 4BF 
 
 
 293
 
 (ﻧﺴﺨﺔ اﳌﺮﻳﺾ)ورﻗﺔ ﻣﻌﻠﻮﻣﺎت ﻟﻠﻤﺸﺎرﻛﲔ 
 ﺗﻘﯾﯾم اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري ﺑﻣدﯾﻧﺔ أﺑﮭﺎ، اﻟﻣﻣﻠﻛﺔ اﻟﻌرﺑﯾﺔ اﻟﺳﻌودﯾﺔ
 
 اﻟدﻋوة ﻟﻠﻣﺷﺎرﻛﺔ ﻓﻲ دراﺳﺔ ﺑﺣﺛﯾﺔ
ف ﻋﻠﻰ اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ واﺣﺗﯾﺎﺟﺎت اﻟﻌﻧﺎﯾﺔ اﻟﺻﺣﯾﺔ أﻧت ﻣدﻋو ﻟﻠﻣﺷﺎرﻛﺔ ﻓﻲ ﻣﺷروع ﺑﺣﺛﻲ ﯾﮭدف إﻟﻰ اﻟﺗﻌرﱡ 
ﺣن ﻣﺟﻣوﻋﺔ ﻣن اﻟﻣﺗﺧﺻﺻﯾن ﻓﻲ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ وﻧرﻏب ﻓﻲ ﻧ. ﻟﻠﻣرﺿﻰ اﻟذﯾن ﯾﻌﺎﻧون ﻣن ﻣرض اﻟﺳﻛري 
ﻗﺎﺋد اﻟﻔرﯾﻖ ھو اﻟدﻛﺗور ﻋﺑد ﷲ اﻟﺷﮭري واﻟﻣﺷرف ﻋﻠﻰ  . ﺗﺣﺳﯾن اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري ﻓﻲ ﻣدﯾﻧﺔ أﺑﮭﺎ
 .اﯾﺎن ﻛروﻣﺑﻲ اﻟﺑﺣث ھو اﻟﺑروﻓﯾﺳور
 اﻟﻐرض ﻣن ھذه اﻟدراﺳﺔ
ﻓﻲ ھذه اﻟدراﺳﺔ ، ﺳﯾﻘﺎﺑل ﻓرﯾﻖ اﻟﺑﺣث ﻛل ﻣن ﻣرﺿﻰ اﻟﺳﻛري وﻣﻘدﻣﻲ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ وﻣدﯾري اﻟﻣراﻛز 
واﻟﻣﺳﺗﺷﻔﯾﺎت وﺳﯾﺗم ﺳؤاﻟﮭم ﻋن ﺗﺻوراﺗﮭم ﻟﻣﺎ ﯾﺣﺗﺎﺟﮫ اﻟﻣرﺿﻰ اﻟذﯾن ﯾﻌﺎﻧون ﻣن ﻣرض اﻟﺳﻛري ﻣن ﺣﯾث 
ﺷروع ﺳﯾﺗم دﻋوﺗك إﻟﻰ ﻟﻘﺎء  ﻣن أﺟل اﻋطﺎء وﺟﮭﺔ ﻧظرﻛم ﺣول ﺧﻼل ھذا اﻟﻣ. اﻟﺣﺎﺟﺔ ﻟﻠﺻﺣﺔ واﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ
ﻗد ﯾُطﻠب ﻣﻧك أن ﺗﺟﯾب ﻋﻠﻰ اﺳﺗﺑﯾﺎن ﯾﺳﺄل ﻋن  . اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻠﻣرﺿﻰ اﻟذﯾن ﯾﻌﺎﻧون ﻣن ﻣرض اﻟﺳﻛري
 .ﺣﺎﻟﺗك اﻟﺻﺣﯾﺔ وﻋن اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري وﻋن ﺧدﻣﺎت اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ اﻟﻣﻘدﻣﮫ ﺣﺎﻟﯾﺎ ً 
ﻣﺷروع اﻟﺑﺣﺛﻲ ﺳﺗﻔﯾد أوﻻ ًﻣﺻﻠﺣﺔ وطﻧﻧﺎ وﺣﻛوﻣﺗﻧﺎ اﻟرﺷﯾدة ﻣﻣﺛﻠﺔ ﻓﻲ وزارة اﻟﺻﺣﺔ، وذﻟك ﻣن اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ھذا اﻟ
ﺛﺎﻧﯾﺎ ﺳﯾﻔﯾد اﻟﺑﺣث ﻣرﺿﻰ . ﺧﻼل ﺗﺣﺳﯾن ﺗﻘدﯾم ﺧدﻣﺎت اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻋﻠﻰ أﺳﺎس ﻓﮭم ﻣﺎ ﯾﺣﺗﺎﺟﮫ اﻟﻣرﺿﻰ
روع اﻟﺑﺣﺛﻲ  اﻟﻣﺗﺧﺻﺻﯾن ﺛﺎﻟﺛﺎ ًﺳﯾﻔﯾد ھذا اﻟﻣﺷ. اﻟﺳﻛري ﻣن ﺧﻼل ﺗﻠﻘﻲ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ أﻓﺿل وﺗﻠﺑﻲ اﺣﺗﯾﺎﺟﺎﺗﮭم 
 .ﻓﻲ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻣن ﺧﻼل اﻟﻔﮭم اﻟﻣﺗﻌﻣﻖ ﻟﻣﺎ ﯾﺣﺗﺎﺟﮫ ﻣرض اﻟﺳﻛري
 
 اﻟﺗزاﻣﺎت اﻟوﻗت
اﻟﻠﻘﺎء  .دﻗﯾﻘﺔ وﻟﻘﺎء ﻟﻣدة أﻗل ﻣن ﺳﺎﻋﺔ 03اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ھذه اﻟدراﺳﺔ ﺗﺣﺗﺎج ﻣﻧك ﻓﻘط ﻟﻣﻘﺎﺑﻠﺔ اﻟﺑﺎﺣث ﻟﻣدة ﺗﻘﺎرب 
 .ﺳﯾﻛون إﻣﺎ ﺑﺎﻟﻣرﻛز اﻟﺻﺣﻲ أو اﻟﻣﺳﺗﺷﻔﻰ أو ﻣرﻛز اﻟﺳﻛري
 
 إﻧﮭﺎء ﻣﺷﺎرﻛﺔ
 .اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ھذا اﻟﺑﺣث ﺗطوﻋﯾﺔ ﺗﻣﺎﻣﺎ وﯾﻣﻛن أن ﺗﻘرر اﻟﺗوﻗف ﻋن اﻟﻣﺷﺎرﻛﺔ ﻓﻲ أي وﻗت دون ﺗﻔﺳﯾر
 
 اﻟﻣﺧﺎطر
 .ﻻ ﯾُﻌرف ھﻧﺎك أﯾﺔ ﻣﺧﺎطر ﺑﺎﻟﻧﺳﺑﺔ ﻟﻣﺷﺎرﻛﺗك ﻓﻲ ھذه اﻟدراﺳﺔ
 
 ﻋدم اﻟﻛﺷف ﻋن اﻟﮭوﯾﮫ/ اﻟﺳرﯾﺔ 
ﻻ أﺣد ﯾﺳﺗطﯾﻊ رﺑط اﻟﺑﯾﺎﻧﺎت اﻟﺗﻲ ﻗدﻣﺗﮭﺎ ﻟﮭوﯾﺗك  .اﻟﺑﯾﺎﻧﺎت اﻟﺗﻲ ﻧﺟﻣﻌﮭﺎ ﻻ ﺗﺣﺗوي ﻋﻠﻰ أﯾﺔ ﻣﻌﻠوﻣﺎت ﺷﺧﺻﯾﺔ ﻋﻧك
. ﻣن اﻟﻣﺗوﻗﻊ أن اﻟﻧﺗﺎﺋﺞ اﻟﺗﻲ ﺗوﺻﻠت إﻟﯾﮭﺎ اﻟدراﺳﺔ ﺳوف ﺗﻛون ﻣﻛﺗوﺑﺔ وﻣﻧﺷورة ﻓﻲ ﻣﺟﻼت ﻋﻠﻣﯾﺔ ﻣﺣﻛﻣﺔ. واﺳﻣك
ﻛل ﻧﺗﺎﺋﺞ اﻟدراﺳﺔ ﺳﺗﻛون ﻣﺟﮭول اﻟﻣﺻدر ﺑﺣﯾث ﻟن ﯾﺗﻣﻛن أي أﺣد ﻣن  .وﯾﻣﻛن أن ﺗُﻘَدم ﻓﻲ اﻟﻣؤﺗﻣرات اﻟدوﻟﯾﺔ
 . اﻷﻓراد اﻟﻣﺷﺎرﻛﯾن أو اﻟﻣراﻛز اﻟﺻﺣﯾﺔ واﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﻣﺷﺎرﻛﺔﺗﺣدﯾد ھوﯾﺔ 
 
 ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻋن ھذه اﻟدراﺳﺔ اﻟﺑﺣﺛﯾﺔ
إذا ﻛﻧت ﺗرﯾد ﻣﻌرﻓﺔ  .اﻟدﻛﺗور ﻋﺑد ﷲ اﻟﺷﮭري ﺳﯾﻛون ﺳﻌﯾدا ﻟﻺﺟﺎﺑﺔ ﻋﻠﻰ أﺳﺋﻠﺗﻛم ﺣول ھذه اﻟدراﺳﺔ ﻓﻲ أي وﻗت
 أو moc.liamtoh@inaabasla.rd  :اﻟﻧﺗﺎﺋﺞ اﻟﻧﮭﺎﺋﯾﺔ ﻟﮭذه اﻟدراﺳﺔ ، ﯾﻣﻛﻧك ﻓﻘط إرﺳﺎل ﺑرﯾد إﻟﻛﺗروﻧﻲ إﻟﻰ
 ku.ca.eednud.espc@irhehsla.a 
 : ﺔ ﺟﺎﻣﻌﺔ دﻧدي ﺑﺎﺳﻛوﺗﻼﻧدا ﻋﻠﻰ اﻟﻌﻧوان اﻟﺗﺎﻟﻲﻛﻣﺎ ﯾﻣﻛﻧك ﻣراﺳﻠ
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 (ﻧﺴﺨﺔ اﳌﻤﺎرﺳﲔ اﻟﺼﺤﻴﲔ)ورﻗﺔ ﻣﻌﻠﻮﻣﺎت ﻟﻠﻤﺸﺎرﻛﲔ 
 ﻟﺳﻛري ﺑﻣدﯾﻧﺔ أﺑﮭﺎ، اﻟﻣﻣﻠﻛﺔ اﻟﻌرﺑﯾﺔ اﻟﺳﻌودﯾﺔﺗﻘﯾﯾم اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ ا
 اﻟدﻋوة ﻟﻠﻣﺷﺎرﻛﺔ ﻓﻲ دراﺳﺔ ﺑﺣﺛﯾﺔ
أﻧت ﻣدﻋو ﻟﻠﻣﺷﺎرﻛﺔ ﻓﻲ ﻣﺷروع ﺑﺣﺛﻲ ﯾﮭدف إﻟﻰ اﻟﺗﻌرﱡ ف ﻋﻠﻰ اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ واﺣﺗﯾﺎﺟﺎت اﻟﻌﻧﺎﯾﺔ اﻟﺻﺣﯾﺔ 
ﻓﻲ ﺣن ﻣﺟﻣوﻋﺔ ﻣن اﻟﻣﺗﺧﺻﺻﯾن ﻓﻲ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ وﻧرﻏب ﻧ. ﻟﻠﻣرﺿﻰ اﻟذﯾن ﯾﻌﺎﻧون ﻣن ﻣرض اﻟﺳﻛري 
ﻗﺎﺋد اﻟﻔرﯾﻖ ھو اﻟدﻛﺗور ﻋﺑد ﷲ اﻟﺷﮭري واﻟﻣﺷرف ﻋﻠﻰ  . ﺗﺣﺳﯾن اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري ﻓﻲ ﻣدﯾﻧﺔ أﺑﮭﺎ
 .اﻟﺑﺣث ھو اﻟﺑروﻓﯾﺳور اﯾﺎن ﻛروﻣﺑﻲ
 اﻟﻐرض ﻣن ھذه اﻟدراﺳﺔ
ﻓﻲ ھذه اﻟدراﺳﺔ ، ﺳﯾﻘﺎﺑل ﻓرﯾﻖ اﻟﺑﺣث ﻛل ﻣن ﻣرﺿﻰ اﻟﺳﻛري وﻣﻘدﻣﻲ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ وﻣدﯾري اﻟﻣراﻛز 
ﯾﺎت وﺳﯾﺗم ﺳؤاﻟﮭم ﻋن ﺗﺻوراﺗﮭم ﻟﻣﺎ ﯾﺣﺗﺎﺟﮫ اﻟﻣرﺿﻰ اﻟذﯾن ﯾﻌﺎﻧون ﻣن ﻣرض اﻟﺳﻛري ﻣن ﺣﯾث واﻟﻣﺳﺗﺷﻔ
ﺧﻼل ھذا اﻟﻣﺷروع ﺳﯾﺗم دﻋوﺗك إﻟﻰ ﻟﻘﺎء ﻣن أﺟل اﻋطﺎء وﺟﮭﺔ ﻧظرﻛم ﺣول . اﻟﺣﺎﺟﺔ ﻟﻠﺻﺣﺔ واﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ
ﺳﺗﺑﯾﺎن ﯾﺳﺄل ﻋن ﻗد ﯾُطﻠب ﻣﻧك أن ﺗﺟﯾب ﻋﻠﻰ ا . اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻠﻣرﺿﻰ اﻟذﯾن ﯾﻌﺎﻧون ﻣن ﻣرض اﻟﺳﻛري
ﺳﯾﻘوم ﻓرﯾﻖ اﻟﺑﺣث ﺑﻌد ذﻟك  .اﻻﺣﺗﯾﺎﺟﺎت اﻟﺻﺣﯾﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري وﻋن ﺧدﻣﺎت اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ اﻟﻣﻘدﻣﮫ ﺣﺎﻟﯾﺎ ً 
ﺑﻌﻘد ﻣﺟﻣوﻋﺔ ﻣن ﺣﻠﻘﺎت اﻟﻧﻘﺎش ﻟﺗرﺗﯾب اﻻﺣﺗﯾﺎﺟﺎت ﺣﺳب اﻷوﻟوﯾﺔ وﻣن ﺛم اﻟﺗﺧطﯾط ﻟﺗﻘدﯾم ﺗدﺧﻼت ﻣﻧﺎﺳﺑﺔ ﻟﺗﻠﺑﯾﺔ 
وﺿﻊ ﻣﺟﻣوﻋﺔ ﻣن اﻟﺗوﺻﯾﺎت ﻟﻺرﺷﺎد ودﻋم ﻋﻣﻠﯾﺔ ﺗطوﯾر اﻟﺧدﻣﺎت ھذه اﻻﺣﺗﯾﺎﺟﺎت وﺑﻧﺎء ﻋﻠﯾﮫ ﺳﯾﺗم اﻟﺗوﺻل اﻟﻰ 
 . اﻟﺻﺣﯾﺔ اﻟﻣﻘدﻣﺔ ﻟﻣرﺿﻰ اﻟﺳﻛري
اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ھذا اﻟﻣﺷروع اﻟﺑﺣﺛﻲ ﺳﺗﻔﯾد أوﻻ ًﻣﺻﻠﺣﺔ وطﻧﻧﺎ وﺣﻛوﻣﺗﻧﺎ اﻟرﺷﯾدة ﻣﻣﺛﻠﺔ ﻓﻲ وزارة اﻟﺻﺣﺔ، وذﻟك ﻣن 
ﺛﺎﻧﯾﺎ ﺳﯾﻔﯾد اﻟﺑﺣث ﻣرﺿﻰ  .ﺧﻼل ﺗﺣﺳﯾن ﺗﻘدﯾم ﺧدﻣﺎت اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻋﻠﻰ أﺳﺎس ﻓﮭم ﻣﺎ ﯾﺣﺗﺎﺟﮫ اﻟﻣرﺿﻰ
ﺛﺎﻟﺛﺎ ًﺳﯾﻔﯾد ھذا اﻟﻣﺷروع اﻟﺑﺣﺛﻲ  اﻟﻣﺗﺧﺻﺻﯾن . اﻟﺳﻛري ﻣن ﺧﻼل ﺗﻠﻘﻲ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ أﻓﺿل وﺗﻠﺑﻲ اﺣﺗﯾﺎﺟﺎﺗﮭم 
 .ﻓﻲ اﻟرﻋﺎﯾﺔ اﻟﺻﺣﯾﺔ ﻣن ﺧﻼل اﻟﻔﮭم اﻟﻣﺗﻌﻣﻖ ﻟﻣﺎ ﯾﺣﺗﺎﺟﮫ ﻣرض اﻟﺳﻛري
 
 اﻟﺗزاﻣﺎت اﻟوﻗت
اﻟﻠﻘﺎء  .دﻗﯾﻘﺔ وﻟﻘﺎء ﻟﻣدة أﻗل ﻣن ﺳﺎﻋﺔ 03ث ﻟﻣدة ﺗﻘﺎرب اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ھذه اﻟدراﺳﺔ ﺗﺣﺗﺎج ﻣﻧك ﻓﻘط ﻟﻣﻘﺎﺑﻠﺔ اﻟﺑﺎﺣ
 .ﺳﯾﻛون إﻣﺎ ﺑﺎﻟﻣرﻛز اﻟﺻﺣﻲ أو اﻟﻣﺳﺗﺷﻔﻰ أو ﻣرﻛز اﻟﺳﻛري
 
 إﻧﮭﺎء ﻣﺷﺎرﻛﺔ
 .اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ھذا اﻟﺑﺣث ﺗطوﻋﯾﺔ ﺗﻣﺎﻣﺎ وﯾﻣﻛن أن ﺗﻘرر اﻟﺗوﻗف ﻋن اﻟﻣﺷﺎرﻛﺔ ﻓﻲ أي وﻗت دون ﺗﻔﺳﯾر
 
 اﻟﻣﺧﺎطر
 .ك ﻓﻲ ھذه اﻟدراﺳﺔﻻ ﯾُﻌرف ھﻧﺎك أﯾﺔ ﻣﺧﺎطر ﺑﺎﻟﻧﺳﺑﺔ ﻟﻣﺷﺎرﻛﺗ
 
 ﻋدم اﻟﻛﺷف ﻋن اﻟﮭوﯾﮫ/ اﻟﺳرﯾﺔ 
ﻻ أﺣد ﯾﺳﺗطﯾﻊ رﺑط اﻟﺑﯾﺎﻧﺎت اﻟﺗﻲ ﻗدﻣﺗﮭﺎ ﻟﮭوﯾﺗك  .اﻟﺑﯾﺎﻧﺎت اﻟﺗﻲ ﻧﺟﻣﻌﮭﺎ ﻻ ﺗﺣﺗوي ﻋﻠﻰ أﯾﺔ ﻣﻌﻠوﻣﺎت ﺷﺧﺻﯾﺔ ﻋﻧك
. ﻣن اﻟﻣﺗوﻗﻊ أن اﻟﻧﺗﺎﺋﺞ اﻟﺗﻲ ﺗوﺻﻠت إﻟﯾﮭﺎ اﻟدراﺳﺔ ﺳوف ﺗﻛون ﻣﻛﺗوﺑﺔ وﻣﻧﺷورة ﻓﻲ ﻣﺟﻼت ﻋﻠﻣﯾﺔ ﻣﺣﻛﻣﺔ. واﺳﻣك
ﻛل ﻧﺗﺎﺋﺞ اﻟدراﺳﺔ ﺳﺗﻛون ﻣﺟﮭول اﻟﻣﺻدر ﺑﺣﯾث ﻟن ﯾﺗﻣﻛن أي أﺣد ﻣن  .أن ﺗُﻘَدم ﻓﻲ اﻟﻣؤﺗﻣرات اﻟدوﻟﯾﺔ وﯾﻣﻛن
 . ﺗﺣدﯾد ھوﯾﺔ اﻷﻓراد اﻟﻣﺷﺎرﻛﯾن أو اﻟﻣراﻛز اﻟﺻﺣﯾﺔ واﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﻣﺷﺎرﻛﺔ
 
 ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻋن ھذه اﻟدراﺳﺔ اﻟﺑﺣﺛﯾﺔ
إذا ﻛﻧت ﺗرﯾد ﻣﻌرﻓﺔ  .ﻠﺗﻛم ﺣول ھذه اﻟدراﺳﺔ ﻓﻲ أي وﻗتاﻟدﻛﺗور ﻋﺑد ﷲ اﻟﺷﮭري ﺳﯾﻛون ﺳﻌﯾدا ﻟﻺﺟﺎﺑﺔ ﻋﻠﻰ أﺳﺋ
 أو moc.liamtoh@inaabasla.rd  :اﻟﻧﺗﺎﺋﺞ اﻟﻧﮭﺎﺋﯾﺔ ﻟﮭذه اﻟدراﺳﺔ ، ﯾﻣﻛﻧك ﻓﻘط إرﺳﺎل ﺑرﯾد إﻟﻛﺗروﻧﻲ إﻟﻰ
 spc@irhehsla.aku.ca.eednud.e 
 : ﻛﻣﺎ ﯾﻣﻛﻧك ﻣراﺳﻠﺔ ﺟﺎﻣﻌﺔ دﻧدي ﺑﺎﺳﻛوﺗﻼﻧدا ﻋﻠﻰ اﻟﻌﻧوان اﻟﺗﺎﻟﻲ
 htlaeH cilbuP fo tnemtrapeD
  enicideM fo loohcS
 eednuD fo ytisrevinU
 gnidliuB eiznekcaM
 yaW elpmeS ytsriK
 eednuD
 dnaltocS
 FB4 2DD
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Appendix 18: Informed consent form for taking part in the study 
INFORMED CONSENT FORM                                                  مﻠﻋ نﻋ ﺔﻘﻓاوﻣﻟا جذوﻣﻧ 
DIABETES HEALTH NEEDS ASSESSMENT IN ABHA CITY, SAUDI ARABIA 
ﻟا ﺔﻛﻠﻣﻣﻟا ،ﺎﮭﺑأ ﺔﻧﯾدﻣﺑ يرﻛﺳﻟا ﻰﺿرﻣﻟ ﺔﯾﺣﺻﻟا تﺎﺟﺎﯾﺗﺣﻻا مﯾﯾﻘﺗﺔﯾدوﻌﺳﻟا ﺔﯾﺑرﻌ  
 
PROJECT SUMMARY 
Health needs assessment is a systematic method of identifying unmet health and 
health care needs of a population, and making changes to meet these unmet needs. 
The aim of this project is to identify the health and healthcare needs of people with 
diabetes, by interviewing patients, healthcare providers and managers. The identified 
needs will be prioritized and actions will be planned to meet the most significant 
needs. A set of recommendations then will be developed to guide and influence the 
health policy of delivering healthcare services to patients with diabetes. 
By signing below you are agreeing that you have read and understood the Participant 
Information Sheet and that you agree to take part in this research study.  
 صﺧﻠﻣعورﺷﻣﻟا 
 
مﯾﯾﻘﺗ ﺔﯾﺣﺻﻟا تﺎﺟﺎﯾﺗﺣﻻا وھ بوﻠﺳأ ﻲﺟﮭﻧﻣ ﻟﻠﻟ نﺎﻛﺳﻟا تﺎﺟﺎﯾﺗﺣا دﯾدﺣﺗﺔﺣﺻ ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻠﻟو بﻠﺗ مﻟ ﻲﺗﻟا ،و ءارﺟإ
 تارﯾﯾﻐﺗتﺎﺟﺎﯾﺗﺣﻻا هذھ ﺔﯾﺑﻠﺗﻟ .فدﮭﻟا نﻣ اذھ عورﺷﻣﻟا وھ دﯾدﺣﺗ ﻟ تﺎﺟﺎﯾﺗﺣﻻاو ﺔﯾﺣﺻﻟا تﺎﺟﺎﯾﺗﺣﻻا ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻠ
 نﻣ نوﻧﺎﻌﯾ نﯾذﻟا صﺎﺧﺷﻸﻟو ،يرﻛﺳﻟا ضرﻣ لﻼﺧ نﻣ كﻟذ تﻼﺑﺎﻘﻣ ءارﺟإﻰﺿرﻣﻟا ﻊﻣ ﻲﻣدﻘﻣو ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟا 
نﯾرﯾدﻣﻟاو.  تﺎﺑﯾﺗرﺗو لﺎﻣﻋﻷ طﯾطﺧﺗﻟاو تﺎﺟﺎﯾﺗﺣﻻا هذھ ﺔﺷﻗﺎﻧﻣ مﺗﯾﺳ مﺛ نﻣو ﺔﯾوﻟوﻷا بﺳﺣﺑ بﺗرﺗﺳ ﺔﻔﺷﺗﻛﻣﻟا تﺎﺟﺎﯾﺗﺣﻻا
 ﺔﯾﺑﻠﺗﻟ ﺔﺣﺎﺗﻣتﺎﺟﺎﯾﺗﺣﻻا رﺛﻛﻷا ﺔﯾﻣھأ. مﺗﯾﺳو ﻊﺿو تﺎﯾﺻوﺗﻟا نﻣ ﺔﻋوﻣﺟﻣ كﻟذ دﻌﺑ ﻟﮫﯾﺟوﺗﻠ ﺄﺗﻟاوﻲﻓ رﯾﺛ  ﺔﯾﺣﺻﻟا ﺔﺳﺎﯾﺳﻟا
ﻟ ﺔﻣﺎﻌﻟا مﯾدﻘﺗتﺎﻣدﺧ ﻟ ﺔﯾﺣﺻﻟا ﺔﯾﺎﻋرﻟايرﻛﺳﻟا ﻰﺿرﻣ. 
ﻊﯾﻗوﺗﻟﺎﺑ هﺎﻧدأ ﻖﻓاوﺗ كﻧﺈﻓ ،تأرﻗ دﻗ كﻧأ ﻰﻠﻋ و تﻣﮭﻓنﯾﻛرﺗﺷﻣﻟﺎﺑ ﺔﻘﻠﻌﺗﻣﻟا تﺎﻣوﻠﻌﻣﻟا ﺔﻗرو كﻧأو ﻖﻓاوﺗ ﻲﻓ ﺔﻛرﺎﺷﻣﻟا ﻰﻠﻋ 
ﺔﯾﺛﺣﺑﻟا ﺔﺳاردﻟا هذھ. 
كرﺎﺷﻣﻟا مﺳإ 
 
Participant’s name    
...................................................... 
 
  
ﻊﯾﻗوﺗﻟا Participant’s signature    
Date                  ﺦﯾرﺎﺗﻟا 
 
       ..../..../2011 
......................................................  
 ﻰﻠﻋ لﺻﺣﺗﻣﻟا ثﺣﺎﺑﻟا مﺳإ
ﺔﻘﻓاوﻣﻟا 
 
Name of person obtaining consent  
............................................................... 
 
 
 ﻰﻠﻋ لﺻﺣﺗﻣﻟا ثﺣﺎﺑﻟا ﻊﯾﻗوﺗ
ﺔﻘﻓاوﻣﻟا 
 
Signature of person obtaining consent  
Date                  ﺦﯾرﺎﺗﻟا 
 
       ..../..../2011 ............................................................... 
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Appendix 19: Combined lists of responses (codes), themes and categories to the 
interview questions for all the key informants.  
List 19.1: List of reported responses to the questions* about the health needs and 
problems encountered during diabetes management.  
* Patient interview: questions number 3, 4, 7, 8, 11 and 12; healthcare professional interview: 
questions number 3, 4, 7, 8, 11 and 12; healthcare manager interview: questions number 3, 4, 
7, 8, 11 and 12; pharmacist interview: questions number 2, 3, 6 and 7. 
 
Category Theme Response (code) 
Av
ai
la
bi
lit
y 
of
 h
ea
lth
ca
re
 re
so
ur
ce
s 
Laboratory and  
its resources 
Laboratory and all laboratory investigations 
HbA1C test 
ECG test 
X-ray machine 
Cholesterol and triglyceride tests 
Urinalysis strips 
Glucometer strips for laboratory 
Renal function tests and liver function tests 
Specific Laboratory  for diabetics only 
Pharmacy and  
its resources 
  
A Pharmacy  
Insufficient availability of drugs (including anti-diabetes 
drugs) 
New anti-diabetes drugs 
High quality anti-diabetes drugs  
Insulin 
Angiotensin receptor blockers (ARBs) drugs 
Increase range of insulin types available (Lantus, 
Mixtard, and Apidra)  
Insulin devices and pens 
Aspirin 
Statins 
Multivitamins 
Impotence treatments 
Glucometer, its strips and needles 
Insulin syringes 
Small insulin syringes (for children) 
Alcohol swabs 
Nearly to expire drugs 
Device for printing dosage information 
Medical support devices such as wheelchair, medical 
shoes, spectacles, drawers 
Sphygmometer / electronic sphygmometer 
Insulin Keeper (small refrigerators) 
Healthcare 
manpower 
Insufficient working staff 
Trained staff (specialists) 
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 Dietician clinic (dietician) 
Podiatrist clinic (podiatrist) 
Ophthalmology clinic (ophthalmologist) 
Optometrist 
Dental clinic (dentist/dental assistant) 
Diabetologist clinic (diabetologist) 
Health education clinic (Health educator) 
Social worker 
Trained nurses 
Geriatrist 
Family medicine physicians (specialist, trained 
physicians, specialist clinics) 
Female physician 
Female pharmacist 
Trained pharmacist 
Psychiatrist 
Paediatric physician (specialist/ diabetologist) 
Nephrologists 
Adult endocrinologist 
Biomechanics 
Lab technician 
Male nurses 
Physiotherapist 
Other hospital 
and PHCC 
resources 
Diabetes centres (more than one) 
Expanding the diabetes centre 
A laboratory in the diabetes centre 
A laboratory in Johaan PHCC 
A pharmacy in the diabetes centre 
Meeting and gathering space in PHCCs  for patients 
More wider waiting area 
Underdeveloped PHCCs/ Modern PHCCs/ PHCCs with 
insufficient resources 
A library 
Dressing materials 
Torch 
Monofilaments 
Computer and printer 
Peak flow meter 
Old devices/new modern devices 
Electronic system or computer system 
Training courses for all professionals 
New governmental buildings for PHCCs 
Special well equipped department for diabetes 
Pancreas transplantation 
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He
al
th
ca
re
 p
ro
ce
ss
es
 (s
ys
te
m
) 
Laboratory system HbA1c only available for one day per week in Abha 
General Hospital (to be everyday) 
Delayed test results 
Pharmacy system Update the MOH essential drug list/ some drugs 
need to be added to the list  
Pharmacist in PHCC should not himself go to collect 
drugs from the drug supply centre and  leave the 
PHCC pharmacy during working hours/ 
Inappropriate methods of drug transfer  
Delayed provision of requested drugs/ difficulties of 
drug provision 
Providing an amount of drugs less than the 
requested amount 
Electronic drug dispensing and prescription system/ 
Drug information electronic system 
Uncontrolled drug dispensing 
Updating regularly drug dosage information in 
patient's diabetes card 
Provision of a prescription card where diabetics can 
get their medications from any pharmacy 
Deliver drugs to home 
Drugs are not available at the night shift 
Clinic system Opening diabetes clinic many days per week 
Lack of standard protocol for screening test/ inactive 
screening programme 
Too frequent changing of the physicians and nurses 
in PHCCs 
To be managed in one place where all services are 
available, not to visit many clinics and hospitals 
Healthcare staff is not always available in their 
clinics (moving around) 
Absence of clinic  system for regular patient follow 
up / improving the clinic system 
Open the reception in ADC & AGH outpatient clinics 
for 24 hours a day 
System for organizing the movement of patients 
inside the PHCC and  when to enter the clinic 
Lack of enough time to examine patients 
completely/ only doing investigations 
More care , attention, concern and commitment  
from higher authorities 
Health insurance system and financial support 
Working two shifts (day & night) 
Appointment Lack of appointment system for follow up 
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system Inappropriate appointment system and times 
Long appointment waiting list 
Overcrowding 
Long waiting time in front of the clinic while patients 
are fasting 
Long appointment time with ophthalmology clinics 
System for defaulter follow up 
High defaulter rate 
Appointment reminder using mobile (SMS) 
Referral and 
communication 
system 
Not to refer patients to hospitals/ all investigations 
to be in the PHCCs 
Delaying referral or not to refer patients at the right 
time (when needed) 
Referring from one physician/clinic to another 
Lack of proper communication/coordination 
between different healthcare levels 
Lack of communication between hospitals 
Lack of communication between PHCCs  
Inappropriate annual referral system to hospitals 
(difficulties) 
No feedback from hospitals for referrals 
Lack of coordination between PHCCs  and patient 
employers regarding attending clinic appointments 
Lack of good reception in ADC 
Lack of reception in AGH outpatient clinics 
Staff attitudes and 
skills 
Untrained healthcare staff 
Careless healthcare staff  
Coming late at morning 
Lack of good communication with patients 
Language barriers/ foreign doctors  
Lack of proper training 
Lack of motivation/ incentives  
He
al
th
 e
du
ca
tio
n 
an
d 
pr
om
ot
io
n 
Health education Health education materials, systems,  programs and 
clinics 
Educating physician on diabetes management 
Diabetes cards 
Explaining test results to patients 
To train patients on how to use the glucometer  
To train patients on how to take insulin 
Diet and nutrition education 
Health promotion and education campaigns outside 
the PHCCs  
Health promotion 
programs 
Effective diet and nutrition programs/ programmes 
for control of dyslipidemia 
Exercise programs 
Reducing weight programs 
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Lifestyle management programs 
He
al
th
  
re
co
rd
s Electronic health 
records 
Lack of electronic health records 
Maintenance 
Lack of good maintenance of health records 
Incomplete/un-updated records 
Pa
tie
nt
 re
la
te
d 
iss
ue
s 
Patient's 
knowledge and 
behaviours 
Lack of or limited health awareness 
Poor compliance for diet, drug, appointment, and 
exercise 
Patients do not like to wait 
Patients refuse to be annually referred to hospitals 
Patients refuse to visit the clinic but ask to collect  
prescription and drugs 
Lack of knowledge 
Passive and dependent patients  
Patients do not trust physicians 
Patients request collecting drugs without 
prescription or diabetes card  
Patients request drugs for a longer period 
Patient is registered in many PHCCs  
Poor patient communications/ behaviour inside 
PHCCs 
Accessibility and 
transport 
To change  PHCC site, the PHCC is difficult to access/ 
far from home 
Unable to visit the PHCC or hospitals 
Mini-clinic for diabetes should be placed in the 
ground floor 
Patients’ employers do not give permission to 
patients to attend their appointment in the PHCC for 
follow up care 
Transport facilities (difficulties) for some patients  
Home care Home care and home visits, providing care to 
bedridden patients, delivery of drugs to homes 
Income Limited or low income 
Ge
ne
ra
l f
ac
ili
tie
s Exercising facilities Sport clubs Health clubs and gym 
Swimming pools 
A place for walking, boardwalks  
Meeting and 
gathering facilities 
A space in the PHCCs  to meet other diabetic 
patients 
Clubs for diabetic patients 
Other facilities Box for patient suggestions  Limited car parks around the PHCCs 
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List 19.2: List of reported responses to the question “What are the most prevalent 
health problems? Which problems have most impact on health at the national level?” 
Theme  Responses 
Non-
communicable 
Diabetes 
Hypertension 
Obesity 
Dyslipidemia 
Cerebrovascular accident (CVA) 
Bronchial asthma 
Ischemic heart disease (IHD), Myocardial infarction (MI) 
Sickle cell anaemia 
Depression 
Psychiatric diseases 
Musculoskeletal problems 
Gastrointestinal tract diseases (GIT diseases) 
Communicable Upper respiratory tract infection (URTI) 
Tuberculosis (TB) 
Bronchitis 
Behaviour and 
education 
Road traffic accidents (RTA) 
Inactivity or sedentary lifestyle 
Incorrect health behaviours 
Health awareness & education 
Smoking 
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List 19.3: List of reported responses to the question “Please specify if there are any 
population groups with diabetes whose health needs are not being currently met? 
Please tell us who they are and why: e.g. an entire ethnic group?”   
Theme Responses Inside Abha city Older people 
School age children 
Expatriates 
Patients with type 1 DM 
>70 y older people 
Disabled people 
Pregnant ladies 
Patients with co-morbidities 
Illiterate females 
Older people who live alone 
Poor people 
Adults (30 -39) careless patients 
Diabetics with tacit organ involvement  Outside Abha city Tahama population 
The people of remote villages 
 
List 19.4: List of reported responses to the question “What are the barriers for high risk 
groups to participate and utilize the available preventive services?”  
Theme Barriers  
Patient 
related  
Low/lack of health awareness/ knowledge  
Incorrect patient believes/ Social culture and believes 
They are afraid to know that they might have the disease 
Eating habits & social gatherings 
Lack of community participation 
Limited time/ busy life 
Failing to change personal behaviours  
Unawareness of the importance of prevention 
Unawareness of diabetes risk factors 
Service 
related 
Inadequate level of healthcare provision/ inappropriate healthcare 
services at PHCCs 
Ineffective screening programme at PHCCs 
Limited health education  
Difficult access to healthcare / Lack of transport particularly for ladies 
Lack of interventions to attract patients to participate/ Weak motivation 
campaigns 
No barriers There is no actual barriers 
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List 19.5: List of reported responses to the question “What are the other primary 
healthcare services you think people with diabetes need to be available in each 
primary health care centre and currently are not available? E.g making appointment 
system, specific lab facilities, specific drugs, specific clinics...” 
Theme Responses 
Laboratory 
resources 
Some Lab services in PHCC ( a lab with all investigations/services) 
ECG machine/ ECG 
X-ray department 
Hba1c tests 
Lab in Johan PHCC 
Lipid profile tests 
RFT/LFT 
Pharmacy 
resources 
Some drugs (all drugs to be available)  
Glucometer for patients/ with it strips & needles  
All Insulin types (Lantus, Mixtard) 
Insulin syringes 
Alcohol swab 
Statins 
Small insulin syringes for children 
Drugs for impotence 
Drugs with long time before expiry 
Manpower and 
clinics 
Diabetologists in PHCC 
Dieticians/ Dietician clinics/ obesity clinics 
Health educators 
Ophthalmologists/ ophthalmology clinic in PHCC 
Specialist doctors (family physicians & other specialties) 
Podiatrists/ Podiatrist clinic 
Dermatologist 
More working staff 
Nephrologists / nephrology clinic  in PHCC 
Geriatrists/ geriatrics clinic 
Trained nurses 
Female doctors 
Lab technicians 
Insufficient trained physicians 
Social workers 
Endocrinologists 
Other 
resources 
 
Special dental clinic for diabetics 
Modern devices 
Fundoscopy 
Diabetes card for patients where they can visit any clinic 
More wide waiting area 
Insulin pump/ clinic for patients with insulin pump 
Room for urgent cases with all necessary resources 
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Psychosocial support 
Governmental PHCC buildings 
Opening more than one diabetes centre in the city 
Laboratory 
system 
Annual investigation to be in PHCCs 
Late laboratory test results 
To do laboratory tests before the clinic appointment by a long time 
Pharmacy 
system 
Quick response from pharmacy, pharmacists should quickly respond 
to patients 
Clinic system Opening diabetes clinic many days per week 
System for organizing the movement of patients inside the PHCC 
and  when to enter the clinic 
Appointment 
system 
Appointment (follow up) system 
Appointment reminder by calling & SMS 
System for defaulter follow up 
Electronic appointment system 
A mobile for PHCCs to contact patients and remind them 
Quick available appointment 
Referral 
system 
Communication system between PHCC & hospitals 
Effective referral system 
Staff attitude Physicians should reassure and support patients 
To clinically examine the patients completely  
To examine patient foot 
Health 
education 
Health education/ educator, materials/ place/ 
screens/programs/lectures 
Health 
promotion 
Weight reduction and diet programmes 
Exercise education programmes 
Health promotion programmes 
Early diagnosis/ screening services 
Risk scoring system for diabetes to identify those at risk 
Health records Good file maintenance 
Electronic health records 
Home care Home care 
A program to deliver drugs to patient’s home 
Accessibility  To make services more easy accessible 
Administration Improved administration system and monitoring 
Meeting 
facilities 
Patient meetings / to gather all diabetics to know each other 
Clubs for diabetics 
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List 19.6: List of reported responses to the questions “What are the current primary 
healthcare services you think needs to be improved or changed? What are your 
suggestions to improve these services?  E.g making appointment system, mini-clinics 
for diabetes, more clinics for dietician or podiatrists...”  
Theme Services need to 
be improved 
Suggested improvements 
Laboratory 
resources 
Laboratory and Lab 
investigations  
All tests to be available, to support the laboratory 
with computer and printer, to provide HbA1c test all 
the time, to provide good lab maintenance, to 
employ more lab technicians, to provide all the 
essential investigations, to support the lab with 
more devices and technicians, to purchase modern 
devices, to process the test more faster 
A laboratory in ADC To provide a laboratory with all investigations 
available in ADC 
HbA1c To be available in the laboratory 
X-ray  Provision of the device and the specialist  
ECG device Provision of the ECG device 
Pharmacy 
resources 
Pharmacy and 
drugs  
All resources to be available, to provide all necessary 
drugs, provision of alcohol swab, insulin syringes, 
insulin pens, new drugs, not nearly to expire drugs, 
to respond quickly to patients, home delivery of 
drugs 
A pharmacy in ADC To establish a separate pharmacy in the ADC 
Statins  To be available 
Limited drug list To add more options 
Glucometer and its 
strips 
provision of more glucometers for patients 
Manpower and 
clinics 
 
Dieticians/ 
dietician clinics 
To increase number of dieticians, to provide 
nutrition programs 
Lab technician To employ more lab technicians 
Podiatrists/ Clinics 
for podiatrist  
To increase number of podiatrists  
 Healthcare staff To employ more staff, to provide more intensive 
training and education, to employ more specialists 
Female dieticians  To employ female dieticians 
Female doctors  To employ specialist female doctors 
Ophthalmologists/  
Ophthalmology 
clinics in AGH 
To open ophthalmology clinic in the PHCCs, to 
employ more ophthalmologists in AGH, to provide 
AGH with eye examination devices 
Physicians To employ more specialist physicians in the PHCCs  
Male nurses To increase the number of male nurses employed 
Diabetologists To employ more diabetologists in PHCCs and ADC 
Physiotherapists To employ physiotherapists for older people 
Psychiatrists To employ psychiatrists in PHCCs 
Nurses To be specialized in diabetes, to respond quickly to 
patients 
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Female dentist To employ more female dentists 
Paediatric 
diabetologist 
To employ more paediatric diabetologists in ADC 
Dentists and dental 
clinic 
To employ more consultants and provide devices 
Mini-clinics for 
diabetes 
To provide the clinic with nuero-examination tools, 
ECG, diabetologist, specialists, to open the diabetes 
clinic one day for male, one day for female and one 
day for children, to open the clinic for 5 days a week, 
to transfer the clinic to be always in the first floor, to 
be wider, to establish a system where first come first 
served, to provide waiting area for diabetics, to 
provide patients with a mobile clinic, to make sure 
that all resources were provided 
Other 
resources 
 
PHCCs  buildings More wide rooms, more facilities for disabled 
patients, all supply and resources to be available, to 
build a governmental building for the PHCC, to build 
a special department for diabetics, to provide a 
waiting area for diabetics in PHCC, to have wide 
room for diabetes clinic, to provide reception 
services for patients 
Insulin pump To give patients insulin pump 
Training Increase staff  training 
Screening test Increase public awareness about screening 
Fundoscopy  To provide PHCC with fundoscopy  
Reception for 
patients in ADC 
To provide more care and good reception, to 
provide good communication with patients  
Health 
education 
 Health education To employ more educators, to open health 
education clinics, provision of leaflets, pamphlets, 
printer, TV, Videos, to assign a room for dieticians 
and educators, To provide more health education 
for the local community 
Referral and 
communication  
system 
Referral system  To provide an electronic referral system, to initiate a 
good system for referral and feedback, to establish a 
good coordination between PHCCs and hospitals, to 
change the annual referral to be every 6 months, to 
do all the annual investigations in the PHCCs 
Health records Health records To change the paper records to be electronic 
records, to improve the forms to be the same for all 
PHCCs 
Appointment 
system 
Appointment 
system 
(establishing system to prevent duplicate 
appointments)(establishing electronic system for 
appointment) (make appointment system) 
(Reminder system)(reminding system by SMS 
mobile)(to open more than 2 days per week) (less 
waiting time) 
Follow-up system To be regular and tracing defaulters  
Defaulter follow-up 
system 
Activation of defaulter follow-up system, Follow 
defaulter and call them 
Broad, non- Improving all PHC Establishing standards and improving quality 
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specific 
suggestions 
services in ADC  
Medical machines 
& devices 
To be all available 
All services need to 
be improved 
All services need to be improved 
New departments 
in the PHCCs 
To open ophthalmology, ENT, Internal medicine 
departments in the PHCCs 
Clinics Open more clinics 
More research To conduct more research 
Home care Home care (to open a department for home care) (to visit 
bedridden, to deliver drugs to home) 
Administrative 
issues 
Administration  The administration should be more efficient and 
effective 
Job (work) 
monitoring 
Effective monitoring system 
Accessibility PHCC site Change PHCC site 
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List 19.7: List of reported responses to the question “What are the obstacles (barriers) 
and facilitators for the referral system?” 
 
Theme Obstacles 
System and 
process 
related 
There is no clear and obvious referral system 
No feedbacks returned/ uncompleted feedbacks 
Incomplete annual investigations (some investigations are not done) 
Lack of cooperation between PHCCs  and AGH/poor coordination with 
hospitals 
Patient overcrowding in hospitals 
Long waiting list for eye examination in AGH/ only one ophthalmologist 
available in AGH or ADC 
Long waiting time to enter the clinic 
Lack of patient education 
No appointment with dieticians 
Long waiting list 
Patient 
related Coming without Appointment Lack of recognizing the importance of annual investigation by patients 
Some patients just take the investigation results and leave without waiting to 
see the physician/ careless patients 
Patients refuse to be referred 
Theme Facilitators 
System 
and 
process 
related 
Electronic referral system 
Involving patients in the referral process by taking back and forth the referral 
and feedback sheets 
Proper cooperation and coordination between PHCCs and hospitals 
Using the fax to send feedback to PHCCs 
Making appointments through the OPD or ADC's administration 
Good auditing system 
Commitment of higher authorities 
Service 
related 
Improving primary healthcare services to cancel the annual referral through 
provision of all the investigations to the PHCC 
Establishing one big central laboratory for all PHCCs 
Establishing diabetes centre for each health sectors 
Establishing a big central laboratory in AGH 
Patient 
related 
Educating patients 
Close hospital and PHCCs to the patients 
Cooperation of patients 
Quicker management processes to save patient’s time 
Staff 
related 
Trained healthcare professionals 
Employing enough staff 
 
 
408 
 
Staff 
related 
Doctors do not change the doses of medications based on the annual 
investigations or write recommendations 
Patients go to AGH but discovered that physician is not available 
temporarily/cause frustration and refuse to be referred in the future.  
Only one physician available in AGH 
Overloaded PHC physicians 
Negative staff attitude 
 
List 19.8: List of reported responses to the question “From your perspective, what are 
the barriers and challenges to service improvements?” 
Theme Barriers of improving healthcare services (responses) 
Organization 
of diabetes 
care 
Lack of financial support 
PHCCs are ignored by higher authorities MOH and managers/ Weak 
commitment of higher authorities/ Higher authorities do not respond to 
the PHCCs requests/  Lack of attention to PHCCs by higher authorities 
Slow system 
 Routine work 
Bad current system/ Lack of efficient system 
Lack of financial incentives 
Lack of cooperation, communication between healthcare levels 
Lack of support 
Lack of protocols for diabetes management in the ADC 
Patient overcrowding 
Lack of system to communicate with the higher authorities 
Inappropriate annual referral system/ waiting list, lack of feedback, 
referral to hospitals 
Weak governmental  inter-sectoral coordination 
Lack of rules and systems for diabetes care 
No leadership 
Lack of system for defaulter’s follow up  
Lack of computer system 
The mass media ignores the problem of diabetes 
Inactive DM screening program 
Too frequent changing of the physicians in PHCCs 
Referral to hospital (Annual referral to be in the PHCCs) 
Lack of cooperation between governmental sectors 
To be managed in different sites (PHCCs, AGH, ACH...) 
Annual referral to be to diabetes centre instead of AGH 
Lack of specialized clinics 
Lack of good appointment system 
Lack of Special department for diabetes care  
Lack of meeting what patients need 
Administration 
and system 
Underdeveloped and old managers in charge who are unwilling to 
improve or change the current system 
 
 
409 
 
barriers Careless administrators and managers/ administrative problems/  Lack of 
primary health care administration and communication system/ Poor 
management 
Bureaucracy 
The administration system is corrupted/  Administrative barriers 
(corruption) 
Lack of good maintenance of medical devices 
Lack of enough permissions for healthcare managers to improve and 
purchase 
Lack of monitoring & penalizing 
Working only one shift (it should be 2 shifts day & night) 
Staff 
availability 
Insufficient staff/ Shortage of trained healthcare staff (specialists)/  
Difficulties of employing more staff 
Lack of diabetologists (clinics) 
Lack of dieticians 
Lack of female doctors 
Staff training 
and 
performance 
Patient's awareness /  Low patient's health awareness 
Lack of training & specialization 
Low staff awareness of what patients need 
Doctor's attitude, commitment  
No team work 
Lack of good communication with patients 
Careless officials 
Lack of working according to the system 
Lack of trained nurses 
Lack of patient motivation & incentives/ attention to the patients 
Lack of cooperation between PHCC staff 
Patient 
attitudes and 
behaviours 
Poor patient compliance 
Eating habits 
Patient 
knowledge and 
awareness 
Incorrect patient's believes 
Illiteracy 
Unavailable 
services 
Lack of diabetes centres 
Lack of good health education/ lectures, campaigns 
Lack of appointment system & reminder 
Lack of some medical devices 
Lack of psychosocial support for DM patients 
Lack of home care 
Nutrition programs for patients 
Lack of a lab in ADC 
Lack of research centre for diabetes 
Inadequate 
services 
inadequate lab investigations and devices/ resources/  Insufficient lab 
services (lab support) 
Limited resources in PHCCs /  Shortage of supportive services/  Lack of 
enough resources 
Lack of governmental building/ good building 
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Incomplete pharmacy resources/ lack of some drugs 
Low quality & cheap drugs 
Old rented PHCC buildings 
Lack of a place for walking 
Old medical devices 
 
List 19.9: List of reported responses to the question “Is there a continuous auditing 
system for the healthcare services you provide? If yes: How are the services you and 
your colleagues provide audited? If no, do you think the health services should be 
audited?”     
Theme How are the services audited? 
By  regular 
discussion 
Meeting every Saturday and Tuesday to discuss any problem in the ADC 
By reviewing 
statistical 
reports 
 
By reviewing monthly and annually statistical reports 
Through studying  the annual statistical reports of AGH and take decision 
based on that 
By using the annual report and then put an annual plan for the PHCCs 
Every 3 months using a personal efforts by reviewing  the statistical reports 
By using the monthly and annual reports and feedbacks from different  
healthcare levels 
By reviewing the annual reports 
By higher 
authorities  By coordination with the higher health sectors through reviewing the statistics 
It is the responsibility of healthcare sectors 
By regular supervision of higher authorities 
By sending all annual and monthly reports to MOH and it is the 
responsibility of higher authorities 
By other 
methods 
There is no guideline for how to audit PHCC's healthcare services, so 
solutions are just personal efforts of inexperienced staff 
By using standard checklist 
Routine feedback from PHCCs 
Assessment the readings of FBG and changing the management plan 
according to these readings 
By a questionnaire to be filled by patients 
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Appendix 20: Priority questionnaire for healthcare leaders 
Priority questionnaire for healthcare leaders 
Could you please read carefully the following summary of the findings of a research which was conducted in Abha city and the 
recommendations suggested. Then please rate the priority of implementing each recommendation on a scale of 0 to 100%, where 100% being 
the highest priority.  
Where we are (findings) Where we need to be Priority  rate Why? 
National policies and strategies of diabetes care  
• National health system, Office of the 
Presidency Council of Ministers, 1432 
• Health care strategy in the Kingdom of Saudi 
Arabia, Office of the Presidency Council of 
Ministers 1430 
• The detailed implementation plan for the 
Health care strategy in the Kingdom of 
Saudi Arabia, Office of the Presidency 
Council of Ministers 1432 
• National system of healthcare professional 
practice, Office of the Presidency Council of 
Ministers 1426 
• MOH strategic plan for 1431-1440, MOH, 
1431 
1. Need to audit diabetes services at 
the national and regional level. 
  
 
2. Need to conduct national survey 
for diabetes, last one was in 1995 
 
 
 
3. Ensuring the active involvement of 
patients in service development. 
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• Quality assurance in PHC manual (standards 
& indicators, MOH, 1994) 
4. Need to updated the quality 
assurance in PHC manual which 
should  include a national strategy 
for diabetes control, standards for 
clinical care and service delivery for 
both urban and rural areas.  
 
5. National quality assurance manual 
for diabetes care at hospital & 
diabetes centres is needed. 
 
 
• Mini-clinic program for chronic diseases at 
PHC, MOH  
6. Mini-clinic program for chronic 
diseases at PHC need to be audited 
& evaluated to measure its 
implementation, effectiveness  
 
 
• The Gulf Executive Plan for Diabetes Control 
(2008-2018), GCC council of health ministers  
7. The Gulf Executive Plan for 
Diabetes Control (2008-2018) 
needs to be implemented, 
monitored & evaluated.  
 
• MOH Diabetes centres (tertiary centres) 8. MOH Diabetes centre services need 
to be audited & evaluated. 
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Clinical practice guidelines  
• National clinical guideline for care of diabetic 
patients at primary health care, 2011 
9. Ensure implementation of this 
guideline & consider its 
recommendations in any future 
planning.  
 
Health care service computerization  
• There is no national obesity management 
guideline 
• There is no physical activity guideline 
10. Need to develop or adapt obesity 
& physical activity guidelines 
 
 
• There is no computer systems at PHCCs 
• There is no electronic health records at 
PHCCs or hospitals 
• There is no electronic database for diabetes 
at regional level 
• There is diabetes register book at PHCCs as 
part of mini-clinic program and specific 
form for the national diabetes register at 
diabetes centre but there is no electronic 
registry system 
• There is national diabetes registry which 
started in 2001 & by 2011 only 26 hospitals 
from Riyadh region were included as a 
source of data and still in phase I. 
• Failed attempt to computerize PHCCs. 
 
11. Need to computerize all the health 
care system 
 
 
12. Need to complete the database of 
Saudi National Diabetes Registry to 
include all country regions & 
involve PHCCs as sources of data in 
addition to hospitals and diabetes 
centres. 
 
 
13. Need to computerize health 
records and systems to facilitate 
data availability for auditing, 
monitoring improvements & 
performance...etc 
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Occurrence of diabetes  
• The national prevalence of diabetes in 
adults is one of the top ten highest in the 
world (13.6-25%) 
• The prevalence of diabetes in Saudi Arabia 
has risen over the last 2 decades & is 
predicted to continue to rise in the next 
twenty years. 
• The number of people with diabetes in 
Abha city has risen each year over the last 3 
years & every month during the last year 
• The local (Abha city) registered prevalence 
(3.75%) of clinically diagnosed diabetes is 
much lower than the national prevalence 
(14.1%) 
• Almost three quarters (73.4%) of people 
with diabetes in Abha city have not been 
diagnosed 
• There is local variation in prevalence of 
undiagnosed diabetes between PHCCs in 
Abha city. 
• Lack of robust data on diabetes at the 
national, regional & local levels 
• Lack of local data on incidence of diabetes 
14. Effective public health 
interventions are needed to 
reduce the burden of diabetes.  
 
15. High quality of diabetes care is 
needed to reduce the burden of 
diabetes complications.  
 
16. The gap between estimated 
prevalence & actual (registered) 
prevalence of diabetes need to be 
closed.  
 
17. Need to investigate why this gap 
exists & how to close it? 
 
 
18. Need to target catchment area of 
some PHCCs such as Almansak & 
Almowadafeen with high 
percentage of undiagnosed 
diabetes.  
 
19. Activating & enhancing the mini-
clinic screening program is needed 
to identify undiagnosed diabetes. 
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in different age, sex, type of diabetes 
groups. 
20. Enhancing & supporting the new 
health promotion initiative & 
merging the mini-clinic screening 
program within its activity should 
be considered.  
 
21. Robust data on diabetes need to 
be available at the national, 
regional & local levels 
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Demographic issues  
• There is currently lack of local (Abha city) 
data on the breakdown of the local 
population in terms of: 
o 5-years age groups 
o Ethnicity 
o Nationality 
o Literacy 
o Deprivation 
• The total national population number is 
predicted to continue to rise with 16% 
increase between 2010-2020 
• 85% of Abha’s population is young <45 
years which is similar to the whole Saudi 
population 
• At the national level, it is projected that the 
proportion of population who are over 45 
years old will rise from 15% in 2011 to 19% 
in 2020 and to 37.5% in 2050 
• % of illiterate in females is more than 
double of males at the national & regional 
level 
• 38.5% of diabetic patients in Abha city are 
illiterate 
22. Improving & increasing the 
available healthcare services are 
needed & should consider the 
predicted rise in the total 
population number and diabetic 
number particularly if there were 
no interventions to reduce the 
prevalence of diabetes.  
 
 
23. The predicted changes in the 
demographic characteristics such 
as increase the proportion of 
middle aged and older people 
should also be considered.  
 
 
24. Need to consider that a high 
proportion of diabetics are 
illiterate during planning for any 
interventions in Abha city. 
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Diabetes risk factors 
Obesity 
• Obesity prevalence is the third highest rate 
in the world and is increasing with time at 
the national level. 
• Obesity prevalence at regional level (Aseer 
region, 29.9%) is lower than the national 
prevalence, 35.5% among adults aged 30-70 
years. 
•  Obesity estimated prevalence at the 
national level in children Aged 5-18 years is 
9.3%. 
• Obesity prevalence among diabetics in: 
o  Abha city is 44.8% 
o Aseer region is 23.7% 
o National level is 30% 
• There is lack of data on obesity or 
overweight among Abha population. 
 
25. Effective national & local action to 
tackle obesity is urgently needed. 
 
 
26. Local data on obesity prevalence 
should be collected and published 
for research and auditing 
purposes.    
 
27. There is a need to promote 
physical activity & diet control 
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Pre-diabetes  
• Pre-diabetes prevalence at: 
a. National level is  11.8% among 20-
79 years old 
b. Regional level is  13.5% among 30-
70 years old 
c. Local level (Abha city), lack of data 
• People with pre-diabetes are up to 15 times 
more likely to develop type 2 diabetes 
• Intensive lifestyle interventions and/or 
therapeutic interventions can delay or 
prevent onset of type 2 diabetes 
28. Local data on pre-diabetes 
prevalence need to be collected 
and be available for researchers. 
 
 
Gestational diabetes 
• Lack of data on gestational diabetes at the 
national, regional or local level 
 
 
29. Data on gestational diabetes need 
to be collected and be available for 
researchers.  
 
30. There is a need to monitor the 
incidence of gestational diabetes 
 
 
31. There is a need for a local audit of 
care for gestational diabetes at the 
level of antenatal care at PHCCs 
and at maternity hospital (AGH) 
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Population health status 
• There is national data on :  
o Mortality status 
o Morbidity status 
o Fertility status 
o Employment status 
• There is comparative national and 
regional data on: 
o Education status 
o Housing condition 
o Water & electricity resources 
• However, there is lack of local (Abha city) 
data on all of the above items  
32. Central department of statistics 
& information should publish the 
census data for each city and this 
data should be available for 
researchers.    
 
 
• 15,399 deaths are estimated to be 
attributable to diabetes among adults 
(20-79 years) at the national level 
• There is no local data on causes of deaths 
• There is lack of local data on number of 
deaths attributable to diabetes 
 
33. Certificate of death need to be 
improved to include in details 
the causes of death 
 
 
34. Adequate computer system at 
hospitals is needed to collect 
reliable data on diabetes 
emergency visits, admissions, 
length of hospital stay.  
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Healthcare utilization 
Diabetes related follow-up visits at primary healthcare 
• Number of diabetes related follow-up 
visits are recorded at all primary 
healthcare centres in Abha city except 
Almansak PHCC. 
35. Almansak PHCC must record routinely 
the number of diabetes related follow-
up visits.  
 
 
• The mean proportion of diabetes visits 
to PHCCs each month (No. of diabetes 
visits/total No. of registered diabetics) is 
33% and ranges from 20.8% at AlKaabel 
PHCC to 54.8% at Therah PHCC. 
 
36. The following PHCCs should increase 
the mean proportion of diabetes visits 
each month: 
a. Wasat Abha (24%) 
b. Sultan city (21.6%) 
c. Johaan (27%) 
d. AlKaabel (21%) 
 
 
• From reviewing mini-clinic case notes, 
1954 [44%] have not visited their PHCCs 
for the last 6 months which would 
indicate that some patients are using 
their general file not mini-clinic file to 
visit the doctor and collect diabetes 
drugs  
 
37. General PHCC clinics should not accept 
visits of diabetic patients outside the 
appointments of diabetes mini-clinic 
unless it is necessary and the 
prescription of anti-diabetes drugs 
should be only prescribed for a short 
period till the nearest appointment 
with the mini-clinic.  
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• The total number of diabetes visits last 
year to  
o PHCCs is 18463 visits 
o AGH is 2819 visits 
o ACH is 1609 visits 
o ADC is 6852 visits 
38. The largest number of diabetes visits is 
to PHCCs which reflect that there is a 
need to increase the resources of 
PHCCs. 
 
 
 
• Each patient should visit the PHCC at least one time every 3 months, so the mean proportion of diabetes visits each month should not be less than 33% 
• Is there a significant variation among the mean proportion of diabetes visits to each PHCC each month? 
Diabetes related visits to ACH 
• There is no data on classification of visits 
by type of diabetes and occurrence of  
complications 
39. Need for further regional and local data 
on diabetes visits by type of diabetes 
and occurrence of complications 
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Diabetes related visits to ADC 
• 75.5% of diabetic visitors are of type 2 
diabetes and 90% are without any 
complications. This would indicate that 
the majority of patients does not need 
to be managed at ADC  
 
• The quality assurance manual stated 
that those patients with type 2 diabetes 
who do not have any complication 
should be managed at their PHCCs. Only 
those with complication should be 
managed at hospitals. 
40. There is a need to revise the process of 
registering and following patients at 
ADC. 
 
 
Expenditure on diabetes services 
• There is no robust data on cost of 
diabetes at the national & local level 
• The percentage of the national health 
expenditure on diabetes in 2010 is 21% 
(the second highest proportion in the 
world [IDF]) 
41. Robust data & studies are needed to 
estimate the total cost of diabetes at 
the national & local level 
 
 
Referral & feedback system 
• % of diabetics annual referral to Abha 
general hospital was 44% 
• % of hospital feedback for those who 
were referred was 71% 
42. Need to increase the referral rate and 
hospital feedback to 100% 
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Attendance at primary care 
• % of patients attended for 2 or more 
follow-up visits during the last 6 months 
of 2011/1432 was 38% 
• % of patients who have not attended for 
follow-up visits during the last 6 months 
of 2011/1432 was 44% 
 
43. Patient's appointment compliance 
needs to be improved.   
 
 
Drug prescriptions 
• % of diabetic patients in each PHCCs  
receiving specific drugs varies 
significantly: 
o ACE (0%-42.7%)  
o Aspirin (9%-72%) 
o Statins (0%-28%) 
 
 
44. Inequity in prescribing must be 
addressed by the Regional Health 
Affairs.  
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Current diabetes service provision 
• 10 PHCCs & its Mini-clinics were evaluated 
and several needs were identified:  
o Only 6 family medicine physicians are 
available 
o 10 lab technicians are available  
o There are only 3 x-ray technicians 
o There are limited lab services 
(investigations) in PHCCs 
o There is no lab at Johan PHCC 
o There is no podiatrists, dieticians or health 
educators 
o There is no home care or community 
health care services  
• ADC was evaluated and several needs 
were identified: 
o Only 1 paediatric endocrinologists 
available 
o There is no podiatrist or podiatry services 
at ADC 
o There is no health educators or social 
workers at ADC 
• There is no tertiary care hospital in Abha 
city especially for eye care 
45. More Family medicine specialists are 
needed 
 
 
46. More lab technicians are needed 
especially for Johan and Almansak PHCCs 
(with equal distribution)  
 
47. More lab investigations were requested 
by patients, healthcare professionals 
 
 
48. More X-ray technicians are needed 
 
 
49. There is a need for a lab at Johan PHCC 
 
 
50. There is a need to employ podiatrists, 
dieticians &health educators in each 
PHCC  
 
51. There is a need for home care or 
community health care services 
 
 
52. There is a need for more diabetologists 
and endocrinologists at ADC 
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53. There is a need to employ podiatrists, 
dieticians & health educators in ADC 
 
 
54. There is a need for tertiary care hospital 
in Abha city especially for eye care 
 
 
55. Patients, Healthcare professionals 
perceived they need more drugs to be 
available  
 
56. Patients, Healthcare professionals 
perceived they need more working staff  
 
 
57. Patients, Healthcare professionals, & 
managers perceived that diabetics need 
glucometer to be offered for free 
 
 
58. Children diabetes services at ADC need to 
be evaluated & monitored to ensure that 
key processes of diabetes care are 
provided.  
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Mini clinic resource evaluation    
• Mini-clinic resources are not complete for 
any PHCC 
59. Mini-clinic resources need to be available 
all the time particularly for Alaziziah, 
Therah, Wasat Abha and Johan PHCCs 
 
 
Health Education  
• PHCC,s Health education program was 
evaluated and it was partially 
implemented, From reviewing the best 
most completed education checklist 
sheet of 4458 case notes, only 18.2% 
were completed, 74.4% were partly 
completed & 6% of the case note were 
not including education checklist sheet. 
60. Health education program need to be 
implemented efficiently and effectively.  
 
 
 
Preventive services 
• PHC screening for diabetes & health promotion 
programs are available based on MOH & ADA 
guidelines  
• Diabetes complications were unrecognised 
because of lack of examining patients to detect 
these complications: 
a. Hypertension : 22% of diabetics  
b. Ischemic heart disease: 3%  
c. Cerebrovascular disease : 1.4% 
d. Peripheral arterial disease : 0.4% 
61. These screening programs need to 
be enhanced & implemented 
effectively and evaluated for its 
effectiveness.  
 
62. Annual examination needs to be 
implemented effectively & 
completely.  
 
63. Retinopathy screening program 
for all diabetics is needed 
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e. Retinopathy       (Eye diseases) : 10.5% 
f. Nephropathy     (Kidney diseases) : 1.8% 
g. Neuropathy        (Nerve damage) : 0.7% 
h. Foot problems   (amputations)  : 1% 
• Annual examinations from the most recent 
hospital feedbacks: 
a. BP examination: 51% of diabetics 
b. Cardiovascular : 42% 
c. ECG: 74% 
d. Chest x ray: 3% 
e. Eye examination: 52% 
f. Creatinine: 75% 
g. Neuro-examination: 37% 
h. Foot examination: 6% 
i. 24 hours urine proteins: 2.5% 
64. Foot screening for those diabetics 
at high risk is needed 
 
 
Blood glucose control 
• % of patients with diabetes who have at least three 
record of FBG in the previous 12 months at PHCC is 
31.4% 
• Mean FBS in the previous 12 months is 179.23 
mg/dl 
• % of patients with diabetes in whom the mean FBG 
is 130 mg/dl or less in the previous 12 months was 
23% 
• % of patients with diabetes in whom the mean FBG 
is more than 130 mg/dl  in the previous 12 months 
was 77% 
65. Effective interventions to improve 
monitoring of blood glucose and its 
control is needed 
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HbA1c control 
• % of patients with diabetes who have a record of 
HbA1C so far was 3.61% with mean HbA1C of 
11.41% 
• % of patients with diabetes in whom the last HbA1C 
is more than 7.5% was 82.6% 
66. There is a need for provision of 
HbA1C machine at all PHCCs and 
ADC  
 
67. There is a need for HbA1C machine 
to be available at all the time  
 
 
Blood pressure control 
• % of patients with diabetes who have at least 
three record of BP in the previous 12 months was 
38% 
68. Need to increase number of 
diabetics with more than 3 records 
of BP in the previous 12 months 
 
 
Control of blood lipid 
• % of patients with diabetes who have a record of 
cholesterol by reviewing the most recent hospital feedback 
at any time was 77% with a mean value of 195.3 mg/dl 
• % of patients with diabetes in whom the most recent 
cholesterol is more than 156 mg/dl (4 mmol/l) was 81.26% 
• % of patients with diabetes in whom the most recent 
cholesterol is more than 195 mg/dl (5 mmol/l) was 47.29% 
69. Need to reduce the high 
number of diabetic patients 
with cholesterol more than 
156 mg/dl (4 mmol/l)   
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Appendix 21: The mean priority score for each recommendation categorized by 
themes. 
Theme Recommendations Mean 
priority 
score 
Pr
ev
en
ti
on
 
Effective public health interventions are needed to reduce the 
burden of diabetes. 
95.94 
Activating and enhancing the mini-clinic screening program is 
needed to identify undiagnosed diabetes. 
97.81 
Enhancing and supporting the new health promotion initiative and 
merging the mini-clinic screening program within its activity should 
be considered. 
92.81 
Effective national and local action to tackle obesity is urgently 
needed. 
94.69 
There is a need to promote physical activity and diet control. 97.19 
Health education program need to be implemented efficiently and 
effectively.  
94.69 
These screening programs need to be enhanced and implemented 
effectively and evaluated for its effectiveness. 
94.69 
 Annual examination needs to be implemented effectively and 
completely. 
96.56 
Retinopathy screening program for all diabetics is needed. 94.69 
Foot screening for those diabetics at high risk is needed. 95.31 
Effective interventions to improve monitoring of blood glucose and 
its control is needed. 
95.94 
Need to increase number of diabetics with more than 3 records of 
BP in the previous 12 months. 
90.94 
Need to reduce the high number of diabetic patients with 
cholesterol more than 156 mg/dl (4 mmol/l). 
91.56 
Po
lic
ie
s 
an
d 
st
ra
te
gi
es
 fo
r 
di
ab
et
es
 
ca
re
 
Need to conduct national survey for diabetes, last one was in 1995. 90.63 
Ensuring the active involvement of patients in service 
development. 
88.13 
Need to updated the quality assurance in PHC manual which 
should  include a national strategy for diabetes control, standards 
for clinical care and service delivery for both urban & rural areas. 
91.88 
National quality assurance manual for diabetes care at hospital and 
diabetes centres is needed. 
96.88 
The Gulf Executive Plan for Diabetes Control (2008-2018) needs to 
be implemented, monitored and evaluated. 
80.63 
Ensure implementation of this guideline and consider its 
recommendations in any future planning. 
91.88 
Need to develop or adapt obesity and physical activity guidelines. 90.94 
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High quality of diabetes care is needed to reduce the burden of 
diabetes complications. 
95.94 
The gap between estimated prevalence and actual (registered) 
prevalence of diabetes need to be closed. 
94.69 
Need to investigate why this gap exists and how to close it? 84.06 
Need to target catchment areas of some PHCCs such as Almansak 
and Almowadafeen with high percentage of undiagnosed diabetes. 
83.44 
The following PHCCs (wasat Abha, Sultan city, Johan, and AlKaabel) 
should increase the mean proportion of diabetes visits each 
month. 
88.44 
General PHCC clinics should not accept visits of diabetic patients 
outside the appointments of diabetes mini-clinic unless it is 
necessary and the prescription of anti-diabetes drugs should be 
only prescribed for a short period till the nearest appointment with 
the mini-clinic.  
91.25 
There is a need to revise the process of registering and following 
patients at ADC. 
89.69 
Need to increase the referral rate and hospital feedback to 100%. 77.81 
Patient's appointment compliance needs to be improved.   90.94 
Av
ai
la
bi
lit
y 
of
 d
at
a 
Need to complete the database of Saudi National Diabetes Registry 
to include all country regions and involve PHCCs as sources of data 
in addition to hospitals and diabetes centres. 
90.94 
Robust data on diabetes need to be available at the national, 
regional and local levels. 
90.31 
Local data on obesity prevalence should be collected and published 
for research and auditing purposes.   
90.94 
Local data on pre-diabetes prevalence need to be collected and be 
available for researchers. 
87.81 
Data on gestational diabetes need to be collected and be available 
for researchers. 
85.31 
Central department of statistics and information should publish 
the census data for each city and this data should be available for 
researchers. 
87.19 
Certificate of death need to be improved to include in details the 
causes of death. 
85.31 
Almansak PHCC must record routinely the number of diabetes 
related follow-up visits.  
94.06 
Need for further regional and local data on diabetes visits by type 
of diabetes and occurrence of complications. 
87.19 
Robust data and studies are needed to estimate the total cost of 
diabetes at the national and local level. 
86.56 
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e 
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n 
Improving and increasing the available healthcare services are 
needed and should consider the predicted rise in the total 
population number and diabetic number particularly if there were 
no interventions to reduce the prevalence of diabetes.  
89.06 
The predicted changes in the demographic characteristics such as 
increase the proportion of middle aged and older people should 
also be considered.  
85.94 
Need to consider that a high proportion of diabetics are illiterate 
during planning for any interventions in Abha city.   
79.69 
The largest number of diabetes visits is to PHCCs which reflect that 
there is a need to increase the resources of PHCCs 
91.25 
Inequity in prescribing must be addressed by the Regional Health 
Affairs.  
84.69 
More Family medicine specialists are needed. 86.88 
More lab technicians are needed especially for Johan and 
Almansak PHCCs (with equal distribution). 
90.31 
More lab investigations were requested by patients, healthcare 
professionals. 
92.5 
More X-ray technicians are needed. 62.81 
There is a need for a lab at Johan PHCC. 82.19 
There is a need to employ podiatrists, dieticians and health 
educators in each PHCC. 
89.38 
There is a need for home care or community health care services. 82.19 
There is a need for more diabetologists and endocrinologists at 
ADC. 
84.06 
There is a need to employ podiatrists, dieticians and health 
educators in ADC. 
90.94 
There is a need for tertiary care hospital in Abha city especially for 
eye care. 
94.06 
Patients, healthcare professionals perceived they need more drugs 
to be available. 
89.69 
Patients, healthcare professionals perceived they need more 
working staff . 
87.81 
Patients, healthcare professionals, and managers perceived that 
diabetics need glucometer to be offered for free. 
85.94 
Mini-clinic resources need to be available all the time particularly 
for Alaziziah, Therah, Wasat Abha and Johan PHCCs. 
91.56 
There is a need for provision of HbA1C machine at all PHCCs and 
ADC. 
93.44 
There is a need for HbA1C machine to be available at all the time. 90.31 
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Se
rv
ic
e 
au
di
t a
nd
 e
va
lu
at
io
n Need to audit diabetes services at the national and regional level. 93.75 
Mini-clinic program for chronic diseases at PHC need to be audited 
and evaluated to measure its implementation, effectiveness. 
93.13 
MOH Diabetes centre services need to be audited and evaluated. 93.75 
There is a need to monitor the incidence of gestational diabetes. 90.31 
There is a need for a local audit of care for gestational diabetes at 
the level of antenatal care at PHCCs and at maternity hospital 
(AGH). 
90.94 
Children diabetes services at ADC need to be evaluated and 
monitored to ensure that key processes of diabetes care are 
provided. 
92.19 
H
ea
lt
hc
ar
e 
se
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e 
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pu
te
ri
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ti
on
 Need to computerize all the health care system. 86.56 
Need to computerize health records and systems to facilitate data 
availability for auditing, monitoring improvements and 
performance...etc. 
 
88.44 
Adequate computer system at hospitals is needed to collect 
reliable data on diabetes emergency visits, admissions, length of 
hospital stay. 
85.94 
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 وﺻﻠﻰ ﷲ وﺳﻠم ﻋﻠﻰ ﺳﯾدﻧﺎ ﷴ وﻋﻠﻰ آﻟﮫ وﺻﺣﺑﮫ وﺳﻠم ﺗﺳﻠﯾﻣﺎ ًﻛﺛﯾرا
 
 
